Final Program

Transcription

Final Program

Meeting Information and Daily Schedule
• Final Program
Talking to a fertility
doctor could be
the start of
something small.
Merck is committed to helping fertility patients. One small part of that dedication is
the Start of Something Small Educational Campaign designed to encourage women
to seek advice from a fertility specialist. We also have online tools,
a fertility clinic locator, and many other resources for OB/GYN offices.
Copyright © 2012 MSD Oss B.V., a subsidiary of Merck & Co., Inc. All rights reserved. WOMN-1048124-0000 08/12
Merck
Helping you help
families grow
Copyright © 2012 MSD Oss B.V., a subsidiary of Merck & Co., Inc. All rights reserved. WOMN-1048125-0000 08/12
V
A
S
E DATES & JOIN
H
T
E
US
!
A joint meeting of the
European Society of Human
Reproduction and Embryology
and the American Society for Reproductive Medicine
THE BEST OF ESHRE & ASRM
March 7-9, 2013
Atlantis, Paradise Island, Bahamas
Registration and program details available
in July 2012 at www.asrm.org
Welcome to
San Diego
California’s second largest city and the United States’ eighth
largest, San Diego boasts a citywide population of nearly 1.3
million residents and more than 3 million residents countywide. San
Diego County encompasses numerous charming neighborhoods
and communities, including downtown’s historic Gaslamp Quarter,
Little Italy, Coronado, La Jolla, Del Mar, Carlsbad, Escondido, La
Mesa, Hillcrest, Barrio Logan and Chula Vista, just to name a few.
San Diego is renowned for its idyllic climate, pristine beaches and a dazzling
array of world-class family attractions. Popular attractions include the worldfamous San Diego Zoo and San Diego Zoo Safari Park, SeaWorld San Diego
and LEGOLAND California. San Diego offers an expansive variety of things to
see and do, appealing to guests of all ages from around the world.
San Diego’s arts and culture and culinary arts are booming. The hottest, new
culinary arts talents prepare award-winning meals throughout the region’s
6,400 eating establishments. Balboa Park, the largest urban cultural park in
the U.S., is home to 15 museums, numerous art galleries, beautiful gardens, the
Tony Award-winning The Globe Theatres and the world-famous San Diego Zoo.
San Diego County also features 92 golf courses and a variety of exciting
participatory and spectator sports, beachfront resorts and luxury spas, gaming,
a dynamic downtown district, annual special events and unique holiday
offerings, multicultural festivals and celebrations, colorful neighborhoods and
communities, a rich military history and much more.
The most difficult decision to make regarding a visit to San Diego is
determining what to do and see among the region’s vast and diverse offerings.
San Diego County promises a truly remarkable experience for everyone.
CONVENTION &
VISITORS BUREAU
REI Fellow Reunions
New to the ASRM Annual MeeƟng! Find your REI fellowship class on the schedule,
and join your friends and colleagues on the Exhibit Floor for an informal meet-up.
No sign-up required!
Fellow Class
Meet-Up Time
Meet-Up LocaƟon
2011/2012
Tuesday aŌernoon break
ASRM Booth #345 (right side)
2009/2010
Tuesday morning break
2006/2007/2008
Monday aŌernoon break
2000-2005
Tuesday aŌernoon break
ASRM Booth #345 (leŌ side)
1990-1999
Tuesday morning break
1980-1989
Monday aŌernoon break
Prior to 1980
Wednesday morning break
Look for signage at the ASRM Booth to direct you to the correct locaƟon.
3rd Annual Run for Reproductive Health
San Diego Convention Center
Monday, October 22, 2012 @ 6:30 a.m.
$50 Per Person
Register on site at the Run for Reproductive
Health booth in Lobby A on October 20th or
21st between the hours of 9 a.m. and 5 p.m.
Supported by:
EMD Serono
• Invite others to participate!
• Ask about additional
st
e
fundraising opportunities!
rg d,
• Dress in costume!
La ise
e a
th y R e!
to ne um
n
Proceeds benefit ASRM’s Write the Next Chapter
o t
ve t M os
i
which sustains education, research and advocacy
g s tC
s
programs for the future.
d Mo es
r
B
a ,
Aw eam and
T
Write the Next Chapter!
Run_Ad_Half_Page.indd 1
9/7/2012 9:52:18 AM
Write the Next Chapter
Sustaining education, research, and advocacy programs for the future
The American Society for Reproductive Medicine has had a long and distinguished history, contributing
to reproductive medicine for more than 68 years. Please join us in ensuring our continued excellence in
education, research and advocacy by supporting the ASRM Fund Development Program.
Ways to be a Champion
Donate to support these programs:
Education
Advocacy
•
•
•
•
•
•
• J. Benjamin Younger Office of Public Affairs
• Reproduction and Public Policy Fellowship
in the J. Benjamin Younger Office of Public
Affairs
SMRU Traveling Scholar
Contraception Lecturer
Menopause Lecturer
Resident Reporter Program
ASRM Fellows Retreat
Resident Education eLearn™ Program
Research
• ASRM Distinguished Researcher Award
• Trainee Travel Fund
• CREST Program
Other Programs
•
•
•
•
•
Memorial and Special Occasion Giving
Planned Giving
Bequests
Charitable Remainder Trusts
Life Insurance
For more information about these programs, please contact Pam Nagel,
ASRM Director of Society Advancement, at 205-978-5000, ext. 121 or [email protected].
JOINT MEETING WITH IFFS/ASRM • OCT. 12-17, 2012 • BOSTON, MA.
ASRM MEMBER GUIDE - 7
2012 ASRM Product Theater
Monday, October 22nd, 2012
10:30 am – 11:10 am
“Debating the Role of IM vs. Vaginal Progesterone in ART: IVF and Replacement Cycles”
Presenters: Robert Boostanfar, MD
Kevin J.Doody, MD,
James Grifo, MD, Ph.D.
Kaylen Silverberg, MD
Supported by Watson Pharmaceuticals, Inc.
___________________________________________
1:00 pm – 1:40 pm
“Helping Ourselves and Other's Through a Health Crisis: Information, Inspiration and Hope”
Presenter: Mark Lerner, MD
Supported by Walgreen’s Specialty Pharmacy
___________________________________________
Tuesday, October 23rd, 2012
2:00 pm – 2:40 pm
“Taking IVF to the Next Level”
Description: EmbryoScope® Time-lapse System – First Clinical Experiences in the United States
Supported by Unisense FertiliTech A/S
The American Society for Reproductive Medicine’s official photographer,
Robb D. Cohen Photography & Design, LLC, will be taking photographs throughout
the meeting. These photos are the property of ASRM and may be used in future ASRM
promotional materials at ASRM’s discretion.
WELCOME
I would like to personally welcome you to San Diego and the
68th Annual Meeting of the American Society for Reproductive
Medicine.
This year’s meeting theme, “Setting the Course in
Reproductive Medicine,” reflects the focus of the meeting with
state-of-the-art plenary and symposium presentations on areas
of broad interest such as assisted reproductive technologies,
contraception, obesity, environmental toxins, surgical
challenges, fertility preservation, stem cells, reproductive
genetics, urology, psychosocial aspects, and the newest
research advances in our field. Indeed, Dr. Bob Oates, together
with the Scientific Program Committee, has developed a superb
program that addresses the clinical and research challenges of all aspects of reproductive
medicine.
INSIDE
WELCOME TO SAN DIEGO . . . . . . . . . 5
NETWORKING MIXER . . . . . . . . . . . . . . . .6
REI FELLOW REUNIONS . . . . . . . . . . . . . . .6
OPENING CEREMONY
& PARTY AT P E T C O PA R K . . . . . . . . 7
ASRM 5K RUN INFORMATION . . . . . . . 7
WRITE THE NEXT CHAPTER
CONTRIBUTION OPPORTUNITIES . . . . . 8
PRODUCT THEATER . . . . . . . . . . . . . . . . . 9
Dr. Kirk Lo and the Postgraduate Program Committee have worked closely with the
affiliated societies, professional groups, and special interest groups to develop postgraduate PRESIDENT’S WELCOME . . . . . . . . . . 11
courses that meet the needs of our clinicians, scientists, laboratory technologists, nurses and
SPOUSE/GUEST PROGRAM . . . . . . . 12
other healthcare professionals.
The meeting includes the popular roundtables, videos and interactive sessions, as well
as sessions focused on menopause and contraception. Our new Surgery Day will focus
on robotic surgery mini-labs and surgical instrument demonstrations, as well as lectures
and tutorials. The special interest groups, professional groups, and affiliated societies will
highlight the advances in their fields and provide opportunities for in-depth participation
and communication. The most recent advances in reproductive medicine will be
highlighted in the oral and poster presentations.
We welcome our members and trainees, as well as our colleagues from abroad, to
attend the meeting. Indeed, several symposia will be presented by a group of experts from
sister societies around the world. As always, opportunities for networking and interactive
sessions abound.
FUTURE ASRM MEETING DATES . . . . . 12
SCIENTIFIC PROGRAM
& ABSTRACT REVIEW
COMMITTEES . . . . . . . . . . . . . . . . . 13-14
ASRM ANNUAL MEETING
POLICIES & DISCLAIMERS . . . . . . . . . 15
AWARDS . . . . . . . . . . . . . . . . . . . . 16-26
AMA TOWN HALL MEETING . . . . . . . . . . 24
SAN DIEGO CONVENTION
CENTER FLOOR PLANS . . . . . . . . . . . 28-32
San Diego is a delightful city, and the meeting also offers a most enjoyable social
program for attendees and their guests.
MARRIOTT MARQUIS SAN DIEGO
MARINA FLOOR PLANS . . . . . . . . . . . . . . 33
I look forward to meeting you in San Diego, where together we will be “Setting the
Course in Reproductive Medicine.”
Sincerely,
SCIENTIFIC PROGRAM
DAILY SCHEDULE . . . . . . . . . . . . . . 34-41
Dolores J. Lamb, Ph.D., H.C.L.D.
ASRM President 2011-2012
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE
OFFICERS
President
Dolores J. Lamb, Ph.D.
President-Elect
Linda C. Giudice, M.D., Ph.D.
Vice President
Richard Reindollar, M.D.
Immediate Past President
Roger A. Lobo, M.D.
Past President
William E. Gibbons, M.D.
DIRECTORS
Nancy L. Brackett, Ph.D., H.C.L.D.
Marcelle I. Cedars, M.D.
Christos Coutifaris, M.D., Ph.D.
Ann J. Davis, M.D.
Marc A. Fritz, M.D.
Michael P. Diamond, M.D.
Bradley J. Van Voorhis, M.D. (SREI)
Mark Sigman, M.D. (SRS)
Robert D. Oates, M.D. (SMRU)
Sangita K. Jindal, Ph.D. (SRBT)
Glenn L. Schattman, M.D. (SART)
Secretary
Catherine Racowsky, Ph.D., H.C.L.D.
EXECUTIVE DIRECTOR
Robert W. Rebar, M.D.
Treasurer
Stuart S. Howards, M.D.
SCIENTIFIC DIRECTOR
Andrew R. La Barbera, Ph.D., H.C.L.D.
11
CONTRACEPTION DAY . . . . . . . . . . . 42
SURGERY DAY . . . . . . . . . . . . . . . . 43-44
MENOPAUSE DAY . . . . . . . . . . . . . . . 45
NICHD OVARIAN RESERVE
SYMPOSIUM . . . . . . . . . . . . . . . . . . . . 46
GROUP & AFFILIATE
MEMBERS' MEETINGS . . . . . . . . . . . . . 47
ROUNDTABLES . . . . . . . . . . . . . . . 48-51
ORAL ABSTRACTS . . . . . . . . . . . . . 52-86
POSTER PRESENTATIONS . . . . . . 87-135
INDEXES . . . . . . . . . . . . . . . . 136-166
PREMIERE SUPPORTERS . . . . . . . . . . 167
CORPORATE MEMBER COUNCIL . . . . .167
RESIDENT REPORTER PROGRAM
SUPPORTERS . . . . . . . . . . . . . . . . . . . 168
2012 Spouse/Guest Program in San Diego, CA
Welcome to San Diego! Dorrie and I hope you will
enjoy the time you are about to spend in this lovely
city.
Beginning Saturday, October 20th through Wednesday,
October 24th, registered spouses and guests of those
attending the meeting are most welcome to join me for
a continental breakfast in the Hospitality Suite located
in the Carlsbad Room, South Tower, Level 3 of the
San Diego Marriott Marquis & Marina. The room will be
open between 8:00 and 10:00 each morning.
We hope you will enjoy the programs that have been
Michael Cook and Dorrie Lamb
arranged to highlight areas of interest. Gabe Salek from
the San Diego History Center will speak on Monday and Scott McGaugh from the USS Midway will be
our speaker on Tuesday. In addition, information will be available to help you make plans to explore
and enjoy the many attractions Southern California has to offer.
Our Hospitality Suite will be the perfect place to visit with friends and to make new acquaintances
over a cup of coffee and a bite to eat. I look forward to seeing you there!
Warmest Regards,
Michael Cook
Guest speakers on Monday, October 22nd and
Tuesday, October 23rd are from 9:00 am - 10:00 am.
Spouse/Guest badge will be required for entry.
FUTURE ASRM ANNUAL MEETINGS
October 12-17, 2013 • Boston, MA
Boston Convention & Exhibition Center
In conjunction with the Meeting of the International Federation of Fertility Societies
October 18-22, 2014 • Honolulu, HI
Hawaii Convention Center
October 17-21, 2015 • Baltimore, MD
Baltimore Convention Center
SCIENTIFIC PROGRAM AND ABSTRACT REVIEW COMMITTEE
SCIENTIFIC PROGRAM
COMMITTEE
Robert D. Oates, M.D.
Scientific Program Chair
Serdar E. Bulun, M.D.
Interactive Sessions Chair
Lawrence Layman, M.D.
Roundtables Chair
Joe Conaghan, Ph.D.
At Large
Wendy Kuohung, M.D.
At Large
Thomas L. Toth, M.D.
At Large
G. David Ball, Ph.D.
SART Program Chair
Kurt T. Barnhart, M.D.
SREI Program Chair
Grace M. Centola, Ph.D.
SMRU Program Chair
Grace M. Janik, M.D.
SRS Program Chair
Thomas G. Turner, E.L.D., M.S.
SRBT Program Chair
Kira Copperman, M.S.W.
ARM Program Chair
Nidhi Desai, J.D.
LPG Program Chair
Claudia Pascale, Ph.D.
MHPG Program Chair
Deb Jaffe, R.N.
NPG Program Chair
Dolores J. Lamb, Ph.D., H.C.L.D.
President, ASRM
Robert W. Rebar, M.D.
Executive Director
Andrew R. La Barbera, Ph.D.,
H.C.L.D.
Scientific Director
Lee Hutchison Boughton, M.A.
Program Coordinator
VIDEO COMMITTEE
Steven F. Palter, M.D. Chair
Tien-Cheng Chang, Ph.D.
Tommaso Falcone, M.D.
Emilio Fernandez, M.D.
Antonio R. Gargiulo, M.D.
Arik Kahane, M.D.
Philip Li, M.D.
Steven R. Lindheim, M.D.
Marius Meintjes, Ph.D.
Dana A. Ohl, M.D.
David L. Olive, M.D.
Marc P. Portmann, M.T.
Togas Tulandi, M.D.
Paul J. Turek, M.D.
ABSTRACT REVIEW
COMMITTEES
Glen Adaniya
Ashok Agarwal
David Albertini
Joao Batista Alcantara Oliveira
Ayman Al-Hendy
Rebecca H. Allen
Ruben Alvero
Paula Amato
Tony Anderson
Marlane Angle
Alicia Armstrong
Awoniyi Awonuga
Jean-Patrice Baillargeon
Donna Baird
ValerieBaker
G. David Ball
Kurt T. Barnhart
Brent Barrett
Jason Barritt G. Wright Bates
David Battaglia
Mosammat Rashida Begfum
Claudio Benadiva
Susan Benoff
Cecily Bishop
Lauri Black
Zeer Blumenfeld
Silvina Bocca
Jeff Boldt
Andrea Borini
Hillary Boswell
Nancy Brackett
Christine Briton-Jones
Richard Bronson
Kaylon L. Bruner-Tran
Orhan Bukulmez
Maria Bustillo
Samantha Butts
Erkan Buyuk
Robert Casper
Arthur Castelbaum
William H. Catherino
Grace M. Centola
Ching-Chien Chang
Arthur Chang
R. Jeffrey Chang
Jorge Chavarro
Christopher Chen
Greg Christman
Karine Chung
Charles Coddington
Pierre Comizzoli
Joe Conaghan
Alan Copperman
Serdar Coskun
Carolyn Coulam
Sharon Covington
13
Andre Monteiro da Rocha
Mariabeatrice dal Canto
Mark Damario
Gina M. Davis
Lynn Davis
Owen Davis
Chris De Jonge
Alan H. DeCherney
Todd Deutch
Alexander Dlugi
Alice Domar
Alan Dudkiewicz Antoni J. Duleba
Eyup Haken Duran
Alison Edelman
Michael Eisenberg
Karen Elkind-Hirsch
Joanna Ellington
Teresa Erb
Ofer Fainaru
Huai L. Feng
Bo Feng
Rita Fields Jill Fischer
Gregory Fossum
Nastaran Foyouzi
Elpida Fragouli
Mary Francis John Frattarelli
Victor Y. Fujimoto
Mahesh Fuldeore
Bhushan K. Gangrade
Juan Garcia-Velasco
Forest Garner
Mehmet Genc
Vanessa Krebs Genro
Marybeth Gerrity
Manda Ghahremani
Bruce Gilbert
Elizabeth S. Ginsburg
Gnanaratnam Giritharan
Sue Gitlin Karen Glass
Kathyrn J. Go
James Goldfarb
Frank Gonzalez
ClarisaGracia
Adam M. Griffin
Daniel R. Grow
Sajal Gupta
Shawn Gurtcheff
MarinaGvakharia Lisa Halvorson
Karen Hammond
Gary Harton
Michael J. Heard
Jon Hennebold
Patricia Hershberger
Laura Hewitson
SCIENTIFIC PROGRAM AND ABSTRACT REVIEW COMMITTEE
Tim Hickman
Michah Hill
Ramie Hinckley
Jennifer Hirshfeld-Cytron
Hananel Holzer
Stanton Honig
Amjud Hossain
BrendaHoumard
Mark Hughes
William Hurd
Bradley Hurst
KristenIvani
Tarun Jain
Grace M. Janik
Keith Jarvi
Teru Jellerette-Nolan
Sangita Jindal Beth Johnson
Erica Johnstone
Amy Jordan
Emily Jungheim
Suleena Kansel Kalra
David Karabinus
Dawn Kelk S. Samuel Kim
Helen Kim
Sheryl Kingsburg
Nancy Klein
Peter Kolettis
Ertug Kovanci
WendyKramer
Sacha Krieg
Seung-Yup Ku
Anver Kuliev
Joanne Kwak-Kim
Shannon Laughlin-Tommaso
Arthur Leader
Richard Legro
Phyllis Leppert
Bruce A. Lessey
Gerrie Letterie
Eric Levens
Sherilyn Levy
Fred Licciardi
Juergen Lieberman
Paul Lin
Steven Lindheim
Richard Lucidi
Kerri Luzzo
Courtney Lynch
Paul Magarelli
Henry Malter
George Maroulis
Sachiko Matsuzaki
DennisMatt
Michelle Matthews
Jake Mayer
JeniferMcCarthy
Janet McLaren
Zaher Merhi
Jennifer Mersereau
Shoukhrat Mitalipov
Thomas Molinaro
Mahmood Morshedi
Santiago Munne
Zsolt Peter Nagy
Steve Nakajima
Ajay Nangia
Ahmed Nasr
Genevieve Neal-Perry
John Nichols, Jr.
Warren Nothnick
Nicole L. Noyes
Evangelos Ntrivalas
John Nulsen
Jeanne O›Brien
Sergio Oehninger
Kutluk Oktay
Lubna Pal
Gianpiero Palermo
John Park
Patrizio Pasquale
SamuelA. Pauli
Mary Ellen Pavone
Antonio Pellicer
MarinaPeluffo
Alan Penzias
James Pickar
Anja Pinborg
Margareta D. Pisarska
Alex Polotsky
Anthony Propst
Scott Purcell
Elizabeth E. Puscheck
Catherine Racowsky
ValerieRatts
Alice Rhoton
Gloria A. Richard-Davis
Jon Richards Paolo Rinaudo
Jared Robins
RandalRobinson
Jeanette Rodriguez
Mitchell P. Rosen
Greg Rosen
Denny Sakkas
Nanette Santoro
GeraldSchatten
Glenn L. Schattman
Danny Schust
Humberto Scoccia
James Segars
David B. Seifer
LeventM. Senturk
Paulo Serafini
Donna Session
Daniel B. Shapiro
KaylenM. Silverberg
14
Judy Simon
Carlos Simon
Malgorzata Skaznik-Wikiel
Gary D. Smith
Rebecca Z. Sokol
Samer Soubra
StevenD. Spandorfer
Amy E. Sparks
Vyjayanthi Srinivasan
SereneSrouji
Laurel A. Stadtmauer
Aleksander Stanic-Kostic
Barbara Stegmann
Andrea Stein
Anne Steiner
Michael Steinkamp
Judy Stern
Pamela Stratton
Rodriq E. Stubbs
Irene H. Su
CarlosSueldo
Eric S. Surrey
Janet Takefman
Takumi Takeuchi
Tao Tao
Laura Tatpati
Hugh S. Taylor
Maida Taylor
Tyl Taylor
Michael Thomas
AngelaThyer
Kathy Timms
James Toner
Nam Tran
Nathan R. Treff J.C. Trussell
Thomas G. Turner
Meike L. Uhler
Amy Vance
Bill Venier Bradley Van Voorhis
Kedra Wallace
Melissa Wellons
Dagan Wells
Eric Widra
Cynthia Willson
Gil Wilshire
Kathryn Worrilow
Diane Wright
Bill Yee
Ying Ying
StevenL. Young
Abdelmoneim Younis
Musa Zamah
Nikica Zaninovic
Paul Zarutskie
Yulian Zhao
ASRM Annual Meeting
Policies and Disclaimers
CANCELLATION POLICY
The American Society for Reproductive Medicine reserves the right to cancel this activity
due to unforeseen circumstances. In the event of such cancellation, the full enrollment fee
will be returned to the registrant.
REFUND/NON-ATTENDANCE POLICY
Cancellations received before or by September 14th will receive a full refund minus a $50
processing fee. Cancellations received after September 14th will not be eligible for a refund.
ADA STATEMENT
The American Society for Reproductive Medicine fully complies with the legal requirements
of the ADA and the rules and regulations thereof. Accommodations for Disabilities: Please
notify the American Society for Reproductive Medicine, 1209 Montgomery Highway,
Birmingham, Alabama, USA 35216, telephone 1-205-978-5000, a minimum of 10 working days
in advance of the event if a reasonable accommodation for a disability is needed.
EQUAL OPPORTUNITY STATEMENT
The American Society for Reproductive Medicine values and promotes diversity among
its members, officers and staff. The Society prohibits discrimination toward any member
or employee due to race, color, religion, age, gender, sexual orientation, national origin,
citizenship, disability, military status or other basis prohibited by law. The Society strives to
achieve gender, racial and ethnic balance in hiring and governance. The Society maintains
policies, procedures and personnel actions that conform to the letter and spirit of all laws
and regulations pertaining to equal opportunity and nondiscrimination in employment,
appointments and elections to office.
DISCLAIMER STATEMENT
The content and views presented in this educational activity are those of the faculty/authors
and do not necessarily reflect those of the American Society for Reproductive Medicine.
This material is prepared based upon a review of multiple sources of information, but it is not
exhaustive of the subject matter. Therefore, healthcare professionals and other individuals
should review and consider other publications and materials on the subject matter before
relying solely upon the information contained within this educational activity to make clinical
decisions about individual patients.
Room numbers of sessions are listed in the meeting app,
the fold-out Schedule-at-a-Glance
and on signage throughout the convention center.
15
AWARDS
American Society for Reproductive Medicine 2012 Society Awards
Distinguished Researcher Award
The 2012 recipient of the ASRM Distinguished Researcher Award is Serdar E. Bulun,
M.D., John J. Sciarra Professor and Chair of the Department of Obstetrics and
Gynecology at the Northwestern University Feinberg School of Medicine. Dr. Bulun has
had a distinguished career in both clinical obstetrics and gynecology and in basic
and clinical research in the area of estrogen-responsive abnormalities of the uterus. He
has made a significant global impact on medicine via pioneering contributions to the
epigenetics, pathology and therapeutic aspects of steroid production and action in
understudied areas of gynecology, namely, endometriosis and uterine fibroids, which
impact some 15 million US women. At the bench, he revolutionized our understanding
of the molecular basis of endometriosis and, at the bedside, single-handedly
introduced aromatase inhibitors as an effective and novel class of drugs to treat
it. He demonstrated progesterone resistance as a key mechanism in endometriosis
Serdar E. Bulun, M.D.
and infertility. To support his research endeavors, Dr. Bulun has secured more than $20
million in federal funding. He has published more than 140 peer-reviewed articles and trained 38 pre- and postdoctoral students. As a leader in our field, he serves as a role model for the physician-scientists in reproductive
endocrinology-infertility.
Ira and Ester Rosenwaks New Investigator Award
(supported by an endowment from Zev Rosenwaks, M.D.)
Clarisa R. Gracia, M.D., M.S.C.E., has been selected as the 2012 recipient of the Ira and
Ester Rosenwaks New Investigator Award. This award recognizes a member of ASRM
who has made outstanding contributions to clinical or basic research in reproductive
sciences published within 10 years after completing research or clinical training and
initiating an independent career as an investigator. Dr. Gracia is Associate Professor
of Obstetrics and Gynecology at the University of Pennsylvania Perelman School of
Medicine, where she has authored more than 60 peer-reviewed articles and obtained
a prestigious R01 grant in the area of fertility preservation. Her primary research focus
is on ovarian aging, either “natural” or “induced” as part of gonadotoxic cancer
treatments. She has been able to demonstrate that measures of ovarian reserve are
impaired in cancer survivors in a dose-dependent fashion. Dr. Gracia also serves on
the ASRM Practice Committee.
Clarisa R. Gracia, M.D.,
M.S.C.E.
Suheil J. Muasher, M.D., Distinguished Service Award
(supported by an endowment from Suheil J. Muasher, M.D.)
Each year ASRM honors individuals or organizations that have provided distinguished
service to ASRM. Recipients are selected based on their scientific, leadership,
organizational, political or societal service contributions to ASRM, reproductive
medicine and/or reproductive medicine patients. In 2012 ASRM honors Eli Reshef, M.D.,
a member of the Society who has labored tirelessly to advocate for open access to
reproductive health care for all who desire to build families. Through his and others’
efforts, legislation impinging on individuals’ reproductive freedom was thwarted.
Eli Reshef, M.D.
16
AWARDS
SOCIETY FOR REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY, NATIONAL RESEARCH SERVICE INSTITUTIONAL
TRAINING AWARD (T32)
The Society for Reproductive Endocrinology was awarded a competitive training grant from the National
Institute of Child Health and Human Development to provide reproductive endocrinology and infertility fellows
with specialized training in reproductive medicine and biology. Ten Board-approved REI fellowship programs
currently participate in the program, which is administered through the University of Pennsylvania. Each year,
REI fellows are awarded 1- or 2-year NIH traineeships to conduct cutting edge research in the laboratories of
NIH-funded investigators. In the final year of training, fellows present their research in the ASRM Annual Meeting
Scientific Program. For 2012, the new trainee is: Kasey Reynolds, M.D., Washington University in St. Louis. The title
of her project is “The Effect of Obese Maternal Environment on Reproductive Outcomes Begins at the Oocyte
Stage” and her mentor is Kelle Moley, M.D.
ASRM/NIH/Duke Clinical Research/Reproductive Scientist Training (CREST) Program
The CREST training program is offered by the National Institute of Child Health and Human Development
(NICHD), the Clinical Research Training Program (CRTP) at Duke University, and the American Society for
Reproductive Medicine (ASRM). This two-year program meets an existing need for physicians in private or
academic clinical practice to obtain formalized academic training in the quantitative and methodological
principles of clinical research in reproductive medicine. The members of the new Class of 2012 – 2014 are:
Joshua J. Berger, M.D. (Kaiser Permanente), Mary Elizabeth Fino, M.D. (New York University), Heather Huddleston,
M.D. (University of California San Francisco), Christine M. Mullin, M.D. (North Shore-Long Island Jewish Health
System), and Andrea Reh, M.D. (Dominion Fertility).
Society for Male Reproduction and Urology Traveling Scholars Program
The annual Society for Male Reproduction and Urology Traveling Scholars Program allows a diverse group
of young clinical physicians and basic science researchers the opportunity to explore a career in male
reproductive medicine. The primary purpose of the program is to stimulate the scientific interests of residents
and fellow in the study of male reproduction. Scholars are selected by the SMRU Research Committee based
on the scores of their abstracts submitted for the Scientific Program. Each awardee will present an oral abstract
on Tuesday, October 23rd, 4:15 pm – 5:45 pm. The 2012 Scholars are: L. A. Ross, D. C. Snow-Lisy, B. B. Nayarit, M.
Afeiche, L. C. Jenkins, and E. Goldenberg.
ASRM Resident/Fellow In-training Award for Research in Heavy Menstrual Bleeding
(supported by a grant from Ferring Pharmaceuticals, Inc.)
A grant of $10,000 was awarded to a resident or fellow in obstetrics and gynecology to conduct an innovative,
short-term research project focused on heavy menstrual bleeding. Competitive selection of the recipient was
made by the ASRM Research Committee based primarily on the scientific merit of the proposed study and
the applicant’s potential for continued scholarship and research. The 2012 awardee is Cpt. Gary Levy, M.D.
(Reproductive Endocrinology and Infertility Fellow, Eunice Kennedy Shriver National Institute of Child Health and
Human Development) for his project titled “Ulipristal acetate for the treatment of abnormal uterine bleeding.”
ASRM Research Grants
The ASRM 2012 Research Grants provide funds in amounts of $10,000 to $50,000 to foster the development of
innovative research, to facilitate the research endeavors of new investigators, and to provide bridge funding
for projects that advance the Society’s mission. Proposals from junior faculty, particularly those in their first three
years of faculty appointment, receive priority. Following are the projects funded by the 2012 ASRM Research
Grants:
Judy Stern, Ph.D., Dartmouth-Hitchcock Medical Center, “Ongoing Development of the Infertility Family
Research Registry (IFRR),” $40,000
Margareta Pisarska, M.D., Cedars-Sinai Medical Center, “Differential Gene Expression and Epigenetic Profiles
in ART Pregnancies,” $40,000
Kathleen Hwang, M.D., Brown University, “Defining the Role of Ghrelin in Wound Healing and the
Inflammatory Response in the Post-operative Setting,” $25,000
Malgorzata E. Skaznik-Wikiel, M.D., University of Pittsburgh Magee-Womens Hospital, “Female Fertility
Peservation after High-dose Alkylating Chemotherapy with Granulocyte Colony-stimulating Factor,” $25,000
Nam Tran, M.D., Ph.D., University of California San Francisco, “Strategies for the Development of an Effective
Model of Human spermatogenesis,” $25,000
Kedra Wallace, Ph.D., University of Mississippi Medical Center, “The Role of Hypoxia -stimulated Vasoactive
Peptides in the Development of Uterine Leiomyomas, $25,000
Alberuni Zamah, M.D., Ph.D., University of California San Francisco, “Analysis of Human Follicular Fluid and
Oocyte Translational Patterns to Elucidate Novel Pathways of Somatic Cell-oocyte Communication,”
$20,000
__________________________________________________________________________________________
17
AWARDS
2012 SCIENTIFIC PROGRAM PRIZES
SCIENTIFIC PROGRAM PRIZE PAPERS
Candidates for two Scientific Program Prizes are selected by the Research Committee from all abstracts
submitted to the meeting regardless of designation of group for initial review. These oral presentations will be
judged at the meeting and selection will be determined by the Research Committee. The presenters of the two
Scientific Program Prize papers will be awarded:
• $1,000
• One-year free ASRM membership
• Free registration for ASRM 2013 in Boston, MA
SCIENTIFIC PROGRAM PRIZE POSTERS
Posters must be put up on the appropriate boards on Sunday, October 21, between noon and 5:00 p.m. or on
Monday, October 22, between 8:00 a.m. and noon, and must remain in place for the entire meeting. Posters
must be removed by 2:00 p.m. on Wednesday, October 24. Posters will be judged by the Scientific Program
Committee beginning at 12:00 noon Monday. The awardees will receive:
• First Prize: $500
• Second Prize: $300
• Third Prize: $200
ASRM CORPORATE MEMBER COUNCIL IN-TRAINING TRAVEL AWARDS
Ten awards to trainee abstract presenters from the United States and five awards to trainee abstract
presenters from countries outside the United States are made possible through the generous support of the
ASRM Corporate Member Council. Recipients of this award are undergraduate, graduate, medical or allied
health professions students, postdoctoral trainees, or clinical residents or fellows. Candidates are the first and
presenting author of an abstract that has been selected for oral or poster presentation in the ASRM 2012
Scientific Program. Selection is based on the scientific merit of the abstract and the qualifications of the author.
The awardees receive:
• $1,500 (US presenters)
• $2,000 (Non-US presenters)
O-5, Monday, October 22, 2012, 12:15 PM
MACAQUE OVARIAN TISSUE VITRIFIED IN A CLOSED SYSTEM YIELDS FUNCTIONAL SECONDARY FOLLICLES
A. Y. Ting, R. R. Yeoman, J. R. Campos, M. S. Lawson, M. B. Zelinski. Division of Reproductive and
Developmental Sciences, Oregon National Primate Research Center, Beaverton, OR.
INFERTILITY AND THE UTILIZATION OF INFERTILITY TREATMENT IN FEMALE SURVIVORS OF CHILDHOOD CANCER:
A REPORT FROM THE CHILDHOOD CANCER SURVIVOR STUDY
S. E. Barton1, J. Najita2, E. S. Ginsburg1, L. R. Diller3. 1Division of Reproductive Medicine; Department of
Obstetrics and Gynecology, Brigham and Women’s Hospital, Boston, MA; 2Department of Biostatistics and
Computational Biology, Dana-Farber Cancer Institute, Boston, MA; 3Department of Pediatric Oncology,
Dana-Farber Childrens Hospital Cancer Center, Boston, MA.
O-224, Wednesday, October 24, 2012, 11:30 AM
A PROSPECTIVE STUDY OF ENDOMETRIOSIS AND CORONARY HEART DISEASE RISK
F. Mu1, J. Rich-Edwards2, E. Rimm3, K. Mukamal4, S. Missmer5. 1Department of Epidemiology, Harvard School
of Public Health, Boston, MA; 2Connors Center for Women’s Health, Brigham and Women’s Hospital,
Boston, MA; 3Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard
Medical School, Boston, MA; 4Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA;
5
Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women’s Hospital and
Harvard Medical School, Boston, MA.
O-115, Tuesday, October 23, 2012, 4:15 PM
EVALUATION OF OVARIAN AND TESTICULAR TISSUE CRYOPRESERVATION AND THEIR BUNDLING WITH
MEDICALLY-INDICATED PROCEDURES IN CHILDREN UNDERGOING GONADOTOXIC THERAPIES FOR BLOOD
DYCRASIAS OR CANCER
S. Babayev1, M. Karsy1, E. Arslan1,2, S. Kogan2,3, K. Oktay1. 1Obstetrics and Gynecology, New York Medical
18
AWARDS
College, Valhalla, NY; 2Institute for Fertility Preservation and Reproductive Surgery of New York, Rye, NY;
3
Urology, New York Medical College, Valhalla, NY.
LAPAROSCOPIC TUBAL REANASTOMOSIS VERSUS IN VITRO FERTILIZATION: COST-BASED DECISION ANALYSIS
INCOPORATING MULTIPLE PATIENT AGES, LIGATION TECHNIQUE AND IMPACT OF MULTIPLE GESTATION J. A. Winter, J. E. Hirshfeld-Cytron. Obstetrics and Gynecology, University of Illinois Medical Center, Chicago,
IL.
O-299, Wednesday, October 24, 2012, 3:45 PM
ICE BLOCKERS IMPROVE VITRIFICATION OUTCOME OF MOUSE EMBRYOS BY ALLOWING LOWER
CRYOPROTECTANT CONCENTRATION IN VITRIFICATION MEDIA WITHIN A CLOSED SYSTEM
T. A. Farghaly1,2, S. Israel1, M. Marconi1, A. Loeb1, J. Goldfarb1, A. Ahmady1. 1University Hospitals Fertility
Center, Ahuja Medical Center, Beachwood, OH; 2Womens’ Health Center, Assiut University, Assiut, Egypt.
SPHINGOSINE-1-PHOSPHATE PREVENTS HUMAN PRIMORDIAL FOLLICLE DEATH INDUCED BY A DIVERSE SET OF
CHEMOTHERAPY AGENTS
F. Li1, K. Akula1, E. Ozkaya1, P. De Sutter3, K. Oktay1,2. 1Laboratory of Molecular Reproduction and Fertility
Preservation, Obstetrics & Gynecology, New York Medical College, Valhalla, NY; 2Institute for Fertility
Preservation and Reproductive Specialists of New York, Rye, NY; 3Department of Reproductive Medicine,
Ghent University, Ghent, Belgium.
A SHORTER FOLLICULAR PHASE DOES NOT HAVE A DELETERIOUS EFFECT ON THE OUTCOME OF OVULATION
INDUCTION/INTRAUTERINE INSEMINATION (OI/IUI) CYCLES
A. N. Imudia, I. Dimitriadis, J. C. Petrozza, I. Souter. Vincent Department of Obstetrics and Gynecology,
Massachusetts General Hospital Fertility Center, Boston, MA.
BLASTOCYST EUPLOID SELECTIVE TRANSFER (BEST): AN RCT OF COMPREHENSIVE CHROMOSOME SCREENING –
SINGLE EMBRYO TRANSFER (CCS-SET) VS DOUBLE EMBRYO TRANSFER (DET) – EQUIVALENT PREGNANCY RATES,
ELIMINATES TWINS
E. J. Forman1,2, K. H. Hong1,2, K. M. Ferry1,2, X. Tao1, N. R. Treff1,2,3, R. T. Scott, Jr.1,2. 1Reproductive Endocrinology,
Reproductive Medicine Associates of New Jersey, Morristown, NJ; 2Obstetrics, Gynecology and
Reproductive Sciences, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ; 3Genetics,
Rutgers-The State University of New Jersey, Piscataway, NJ.
ALTERATIONS IN THE SPERM PROTEOME MAY IDENTIFY IDIOPATHIC INFERTILITY AND POOR IVF OUTCOME
S. McReynolds1, M. Dzieciatkowska2, K. C. Hansen2, M. Katz-Jaffe1,3. 1National Foundation for Fertility
Research, Lone Tree, CO; 2University of Colorado Denver, Aurora, CO; 3Colorado Center for Reproductive
Medicine, Lone Tree, CO.
THE USE OF CUMULUS CELL (CC) mRNA LEVELS TO PREDICT BLASTOCYST DEVELOPMENT AND LIVE BIRTH
OUTCOMES IN WOMEN UNDERGOING INTRACYTOPLASMIC SPERM INJECTION (ICSI) AND SINGLE EMBRYO
TRANSFER J. Ekart1,2, J. D. Hutton2, K. P. McNatty1, K. Coetzee2, J. L. Pitman1. 1Victoria University of Wellington, Wellington,
WGT, New Zealand; 2Fertility Associates Ltd, Wellington, WGT, New Zealand.
PRACTICING COGNITIVE BEHAVIORAL INTERVENTIONS (CBI) INCREASES PREGNANCY RATES IN WOMEN
UNDERGOING IVF J. Czamanski-Cohen1, O. Sarid1, J. Cwikel1, A. Zeadna2, E. Levitas1,2, I. Har-Vardi1,2. 1Ben Gurion University of
the Negev, Beer Sheeba, Israel; 2Soroka University Medical Center, Beer Sheeba, Israel.
19
AWARDS
O-318, Wednesday, October 24, 2012, 4:30 PM
FERTILITY PRESERVATION WITH IVF OR IVM FOR WOMEN WITH HEMATOLOGICAL MALIGNANCY – EXPERENCES
AND EXPECTATIONS
J. H. Hyman, J.-T. Chung, T. Sokal-Arnon, E. Shalom-Paz, A. Wiser, H. Holzer. MUHC Reproductive Centre,
Department of Obstetrics and Gynecology, McGill University, Montreal, QC, Canada.
O-73, Monday, October, 22, 2012, 5:15 PM
THE EXPRESSION PATTERN OF STAGE SPECIFIC-GERM CELL MARKERS IN SEMINIFEROUS TUBULE INJECTED WITH
SPERMATOGONIAL STEM CELLS DURING IN VITRO SPERMATOGENESIS
H. J. Kim, Y. J. Cho, J. J. Lim, S.-H. Song, T. K. Yoon, D. R. Lee. Fertility Center of CHA Gangnam Medical
Center, CHA Research Institute, Seoul, Republic of Korea.
P-21
VITRIFICATION OF BOVINE OOCYTES SUBSTANTIALLY IMPAIRS THEIR REPRODUCTIVE CAPACITY INDEPENDENTLY
OF MATURATION STAGE
D. L. Bulgarelli, A. A. Vireque, C. P. Pitangui, M. P. Bernuci, M. F. Silva-de-Sá, A. C. Sá Rosa-e-Silva.
Department of Obstetrics and Gynecology, Faculty of Medicine of Ribeirão Preto, University of São Paulo,
Ribeirão Preto, SP, Brazil.
RESIDENT IN-TRAINING AWARD
This award recognizes the presenter of an exceptional abstract who is currently a resident in training in the field
of obstetrics and gynecology or urology. Recipients of these awards specified that they would like to be eligible
for the “Resident In-Training Award” during the online abstract submission process. The awardee receives:
• $500
• Free registration to ASRM 2012 in San Diego, CA
O-258, Wednesday, October 24, 2012 - Time: 11:15 am
IN VITRO FERTILIZATION (IVF) YIELDS MUCH HIGHER SUCCESS RATES THAN INTRAUTERINE INSEMINATION (IUI)
AMONG OLDER WOMEN AGED 38-44 YEARS
C. M. Eguiguren1, K. S. Richter2, J. A. Horne3, J. E. Osheroff2, E. A. Widra2. 1Georgetown University Hospital,
Washington, DC; 2Shady Grove Fertility Reproductive Science Center, Rockville, MD; 3Georgetown University
Medical School, Washington, DC.
IN-TRAINING AWARDS FOR RESEARCH
Five In-Training Awards for Research are granted in recognition of outstanding research conducted by
individuals who are in-training. Recipients of these awards specified that they would like to be eligible for
the “In-Training Award for Research” during the online abstract submission process. He/she is the presenting
author (first) and a medical student, resident, fellow or undergraduate, graduate or postdoctoral student. The
awardees receive:
• $250
• Free registration to ASRM 2013 in Boston, MA
O-8, Monday, October 22, 2012 - Time: 4:30 pm
CLOMID-GONADOTROPIN OVARIAN HYPERSTIMULATION AND INTRAUTERINE INSEMINATION: EFFICACY WITH
MULTIPLE CYCLES
J. M. Cox3, M. Maguire1, A. H. DeCherney1, K. S. Richter2, M. Levy2, M. B. Henne3. 1Program in Reproductive
and Adult Endocrinology, NICHD, NIH, Bethesda, MD; 2Shady Grove Fertility Reproductive Science Center,
Rockville, MD; 3Walter Reed National Military Medical Center, Bethesda, MD.
INFERTILITY AND THE UTILIZATION OF INFERTILITY TREATMENT IN FEMALE SURVIVORS OF CHILDHOOD CANCER: A
REPORT FROM THE CHILDHOOD CANCER SURVIVIOR STUDY (CCSS)
S. E. Barton1, J. Najita2, E. S. Ginsburg1, L. R. Diller3. 1Division of Reproductive Medicine; Department of
Obstetrics and Gynecology, Brigham and Women’s Hospital, Boston, MA; 2Department of Biostatistics and
Computational Biology, Dana-Farber Cancer Institute, Boston, MA; 3Department of Pediatric Oncology,
Dana-Farber Childrens Hospital Cancer Center, Boston, MA.
20
AWARDS
microRNA TESTING: A NOVEL, NON-INVASIVE TECHNIQUE TO DETECT ANEUPLOIDY AND LIVE BIRTH POTENTIAL
IN HUMAN EMBRYOS
E. M. Rosenbluth1, D. N. Shelton1, L. M. Wells2, A. E. Sparks1, B. J. Van Voorhis1. 1Obstetrics and Gynecology,
University of Iowa, Iowa City, IA; 2Audubon Fertility & Reproductive Medicine, New Orleans, LA.
O-258, Wednesday, October 24, 2012 - Time: 11:15 am
IN VITRO FERTILIZATION (IVF) YIELDS MUCH HIGHER SUCCESS RATES THAN INTRAUTERINE INSEMINATION (IUI)
AMONG OLDER WOMEN AGED 38-44 YEARS
C. M. Eguiguren1, K. S. Richter2, J. A. Horne3, J. E. Osheroff2, E. A. Widra2. 1Georgetown University Hospital,
Washington, DC; 2Shady Grove Fertility Reproductive Science Center, Rockville, MD; 3Georgetown University
Medical School, Washington, DC.
O-236, Wednesday, October 24, 2012 - Time: 12:45 pm
THE PROTECTIVE MECHANISM OF CETRORELIX ACETATE IN A CHEMOTHERAPY-INDUCED MURINE MODEL OF
OVARIAN DAMAGE
C. M. P. Duke1, I. Khachikyan2, A. Z. Rosenberg3, X. C. Guo2, J. H. Segars2, A. Y. Armstrong2. 1Gynecology
and Obstetrics, Johns Hopkins University, School of Medicine, Baltimore, MD; 2Program in Reproductive and
Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development,
National Institutes of Health, Bethesda, MD; 3Laboratory of Pathology, Clinical Center, National Institutes of
Health, Bethesda, MD.
SRS IN-TRAINING AWARDS FOR RESEARCH
Three (3) SRS In-Training Awards for research are granted. The purpose of these awards is to recognize
outstanding research conducted by individuals in-training. Recipients of these awards specified that they would
like to be eligible for the “SRS In-Training Award for Research” during the online abstract submission process.
He/she is the presenting author (first) and a medical student, resident, fellow or undergraduate, graduate or
postdoctoral student. They will attend ASRM 2012 and present the abstract. The awardees receive:
• $250
• One-year free ASRM and SRS membership
• Free registration to the 2012 ASRM Annual Meeting in San Diego, CA
O-122, Tuesday, October 23, 2012 - Time: 6:00 pm
DETERMINING THE FERTILITY BENEFIT OF CONTROLLED OVARIAN HYPERSTIMULATION (COH) AND INTRAUTERINE
INSEMINATION (IUI) AFTER OPERATIVE LAPAROSCOPY IN PATIENTS WITH ENDOMETRIOSIS
A. Gandhi1, L. Carvalho2, B. Nutter2, T. Falcone2. 1Obstetrics and Gynecology; Lerner College of Medicine
of CWRU, Cleveland Clinic Foundation, Cleveland, OH; 2Obstetrics and Gynecology, Cleveland Clinic
Foundation, Cleveland, OH.
COMPARISON OF LONG TERM FERTILITY AND BLEEDING OUTCOMES AFTER ROBOTIC, LAPAROSCOPIC, AND
OPEN MYOMECTOMY
R. Flyckt, E. Soto, B. Nutter, T. Falcone. Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH.
ASSESSMENT OF LONG TERM BOWEL SYMPTOMS AFTER SEGMENTAL RESECTION FOR DEEPLY INFILTRATING
ENDOMETRIOSIS
M. Catenacci, C. Bedient, J. E. Jelovsek, B. Nutter, T. Falcone. Cleveland Clinic Foundation, Cleveland, OH.
AFFILIATED SOCIETY PRIZE PAPERS
The Society for Assisted Reproductive Technology, The Society for Reproductive Endocrinology and Infertility,
The Society of Reproductive Surgeons, and The Society for Male Reproduction and Urology have selected prize
papers for an award of $500 each.
SART Prize Paper
O-2, Monday, October 22, 2012 - Time: 11:30 am
USE OF DEPOT GnRH ANTAGONIST (DEGARELIX) IN THE OVARIAN STIMULATION IN WOMEN WITH PCOS
UNDERGOING IVF. A CONTROLLED TRIAL
M. Sbracia, F. Scarpellini. CERM, Hungaria IVF, Rome, Italy.
21
AWARDS
SREI Prize Paper
METHOTREXATE OR EXPECTANT MANAGEMENT IN WOMEN WITH ECTOPIC PREGNANCY OR PUL AND LOW
SERUM hCG CONCENTRATIONS? A RANDOMIZED CONTROLLED TRIAL
N. M. van Mello, On behalf of the METEX Study Group. Department of Obstetrics and Gynaecology,
Academic Medical Centre, University of Amsterdam, Amsterdam, Noord-Holland, Netherlands.
SRS Prize Paper
PRESERVATION OF FERTILITY
S. J. Silber1, D. Z. Silber1, N. Kagawa2, M. Kuwayama3. 1Infertility Center of St. Louis, St. Luke’s Hospital, St.
Louis, MO; 2Kato Ladies Clinic, Tokyo, Japan; 3Repro Support Medical Research Centre, Tokyo, Japan.
SMRU Prize Paper
O-3, Monday, October 22, 2012 - Time: 11:45 am
GLUT3 AND CASPR5 - NOVEL GENETIC FACTORS IN MALE INFERTILITY
A. W. Pastuszak, C. J. Jorgez, L. I. Lipshultz, D. J. Lamb. Scott Department of Urology, Center for
Reproductive Medicine, Baylor College of Medicine, Houston, TX.
SRBT BASIC SCIENCE AWARD
A prize of $500, made possible by a donation from Cryoport, Inc., is awarded to a basic reproductive science
abstract submitted in either a Reproductive Biology or Reproductive Technology category for the 2012 ASRM
Annual Meeting. The abstract was selected for either oral or poster presentation. Abstracts were evaluated
by the corresponding abstract grading committee based on originality, experimental design, quality, and
significance.
O-195, Tuesday, October 23, 2012 – Time: 4:45 PM
DEVELOPMENT AND IMPROVEMENT OF A NEW MULTI-GENETIC TEST FOR THE DETECTION OF 221 OF THE MOST
HIGHLY PENETRANT MONOGENIC DISEASES.
J.A. Horcajadas1,2, J. Fischer3,4, K. Ketterson3,4, A. Bisignano3. 1Recombine-EU, Recombine-EU, Alicante, Spain;
2
Laboratory of Traslational Research, Hospital Miguel Servet, Zaragoza, Spain; 3Recombine LL, Recombine
LLC, Livingston, NJ; 4Reprogenetics, Reprogenetics, Livingston, NJ.
SRBT/ACE CLINICAL SCIENCE AWARD
A prize of $500, made possible by a donation from the American College of Embryology, is awarded to a
clinical reproductive science abstract submitted in either a Reproductive Biology or Reproductive Technology
category for the 2012 ASRM Annual Meeting. The abstract was selected for either oral or poster presentation.
Abstracts were evaluated by the corresponding abstract grading committee based on originality, experimental
design, quality, and significance.
O-69, Monday, October 22, 2012 – Time: 4:15 PM
microRNA miR-146a INHIBITS THE MEDIATOR COMPLEX SUBUNIT 1 AND PROMOTES SELF-RENEWAL IN
SPERMATOGONIAL STEM CELLS.
J. M. Huszar, C. J. Payne. Northwestern University Feinberg School of Medicine, Chicago, IL.
PROFESSIONAL AND SPECIAL INTEREST GROUPS
Several groups have selected prize papers for cash awards.
Reproductive Immunology SIG Prize Paper
UROMODULIN LIKE-1, A KEY PLAYER IN COORDINATING THE FUNCTION OF THYMUS-PITUITARY-OVARIAN AXIS
Y. Tang, L. Ni, W. Wang, H.-C. Liu, Z. Rosenwaks. CRMI Endocrine Research Laboratory, Weill Medical College
of Cornell University, New York, NY.
Mental Health Professional Group Prize Paper
ARE DEPRESSED INFERTILITY PATIENTS OFFERED AND DO THEY RECEIVE MENTAL HEALTH SERVICES?
L. A. Pasch1, S. R. Holley2, M. E. Bleil1, D. Shehab3, R. D. Nachtigall4, P. P. Katz3. 1Psychiatry, University of
22
AWARDS
California, San Francisco, San Francisco, CA; 2Psychology, San Francisco State University, San Francisco,
CA; 3Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA; 4Institute for
Health and Aging, University of California, San Francisco, San Francisco, CA.
Fertility Preservation SIG Prize Paper
(Supported by a grant from Ferring Pharmaceuticals, Inc.)
O-233, Wednesday, October 24, 2012 - Time: 12:00 pm
AKT1 SIGNALING PATHWAY ACTIVATION IMPROVES ANGIOGENESIS OF OVARIAN GRAFTS
Y. Cohen1,2, H. Dafni1, K. Walsh3, L. E. Benjamin4, T. Raz1, M. Neeman1. 1Biological Regulation, Weizmann
Institute of Science, Rehovot, Israel; 2Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky
Medical Center, Tel Aviv, Israel; 3Department of Medicine, Boston University School of Medicine, Boston, MA;
4
Beth Israel Deaconess Medical Center, Boston, MA.
ASRM NURSE RESEARCH AWARDS
A prize of $1000, made possible by a donation from Merck, Inc., will be awarded to up to 10 individuals for oral
or poster abstracts submitted in the Nursing category for the 2012 Annual Meeting. Recipients must be both a
licensed nursing professional and the first author of the submitted work in order to qualify. The abstract must
be selected for either oral or poster presentation. Abstracts will be evaluated by the corresponding abstract
grading committee based on originality, experimental design, quality, presentation and significance. The
winners will be notified prior to the meeting.
O-244, Wednesday, October 24, 2012 – Time: 11:15 AM
NURSES MAKE THE DIFFERENCE: VIGILANT COMMUNICATION MAY HELP PATIENTS WITH SEVERE OHSS AVOID
MEDICAL INTERVENTION.
H. I. G. Cotton1, M. Acosta1, J. A. Lee1, M. Whitehouse1, L. Grunfeld1,2, A. B. Copperman1,2. 1Reproductive
Medicine Associates of New York, New York, NY; 2Obstetrics, Gynecology and Reproductive Science, Mount
Sinai School of Medicine, New York, NY.
O-246, Wednesday, October 24, 2012 – Time: 11:45 AM
WHO DOES WHAT: A NATIONAL SURVEY OF ROLES WITHIN OOCYTE DONATION (OD) IVF PRACTICES.
K. R. Hammond1, N. A. Cataldo2, M. P. Steinkampf1. 1Alabama Fertility Specialists, Birmingham, AL;
2
Birmingham, AL.
O-249, Wednesday, October 24, 2012 – Time: 12:30 PM
POTENTIAL REASONS FOR PATIENTS NOT PURSUING FERTILITY PRESERVATION AFTER REFERRAL FOR
CONSULTATION AND COUNSELING.
L. Pepin, J. Nulsen, C. Benadiva, M. Rescildo, L. Engmann. Center for Advanced Reproductive Services,
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology,
Farmington, CT.
P-418, Wednesday, October 24, 2012
USING SOCIAL MEDIA IN AN INFERTILITY POPULATION: A PRELIMINARY REPORT.
L. G. Mickey, R. L. Flyckt, E. Soto, M. Catenacci, J. Goldberg. Reproductive Endocrinology and Infertility,
Cleveland Clinic Fertility Center, Beachwood, OH.
P-4, Tuesday, October 23, 2012
PREGNANCY SPECIFIC STRESS EXPERIENCED BY WOMEN WHO CONCEIVED PREGNANCIES VIA IN-VITRO
FERTILIZATION: A MIXED-METHODS APPROACH.
E. L. Stevenson1, C. M. Bergh2. 1School of Nursing, Duke University, Durham, NC; 2Reproductive Medicine
Associates of New Jersey, Morristown, NJ.
P-484, Wednesday, October 24, 2012
RECIPIENT INFLUENCE ON PREGNANCY OUTCOMES IN DONOR OOCYTE CYCLES.
K. A. Wyckoff, M. Arny, P. St. Marie, K. A. Lynch, C. Sites, H. Wiczyk. Baystate Reproductive Medicine,
Springfield, MA.
23
AWARDS
VIDEO PRESENTATIONS
The committee selects an overall first prize award video ($1,000) and a runner-up ($500). Individual category
recognition may be identified by a certificate.
First Prize for Technical Achievement in Video 2012
V-17, Tuesday, October 23, 2012 – Time: 05:21 PM
STANDARDIZATION OF LAPAROSCOPIC PELVIC EXAMINATION
M. A. Bedaiwy1, D. Henry1, T. Falcone2. 1OB/GYN, CWRU, Cleveland, OH; 2OB/GYN, Cleveland Clinic, Cleveland, OH.
Honorable Mention for Technical Achievement in Video: Assisted Reproductive Technology Category
V-2, Tuesday, October 23, 2012 – Time: 11:26 AM
DYNAMIC ANALYSIS OF THE RELATIONSHIP BETWEEN BLASTOCOEL COLLAPSE AND THE HATCHING PROCESS IN
HUMAN EMBRYOS USING TIME-LAPSE CINEMATOGRAPHY
Y. Mio, K. Yumoto, K. Iwata, Y. Iba. Reproductive Centre, Mio Fertility Clinic, Yonago, Tottori Prefecture, Japan.
Honorable Mention for Technical Achievement in Video: Surgery Category
V-9, Tuesday, October 23, 2012 – Time: 04:15 PM
SINGLE INCISION ROBOTIC MYOMECTOMY
A. R. Gargiulo, A. P. Bailey, S. S. Srouji. Center for Infertility and Reprductive Surgery, Brigham and Women’s
Hospital/Harvard Medical School, Boston, MA.
Town Hall Meeting:
An update from the American
Medical Association
During ASRM’s 68th Annual Meeting, Robert Wah, MD,
a reproductive endocrinologist and Immediate past
chairman of the AMA Board of Trustees, will lead a Town
Hall Meeting to discuss updates about the AMA’s work.
Tuesday, October 23
7–8:45 a.m.
San Diego Convention Center – Room 3
Continental breakfast will be served.
24
AWARDS
2012 ASRM STAR AWARDS
Awarded to the following reproductive health professionals who have presented at at least nine of the last 10
ASRM Annual Meetings:
Mohamed Aboulghar, M.D.
Mostafa Abuzeid, M.D.
Michael Alper, M.D.
David Archer, M.D.
Alicia Armstrong, M.S.
Foad Azem, M.D.
Ricardo Azziz, M.D., M.P.H., M.B.A.
David Barad, M.D.
Kurt Barnhart, M.D.
Jason Barritt, Ph.D.
Mohamed Bedaiwy, M.D., Ph.D.
Barry Behr, Ph.D.
Claudio Benadiva, M.D.
Susan Benoff, Ph.D.
William Boone, Ph.D.
Nancy Brackett, Ph.D.
Robert Brannigan, M.D.
Andrea Braverman, Ph.D.
Serdar Bulun, M.D.
John Buster, M.D.
Douglas Carrell, H.C.L.D.
Sandra Carson, M.D.
Robert F. Casper, M.D.
William Catherino, M.D., Ph.D.
Marcelle Cedars, M.D.
Jerome Check, M.D.
Charles Coddington, M.D.
Alan Copperman, M.D.
Thomas D’Hooghe, M.D., Ph.D.
Alan DeCherney, M.D.
Michael Diamond, M.D.
W. Paul Dmowski, M.D., Ph.D.
Anuja Dokras, M.D., Ph.D.
Antoni Duleba, M.D.
Daniel Dumesic, M.D.
Adrian Ellenbogen, M.D.
Navid Esfandiari, D.V.M., Ph.D.
Sandro Esteves, M.D., Ph.D.
Renato Fanchin, M.D., Ph.D.
David Frankfurter, M.D.
Rene Frydman, M.D.
Victor Fujimoto, M.D.
Joann Galst, Ph.D.
Juan Garcia-Velasco, M.D.
David Gardner, Ph.D., D.Phil.
William Gibbons, M.D.
Elizabeth Ginsburg, M.D.
Linda Giudice, M.D., Ph.D.
Norbert Gleicher, M.D.
James Goldfarb, M.D., M.B.A.
Marc Goldstein, M.D.
Clarisa Gracia, M.D.
James Grifo, M.D., Ph.D.
Jacqueline Gutmann, M.D.
Karen Hammond, D.N.P.
David Hill, Ph.D.
Kathleen Hoeger, M.D., M.P.H.
Mark Hughes, M.D., Ph.D.
Bradley Hurst, M.D.
Keith Isaacson, M.D.
William Kearns, Ph.D.
David Keefe, M.D.
Sheryl Kingsberg, Ph.D.
George Kovalevsky, M.D.
Lewis Krey, Ph.D.
William Kutteh, M.D., Ph.D.
Richard Legro, M.D.
Bruce Lessey, M.D., Ph.D.
Frederick Licciardi, M.D.
Roger Lobo, M.D.
Joel Marmar, M.D.
Pablo Mashburn, M.D.
Sachiko Matsuzaki, M.D., Ph.D.
Magdy Milad, M.D.
Yoshiharu Morimoto, M.D., Ph.D.
Suheil Muasher, M.D.
Santiago Munne, Ph.D.
Zsolt Nagy, M.D., Ph.D.
Queenie Neri, M.S.
Sergio Oehninger, M.D., Ph.D.
Kutluk Oktay, M.D.
Francois Olivennes, M.D., Ph.D.
Kevin Osteen, Ph.D.
Lubna Pal, M.B.B.S., M.Sc.
Richard Paulson, M.D.
Antonio Pellicer, M.D.
William Petok, Ph.D.
Marc Portmann, M.H.A., M.T.
Samuel Prien, Ph.D.
Elizabeth Puscheck, M.D.
Catherine Racowsky, Ph.D.
Richard Reindollar, M.D.
Jose Remohi, M.D.
Botros R.M. Rizk, M.D.
Zev Rosenwaks, M.D.
Ghassan Saed, Ph.D.
Denny Sakkas, Ph.D.
Mary Sammel, Sc.D.
Jay Sandlow, M.D.
Nanette Santoro, M.D.
Mark Sauer, M.D.
Glenn Schattman, M.D.
Robert Schenken, M.D.
Peter Schlegel, M.D.
William Schoolcraft, M.D.
Danny Schust, M.D.
Richard Scott, M.D.
James Segars, M.D.
25
Continued on next page
AWARDS
Paulo Serafini, M.D., Ph.D.
Fady Sharara, M.D.
Rakesh Sharma, Ph.D.
Shehua Shen, M.D.
Geoffrey Sher, M.D.
Yimin Shu, M.D., Ph.D.
Mark Sigman, M.D.
Carlos Simon, M.D., Ph.D.
Cynthia Sites, M.D.
Gary Smith, Ph.D.
Steven Spandorfer, M.D.
Amy Sparks, Ph.D.
Laurel Stadtmauer, M.D., Ph.D.
Dale Stovall, M.D.
Carlos Sueldo, M.D.
Eric Surrey, M.D.
Takumi Takeuchi, M.D., Ph.D.
Michael Thomas, M.D.
Ilan Tur-Kaspa, M.D.
Paul Turek, M.D.
Bulent Urman, M.D.
Bradley Van Voorhis, M.D.
Lawrence Werlin, M.D.
Lynn Westphal, M.D.
Eric Widra, M.D.
Kathryn Worrilow, Ph.D.
2012 ASRM SERVICE MILESTONE AWARDS
Awarded to the following ASRM members who have served on ASRM boards and/or committees for at least 10,
15, or 20 years:
10 Years
20 years
Jill Fischer, M.S.
Botros R.M. Rizk, M.D.
Linda Applegarth, Ed.D.
Andrea Braverman, Ph.D.
Sandra Carson, M.D.
Marcelle Cedars, M.D.
R. Jeffrey Chang, M.D.
Sharon Covington, M.S.W.
Alan DeCherney, M.D.
Esther Eisenberg, M.D., M.P.H.
Richard Falk, M.D.
Arthur Haney, M.D.
David Hoffman, M.D.
Stuart Howards, M.D.
Roger Kempers, M.D.
William Keye, M.D.
Larry Lipshultz, M.D.
James Liu, M.D.
Roger Lobo, M.D.
Guillermo Marconi, M.D.
George Maroulis, M.D., Ph.D.
R. Dale McClure, M.D.
Philip McNamee, M.D.
Kamran Moghissi, M.D.
Suheil Muasher, M.D.
Steven Ory, M.D.
Mary Lake Polan, M.D., Ph.D.
Joseph Sanfilippo, M.D.
Robert Schenken, M.D.
Rebecca Sokol, M.D., M.P.H.
Michael Soules, M.D.
Ronald Strickler, M.D., M.B.A.
Carlos Sueldo, M.D.
Barry Verkauf, M.D., M.B.A.
Elizabeth West, R.N., R.N.C.
15 years
G. David Adamson, M.D.
Ricardo Azziz, M.D., M.P.H., M.B.A.
John Buster, M.D.
Maria Bustillo, M.D.
Marian Damewood, M.D.
Owen Davis, M.D.
Marc Fritz, M.D.
William Gibbons, M.D.
Paul Gindoff, M.D.
Dorothy Greenfeld, M.S.W.
James Grifo, M.D., Ph.D.
Karen Hammond, D.N.P., N.P.
George Hill, M.D.
William Hurd, M.D., M.P.H., M.S.
Dolores Lamb, Ph.D.
Howard McClamrock, M.D.
Richard Paulson, M.D.
Catherine Racowsky, Ph.D.
Nanette Santoro, M.D.
William Schlaff, M.D.
Peter Schlegel, M.D.
Samuel Smith, M.D.
Basil Tarlatzis, M.D., Ph.D.
Michael Thomas, M.D.
Ilan Tur-Kaspa, M.D.
R. Stan Williams, M.D.
Craig Witz, M.D.
Bill Yee, M.D.
26
SAN DIEGO CONVENTION CENTER FLOORPLANS
27'
For columns:
33-34
GROUND LEVEL EXHIBIT HALLS
35'
35'
BOX OFFICE E
DESK
For columns:
29-32
Column
For columns:
23-24
27-28
26'
23"
Airwall pocket
8'-2"
For columns:
13-16
Column
ELEVATOR
8'-6"
AIRS
ELEVATOR/ST
ESCALATOR/
BY
BAYSIDE LOB
39'-10"
15'-4"
3'-3"
SIDE VIEW
8'-6"
15'-0"
3'-3"
3'-3"
15'-0" 8'-6"
3'-3"
3'-3"
TOP VIEW
8'-6"
15'-0"
3'-3"
*B2 DOES NOT STAND ALONE
* G DOES NOT STAND ALONE
* 50 LOADING DOCKS WITH 8 DIRECT
DRIVE INS TO EXHIBIT HALLS
For columns:
1-12
ST TIDE
AU S
RA
NT
RE
28
San Diego Bay
RESTAURANT RESERVATIONS
26'
5'
For columns:
17-22
25-26
3'
For columns
23-24
27-32
Airwall
COLUMN DETAILS
Dimensions are close approximates and
field measurements are recommended.
For columns
17-22
25-26
33-34
Airwall
LOBBY DETAILS
RESTAURANT
RESERVATIONS DESK
29
MEZZANINE LEVEL MEETING ROOMS
San Diego Bay
30
UPPER LEVEL MEETING ROOMS
San Diego Bay
31
SAILS PAVILION
32
MARRIOTT MARQUIS SAN DIEGO MARINA FLOORPLANS
MEETING SPACE
Lobby Level
2012
CABANAS
(LEVEL 1)
PRESIDIO
ROOMS
R
AN
TO C
R HO
R
EY SA
PI NTA
N
ES FE
R RO
O
O OM
M
S S
RESTAURANT & BAR
RESTAURANT
& BAR
TEQUILA
BAR & GRILLE
(LEVEL 1)
BUSINESS
CENTER/
UPS STORE
Level 1
CABANAS
VISTA
TEQUILA
BAR & GRILLE
South Tower - Level 4
South Tower - Level 3
LA JOLLA
PALOMAR
ROOM
MIRAMAR
ROOM
4
CO
NF
ER
LA MESA
EN
CE
RO
O
CATALINA
MS
LA COSTA
DANA POINT
MALIBU
333 WEST HARBOR DRIVE • SAN DIEGO, CALIFORNIA 92101-7700 • PHONE 619-234-1500
33
Room numbers of sessions are listed in the meeting app, the fold-out Schedule-at-a-Glance
Sunday, October 21, 2012
Introducer: Dolores J. Lamb, Ph.D.
12:00 pm - 5:00 pm • Poster Setup
Endowed by a 1987 Grant from Ortho Women’s Health
5:15 pm - 6:00 pm • Members’ Meetings
• Association of Reproductive Managers
• Mental Health Professional Group
• Nurses’ Professional Group
• Early Pregnancy Special Interest Group
• Preimplantation Genetic Diagnosis Special Interest
Group
9:45 am - 10:30 am • Plenary Lecture 2
Society of Reproductive Surgeons Lecture - Surgical
Management of Endometriosis
6:30 pm - 7:30 pm • Opening Ceremony
10:30 am - 11:15 am • Breaks/Exhibits
7:30 pm • Opening Night Party at PETCO Park
(Ticket required for entry)
11:15 am - 1:00 pm • Contraception Day Special Session
Metabolic Effects of Hormonal Contraceptives in
PCOS: Case Presentations
Richard S. Legro, M.D.
SUNDAY
Scientific Program Daily Schedule
Cleveland Clinic
Introducer: Mark Sigman, M.D.
Endowed by a 1999 Grant from Ethicon Endo-Surgery, Inc.
Pennsylvania State University
Monday, October 22, 2012
11:15 am - 1:00 pm • Scientific Program Prize Paper
Abstract Session 1/Special Research Presentation
7:00 am - 12:00 pm • Poster Setup
7:00 am - 9:00 am
Workshop
Hands-on Robotic Surgery Intensive
Ceana H. Nezhat, M.D. (Chair)
11:15 am - 1:00 pm • Society of Reproductive Surgeons
Telesurgery
Robotic Surgery Myomectomy
Steven F. Palter, M.D. (Chair)
Atlanta Center for Special Minimally Invasive Surgery & Reproductive
Medicine
Gold Coast IVF
Antonio R. Gargiulo, M.D. (Surgeon)
Serene S. Srouji, M.D.
Brigham and Women’s Hospital
Gregory T. Fossum, M.D.
11:15 am - 1:00 pm • Symposium
Mental Health Professional Group Symposium - Making
Babies, Raising Babies: A Collaborative Approach to
Ensuring Children’s Well-Being
Madeline L. Feingold, Ph.D. (Chair)
Thomas Jefferson University
Charles E. Miller M.D.
Advanced Gynecologic Surgery Institute
Melinda Henne, M.D.
U.S. Army
Private Practice, Berkley, CA
Dobie Giles, M.D.
Susan Golombok, Ph.D.
Reproductive Specialty Center, Milwaukee
University of Cambridge
Sejal P. Patel, M.D.
Diane Ehrensaft, Ph.D.
Center for Reproductive Medicine, Florida
University of California, San Francisco
Camran R. Nezhat, M.D.
Stanford University
Nurses’ Professional Group Symposium - Fertility
Preservation: Time is of the Essence
Andrea J. Speck-Zulak, N.P., R.N. (Chair)
8:00 am - 8:45 am
Members’ Meetings
• Society for Assisted Reproductive Technology
• Chinese Special Interest Group
• Health Disparities Special Interest Group
• Reproductive Immunology Special Interest Group
• Complementary and Alternative Medicine Group
• Database Management Solutions Group
• Indian Group
• Recurrent Pregnancy Loss Group
• Turkish Group
Oregon Reproductive Medicine
Deborah Mecerod, R.N.
Reproductive Biology Associates
Lynn Westphal, M.D.
Stanford University
Association of Reproductive Managers Symposium
- Using Metrics and Dashboards for Measuring
Productivity in the REI Practice
Rita Gruber, B.A.(Chair)
9:00 am - 9:45 am • Plenary Lecture 1 ARS
President’s Guest Lecture The Animal Research War: Animal Research and
Medical Progress
P. Michael Conn, Ph.D.
Reproductive Medicine Associates of New Jersey
Catherine M. Bergh, M.S.N., R.N.
Paul A. Bergh, M.D.
Oregon National Primate Research Center
34
Continued on Next Page...
MONDAY
_______________________________________
1:00 pm - 2:30 pm • Surgical Tutorial
Tips and Tricks on Management of Endometrioma and
Deep-infiltrating Endometriosis
Grace M. Janik, M.D. (Chair)
Trevor Tejada Berges, M.D.
Women and Infants Hospital of Rhode Island
Christopher M. Estes, M.D., M.P.H.
University of Miami School of Medicine
Reproductive Specialty Center
1:15 pm - 2:15 pm • Interactive Session ARS
Pediatric and Adolescent Gynecology Special Interest
Group Interactive Session - Obesity in Adolescents:
Diagnosis and Management
Michael J. Heard, M.D. (Chair)
Charles H. Koh, M.D.
Cleveland Clinic
Ceana H. Nezhat, M.D.
Heard Clinic
Medicine
Janice L. Bacon, M.D.
Lexington Medical Center
Erik B. Wilson, M.D.
1:15 pm - 2:15 pm • Interactive Session
Meet the Professor Interactive Session
P. Michael Conn, Ph.D.
Carol Wolin Riklin, M.A., R.D., L.D.
University of Texas Medical School
University of Texas Medical School at Houston
Regenerative Medicine and Stem Cell Biology Special
Interest Group Interactive Session - Regenerative Cells
Mahendra Rao, M.D., Ph.D. (Chair)
Oregon National Primate Research Center
Society for Male Reproduction and Urology Interactive
SessionPaternal Age Concerns: What Should We Be Telling
Our Couples?
Grace M. Centola, Ph.D. (Chair)
National Institutes for Health Center for Regenerative Medicine
Gianpiero D. Palermo, M.D., Ph.D.
Weill Cornell Medical College
1:15 pm - 2:15 pm • Roundtable Luncheons
Cryobank Compliance Services
(Non-CME/CE)
Paul J. Turek, M.D.
Turek Clinic
2:45 pm - 3:30 pm • Contraception Day Keynote Lecture
Lessons Learned from Developing Contraceptives
C. Wayne Bardin, M.D.
Edward D. Kim, M.D.
University of Tennessee Graduate School of Medicine
Past President, Population Council; Independent Consultant
Environment and Reproduction Special Interest Group
Interactive Session - Environmental Toxins
Victor Y. Fujimoto, M.D. (Chair)
Introducer: Rebecca H. Allen, M.D.
2:45 pm - 3:30 pm • Plenary Lecture 3
Society for the Study of Reproduction Exchange
Lecture: Role of the Epididymis in the Acquisition of
Male Fertility: How Epithelial Cells Create the Optimal
Luminal Environment for Sperm Maturation
Sylvie Breton, Ph.D.
University of California San Francsico School of Medicine
Kevin G. Osteen, Ph.D.
Vanderbilt University
Kaylon L. Bruner-Tran, Ph.D.
Vanderbilt University School of Medicine
Massachusetts General Hospital
Legal Professional Group and the Society of
Reproductive Biologists and Technologists Interactive
Session - Laboratory and Clinical Errors: Real Life
Pitfalls and How to Avoid Them
Jacob F. Mayer, Jr., Ph.D. (Chair)
Introducer: Linda C. Giudice, M.D.
2:45 pm - 3:30 pm • Surgery Day Keynote Lecture
Surgical Management of Pelvic Pain
Fred M. Howard, M.D.
University of Rochester
Jones Institute for Reproductive Medicine
Susan L. Crockin, J.D.
Introducer: Grace M. Janik, M.D.
Crockin Law & Policy Group
3:00 pm - 5:00 pm • Workshop
C. Brent Barrett, Ph.D.
Boston IVF Laboratory
Contraception Special Interest Group Interactive
Session Standard Laparoscopic Tubal Ligation vs. Bilateral
Salpingectomy for Both Tubal Ligation and Cancer
Prevention: An Interactive Debate
Jeffrey T. Jensen, M.D., M.P.H. (Chair)
Medicine
Melinda Henne, M.D.
Oregon Health and Science University
U.S. Army
35
MONDAY
1:00 pm - 2:45 pm • Lunch Break
Dobie Giles, M.D.
4:15 pm - 6:15 pm • Symposium ARS
The Basics of Comprehensive Chromosomal
Screening: What We All Need to Know for Our Practice
Nathan R. Treff, Ph.D. (Chair)
Stanford University
Mandy Katz-Jaffe, Ph.D.
Colorado Center for Reproductive Medicine
3:30 pm - 4:15 pm • Break/Exhibits
Brynn Levy, Ph.D.
Columbia University
4:15 pm - 6:15 pm • Oral Abstract Sessions
(Non-CME/CE)
University of Kansas Medical Center
S. Samuel Kim, M.D.
Cleveland Clinic
Evelyn Telfer, Ph.D.
The University of Edinburgh
Surgery Day Symposium - Management of Tubal
Disease in the Modern Era
Jeffrey Goldberg, M.D. (Chair)
4:15 pm - 6:15 pm • Symposium
Howard and Georgeanna Jones Symposium on ARTLandmarks in ART: Historical Breakthroughs and
Future Perspectives
Zev Rosenwaks, M.D. (Chair)
Cleveland Clinic
Grace Janik, M.D.
Steven F. Palter, M.D.
Gianpiero D. Palermo, Ph.D., M.D.
Gold Coast IVF
Alan H. Handyside, Ph.D.
Fertility Physicians of Northern California
University of Leeds
Alan O. Trounson, Ph.D.
Legal Professional Group, Society for Male
Reproduction and Urology, and the Society of
Reproductive Biologists and Technologists Symposium
- Assisted Reproduction for the HIV-discordant Couple
Erma Z. Drobnis, Ph.D. (Chair)
California Institute for Regenerative Medicine
Endowed by a 2010 educational grant from EMD Serono,
Inc.
Indian Society for Assisted Reproduction Symposium PCOS: A Comprehensive Review
Dhiraj B. Gada, M.D. (Chair)
University of Missouri Women’s Health Center
Sangita K. Jindal, Ph.D.
Montefiore Institute
Indian Society for Assisted Reproduction
Ann Kiessling, Ph.D.
Narendra A. Malhotra, M.D.
Bedford Research Foundation
Malhotra Hospitals
John Y. Phelps, J.D., Ph.D.
Mandakini Parihar, M.D.
University of Texas Health Branch
Mangal Anand Hospital
5:45 pm - 6:15 pm • Minisymposium
Society for Male Reproduction and Urology
Minisymposium - Drugs, Chemicals and Sperm
Rebecca Z. Sokol, M.D., M.P.H.
Manish R. Banker, M.D.
Nova Pulse IVF Clinics
Surgery Day Symposium - Additional Indications for
Varicocele Repair
Marc Goldstein, M.D. (Chair)
University of Southern California Keck School of Medicine
6:15 pm - 7:00 pm
Members’ Meetings
• Society of Reproductive Surgeons
• Society of Reproductive Biologists and Technologists
• Genetic Counseling Special Interest Group
• Imaging in Reproductive Medicine Special Interest
Group
Armand S. Zini, M.D.
McGill University
Edward D. Kim, M.D.
The University of Tennessee Graduate School of Medicine
36
MONDAY
What Comes After the Big Chill: The Metabolic and
Clinical Consequences of Oocyte and Ovarian Tissue
Cryopreservation - A Look to the Future
David F. Albertini, Ph.D. (Chair)
• Clinical Female Infertility and Gynecology
• Male Reproduction and Urology: Research
• Other: ART - Clinical, Outcome Predictors-Lab: ART
• Regenerative Medicine & Stem Cell Biology
• Reproductive Biology: Animal and Experimental Studies
• Reproductive Endocrinology: Research
• Reproductive Immunology
• Reproductive Laboratory Technology
• Contraception, Fertility Preservation
• Genetic Counseling
• Pediatric and Adolescent Gynecology
• Environment and Reproduction
• Legal Professional Group
• Regenerative Medicine and Stem Cell Biology Special
Interest Group
• Androgen Excess Special Interest Group
• Pediatric and Adolescent Gynecology Special Interest
Group
• Contraception Special Interest Group
Herbert H. Thomas Lecture - The Neurobiology of
Sexuality: It’s Not Just About Testosterone
James G. Pfaus, Ph.D.
Concordia University
Introducer: William E. Gibbons, M.D.
Endowed by a 1992 Grant from EMD Serono, Inc.
_______________________________________
10:30 am - 11:15 am • Breaks/Exhibits
Tuesday, October 23, 2012
11:15 am - 1:00 pm • ASRM Video Program 1
Menopause Day Symposium Perspectives on Depression and Diabetes
Melissa Wellons, M.D. (Chair)
(Non-CME/CE)
With continental breakfast
7:00 am - 9:00 am • Workshop
University of Alabama at Birmingham
Elizabeth Barrett-Connor, M.D.
University of California San Diego
Medicine
Claudio N. Soares, M.D., Ph.D.
McMaster University
11:15 am - 1:00 pm • Scientific Program Prize Paper
Abstract Session 2/Special Research Presentation
MONDAY
7:00 am - 9:00 am • Poster Abstract Session 1
Mental Health Professional Group Symposium - Nature
and Nurture: Epigenetics and Prenatal Environment Implications for the Mental Health Professional
Shelley S. Lee, Ph.D. (Chair)
Melinda Henne, M.D.
U.S. Army
Dobie Giles, M.D.
New York University Langone Medical Center
Columbia University
Benjamin Tycko, M.D., Ph.D.
Stanford University
Columbia University
7:00 am - 8:45 am • Symposium ARS
Menopause Day Symposium Relevance of Progesterone in Mid-Reproductive Years
Lubna Pal, M.B.B.S., M.Sc. (Chair)
11:15 am - 1:00 pm • Symposium ARS
Association of Reproductive Managers Symposium What Successful IVF Practices Do Differently
Robert R. Strickland, M.Ed. (Chair)
Yale University
Independent Consultant
Genevieve Neal-Perry, M.D., Ph.D.
Alan B. Copperman, M.D.
Albert Einstein College of Medicine
Mount Sinai School of Medicine
Sandra A. Carson, M.D.
Joseph J. Travia, M.B.A.
IntegraMed
Julia V. Johnson, M.D.
University of Massachusetts Medical School
Nurses’ Professional Group Symposium Cultural Sensitivity Across Borders
Susan L. Crockin, J.D. (Chair)
8:00 am - 8:45 am • Members’ Meetings
• Latin American Association of Reproductive Medicine
(ALMER)
Crockin Law & Policy Group, Newton, MA
Camran Nezhat, M.D. Lectureship in Innovations in
Medicine - Novel Genetic Tools for the Diagnosis and
Screening of Human Embryos
Dagan Wells, Ph.D.
Susan Gordon-Pinnell, R.N., B.S.N.
Boston IVF
David B. Smotrich, M.D.
La Jolla IVF
University of Oxford
Dagan Wells, Ph.D.
Introducer: William E. Gibbons, M.D.
Endowed by a 2011 Gift from Camran Nezhat, M.D.
University of Oxford
37
TUESDAY
Catherine Monk, Ph.D.
Society for Assisted Reproductive Technology
Interactive Session - PGD: The How and When
G. David Ball, Ph.D. (Chair)
Menopause Day Interactive Session - Hormone Therapy
in Early Menopause
Seattle Reproductive Medicine
Yale University
Paul S. Dudley, M.D.
Hugh S. Taylor, M.D.
Yale University
William G. Kearns, M.D.
Nanette F. Santoro, M.D.
Shady Grove Fertility
University of Colorado Denver
Fertility Preservation Special Interest Group Interactive
Session- Why Ask Why: Should the Reason for Oocyte
Cryopreservation Matter?
Karine Chung, M.D. (Chair)
(Non-CME/CE)
Normal and Premature Puberty: What Is It That Actually
Regulates This?
Ana Claudia Latronico, M.D., Ph.D.
Infertility USC Fertility
Nicole L. Noyes, M.D.
San Paulo University
Introducer: Dolores J. Lamb, Ph.D.
Androgen Excess Special Interest Group Interactive
Session -PCOS Diagnostic Criteria
Antoni J. Duleba, M.D. (Chair)
Endowed by a 1990 Grant from AstraZeneca
2:45 pm - 3:30 pm • Menopause Day Keynote Lecture
A Decade Since the Women’s Health Initiative
Roger A. Lobo, M.D.
University of California, Davis
Columbia Presbyterian Medical Center
University of California San Francisco
Richard S. Legro, M.D.
Introducer: Lubna Pal, M.B.B.S., M.Sc.
3:00 pm - 5:00 pm • Workshop
Imaging in Reproductive Medicine Special Interest
Group and the Chinese Special Interest Group
Interactive Session -Imaging of the Embryo vs. Imaging
of the Embryo Transfer for Maximizing Pregnancy
Rates
Ilan Tur-Kaspa, M.D. (Chair)
TUESDAY
Atlanta Center for Special Minimally Invasive
Surgery & Reproductive Medicine
Institute of Human Reproduction
Edmond Confino, M.D.
Northwestern University
Melinda Henne, M.D.
U.S. Army
Society for Reproductive Endocrinology and Infertility
Interactive Session: A Nonviable Early Pregnancy,
When and How Do You Intervene?
Kurt T. Barnhart, M.D. (Chair)
Dobie Giles, M.D.
University of Pennsylvania
Stanford University
Mary D. Stephenson, M.D., M.Sc.
University of Chicago Pritzker School of Medicine
3:30 pm - 4:15 pm • Breaks/Exhibits
Ruth B. Lathi, M.D.
4:15 pm - 6:15 pm • ASRM Video Program 2
Stanford University
ARS
Society of Reproductive Surgeons Interactive
Session:
Minimally Invasive Myoma Therapy - Myomectomy,
UAE, and MRgFUS
Charles E. Miller, M.D. (Chair)
4:15 pm - 6:15 pm • Oral Abstract Sessions
(Non-CME/CE)
• Reproductive Surgery
• Imaging and ART Imaging
• Male Reproduction and Urology: Traveling Scholars
• Menopause, Mental Health
• Outcome Predictors-Clinical: ART
• Ovarian Stimulation – High Responders: ART
• Preimplantation Genetic Diagnosis
• Procedures and Techniques-Clinical: ART
• Reproductive Biology: Human Studies
Elizabeth A. Stewart, M.D.
Mayo Clinic
Steven J. Smith, M.D.
LaGrange Memorial Hospital, Illinois
38
• Reproductive Endocrinology: Fellows Research
• Nutrition
• Sexuality
William D. Petok, Ph.D.
Private Practice, Maryland
Mohit Khera, M.D.
Baylor College of Medicine
KY Cha Symposium in Stem Cell Technology and
Regenerative Medicine - Challenges and Opportunities
for Stem Cell Based Therapies
Lawrence S.B. Goldstein, Ph.D. (Chair)
Middle East Fertility Symposium - An OHSS-Free IVF
Clinic: Should This Be a Goal and Is It Possible?
Suheil J. Muasher, M.D. (Chair)
Duke University
James M. Goldfarb, M.D.
Amander Clark, Ph.D.
Cleveland Clinic
University of California Los Angeles
Paul Devroey, M.D., Ph.D.
Dieter Egli, Ph.D.
Centre for Reproductive Medicine, Brussels
New York Stem Cell Foundation
Botros B. Rizk, M.D.
Endowed by a 2011 Gift from the Asia-Pacific Biomedical
Research Foundation
University of South Alabama
Minisymposium
Detecting and Treating Male Factor Infertility
Gianpiero D. Palermo, M.D., Ph.D.
Ken Ryan Ethics Symposium - Multiple Pregnancy and
ART
Bonnie Steinbock, Ph.D. (Chair)
University at Albany - SUNY
University of Iowa
European Society of Human Reproduction and
Embryology Exchange Symposium - Scientific and
Social Aspects of Fertility Preservation
Anna Veiga, Ph.D. (Chair)
Servei de Medicina de l’Institut Universitari Dexeus
Helen M. Picton, Ph.D.
University of Leeds
_______________________________________
Guido Pennings, Ph.D.
Ghent University
Ursula Eichenlaub-Ritter, M.D., Ph.D.
Wednesday, October 24, 2012
Universität Bielefeld
7:30 am - 8:45 am • Women’s Council Breakfast
Latin American Association of Reproductive Medicine
Symposium - Challenges in Assisted Reproduction
Carlos E. Sueldo, M.D. (Chair)
7:00 am - 9:00 am • Poster Abstract Session 2
(Non-CME/CE)
With continental breakfast
Women’s Speciality Fertility Center, Clovis, CA
The Jones Institute, Eastern Virginia Medical School
Robert J. Casper, M.D.
University of Toronto
Z. Peter Nagy, M.D., Ph.D.
Harvard Reproductive Endocrine Sciences Center
Androgen Excess Special Interest Group and
the Society for Male Reproduction and Urology
Symposium - Androgen Use and Abuse in the Male
and Female: What All Reproductive Clinicians Need to
Know
Ajay K. Nangia, M.D. (Chair)
Introducer: Robert D. Oates, M.D.
9:45 am - 10:00 am • ASRM Awards Ceremony
10:00 am - 10:30 am • ASRM Members’ Meeting
10:30 am - 11:15 am • Break/Exhibits
11:15 am - 1:00 pm • AAGL Film Festival
Rebecca Z. Sokol, M.D.,M.P.H.
University of Southern California Keck School of Medicine
39
WEDNESDAY
American Urological Association Bruce Stewart
Memorial Lecture - Identifying the Genes that Control
Reproduction Using a Human Disease Model
William F. Crowley, Jr., M.D.
Sergio C. Oehninger, M.D., Ph.D.
TUESDAY
6:15 pm - 7:00 pm
Members’ Meetings
• Society for Male Reproduction and Urology
• Society for Reproductive Endocrinology and Infertility
• Endometriosis Special Interest Group
• Fertility Preservation Special Interest Group
• Fibroid Special Interest Group
• Menopause Special Interest Group
• Nutrition Special Interest Group
• Environment and Reproduction Special Interest Group
• Sexuality Special Interest Group
Bradley J. Van Voorhis, M.D.
11:15 am - 1:00 pm • Oral Abstract Sessions
11:15 am - 1:00 pm • Symposium ARS
Society of Reproductive Biologists and Technologists
and Society for Male Reproduction and Urology
Symposium - Is the Basic Semen Analysis Still Valuable
or Is Sperm Function Testing the Best Way to Assess
Male Reproductive Capacity?
Amy E. Sparks, Ph.D. (Chair)
(Non-CME/CE)
• Androgen Excess
• Cryopreservation and Frozen Embryo Transfer – Clinical:
ART
• Endometriosis
• Fertility Preservation
• Fibroid
• Male Factor: ART
• Ovarian Stimulation – Poor Responders: ART
• Procedures and Techniques-Laboratory: ART
• Reproductive Endocrinology: Clinical
• Nursing
University of Iowa
McGill University
Sergio C. Oehninger, M.D., Ph.D.
The Jones Institute, Eastern Virginia Medical School
Michael W. Vernon, Ph.D.
West Virginia University Center for Reproductive Medicine
Mental Health Professional Group Symposium Transparency in Surrogate Arrangements: The Good,
The Bad, The Forgettable
Elaine R. Gordon, Ph.D. (Chair)
William F. Crowley, Jr., M.D.
Harvard Reproductive Endocrine Sciences Center
Health Disparities Special Interest Group Interactive
Session - Healthcare Reform: Is it Good Medicine for
All Women?
Gloria Richard-Davis, M.D. (Chair)
Santa Monica/University of California Los Angeles Hospital
Patricia A. Mendell, M.S.W.
Private Practice, New York
Richard J. Paulson, M.D.
University of Southern California
Andrew W. Vorzimer, J.D.
Meharry Medical College
Vorzimer and Masserman, P.C.
David S. Guzick, M.D., Ph.D.
Nurses’ Professional Group Symposium - Ready or
Not, Here We Come: Managing Regulatory Inspections
from Big to Small Practices
Marsha H. Deweese, R.N.C., M.S. (Chair)
University of Florida
Reproductive Immunology Special Interest Group
Interactive Session - Antisperm Antibodies
Grace M. Centola, Ph.D. (Chair)
Shady Grove Fertility Reproductive Science Center
Carol Levy, B.S.N.
Kathi Bernat, B.S.N.
Cryobank Compliance Services
Reproductive Endocrinology Associates of Charlotte
Ajay K. Nangia, M.D.
Association of Reproductive Managers Symposium Modernizing the Patient Experience in Reproductive
Medicine
Kira Copperman, L.M.S.W. (Chair)
Erma Z. Drobnis, Ph.D.
University of Missouri
Endometriosis Special Interest Group Interactive
Session- The Value of Removing Endometriomas
Pamela Stratton, M.D. (Chair)
KBC Consulting
Sharon L. LaMothe
LaMothe Surrogacy Consulting
Douglas Weiss
Fertility Preservation Special Interest Group and the
Symposium - Fertility, Maternal and Offspring Health in
Women Subsequent to Cancer and its Treatment: What
is Known, What is Safe, What is Appropriate
Elizabeth S. Ginsburg, M.D. (Chair)
Paolo Vercellini, M.D.
University of Milan
Louise Wilkins-Haug, M.D., Ph.D.
Imaging in Reproductive Medicine Special Interest
Group Interactive Session - The Best Imaging Modality
for Uterine Anomalies and Effect on Pregnancy Rates
Ilan Tur-Kaspa, M.D. (Chair)
Jacques G. Donnez, M.D.
Beth W. Rackow, M.D.
Nicole L. Noyes, M.D.
Laurel A. Stadtmauer, M.D., Ph.D.
Brigham & Women’s Hospital
Brigham & Women’s Hospital
Institute of Human Reproduction
Universite Catholique de Louvain
Columbia University
Eastern Virginia Medical School
40
WEDNESDAY
Eunice Kennedy Schriver National Institute of Child Health and Human
Development
IntegraMed
• Male Reproduction and Urology: Clinical
• Other: ART – Laboratory/Basic
• Ovarian Stimulation: ART
• Procedures and Techniques-Laboratory: ART
Fibroid Special Interest Group Interactive SessionEliminating Uterine Fibroids: To Prevent or Treat
Erica E. Marsh, M.D. (Chair)
Phyllis C. Leppert, M.D., Ph.D.
Duke University
Ayman Al-Hendy, M.D., Ph.D.
Session will be presented in Spanish
Asociación Mexicana de Medicina de la Reproducción
Exchange Symposium -Trastornos Reproductivos
Endocrinos y Metabólicos en Diferentes Poblaciones
Incluyendo Migración
Ranferi Gaona-Arreloa, M.D.(Chair)
Nutrition Special Interest Group Interactive SessionPCOS: Comparing Nutritional Intervention with
“Standard” Medical Therapy
Kaylon L. Bruner-Tran, Ph.D. (Chair)
Vanderbilt University
Hospital Luis Castelazo Ayala
Gilbert B. Wilshire, II, M.D.
Carlos Moran, M.D.
Mid-Missouri Reproductive Medicine and Surgeons, Inc.
Mexican Institute of Social Security
Antoni J. Duleba, M.D.
Efrain Perez-Pena, M.D., Ph.D.
University of California, Davis
Instituto Vida Guadalajara
Society of Reproductive Surgeons Interactive Session:
Cryptospermia: TESA vs. Ejaculated Sperm for ICSI?
Peter Chan, M.D. (Chair)
Richard J. Paulson, M.D.
Keck School of Medicine
Chinese Society for Reproductive Medicine Symposium
- Reproductive Medicine in China: Genetics, PGD, and
Recurrent Implantation Failure
Zi-Jiang Chen, M.D. (Chair)
McGill University Health Center
Paul J. Turek, M.D.
Turek Clinic
Peter N. Schlegel, M.D.
Shadong University
Canquan Zhou, M.D.
Sun Yat-sen University
(Non-CME/CE)
Jie Qiao, M.D., Ph.D.
Peking University Third Hospital
2:00 PM • Exhibits & Posters Close
Society for Male Reproduction and Urology - Stem Cell
Developments and Medical Applications
Alan O. Trounson, Ph.D.
The Genetic Basis of Female Reproductive Failure:
What Every Reproductive Clinician Should Know
Lawrence C. Layman, M.D.
California Institute for Regenerative Medicine
Georgia Health Sciences University
Introducer: Richard H. Reindollar, M.D.
Endowed by a 1990 grant from TAP Pharmaceuticals
Hormonal Aging in Women
WEDNESDAY
Introducer: Roger A. Lobo, M.D.
Endowed by a 1992 grant from Wyeth
3:30 pm - 3:45 pm • Break
3:45 pm - 5:45 pm
Oral Abstract Sessions
(Non-CME/CE)
• Cryopreservation and Frozen Embryo Transfer–
Laboratory/Basic: ART
• Endometriosis
• Health Disparities
41
MENOPAUSE
DAY DAY
CONTRACEPTION
TUESDAY,
OCTOBER22,
26,2012
2010
MONDAY, OCTOBER
Redefining
the Spectrum
Menopause
Contraception
AcrossofSpecialties
Supported by for
an educational
grantCentury
by TEVA Women's Health
the 21st
11:15 am - 1:00 pm • Contraception Day Special Session
Metabolic
of Hormonal
Contraceptives
in PCOS:
11:15 amEffects
- 1:00 pm
• MENOPAUSE
DAY WORKSHOP
Traditional Hormone
Is There Still a Need?
CaseTherapy:
Presentations
Richard
Legro,
M.D.
Virginia M.S.Miller,
Ph.D.
Mayo
Clinic
Penn State University
Selective Estrogen Receptor Modulators and Tissue Selective Estrogen Complexes
Contraception Special Yale
Interest
Group Interactive Session University
Standard Laparoscopic Tubal Ligation vs. Bilateral Salpingectomy for Both Tubal
Ligation and Cancer Prevention: An Interactive Debate
1:15 pm – 2:15Jeffrey
pm • T.MENOPAUSE
INTERACTIVE
Jensen, M.D.,DAY
M.P.H.
(Chair) SESSION
Cardiovascular Risk in Menopause:
Clinical
Tools
and
Effects of Hormone Therapy
Oregon Health and Science University
Presented by the Menopause Special Interest Group
Trevor
Tejada Berges, M.D.
Women
and Infants
Hospital
of Rhode Island
University
of California
San Francisco
Christopher M. Estes, M.D., M.P.H.
University of Miami School of Medicine
2:15 pm – 2:45 pm • BREAK
1:15 pm - 2:15 pm • Contraception Roundtables
2:45 pm – 3:30 pm • MENOPAUSE DAY KEYNOTE LECTURE
Emergency
for theMenopause?
Obese Patient
What Can a Contraception
SWAN Teach Us About
Jennifer
Salcedo,
M.D.,
Nanette
F. Santoro,
M.D.M.P.H.
University
of
Colorado
Denver
University of California
Anemias, Bleeding Disorders, and Coagulopathies: Contraceptive Considerations
3:30 pm – 4:15 pm • BREAK • EXHIBIT HALL
Tania Basu Serna, M.D
4:15 pm – 6:15 pm • MENOPAUSE ORAL ABSTRACT SESSION
2:45 pm - 3:30 pm • Contraception Day Keynote Lecture
Lessons Learned from Developing Contraceptives
6:15 pm – 7:00 pm • MENOPAUSE SPECIAL INTEREST GROUP MEMBERS’ MEETING
C. Wayne Bardin, M.D.
Past President, Population Council; Independent Consultant
4:15 pm - 6:15 pm • Contraception Day Abstract Session
6:15 pm - 7:00 pm • Contraception Special Interest Group Members' Meeting
42
SURGERY DAY
MONDAY, OCTOBER 22, 2012
Who? When? How?
7:00 am - 9:00 am • Hands-on Robotic Surgery Intensive
Ceana H. Nehzat, M.D. (Chair)
Atlanta Center for Special Minimally Invasive Surgery and Reproductive Medicine
Brigham and Women's Hospital
Charles E. Miller, M.D.
Melinda Henne, M.D.
U.S. Army
Dobie Giles, M.D.
Camran R. Nehzat, M.D.
Stanford University
Pre-registration required (no fee)
Society of Reproductive Surgeons Lecture
Surgical Management of Endometriosis
Cleveland Clinic
11:15 am - 1:00 pm • Society of Reproductive Surgeons Telesurgery
Robotic Surgery Myomectomy
Steven F. Palter, M.D. (Chair)
Gold Coast IVF
Antonio R. Gargiulo, M.D. (Surgeon)
1:00 pm - 2:30 pm • Surgical Tutorial
Tips and Tricks on Management of Endometrioma and Deep-infiltrating
Endometriosis
Grace M. Janik, M.D. (Chair)
Cleveland Clinic
Charles H. Koh, M.D.
Atlanta Center for Special Minimally Invasive Surgery & Reproductive Medicine
43
(SURGERY DAY CONTINUED)
1:15 pm - 2:15 pm • Surgery Day Roundtables
MicroTESE
Vasectomy
2:45 pm - 3:30 pm • Surgery Day Keynote Lecture
Surgical Management of Pelvic Pain
Fred M. Howard, M.D.
University of Rochester
3:00 pm - 5:00 pm • Hands-on Robotic Surgery Intensive
Pre-registration required (no fee)
4:15 pm - 6:15 pm • Surgery Day Symposium
Additional Indications for Varicocele Repair
Peter T. K. Chan, M.D. (Chair)
ARS
McGill University
Edward D. Kim, M.D.
The University of Tennessee Graduate School of Medicine
4:15 pm - 6:15 pm • Surgery Day Symposium ARS
Management of Tubal Disease in the Modern Era
Jeffrey Goldberg, M.D. (Chair)
Cleveland Clinic
Grace M. Janik, M.D.
Steven F. Palter, M.D.
Gold Coast IVF
4:15 pm – 6:15 pm • Reproductive Surgery Oral Abstract Session
6:15 pm – 8:00 pm • Society of Reproductive Surgeons
Members' Meeting and Reception
44
MENOPAUSE DAY
TUESDAY, OCTOBER 23, 2012
Redefining Menopause Management:
From WHI to KEEPS
7:00 am - 8:45 am • Symposium ARS
Menopause Day Symposium - Relevance of Progesterone in
Mid-Reproductive Years
Yale University
Genevieve Neal-Perry, M.D., Ph.D.
University of Massachusetts Medical School
Menopause Day Symposium - Perspectives on Depression and Diabetes
Melissa Wellons, M.D. (Chair)
Elizabeth Barrett-Connor, M.D.
Claudio N. Soares, M.D., Ph.D.
McMaster University
Menopause Day Interactive Session - Hormone Therapy in Early Menopause
Yale University
Yale University
Nanette F. Santoro, M.D.
University of Colorado Denver
2:45 pm - 3:30 pm • Menopause Day Keynote Lecture
A Decade Since the Women’s Health Initiative
Roger A. Lobo, M.D.
Columbia Presbyterian Medical Center
4:15 pm – 6:15 pm • Menopause Oral Abstract Session
6:15 pm – 7:00 pm • Menopause Special Interest Group Members' Meeting
45
OVARIAN RESERVE: REGULATION AND
IMPLICATIONS FOR WOMEN’S HEALTH
Sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development
and the American Society for Reproductive Medicine
Thursday, October 25, 2012 • 7:30 am – 3:30 pm
Manchester Grand Hyatt San Diego Hotel • San Diego, CA
Organizing Committee: David Albertini, Clarisa Gracia, Andrew La Barbera,
Charisee Lamar, Robert Rebar, Susan Taymans
NEEDS ASSESSMENT AND DESCRIPTION
Only a tiny fraction of the ovarian primordial follicles present at birth will survive to mature and
ovulate. This pool of follicles is the ovarian reserve. In theory, snapshots of ovarian reserve over time
might indicate a woman’s maximum reproductive potential and the time remaining until menopause,
with critical implications for women’s fertility and overall health. However, the biomarkers of ovarian
reserve that are currently available are not adequate to make such predictions. This live conference
of reproductive medicine physicians and reproductive biologists will address current questions
surrounding ovarian reserve: How is the follicle pool established and regulated? What is the stateof-the-science for the measurement of ovarian reserve, and can we develop robust predictive
measurements? What are the possible clinical implications of measures of ovarian reserve? How do
reproductive or systemic diseases and their treatment affect ovarian reserve? What is the future of
science in the realm of ovarian reserve, in terms of measurement, clinical implications, and potential for
manipulation?
LEARNING OBJECTIVES
At the conclusion of this conference, participants should be able to:
1. Describe the establishment and regulation of the primordial follicle pool.
2. Critically assess biomarkers of and methods to estimate ovarian reserve.
3. Discuss the implications of diminished ovarian reserve to a woman’s health and fertility.
4. Speculate on how might advances in gene profiling and stem cell biology extend or restore
fertility in aging or disease states.
Keynotes:
Roger Gosden, Marcelle Cedars
Session I: Establishment and Regulation of the Primordial Follicle Pool
Diego Castrillon, Aaron Hsueh, Richard Stouffer
Session II: Session III: Session IV: Measurement of Ovarian Reserve
Richard Anderson, Anne Steiner, Joanne Murabito
Clinical Considerations for Ovarian Reserve
Kutluk Oktay, Clarisa Gracia, R. Jeffrey Chang
Advances on the Horizon
Aleks Rajkovic, David Albertini, Jonathan Tilly
ACCME Accreditation:The American Society for Reproductive Medicine is accredited by the Accreditation Council
for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)™: The American Society for Reproductive Medicine designates this live activity for
a maximum of 5.5 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the
extent of their participation in the activity. Registration
46 Fee: $125
GROUP AND AFFILIATED SOCIETY MEMBERS' MEETINGS
Sunday, October 21, 2012 • 5:15 pm - 6:00 pm
Nurses’ Professional Group
Mental Health Professional Group
Association of Reproductive Managers
Preimplantation Genetic Diagnosis Special Interest Group
Early Pregnancy Special Interest Group
__________________________________________________________________________________________
Monday, October 22, 2012 • 8:00 am - 8:45 am
Society for Assisted Reproductive Technology
Reproductive Immunology Special Interest Group
Health Disparities Special Interest Group
Chinese Special Interest Group
Complementary and Alternative Medicine Group
Indian Group
Recurrent Pregnancy Loss Group
Turkish Group
__________________________________________________________________________________________
Monday, October 22, 2012 • 6:15 pm - 7:00 pm
Society of Reproductive Surgeons
Society of Reproductive Biologists and Technologists
Genetic Counseling Special Interest Group
Imaging in Reproductive Medicine Special Interest Group
Legal Professional Group
Regenerative Medicine and Stem Cell Biology Special Interest Group
Androgen Excess Special Interest Group
Pediatric and Adolescent Gynecology Special Interest Group
Contraception Special Interest Group
__________________________________________________________________________________________
Tuesday, October 23, 2012 • 8:00 am - 8:45 am
Latin American Association of Reproductive Medicine (ALMER)
__________________________________________________________________________________________
Tuesday, October 23, 2012 • 6:15 pm - 7:00 pm
Endometriosis Special Interest Group
Fertility Preservation Special Interest Group
Fibroid Special Interest Group
Menopause Special Interest Group
__________________________________________________________________________________________
Wednesday, October 24, 2012 • 10:00 am - 10:30 am
ASRM Members’ Meeting
Room numbers of sessions are listed in the meeting app, the fold-out
Schedule-at-a-Glance and on signage throughout the convention center.
47
ROUNDTABLE LUNCHEONS
1:15 pm - 2:15 pm
RTM01
ANDROGEN EXCESS
Polytherapy in PCOS - How Much is Too
Much?
Anuja Dokras, M.D., Ph.D.
University of Pennslyvania
RTM02
ASSISTED REPRODUCTIVE TECHNOLOGY
Management of Risk in the IVF
Laboratory
Kathryn J. Go, Ph.D.
Integramed
RTM03
Oocyte Cryopreservation: Slow or Fast
Freeze?
Z. Peter Nagy, Ph.D.
RTM04
Mining the SART Database
Judy E. Stern, Ph.D.
Dartmouth College
RTM05
Ovarian Hyperstimulation Syndrome-Prevention and Management
Mohamed A. Aboulghar, M.D.
Cairo University
RTM06
CHINESE
Social Fertility Preservation
Seang Lin Tan, M.D., M.B.A.
McGill Reproductive Centre
RTM07
CONTRACEPTION
Emergency Contraception for the
Obese Patient
Jennifer Salcedo
RTM08
CONTRACEPTION
Anemias, Bleeding Disorders, and
Coagulopathies: Contraceptive
Considerations
Tania Basu Serna
RTM09
ENDOMETRIOSIS
Animal Models for Studying
Endometriosis
Kathy L. Sharpe-Timms, Ph.D.
RTM10
ENDOMETRIOSIS
Biomarkers for the Diagnosis of
Endometriosis
Thomas M. D’Hooghe, M.D., Ph.D.
RTM11
ENDOMETRIOSIS
Common Sense Management of
Endometriosis
Paolo Vercellini, M.D.
University of Milan
RTM21
MENTAL HEALTH
The Burden of Choice: Helping
Couples Cope with Negative Results of
Prenatal Testing
Joann P. Galst, Ph.D.
Private Practice, New York
RTM12
FERTILITY PRESERVATION
Fertility Preservation in Female Cancer
Patients
Clarisa R. Gracia, M.D., M.S.C.E.
RTM22
NURSES
Egg Donor Recruitment and Retention
Maria M. Jackson, R.N.
RTM13
GENETIC COUNSELING
Incorporating Genetic Counseling Into
Your Practice: Benefits for You and Your
Patients
Lauri Black, M.S.
RTM23
NUTRITION
The Influence of Chinese Medicine/
Herbs on Reproduction
Daoshing Ni, Ph.D., M.B.A.
RTM14
IMAGING IN REPRODUCTIVE MEDICINE
Ultrasound Findings of Asymptomatic
Adnexal Masses
Elizabeth E. Puscheck, M.D.
RTM24
PREIMPLANTATION GENETIC DIAGNOSIS
The Application of PGD for Single Gene
Disorders and Aneuploidy Screening of
Embryos in a Clinical Practice
Mark D. Johnson, M.D.
Pacific Reproductive Genetic Counseling
Wayne State University School Of Medicine
RTM15
MALE REPRODUCTION AND UROLOGY
Sperm Banking and the Cancer Patient
Daniel H. Williams, M.D.
University of Wisconsin
RTM16
Sperm Retrieval in Men with Spinal
Cord Injury
Nancy L. Brackett, Ph.D.
University of Miami Miller School of Medicine
RTM17
The Andrology Lab and Treatment of
HIV-discordant Couples
Erma Z. Drobnis, M.D., Ph.D.
University of Missouri-Columbia
RTM18
MENOPAUSE
Managing Menopause in Cancer
Survivors
H. Irene Su, M.D., M.S.C.E.
RTM19
MENOPAUSE
Contraceptive Needs of Women in
Menopause Transition
University of Massachusetts
RTM20
MENTAL HEALTH
Recipient Consultation: Evaluation or
Education
Madeline L. Feingold, Ph.D.
Private Practice, California
Leuven University Fertility Center
Institute for Reproductive Medicine and
Science
Yo San University of Traditional Chinese Medicine
Arizona Reproductive Medicine Specialists
RTM25
REPRODUCTIVE BIOLOGY AND
TECHNOLOGY
Small Shop’s Big Strategy: Adapting
New Technologies and Equipment into
a Small IVF Laboratory
T. Arthur Chang, Ph.D.
University of Texas Health Science Center, San
Antonio
RTM26
TECHNOLOGY
Moving Your Program to All Day 5
Transfers: Be Brave
Alison Coates, B.Sc.
Oregon Reproductive Medicine
RTM27
TECHNOLOGY
How the Actions of Your Neighbors
Can Influence Your Clinical Outcomes:
HVAC System, Air Filtration and IVF
Laboratory Design - Critical Lessons
Learned Over 10 years
Kathryn C. Worrilow, Ph.D.
RTM28
REPRODUCTIVE ENDOCRINOLOGY AND
INFERTILITY
New Tests of Ovarian Reserve
Barbara J. Stegmann, M.D.
University of Iowa
RTM29
INFERTILITY
Obesity and Fertility
Emily S. Jungheim, M.D.
Washington University in St. Louis
48
RTM30
INFERTILITY
IVF and Childhood Outcomes: What is
the Risk?
Suleena Kansal Kalra, M.D., M.S.C.E.
RTM31
REPRODUCTIVE MEDICINE AND STEM
CELL
What is the ESCRO Committee and Can
Donated Embryos Be Used for Stem Cell
Research?
Pasquale Patrizio, M.D.
Yale Fertility Center
RTM32
REPRODUCTIVE IMMUNOLOGY
Antichlamydial Antibodies and Tubal
Infertility
Mira Aubuchon, M.D.
RTM33
REPRODUCTIVE MANAGERS
Social Media and the REI Practice
Kenan Omurtag, M.D.
Washington University in St. Louis
RTM34
SURGERY
MicroTESE
Cornell University
RTM35
SURGERY
Vasectomy
Cornell University
______________________________________
1:15 pm - 2:15 pm
RTT01
ANDROGEN EXCESS
PCOS Diet-Consensus and Controversy
Mira Aubuchon, M.D.
RTT02
Fertility Preservation with Oocyte IVM
followed by Vitrification
Ri-Cheng Chian, Ph.D.
McGill University
RTT03
Evidence-Based Recurrent Pregnancy
Loss
John A. Schnorr, M.D.
Medical University of South Carolina
RTT04
Hormonal and Epigenetic Influences in
Obesity
Gerard S. Letterie, M.D.
Integramed
RTT05
Embryo Donation: Motivating Donors
and Choosing Embryo Recipients
Craig R. Sweet, M.D.
Embryo Donation International
RTT06
ENVIRONMENT AND REPRODUCTION
Environmental Contaminants and
Oocyte Quality
Victor Y. Fujimoto, M.D.
University of California, San Francisco
RTT07
FIBROIDS
Medical Options for the Treatment of
Fibroids
Erica E. Marsh, M.D.
RTT08
GENETIC COUNSELING
Genetic Screening for Gamete Donors:
What’s New?
Amy C. Vance, M.S.
Bay Area Genetic Counseling
RTT09
HEALTH DISPARITITES
Racial and Ethnic Influences in ART
Outcomes
Alicia Y. Armstrong, M.D.
National Institutes of Health
RTT10
IMAGING
Uterine Anomalies
Silvina Bocca, M.D., Ph.D.
The Jones Institute for Reproductive Medicine
49
RTT11
LEGAL
Incorporating SART Model Consents
Into Daily Practice
Nidhi Desai, J.D.
Ballard, Desai & Miller
RTT12
Social Media and Your Fertility Practice
Paul J. Turek, M.D.
The Turek Clinic
RTT13
Office Andrology: Lab Set-up, Testing,
Licensing and Regulations
Grace M. Centola, Ph.D.
CryoBank Compliance Services
RTT14
HPV Vaccination and Management for
the Male
Darius A. Paduch, M.D.
Cornell University
RTT15
MENTAL HEALTH
Weight Loss and Infertility: For Women
with a BMI of 35+
Alice D. Domar, Ph.D.
Boston IVf
RTT16
MENTAL HEALTH
Developing a Professional Community
Bonnie C. Cochran, M.S.W.
Counseling Services, LLC
RTT17
MENTAL HEALTH
Obtaining a Truly Informed Consent:
The Role of the Mental Health
Professional
Judith E. Horowitz, Ph.D.
Private Practice, Florida
RTT18
NURSES
Annual Screening Check List: Habitual
Loss, Genetic Screening and Karyotype
Catherine M. Bergh, M.S.N., R.N.
Reproductive Medicine Associates of New
Jersey
RTT19
NURSES
In Cycle Nursing Care: From Protocols
to Triggers
Jacqueline B. Ferris, B.A., R.N.
University of California, San Francisco Center for
Reproductive Health
RTT20
NUTRITION
Preconceptional Care for the MotherTo-Be: What Should She Be Eating to
Support her Fertility?
Dian Shepperson-Mills, M.A.
The Endometriosis and Fertility Clinic
RTT21
Current Status and Future Directions of
Preimplantation Genetic Diagnosis
William J. Butler, M.D.
RTT30
REPRODUCTIVE MANAGERS
Solutions for the Small Practice or Solo
Practioner
Joseph J. Travia, Jr., M.B.A.
RTT22
Using Next Generation Sequencing
Santiago Munné, Ph.D.
RTT31
REGENERATIVE MEDICINE AND STEM
CELL
Oncofertility Options for Boys
Kyle Orwig, Ph.D.
RTT23
TECHNOLOGY
Choosing a Vitrification System: Ten
Things to Consider
James J. Stachecki, Ph.D.
RTT32
SEXUALITY
Sexual Issues in the Setting of Infertility
Terri L. Woodard, M.D.
Central Georgia Fertility Institute
Reprogenetics
Innovative Cryo Enterprises, LLC
RTT24
TECHNOLOGY
Navigating Your Research Proposal
Through the IRB
Susan A. Gitlin, Ph.D.
The Jones Institute for Reproductive Medicine
RTT25
TECHNOLOGY
Good Tissue Banking Practices for
Long-term Storage of Gametes and
Embryos
Marybeth Gerrity, Ph.D., M.B.A.
Reproductive Biology Resources, Inc
RTT26
INFERTILITY
Providing a Gestational Carrier
Program - Issues and Experience
Ginny L. Ryan, M.D.
Integramed
University of Pittsburgh School of Medicine
Wayne State University School of Medicine
RTT33
SURGERY
Tips & Tricks for Robot-assisted
Laparoscopic Myomectomy &
Endometriosis Resection
Arnold P. Advincula, M.D.
University of Central Florida
RTT34
SURGERY
Treatment of Deep-infiltrating
Endometriosis
Atlanta Center for Special Minimally Invasive
Surgery & Reproductive Medicine
RTT35
SURGERY
Management of Asherman’s Syndrome
Keith B. Isaacson, M.D.
Partners Healthcare
______________________________________
1:15 pm - 2:15 pm
RTW01
Being Prepared to Handle Potentially
Major Laboratory Error
Dennis W. Matt, Ph.D.
Virginia IVF and Andrology Center
RTW02
Blastocyst Vitrification: What Works
Best?
Joe Conaghan, Ph.D.
Pacific Fertility Center, San Francisco
RTW03
Strategies to Avoid OHSS
Judith L. Albert, M.D.
Reproductive Health Specialists
RTW04
Ultrasound Diagnosis of Adenomyosis
Adelina M. Emmi, M.D.
Reproductive Laboratories of Augusta
RTW05
What Current Methods Should Be Used
in the IVF Lab and When Should New
Technology Be Considered?
Christopher L. Barratt, Ph.D.
The University of Dundee
RTW06
ENDOMETRIOSIS
Endometriosis and Progesterone
Resistance
Steven L. Young, M.D., Ph.D.
University of North Carolina School of Medicine
RTW07
ENDOMETRIOSIS
Evidence-Based Management of
Ovarian Endometriomas
Luciano G. Nardo, M.D.
University of Iowa Carver College of Medicine
RTT27
INFERTILITY
Uterine and Ovarian Blood Flow in the
Prediction of Pregnancy in Infertile
Patients
Ernest H. Ng, M.D.
Gyne Health
RTW08
ENVIRONMENT AND REPRODUCTION
Environmental Contaminants and
Tissue Fibrosis
Michael P. Diamond, M.D.
The University of Hong Kong
Wayne State University
RTT28
INFERTILITY
Screening Ovarian Reserve
Amber R. Cooper, M.D., M.Sc.
RTW09
FERTILITY PRESERVATION
The Current Status of Oocyte
Cryopreservation - Slow Freeze and
Vitrification
Mary M. Francis, E.L.D.
Washington University
RTT29
INFERTILITY
Starting a Fertility Preservation Program
Michelle L. Matthews, M.D.
USC Fertility-UCAR Surgery Center
RTW10
FIBROID
Vitamin D and Uterine Fibroids
Sunil K. Halder, Ph.D.
Carolinas Medical Center
50
RTW11
LEGAL
Treating Patients/Minimizing Conflict:
Legal Aspects of Treating Same Sex
Couples
Reagan N. Rasnic, J.D.
RTW21
MENTAL HEALTH
Not If...But When and How: The
Strengths, Limitations, and Risks of
Internet Counseling
Windy Ezzell, M.A.
RTW29
INFERTILITY
Clinical Characteristics Associated with
Uterine Fibroid Growth
William C. Dodson, M.D.
RTW12
The Role of Sperm Cell in Early
Embryogenesis
Douglas T. Caroll, Ph.D.
RTW22
NURSES
Coordinating a Third Party
Reproduction Program
Holly A. Hughes, B.S.N.
RTW30
INFERTILITY
Diminished Ovarian Reserve:Treatment
Strategies
Valerie L. Baker, M.D.
RTW13
Reactive Oxygen Species and Male
Infertility
Richard A. Bronson, M.D.
RTW23
NURSES
SART and Nurses – Uniform Donor
Application and Introduction Form,
Donor FDA Physical Exam Forms, Donor
FDA Medical History and Interview
Questionnaire, IVF Consent
Tamara M. Tobias, N.P.
Skellenger Bender Family Law Practice Group
University of Utah Health Care
Stony Brook University Medical Center
RTW14
Male Fertility Evaluation: It’s About
Your Health
Larry I. Lipshultz, M.D.
Baylor College of Medicine
RTW15
MEET THE EDITOR
The Role of the Journal Fertility & Sterility
to Members of the ASRM
Antonio Pellicer, M.D.
Fertility and Sterility
RTW16
MENOPAUSE
Premature Ovarian Insufficiency
Samantha F. Butts, M.D.
RTW17
MENOPAUSE
Menopause Management in High Risk
Patients
Melissa Wellons, M.D.
RTW18
MENOPAUSE
Never Too Late to Procreate: Fertility
Options for the Aging Woman
Erkan Buyuk, M.D.
RTW19
MENTAL HEALTH
Sexuality and Infertility
Sara E. Rosenquist, Ph.D.
Private Practice, North Carolina
RTW20
MENTAL HEALTH
The Mental Health Consult for Those
Who Freeze Eggs: Where We Are After
a Few Years
Lisa Shuman, L.C.S.W.
Inner Solutions Counseling
Brigham and Women’s Hospital Boston
Integramed
RTW24
PEDIATRIC AND ADOLESCENT
GYNECOLOGY
Teen Healthcare Update- What’s
Important
Hillary Boswell, M.D.
The Women’s Specialists of Houston at Texas
Children’s Hospital
RTW25
Comprehensive Chromosome
Screening: A Means to Routine Elective
Single Embryo Transfer?
Nathan R. Treff, Ph.D.
Jersey
RTW26
TECHNOLOGY
The Effect of Cryoprotectants on
Oocyte Vitrification
Jeremy Chang, Ph.D.
RTW27
TECHNOLOGY
What To Do About Abandoned Frozen
Embryos
Kristen A. Ivani, Ph.D.
Reproductive Science Center of the Bay Area
RTW28
INFERTILITY
Fertility Care for the High BMI Patient
Rebecca S. Usadi, M.D.
Carolinas Healthcare System
Reproductive Medicine Associates of New York
51
Penn State Milton S. Hershey Medical Center
Stanford University
RTW31
REPRODUCTIVE IMMUNOLOGY
Immune Cell Aberrations - Impact on
Metabolism in PCOS
Frank Gonzalez, M.D.
Indiana University School of Medicine
RTW32
SEXUALITY
Male Sexuality And Aging: How to Talk
With Patients About What is Normal
William D. Petok, Ph.D.
Private Practice, Maryland
RTW33
SURGERY
Laparoscopic Myomectomy
Charles E. Miller, M.D.
RTW34
SURGERY
Robotics in Gynecologic Surgery
Antonio R. Gargiulo, M.D.
Brigham and Women’s Hospital Boston
RTW35
SURGERY
Müllerian Anomalies
Samantha M. Pfeifer, M.D.
ORAL ABSTRACTS
11:15 am - 1:00 pm
Prize Paper Candidates’ Oral Abstract Presentations and Special Research Presentation
Moderators: Lubna Pal and Kenan R. Omurtag
The first six papers are candidates for the ASRM Scientific Program Prize Paper Awards.
Six additional candidates will be presented during the Prize Paper Candidates’ session on Tuesday morning.
11:15 AM O-1 COMPREHENSIVE CHROMOSOME
SCREENING (CCS) WITH VITRIFICATION
RESULTS IN IMPROVED CLINICAL OUTCOME
IN WOMEN >35 YEARS: A RANDOMIZED
CONTROL TRIAL. W. B. Schoolcraft1, E.
Surrey1, D. Minjarez1, R. L. Gustofson1, R.
T. Scott, Jr.2, M. G. Katz-Jaffe1. 1Colorado
Center for Reproductive Medicine,
Lone Tree, CO; 2Reproductive Medicine
12:30 PM O-6 STATIN THERAPY IMPAIRS INSULIN SENSITIVITY
IN WOMEN WITH POLYCYSTIC OVARY
SYNDROME (PCOS): A PROSPECTIVE,
RANDOMIZED, DOUBLE-BLINDED, PLACEBOCONTROLLED STUDY. J. Puurunen1,2, T.
Piltonen1,2,3, A. Ruokonen4, M. J. Savolainen5,
L. Morin-Papunen1, J. S. Tapanainen1,2,6.
1
Department of Obstetrics and
Gynecology, Oulu University Hospital, Oulu,
Finland; 2Department of Obstetrics and
Gynecology, Clinical Research Center,
Oulu University Hospital, Oulu, Finland;
3
Department of Obstetrics, Gynecology
and Reproductive Sciences, The University
of California, San Francisco, San Francisco,
CA; 4Department of Clinical Chemistry,
Institute of Diagnostics, Oulu University
Hospital, Oulu, Finland; 5Department of
Internal Medicine, Institute of Clinical
Medicine, University of Oulu, Oulu,
Gynecology, University of Helsinki and
Helsinki University Central Hospital, Helsinki,
Finland.
11:30 AM O-2 USE OF DEPOT GnRH ANTAGONIST
(DEGARELIX) IN THE OVARIAN STIMULATION
IN WOMEN WITH PCOS UNDERGOING
IVF. A CONTROLLED TRIAL. M. Sbracia, F.
Scarpellini. CERM, Hungaria IVF, Rome, Italy.
11:45 AM O-3 GLUT3 AND CASPR5 – NOVEL GENETIC
FACTORS IN MALE INFERTILITY. A. W.
Pastuszak, C. J. Jorgez, L. I. Lipshultz, D. J.
Lamb. Scott Department of Urology, Center
for Reproductive Medicine, Baylor College
of Medicine, Houston, TX.
12:00 PM O-4 METHOTREXATE OR EXPECTANT
MANAGEMENT IN WOMEN WITH
ECTOPIC PREGNANCY OR PUL AND
LOW SERUM hCG CONCENTRATIONS? A
RANDOMIZED CONTROLLED TRIAL. N. M.
van Mello, On behalf of the METEX Study
Group. Department of Obstetrics and
Gynaecology, Academic Medical Centre,
University of Amsterdam, Amsterdam,
Noord-Holland, Netherlands.
12:45 PM
Special Research Presentation
COMPARATIVE RISK OF ENDOMETRIAL
CANCER FROM ABLATION VERSUS MEDICAL
MANAGEMENT OF DYSFUNCTIONAL UTERINE
BLEEDING
ASRM Research/Fellow In-Training Research
Award in Heavy Menstrual Bleeding
Suneeta Senapati, M.D.
12:15 PM O-5 MACAQUE OVARIAN TISSUE VITRIFIED IN
A CLOSED SYSTEM YIELDS FUNCTIONAL
SECONDARY FOLLICLES. A. Y. Ting, R. R.
Yeoman, J. R. Campos, M. S. Lawson, M.
B. Zelinski. Division of Reproductive and
Developmental Sciences, Oregon National
Primate Research Center, Beaverton, OR.
Room numbers of sessions are listed in the meeting app, the fold-out
Schedule-at-a-Glance and on signage throughout the convention center.
52
ORAL ABSTRACTS
Monday, October 22, 2012 4:15 pm-6:15 pm
Abstract Sessions
05:30 PM O-12 A SHORTER FOLLICULAR PHASE DOES
NOT HAVE A DELETERIOUS EFFECT ON THE
OUTCOME OF OVULATION INDUCTION/
INTRAUTERINE INSEMINATION (OI/IUI)
CYCLES. A. N. Imudia, I. Dimitriadis, J. C.
Petrozza, I. Souter. Vincent Department of
Obstetrics and Gynecology, Massachusetts
General Hospital Fertility Center, Boston,
MA.
• Clinical Female Infertility and Gynecology
• Contraception
• Genetic Counseling
• Pediatric and Adolescent Gynecology
• Male Reproduction and Urology: Research
• Other: ART-Clinical
• Outcome Predictors – Lab: ART
• Regenerative Medicine and Stem Cell Biology
• Reproductive Biology: Animal and Experimental Models
• Reproductive Endocrinology: Research
• Reproductive Immunology
• Reproductive Laboratory Technology
• Environment and Reproduction
05:45 PM O-13 HYSTEROSCOPY PRIOR TO ASSISTED
REPRODUCTIVE TECHNIQUE IN WOMEN
WITH RECURRENT IMPLANTATION FAILURE
IMPROVES PREGNANCY LIKELIHOOD. M.
Aghahosseini, N. Ebrahimi, A. Mahdavi,
A. Aleyasin, L. Safdarian, S. Sina. Infertility,
Tehran University of Medical Sciences,
Tehran, Islamic Republic of Iran.
__________________________________________________________
Clinical Female Infertility and Gynecology
Moderators: Alex J. Polotsky and Ragaa T. Mansour
04:15 PM O-7 HOW GENES INFLUENCE A WOMAN’S
REPRODUCTIVE LIFESPAN: THE IMPACT OF
THE FMR1 GENE ON AGE AT MENARCHE.
A. Weghofer1,2, A. Kim1. 1Center for
Human Reproduction (CHR), New York,
NY; 2Obstetrics & Gynecology, Medical
University Vienna, Vienna, Austria.
06:00 PM O-14 IMPACT OF LUTEAL SUPPLEMENTATION WITH
A WEEKLY PROGESTERONE VAGINAL RING
DURING IN VITRO FERTILIZATION (IVF) BY DAY
OF EMBRYO TRANSFER (ET). M. Perloe1, H.
Weiss2, B. Howard3. 1Georgia Reproductive
Specialists, Atlanta, GA; 2Teva Global
Branded Products R&D, Inc, Petach Tikva,
Center District, Israel; 3Women’s Health R&D,
Teva Global Branded Products R&D, Inc,
Frazer, PA.
__________________________________________________________
04:30 PM O-8 CLOMID-GONADOTROPIN OVARIAN
HYPERSTIMULATION AND INTRAUTERINE
INSEMINATION: EFFICACY WITH MULTIPLE
CYCLES. J. M. Cox3, M. Maquire1, A. H.
DeCherney1, K. S. Richter2, M. Levy2, M. B.
Henne3. 1Program in Reproductive and
Adult Endocrinology, NICHD, NIH, Bethesda,
MD; 2Shady Grove Fertility Reproductive
Science Center, Rockville, MD; 3Walter Reed
National Military Medical Center, Bethesda,
MD.
Contraception
Moderators: Bliss Kaneshiro
04:15 PM O-15 PHARMACOKINETICS (PK) AND EFFECT
ON OVARIAN AND CERVICAL FUNCTION
OF TWO LOW-DOSE LEVONORGESTRELRELEASING INTRAUTERINE SYSTEMS (LNGIUSs): RESULTS OF RANDOMIZED, PHASE
II AND III STUDIES. D. Apter1, K. GemzellDanielsson2, B. Hauck3, K. Rosen4, C.
Zurth5, A. Nelson6. 1Sexual Health Clinic,
Väestöliitto, Helsinki, Finland; 2Department
of Women’s and Children’s Health,
Karolinska University Hospital, Stockholm,
Sweden; 3Department of Obstetrics and
Gynecology, Calgary, AB, Canada; 4Bayer
HealthCare Pharmaceuticals, Montville, NJ;
5
Bayer Pharma AG, P300, Berlin, Germany;
6
Los Angeles Biomedical Research Institute,
Torrance, CA.
04:45 PM O-9 QUANTITATIVE INSULIN-SENSITIVITY CHECK
INDEX (QUICKI) PREDICTS PREGNANCY
OUTCOMES IN PCOS. G. W. Bates1, M. F.
Wellons1, P. R. Casson2. 1Obstetrics and
Gynecology, Reproductive Endocrinology
and Infertility, University of Alabama at
Birmingham, Birmingham, AL; 2Obstretrics
and Gynecology, Univerity of Vermont
Burlington, VT.
05:00 PM O-10 AGE-RELATED NORMOGRAM FOR ANTRAL
FOLLICLES COUNT IN WOMEN WITH
POLYCYSTIC OVARY SYNDROME. A. Wiser,
E. Shalom-Paz, T. Sokal-Arnon, J. Hyman, H.
Holzer, T. Tulandi. Obstetric/Gynecology,
Mcgill University, Montreal, QC, Canada.
04:30 PM O-16 A GLOBAL, RANDOMIZED, PHASE III,
PEARL INDEX STUDY COMPARING THE
EFFICACY AND SAFETY OF TWO LOW-DOSE
LEVONORGESTREL-RELEASING INTRAUTERINE
SYSTEMS (LNG-IUSs) IN NULLIPAROUS AND
PAROUS WOMEN. A. Nelson1, D. Apter2, B.
Hauck3, S. Rybowski4, K. Rosen5, K. GemzellDanielsson6. 1Los Angeles Biomedical
Research Institute, Torrance, CA; 2Sexual
Health Clinic, Väestöliitto, Helsinki,
05:15 PM O-11 EARLY B-hCG TRENDS IN VANISHING TWIN
PREGNANCIES. P. C. Brady, M. D. Hornstein,
S. E. Barton, K. Correia. Obstetrics and
Gynecology, Brigham and Women’s
Hospital, Boston, MA.
53
ORAL ABSTRACTS
METHOD. M. Zieman1, A. Patel2. 1Emory
University School of Medicine, Atlanta, GA;
2
Feinberg School of Medicine, Northwestern
University, Chicago, IL.
__________________________________________________________
Gynecology, Calgary, AB, Canada; 4Bayer
Pharma AG, P300, Berlin, Germany; 5Bayer
HealthCare Pharmaceuticals, Montville, NJ;
6
Department of Women´s and Children´s
Health, Karolinska University Hospital,
Stockholm, Sweden.
Fertility Preservation
Moderators: Clarisa Gracia and Karine Chung
04:45 PM O-17 ANTI-MÜLLERIAN HORMONE AS A MARKER
OF FOLLICULAR INHIBITION BY COMBINED
CONTRACEPTION – A RANDOMIZED STUDY.
S. Kallio1, J. Puurunen1, A. Ruokonen2, T.
Piltonen1,3, J. S. Tapanainen1,4. 1Department
of Obstetrics and Gynecology, Clinical
Research Center, Oulu University Hospital,
Oulu, Finland; 2Department of Clinical
Chemistry, Institute of Diagnostics, University
of Oulu, Finland; 3Deparment of Obstetrics,
Gynecology and Reproductive Sciences,
University of California, San Francisco, San
Francisco, CA; 4Department of Obstetrics
and Gynecology, University of Helsinki and
Helsinki University Central Hospital, Helsinki,
Finland.
04:15 PM O-23 SIMILAR IN VITRO MATURATION (IVM)
AND FERTILIZATION RATES OF OOCYTES
RETRIEVED EITHER AT THE FOLLICULAR OR
THE LUTEAL PHASE OF THE CYCLE OFFERS
FLEXIBLE OPTIONS FOR URGENT FERTILITY
PRESERVATION (FP). M. Grynberg1, M.
Even1, L. Hesters2, R. Treves1, R. Fanchin1,
N. Frydman2. 1Division of Reproductive
Medicine, Hôpital Antoine Béclère, Clamart,
France; 2Department of Reproductive
Biology, Hôpital Antoine Béclère, Clamart,
France.
04:30 PM O-24 BABY BUDGETING: A COST-EFFECTIVENESS
ANALYSIS (CEA) OF ELECTIVE OOCYTE
CRYOPRESERVATION (EOC) AS A MEANS
TO INCREASE LIVE BIRTH RATES (LBR) IN
WOMEN DELAYING REPRODUCTION. K.
Devine1, S. Mumford2, B. Hodes-Wertz3, S.
Druckenmiller3, A. Propst4, N. N. Noyes3.
1
Program in Adult and Reproductive
Endocrinology, NICHD, National Institutes
of Health, Bethesda, MD; 2Epidemiology
Branch, Division of Epidemiology, Statistics,
and Prevention Research, NICHD, National
Institutes of Health, Bethesda, MD; 3NYU
Fertility Center, NYU School of Medicine,
New York, NY; 4Uniformed Services University
of Health Sciences, Bethesda, MD.
05:00 PM O-18 CONTRACEPTIVE AND FERTILITY PRACTICES
IN WOMEN WITH BREAST CANCER
COMPARED TO THOSE WITH OTHER
MALIGNANCIES. B.-S. L. Maslow, C. B.
Morse, A. Schanne, C. Gracia. Obstetrics
and Gynecology, Hospital of University of
Pennsylvania, Philadelphia, PA.
05:15 PM O-19 COMBINATION PHOSPHODIESTERASE (PDE)
INHIBITION: A NOVEL APPROACH TO NONHORMONAL FEMALE CONTRACEPTION. C.
B. Hanna1, S. Yao1, J. T. Jensen1,2. 1Division
of Reproductive and Developmental
Sciences, Oregon National Primate
Research Center, Beaverton, OR;
2
Department of Obstetrics & Gynecology,
Oregon Health and Science University,
Portland, OR.
04:45 PM O-25 INFERTILITY AND THE UTILIZATION OF
INFERTILITY TREATMENT IN FEMALE
SURVIVORS OF CHILDHOOD CANCER: A
REPORT FROM THE CHILDHOOD CANCER
SURVIVIOR STUDY (CCSS). S. E. Barton1, J.
Najita2, E. S. Ginsburg1, L. R. Diller3. 1Division
of Reproductive Medicine; Department of
Obstetrics and Gynecology, Brigham and
Women’s Hospital, Boston, MA; 2Department
of Biostatistics and Computational Biology,
Dana-Farber Cancer Institute, Boston, MA;
3
Department of Pediatric Oncology, DanaFarber Childrens Hospital Cancer Center,
Boston, MA.
05:30 PM O-20 MALE AND FEMALE PUBLIC OPINION
REGARDING A POSSIBLE MALE
CONTRACEPTIVE PILL. A. P. Windsperger,
K. S. Art, A. Epp, A. Greiner, J. Tash, A.
K. Nangia. University of Kansas Medical
Center, Kansas City, KS.
05:45 PM O-21 CELL CYCLE KINETICS, NUCLEAR RECEPTOR
AND GENE EXPRESSION IN HUMAN
ENDOMETRIAL CELLS: DIFFERENTIAL
REGULATION BY PROGESTIN AND SELECTIVE
PROGESTERONE RECEPTOR MODULATOR.
P. L. Morris1,2, K. Hwang1, R. Hara1, C.
Rapelje1, L. Mitchell1. 1Center for Biomedical
Research, Population Council, New York,
NY; 2The Rockefeller University, New York, NY.
05:00 PM O-26 WOMEN OF REPRODUCTIVE AGE RECEIVING
GONADOTOXIC TREATMENT: NEEDS
ASSESSMENT AND PREDICTIVE FACTORS FOR
FERTILITY PRESERVATION. M. S. Christianson1,
M. M. Yates1, I. Woo1, A. Khafagy2, J.
E. Garcia1, L. A. Kolp1. 1Department of
Gynecology and Obstetrics; Divison of
Reproductive Endocrinology and Infertility,
Johns Hopkins Medical Institutions,
Lutherville, MD; 2Population, Family and
Reproductive Health, Johns Hopkins
Bloomberg School of Public Health,
Baltimore, MD.
06:00 PM O-22 CONTRACEPTION IN AMERICA (CIA)
NATIONAL SURVEY: SEGMENT OF RESULTS
FOCUSED ON PATIENT AND PHYSICIAN
ATTITUDES ABOUT BENEFITS OF INTRAUTERINE
DEVICES (IUDs) AS A CONTRACEPTIVE
54
ORAL ABSTRACTS
05:15 PM O-27 A NOVEL OVARIAN STIMULATION
PROTOCOL UTILIZING A COMBINATION OF
TAMOXIFEN AND AROMATASE INHIBITION
FOR FERTILITY PRESERVATION IN BREAST
CANCER PATIENTS. M. Baker1, M. Cross1,
J. Waisman2, K. Bendikson1, R. Paulson1,
K. Chung1. 1Obstetrics & Gynecology,
Division of Reproductive Endocrinology &
Infertility, University of Southern California,
Los Angeles, CA; 2Breastlink Medical Group,
Long Beach, CA.
05:00 PM O-34 THE INCIDENCE OF CHROMOSOME
ERRORS DIFFERS AT THE PREIMPLANTATION
STAGE FROM THAT OBSERVED LATER IN
PREGNANCY. S. Mitchell1, M. Linden2, D.
Young2, N. Treff3, W. Schoolcraft1, M. KatzJaffe1. 1National Foundation for Fertility
Research, Lone Tree, CO; 2Colorado Center
for Reproductive Medicine, Lone Tree, CO;
3
Jersey, Morristown, NJ.
__________________________________________________________
05:30 PM O-28 EMERGENCY LUTEAL PHASE IN VITRO
MATURATION – A RETROSPECTIVE MATCHED
COHORT STUDY. J. H. Hyman, W.-Y. Son,
T. Sokal-Arnon, I. Roux, E. Shalom-Paz,
T. Tulandi. MUHC Reproductive Center,
Department of Obstetrics and Gynecology,
Mc Gill University, Montreal, QC, Canada.
Pediatric and Adolescent Gynecology
Moderators: Janice L. Bacon and Paige Hertweck
05:15 PM O-35 FERTILITY PRESERVATION IN ADOLESCENTS
AND YOUNG WOMEN WITH CANCER:
DOES MALIGNANCY ADVERSELY AFFECT
OVARIAN FUNCTION? S. Cardamone, N.
Noyes, K. Melzer, M. E. Fino. Obstetrics and
Gynecology, New York University Fertility
Center, New York, NY.
05:45 PM O-29 TO PRESERVE OR NOT TO PRESERVE:
DECISIONAL CONFLICT ASSOCIATED WITH
FERTILITY PRESERVATION. L. R. Goodman1, A.
M. Deal1, H. I. Su2, S. Bailey2, FIRST Research
Group2, J. E. Mersereau1. 1Obstetrics
and Gynecology, University of North
Carolina, Chapel Hill, NC; 2Obstetrics and
Gynecology, University of California, San
Diego, La Jolla, CA.
05:30 PM O-36 HUMAN PAPILLOMA VIRUS (HPV)
VACCINATED GIRLS DISPLAY INCREASED
SEXUAL KNOWLEDGE OVER THEIR
UNVACCINATED PEERS. J. Kresowik1,
M. Lessard2, D. Liu2, L. Wells3, G. Ryan1.
1
Obstetrics & Gynecology, University of
Iowa Hospitals & Clinics, Iowa City, IA;
2
Biostatistics, University of Iowa College
of Public Health, Iowa City, IA; 3Audubon
Fertility & Reproductive Medicine, New
Orleans, LA.
06:00 PM O-30 LETROZOLE PLUS GONADOTROPIN IS
SUPERIOR TO GONADOTROPIN ALONE
IN FERTILITY PRESERVATION CYCLES. E.
Ozkaya1, F. Moy1,3, K. Oktay1,2. 1Obstetrics
and Gynecology, New York Medical
College, Valhalla, NY; 2Institute for Fertility
Preservation and Reproductive Specialists
of New York, Rye, NY.
__________________________________________________________
05:45 PM O-37 ARRAY-BASED DNA COPY NUMBER
ANALYSIS FOR MULLERIAN ANOMALIES. X.
M. Santos1, J. Bravo2, X. Wang2, I. B. Van
den Veyver2, J. E. Dietrich1. 1Department
of Obstetrics and Gynecology, Division of
Pediatric and Adolescent Gynecology,
Baylor College of Medicine, Houston, TX;
2
Department of Molecular and Human
Genetics, Baylor College of Medicine,
Houston, TX.
Genetic Counseling
Moderators: Jill Fischer and Amy Jordan
04:15 PM O-31 IS FIRST TRIMESTER PRENATAL DOWN
SYNDROME SCREENING ALTERED AMONG
WOMEN PREGNANT AFTER IVF/ICSI. P.
Cohen-Bacrie1, M. Cohen-Bacrie1, S. Belloc1,
M. Nouchy1, I. Lichtblau1, J. de Mouzon2.
1
ART Unit Eylau Unilabs, Paris, France;
2
Service de Gynécologie Obstétrique II et
Médecine de la Reproduction, CHU Cochin
Port Royal, APHP, Université Paris Descartes,
Paris, France.
06:00 PM O-38 USE OF ANTI-MULLERIAN HORMONE TO
MEASURE REPRODUCTIVE FUNCTION IN
PEDIATRIC CANCER SURVIVORS. A. J.
Lunsford1, K. Whelan3, K. L. McCormick1,
J. F. McLaren2. 1Division of Pediatric
Endocrinology, University of Alabama at
Birmingham, Birmingham, AL; 2Reproductive
Endocrinology and Infertility, University of
Alabama at Birmingham, Birmingham,
AL; 3Division of Hematology-Oncology,
University of Alabama at Birmingham,
Birmingham, AL.
__________________________________________________________
04:30 PM O-32 NATIONAL TELEPHONE GENETIC
COUNSELING SERVICE SUPPORTS INFORMED
AND TIMELY DECISIONS IN REPRODUCTIVE
MEDICINE. M. Schuetzle, K. Steenblock,
A. Trivedi, R. Sutphen. InformedDNA, St.
Petersburg, FL.
04:45 PM O-33 RARE GENETIC VARIANTS USEFUL FOR NONINVASIVE DIAGNOSIS AND PREDICTION
OF ENDOMETRIOSIS. K. Ward, R. Chettier,
P. Farrington, H. Albertsen. Juneau
Biosciences, LLC, Salt Lake City, UT.
55
ORAL ABSTRACTS
Male Reproduction and Urology: Research
Moderators: Darius A. Paduch
Other: ART - Clinical
Moderators: Eric Surrey and Samantha M. Pfeifer
04:15 PM O-39 DNA METHYLATION AT IMPRINTED GENES
AND DNA FRAGMENTATION IN SPERM
OF MEN DIAGNOSED WITH SEVERE
OLIGOZOOSPERMIA AND AZOOSPERMIA.
S. L. Pitigalaarachchige, V. Chow, S.
Ma. Department of Obstetrics and
Gynaecology, Child Family Research
Institute, Vancouver, BC, Canada.
04:15 PM O-45 UNEXPLAINED RECURRENT MISCARRIAGE:
CAN PREIMPLANTATION COMPREHENSIVE
CHROMOSOME SCREENING (CCS) IMPROVE
OUTCOMES? S. McCormick1, J. Stevens1,
R. Smith1, R. T. Scott, Jr.2. 1Colorado Center
2
04:30 PM O-40 POTASSIUM CHANNEL IN HUMAN SPERM
IDENTIFIED BY WHOLE CELL PATCH
CLAMPING PLAYS A ROLE IN NORMAL SPERM
PHYSIOLOGY. S. A. Mansell, C. L. R. Barratt,
S. M. Wilson. Maternal and Child Health
Sciences, University of Dundee, Dundee,
Tayside, United Kingdom.
04:30 PM O-46 INCREASED BLASTOMERE NUMBERS
IN CLEAVAGE STAGE EMBRYOS ARE
ASSOCIATED WITH HIGHER ANEUPLOIDY
RATES DETERMINED BY COMPARATIVE
GENOMIC HYBRIDIZATION. L. Kroener1,
G. Ambartsumyan1,3, D. Hill2, M. Surrey2,
M. Pisarska3, C. Briton-Jones2. 1Obstetrics
and Gynecology, University of California,
Los Angeles, Los Angeles, CA; 2Southern
California Reproductive Center, Beverly Hills,
CA; 3Obstetrics and Gynecology, Cedars
Sinai Medical Center, Los Angeles, CA.
04:45 PM O-41 MARKERS OF SPERM FUNCTION
CHARACTERIZE DONORS WITH BETTER
FERTILIZATION POTENTIAL, INDEPENDENTLY
OF SPERM CONCENTRATION AND
MOTILITY, ACCORDING TO WORLD HEALTH
ORGANIZATION CRITERIA. P. CaballeroCampo1, P. Caballero-Peregrin2, I. Orozco2,
P. Rinaudo1, J. Ramalho-Santos3, A.
Amaral3. 1Ob/gyn, Center for Reproductive
Sciences, University of California San
Francisco, San Francisco, CA; 2Unidad de
Reproduccion Humana. Fundacion Tambre,
Clinica Tambre, Madrid, Spain; 3Center for
Neuroscience and Cell Biology Department
of Life Sciences, University of Coimbra,
Coimbra, Portugal.
04:45 PM O-47 EGG DONOR INFORMED CONSENT
TOOL (EDICT): OOCYTE DONORS’
UNDERSTANDING AS ASSESSED BY A NOVEL
VALID INFORMED CONSENT TOOL. A.
Skillern, L. Pasch, K. Forsberg, M. Cedars,
H. Huddleston. OB/GYN and Reproductive
Francisco, San Francisco, CA.
05:00 PM O-42 MALE INFERTILITY ASSESSMENT: RELATIONSHIP
BETWEEN CHROMATIN STRUCTURE, WHO
PARAMETERS, HYALURONIC ACID BINDING
CAPACITY AND DNA FRAGMENTATION.
N. Saymé, T. Krebs, D. H. A. Maas. Team
Kinderwunsch Hannover, Hannover,
Niedersachsen, Germany.
05:00 PM O-48 ASSOCIATION BETWEEN RESPONSE TO
OVARIAN STIMULATION AND MISCARRIAGE
FOLLOWING IVF TREATMENT: AN ANALYSIS
OF 124 368 PREGNANCIES. S. K. Sunkara, M.
Begari, Y. Khalaf1. 1Assisted Conception Unit,
Guy’s & St Thomas’ Foundation Trust, King’s
College London., London, England, United
Kingdom; 2Department of Statistics, Andhra
University, Visakhapatnam, Andhra Pradesh,
India.
05:15 PM O-43 INTRA-INDIVIDUAL VARIABILITY OF
GLOBAL SPERM 5-METHYLCYTOSINE AND
5-HYDROXYMETHYLCYTOSINE LEVELS
BETWEEN EJACULATES. T. G. Jenkins1, K.
I. Aston1, D. T. Carrell1,2,3. 1Andrology and
IVF Laboratories, University of Utah, Salt
Lake City, UT; 2Obstetrics and Gynecology,
University of Utah, Salt Lake City, UT;
3
Physiology, University of Utah, Salt Lake
City, UT.
05:15 PM O-49 AFTER TWO FAILED IVF CYCLES IN PATIENTS
UNDER 35, TRANSFER OF THREE EMBRYOS
RATHER THAN TWO DRAMATICALLY
INCREASES MULTIPLE GESTATION WITHOUT
IMPROVING PREGNANCY RATES. J. G.
Bromer1, J. Salas Mann2, K. Richter1, E. A.
Widra1, R. J. Stillman1. 1Shady Grove Fertility
Reproductive Science Center, Rockville,
MD; 2Reproductive Science Center of New
Jersey, Eatontown, NJ.
05:30 PM O-44 STATUS OF SOX9 IN THE TESTESOF SRY
NEGATIVE AND POSITIVE AZOOSPERMIC
MALES. H. Okada, Y. Kobori, G. Arai, S.
Soh. Urology, Dokkyo Medical University
Koshigaya Hospital, Koshigaya, Saitama,
Japan.
__________________________________________________________
05:30 PM O-50 NEONATAL AND DEVELOPMENTAL OUTCOME
OF CHILDREN BORN FOLLOWING ASSISTED
OOCYTE ACTIVATION (AOA). F. Vanden
Meerschaut1, E. D’Haeseleer2, H. Roeyers3,
A. Oostra4, K. Van Lierde2, P. De Sutter1.
1
Department for Reproductive Medicine,
University Hospital Ghent, Ghent, Belgium;
2
Department of Otorhinolaryngology
and Head and Neck Surgery, Speech
and Language Pathology, University
56
ORAL ABSTRACTS
Hospital Ghent, Ghent, Belgium;
3
Department of Experimental Clinical
and Health Psychology, Research Group
Developmental Disorders, Ghent University,
Ghent, Belgium; 4Centre for Developmental
Disorders, University Hospital Ghent, Ghent,
Belgium.
K. P. McNatty1, K. Coetzee2, J. L. Pitman1.
1
Victoria University of Wellington, Wellington,
WGT, New Zealand; 2Fertility Associates Ltd,
Wellington, WGT, New Zealand.
05:00 PM O-56 UNIQUE CUMULUS CELL MICRORNA
EXPRESSION PROFILES PREDICT IVF OUTCOME
AND LIVE BIRTH. B. R. McCallie1, A. Streiby1,
J. C. Parks1, S. Mitchell1, W. Schoolcraft1, M.
G. Katz-Jaffe1,2. 1National Foundation for
Fertility Research, Lone Tree, CO; 2Colorado
Center for Reproductive Medicine, Lone
Tree, CO.
05:45 PM O-51 ASSOCIATION BETWEEN MULTIPLE CORPORA
LUTEA AND BIRTHWEIGHT AMONG
SINGLETONS FROM IN VITRO FERTILIZATION:
ANALYSIS USING SOCIETY FOR ASSISTED
REPRODUCTIVE TECHNOLOGY CLINICAL
OUTCOMES REPORTING SYSTEM. V. L.
Baker1, M. B. Brown2, B. Luke3, K. P. Conrad4.
1
Obstetrics and Gynecology, Division
of Reproductive Endocrinology and
Infertility, Stanford University, Stanford, CA;
2
Biostatistics, University of Michigan, Ann
Arbor, MI; 3Obstetrics and Gynecology
& Reproductive Biology, Michigan State
University, East Lansing, MI; 4Physiology and
Functional Genomics, University of Florida
College of Medicine, Gainesville, FL.
05:15 PM O-57 MORPHOLOGY PLUS PLOIDY: A PROSPECTIVE
STUDY COMPARING TRADITIONAL
MORPHOLOGY-BASED SELECTION
FOR SINGLE EMBRYO TRANSFER (SET)
WITH COMPREHENSIVE CHROMOSOME
SCREENING (CCS) RESULTS. E. J. Forman1,2,
K. M. Ferry1, K. Hong1, M. Z. Cheng1, T. Zhao1,
R. Scott1. 1Reproductive Endocrinology,
Reproductive Medicine Associates of
New Jersey, Morristown, NJ; 2Obstetrics,
Gynecology & Reproductive Sciences,
UMDNJ-Robert Wood Johnson Medical
School, New Brunswick, NJ.
06:00 PM O-52 DISTRIBUTION OF LH RECEPTOR (LHCGR)
POLYMORPHISMS IN PATIENTS UNDERGOING
CONTROLLED OVARIAN STIMULATION
(COS) – IVF. P. R. Gindoff1, D. Frankfurter2,
M. Dayal1, M. Marshall1, A. Harralson2,
T. O’Brien1. 1Fertility and IVF Center, The
George Washington University, Washington,
DC; 2Pharmacology, Shenandoah
University, Winchester, VA.
__________________________________________________________
05:30 PM O-58 DEFINING POOR PROGNOSIS MARKERS OF
IMPLANTATION FOR EMBRYO SELECTION
BY TIME-LAPSE. J. Herrero, I. Rubio, A.
Tejera, A. Galán, E. Labarta, M. Meseguer.
IVI Valencia, Universidad de Valencia,
Valencia, Spain.
05:45 PM O-59 microRNA TESTING: A NOVEL, NONINVASIVE TECHNIQUE TO DETECT
ANEUPLOIDY AND LIVE BIRTH POTENTIAL IN
HUMAN EMBRYOS. E. M. Rosenbluth1, D.
N. Shelton1, L. M. Wells2, A. E. Sparks1, B. J.
Van Voorhis1. 1Obstetrics and Gynecology,
University of Iowa, Iowa City, IA; 2Audubon
Fertility & Reproductive Medicine, New
Orleans, LA.
Outcome Predictors-Lab: ART
Moderators: Kathryn J. Go and Luca Gianaroli
04:15 PM O-53 IMPROVED EMBRYO SELECTION ACCURACY
USING CELL DIVISION CHARACTERISTICS
DEFINED BY TIME-LAPSE AND AUTOMATED
IMAGE ANALYSIS. A. A. Chen1, K. Ivani2,
J. Conaghan3, M. Gvakharia4, A. Le5, S.
Shen1. 1Auxogyn, Inc., Menlo Park, CA;
2
Reproductive Science Center of the Bay
Area, San Ramon, CA; 3Pacific Fertility
Center, San Francisco, CA; 4Fertility and
Reproductive Health Institute, San Jose, CA;
5
HRC Fertility, Encino, CA.
06:00 PM O-60 FIRST EVENTS IN EMBRYO DEVELOPMENT
PREDICT EMBRYO QUALITY ON DAY 2 AND
3. A. Mugica, M. Belmonte, A. Calderon, O.
Ruiz, J. Marqueta, A. Serra. FIV Laboratory,
IBILAB, Palma de Mallorca, Balearic Islands,
Spain.
__________________________________________________________
04:30 PM O-54 THE “A, C, D’S” OF ZYGOSITY (ZYG):
DEBUNKING THE MYTH BEHIND
DICHORIONIC-DIAMNIOTIC (DC-DA)
PLACENTATION. J. M. Knopman1, L. C.
Krey1, C. McCaffrey1, M. B. Smith1, C. Oh2,
N. Noyes1. 1OB/GYN, NYU Langone Medical
Center, New York, NY; 2Biostatistics, NYU
Langone Medical Center, New York, NY.
Regenerative Medicine & Stem Cell Biology
Moderators: Anna M. Veiga and Gerald Schatten
04:15 PM O-61 miR-372/let-7 AXIS REGULATES HUMAN
PRIMORDIAL GERM CELL SPECIFICATION. N.
D. Tran, M. Kissner, D. Laird, R. Blelloch. OB/
GYN, University of California, San Francisco,
San Francisco, CA.
04:45 PM O-55 THE USE OF CUMULUS CELL (CC)
mRNA LEVELS TO PREDICT BLASTOCYST
DEVELOPMENT AND LIVE BIRTH OUTCOMES IN
WOMEN UNDERGOING INTRACYTOPLASMIC
SPERM INJECTION (ICSI) AND SINGLE
EMBRYO TRANSFER. J. Ekart1,2, J. D. Hutton2,
04:30 PM O-62 LONG-TERM CULTURE OF HUMAN
EMBRYONIC STEM CELLS UNDER
COMPLETELY DEFINED, FEEDER-FREE, XENOFREE CONDITIONS. J. M. Jones1,2, L. M.
57
ORAL ABSTRACTS
Boehnlein1,2, N. J. George1,2, L. A. Norkosky1.
1
WiCell Research Institute, Madison, WI;
2
Obstetrics and Gynecology, University of
Wisconsin - Madison, WI.
Vincent2, H. Dechaud1,2, S. Hamamah1,2.
1
CHU Montpellier, Institute for Research
in Biotherapy, Université Montpellier1,
INSERM U1040, Montpellier, Hérault,
France; 2Département de Biologie de la
Reproduction, UAM: AMP - DPI, Montpellier,
Hérault, France.
__________________________________________________________
04:45 PM O-63 GENETIC STABILITY DURING DERIVATION
AND CULTURE OF HUMAN EMBRYONIC STEM
CELLS TO ENSURE SAFETY FOR CLINICAL
APPLICATIONS. H. Amir1, L. Laurent2, F.
Boscolo2, M. Malcov1, A. Amit1, D. BenYosef1. 1Stem Cell Research Lab, Racine IVF
Unit, Lis Maternity Hospital, Tel-Aviv Sourasky
Medical Center, Tel Aviv, Israel; 2Department
of Reproductive Medicine, University of
California, San Diego, CA.
Reproductive Biology: Animal and Experimental
Models
Moderators: Dennis W. Matt and Jeremy Chang
04:15 PM O-69 microRNA miR-146a INHIBITS THE MEDIATOR
COMPLEX SUBUNIT 1 AND PROMOTES SELFRENEWAL IN SPERMATOGONIAL STEM CELLS.
J. M. Huszar, C. J. Payne. Northwestern
University Feinberg School of Medicine,
Chicago, IL.
05:00 PM O-64 TRACKING THE PROGRESSION OF
X-CHROMOSOME INACTIVATION AND
REACTIVATION DURING FEMALE HUMAN
EMBRYONIC STEM CELL DERIVATION. T.
O’Leary1, B. Heindryckx1, M. Van der
Jeught1, G. Dugghal1, S. Chuva de Sousa
Lopes2, P. De Sutter1. 1Department for
Reproductive Medicine, Ghent University
Hospital, Ghent, Flanders, Belgium;
2
Department of Anatomy and Embryology,
Leiden University Medical Centre, Leiden,
South Holland, Netherlands.
04:30 PM O-70KISSPEPTIN AND KISSPEPTIN RECEPTOR
ARE EXPRESSED IN MOUSE OOCYTES AND
PARTICIPATE IN MEIOSIS RESUMPTION. A.
M. Rocha1, J. Ding2, M. Lehman2,3, G. D.
Smith2,3,4,5. 1Cell and Developmental Biology,
University of Michigan, Ann Arbor, MI;
2
Michigan, Ann Arbor, MI; 3Urology, University
of Michigan, Ann Arbor, MI; 4Molecular
and integrative Physiology, University of
Michigan, Ann Arbor, MI; 5Reproductive
Sciences Program, University of Michigan,
Ann Arbor, MI.
05:15 PM O-65 LYOPHILIZED AND REHYDRATED METAPHASE
II (MII) OVINE CHROMOSOMES MAINTAIN
FUNCTIONALITY UPON TRANSFER IN FRESH
MII OOCYTES. L. Loi1, D. Iuso1, G. Ptak1,
P. Patrizio2, A. Arav3. 1Department of
Comparative Biomedical Sciences, Faculty
of Veterinary Medicine, Teramo, Italy;
2
Department of Obstetric, Gynecology &
Reproductive Sciences, Yale Fertility Center,
New Haven, CT; 3Coredynamics, Nes Zyona,
Israel.
04:45 PM O-71 THE HEPATOCYTE GROWTH FACTOR SYSTEM
IN MENSTRUATION AND POST-MENSTRUAL
ENDOMETRIAL REPAIR. O. D. Slayden1,
C. Hergert1, J. Evans2, J. Yap2, L. A.
Salamonsen2. 1Division of Reproductive &
Primate Research Center, Beaverton, OR;
2
Endometrial Remodelling, Prince Henry’s
Institute, Monash Medical Centre, Clayton,
VIC, Australia.
05:30 PM O-66 IDENTIFICATION OF PUTATIVE FALLOPIAN
TUBE PROGENITOR STEM CELLS. V.
Snegovskikh1, E. Massasa1, L. Mutlu1, M.
Modi2, H. Taylor1. 1Obstetrics, Gynecology
and Reproductive sciences, Yale University
School of Medicine, New Haven, CT;
2
Vanderbilt University School of Medicine,
Nashville, TN.
05:00 PM O-72 LEUKEMIA INHIBITORY FACTOR IS NECESSARY
FOR RHESUS MACAQUE OVULATION. P. A.
Royer1, M. J. Murphy2, J. D. Hennebold1,2.
1
Obstetrics and Gynecology, Oregon
Health and Sciences University, Portland,
OR; 2Reproductive and Developmental
Research Center, Beaverton, OR.
05:45 PM O-67 DEVELOPMENTAL POTENTIAL OF LATE
MATURING HUMAN OOCYTES AFTER
PARTHENOGENETIC ARTIFICIAL ACTIVATION.
J. A. Lee1, J. Barritt1,2, D. Paull3, H. Martinez3,
D. Egli3, A. B. Copperman1,2. 1Reproductive
Medicine Associates of New York, New York,
NY; 2Department of Obstetrics, Gynecology
and Reproductive Science, Mount Sinai
School of Medicine, New York, NY; 3New
York Stem Cell Foundation, New York, NY.
05:15 PM O-73 THE EXPRESSION PATTERN OF STAGE
SPECIFIC-GERM CELL MARKERS IN
SEMINIFEROUS TUBULE INJECTED WITH
SPERMATOGONIAL STEM CELLS DURING
IN VITRO SPERMATOGENESIS. H. J. Kim, Y.
J. Cho, J. J. Lim, S.-H. Song, T. K. Yoon, D.
R. Lee. Fertility Center of CHA Gangnam
Medical Center, CHA Research Institute,
Seoul, Republic of Korea.
06:00 PM O-68 HUMAN CUMULUS CELLS USED AS FEEDER
TO BOOST THE SELF-RENEWAL PROCESS
OF hiPS AND THEIR DIFFERENTIATION
POTENTIAL INTO THE THREE GERM LAYERS.
S. Assou1, E. Pourret1, D. Haouzi1, C.
58
ORAL ABSTRACTS
05:30 PM O-74 ADIPONECTIN (ADIPO) INHIBITS IN VITRO
GROWTH OF MURINE OVARIAN FOLLICLES.
N. A. Slawny1, J. Ding1, G. D. Smith1,2,3,4.
1
Michigan, Ann Arbor, MI; 2Reproductive
Sciences Program, University of Michigan,
Ann Arbor, MI; 3Physiology, University of
Michigan, Ann Arbor, MI; 4Urology, University
of Michigan, Ann Arbor, MI.
Institute for Women’s Health (IfWH), London,
United Kingdom; 3Vascular Surgery, Royal
Free Campus,University College London,
London, United Kingdom.
05:00 PM O-80 INHIBITORY EFFECT OF GLUCOSAMINE
ON ENDOMETRIAL STROMAL CELL
DECIDUALIZATION IN VITRO. M. M. B.
Schulte, K. E. O’Neill, J.-H. Tsai, K. H. Moley.
Obstetrics & Gynecology, Washington
University in St Louis, St Louis, MO.
05:45 PM O-75 THE EFFECT OF THREE DIMENSIONAL
PREMATURATION CULTURE WITH OR WITHOUT
MEIOTIC INHIBITORS ON THE IN VITRO
MATURATION (IVM) OUTCOME OF BOVINE
OOCYTES. E.-A. M. Khalifa2, T. A. Farghaly1,2,
S. Mostafa2, M. Hussein2, J. Goldfarb1, A.
Ahmady1. 1University Hospitals Fertility
Center, Ahuja Medical Center, Beachwood,
OH; 2Womens’ Health Center, Assiut
University, Assiut, Egypt.
05:15 PM O-81 OUTCOME PREDICTION IN WOMEN AT RISK
FOR ECTOPIC PREGNANCY USING SERIAL
HUMAN CHORIONIC GONADOTROPIN
VALUES: DATA BEYOND 48 HOURS IS
NECESSARY. J. Zee1, M. Sammel1, A.
Shaunik2, K. T. Barnhart1,2,3. 1Department of
Biostatistics and Epidemiology, University of
Pennsylvania Perelman School of Medicine,
Philadelphia, PA; 2Center for Research
on Reproduction and Women’s Health,
University of Pennsylvania Perelman School
of Medicine, Philadelphia, PA; 3Department
of Obstetrics and Gynecology, University of
Pennsylvania Health System, Philadelphia,
PA.
06:00 PM O-76 REPLACEABLE CYCLIN D3 (CycD3) IMPROVES
DECIDUALIZATION (Dcz) DEFECTS IN HOXA10-/- MICE. J. M. Sroga1,2, X. Ma2,3, F. Gao2,3,
S. K. Das2,3. 1Obstetrics and Gynecology,
University of Cincinnati, Cincinnati, OH;
2
Pediatrics, Division of Reproductive
Sciences, Cincinnati Children’s Hospital
Medical Center, University of Cincinnati
College of Medicine, Cincinnati, OH;
3
Perinatal Institute, Cincinnati Children’s
Hospital Medical Center, Cincinnati, OH.
__________________________________________________________
05:30 PM O-82 LUTEAL PHASE DEFICIENCY IN NORMAL
CYCLING WOMEN. A. O. Hammoud1, K. C.
Schliep2, S. L. Mumford3, J. B. Stanford2, C.
A. Porucznik2, E. F. Schisterman3. 1Obstetrics
and Gynecology, University of Utah, Salt
Lake City, UT; 2Family and Preventive
Medicine, University of Utah, Salt Lake City,
UT; 3Division of Epidemiology, Statistics,
and Preventive Research, Eunice Kennedy
Shriver National Institute of Child Health and
Human Development, Rockville, MD.
Reproductive Endocrinology: Research
Moderators: Monica A. Mainagi and Juha S. Tapanainen
04:15 PM O-77 GERMLINE BRCA1 GENE MUTATIONS RESULT
IN ACCELERATED OVARIAN AGING: A
TRANSLATIONAL STUDY. K. Oktay1,2, F. Li1, R.
Stubezski1, K. Jeong1, M. Dickler3, S. Titus1.
1
Laboratory of Molecular Reproduction,
Obstetrics & Gynecology, New York
Medical College, Valhalla, NY; 2Institute
for Fertility Preservation and Reproductive
Specialists of New York, Rye, NY; 3Breast
Oncology, Memorial Sloan Kettering
Cancer Center, New York, NY.
05:45 PM O-83 COMPARISON OF CLINICAL OUTCOMES
BETWEEN GENETICALLY SIMILAR GROUPS
OF IN VITRO FERTILIZATION PATIENTS. S. M.
Shastri1,2, M. Werner1, B. Devkota1, D. M.
Taylor1,2,3, N. Treff1, R. Scott1. 1Reproductive
Medicine Assocaites of New Jersey,
Morristown, NJ; 2Obstetrics, Gynecology,
and Reproductive Sciences, UMDNJ-Robert
Wood Johnson Medical School, New
Brunswick, NJ; 3Department of Genetics,
Rutgers-The State University of New Jersey,
Piscataway, NJ.
04:30 PM O-78 FEMALE OBESITY: PROFOUNDLY
REDUCED ESTROGEN EXCRETION AFTER
AROMATASE INHIBITION MAY UNDERSCORE
EXAGGERATED SENSITIVITY TO ESTROGEN
NEGATIVE FEEDBACK. L. A. Ross, A. J.
Polotsky, A. Bradford, J. Lesh, J. Chosich,
N. Santoro. Obstetrics and Gynecology,
University of Colorado Denver, Aurora, CO.
06:00 PM O-84 ABERRANT STEROID HORMONE RESPONSE
AND INCREASED PRO-INFLAMMATORY
CYTOKINE SECRETION IN ENDOMETRIAL
STROMAL FIBROBLASTS FROM WOMEN WITH
PCOS. T. T. Piltonen, J. Chen, T. L. B. Spitzer,
J. C. Irwin, L. C. Giudice. Department of
Obstetrics, Gynecology and Reproductive
Sciences, University of California, San
Francisco, CA.
__________________________________________________________
04:45 PM O-79 PREGNANT WOMEN WITH POLYCYSTIC
OVARY SYNDROME (PCOS) HAVE
INCREASED INTIMA MEDIA THICKNESS (IMT)
THAT PROGRESSES WITH GESTATION, AND
ENDOTHELIAL DYSFUNCTION (ED). S. Hu1, T.
K. Ho3, J. Barry2, A. Seifalian3, P. Hardiman2.
1
Bourn Hall Clinic, Cambridge, United
Kingdom; 2Obsterics and Gynaecology,
59
ORAL ABSTRACTS
Reproductive Immunology
Moderators: Joanne Y. Kwak-Kim and Mehmet R. Genc
05:45 PM O-91 SELECTION OF CELLULAR IMMUNOLOGICAL
MARKERS IN WOMEN WITH RECURRENT
PREGNANCY LOSS. S. K. Lee1, B. J. Na2, J.
Y. Kim1, J. Kwak-Kim3. 1OB/GYN, Konyang
University Hospital, Daejeon, Korea;
2
Preventive Medicine, Konyang University
Hospital, Daejeon, Korea; 3OB/GYN, The
Chicago Medical School at Rosalind
Franklin University of Medicine and Science,
Vernon Hills, IL.
04:15 PM O-85 UROMODULIN LIKE-1, A KEY PLAYER IN
COORDINATING THE FUNCTION OF THYMUSPITUITARY -OVARIAN AXIS. Y. Tang, L. Ni,
W. Wang, H.-C. Liu, Z. Rosenwaks. CRMI
Endocrine Research Laboratory, Weill
Medical College of Cornell University, New
York, NY.
04:30 PM O-86 HUMAN ENDOMETRIAL CO-CULTURE SYSTEM
REVEALS NOVEL CELL-SPECIFIC EFFECTS
OF NONOXYNOL-9 ON ENDOMETRIAL
TRANSCRIPTOME AND CHEMOKINE
SECRETION. J. C. Chen1, D. W. Erikson1,
F. Barragan1, J. C. Irwin1, W. C. Greene2,
L. C. Giudice1. 1Center for Reproductive
Sciences/OBGYN, University of California,
San Francisco, San Francisco, CA;
2
Gladstone Institute for Virology, University
CA.
06:00 PM O-92 PROGESTERONE INDUCED BLOCKING
FACTOR (PIBF), AN IMMUNOSUPPRESSIVE
PROTEIN THAT INHIBITS NATURAL KILLER (NK)
CELL CYTOLYTIC ACTIVITY, DETECTED 3 DAYS
AFTER EMBRYO TRANSFER (ET). R. Cohen1, J.
H. Check2,3, A. DiAntonio2, M. D. Srivastava4.
1
Philadelphia College of Osteopathic
Medicine, Philadelphia, PA; 2Dept. OB/
GYN, Div. Repro. Endo. & Infertility, UMDNJ,
Robert Wood Johnson Med. School at
Camden, Camden, NJ; 3Dept. OB/GYN, Div.
Repro. Endo. & Infertility, Cooper Medical
School of Rowan University, Camden, NJ;
4
Department of Medicine, Division of Allergy
and Immunology, SUNY at Buffalo, Buffalo,
NY.
__________________________________________________________
04:45 PM O-87 VITAMIN D DEFICIENCY (VDd) AND IMMUNE
PARAMETERS IN RECURRENT PREGNANCY
LOSSES. K. Ota1, A. Han1, A. Gilman-Sachs2,
B. Kenneth2, J. Kwak-Kim1. 1Reproductive
Medicine, Rosalind Franklin University
of Medicine and Scinece, Vernon Hills,
IL; 2Department of Micorbiology and
Immunology, Rosalind Franklin University of
Medicine and Scinece, North Chicago, IL.
Reproductive Laboratory Technology
Moderators: Kathryn C. Worrilow and Carli W. Chapman
04:15 PM O-93 NONINVASIVE PRENATAL ANEUPLOIDY
TESTING OF CHROMOSOMES 13, 18, 21,
X, AND Y. M. Rabinowitz1, G. Gemelos1,
M. Hill1, Z. Demko1, S. McAdoo1, B. Levy2.
1
Natera, Inc, San Carlos, CA; 2Pathology
and Cell Biology, Columbia University, New
York, NY.
05:00 PM O-88 ELEVATED NK CELL LEVEL AND
AUTOIMMUNITY SYNERGISTICALLY DECREASE
UTERINE BLOOD FLOW DURING EARLY
PREGNANCY. H. Yi1, J. Y. Kwak-Kim2, H. Koo1,
M. Choi1, C. Park1, K. M. Yang1. 1Obstetrics
and Gynecology, Cheil General Hospital,
Women’s Healthcare Center,Kwandong
University College of Medicine, Seoul,
Korea; 2Obstetrics and Gynecology, The
Chicago Medical School at Rosalind
Franklin University of Medicine and Science,
North Chicago, IL.
04:30 PM O-94 FACTORS THAT AFFECT MINERAL OIL
TOXICITY: ROLE OF OXYGEN AND PROTEIN
SUPPLEMENT. D. E. Morbeck, J. R.
Fredrickson, D. L. Walker. Obstetrics and
Gynecology, Mayo Clinic, Rochester, MN.
05:15 PM O-89 POOR ICSI OUTCOME IS ASSOCIATED WITH
AN INCREASE OF TOTAL CD16+ CD56+ NK
CELLS AND ACTIVATED CD69+ NK CELLS
IN PERIPHERAL BLOOD. M. Alhalabi1,2, S.
Samawi1, A. Taha1, J. Sharif1, M. Khalaf1,2,
A. Othman2. 1Assisted Reproduction Unit,
Orient Hospital, Damascus, Syrian Arab
Republic; 2Embryology & Reproductive
Medicine, Faculty of Medicine, Damascus
University, Damascus, Syrian Arab Republic.
04:45 PM O-95 12-HOUR PREIMPLANTATION GENETIC
SCREENING (PGS) BY TARGETED
SEQUENCING AND HIGHLY MULTIPLEX PCR
WITH 5% ADO ON BENCHTOP SEQUENCERS.
M. Hill, J. Baner, B. Zimmermann, A. Ryan, G.
Gemelos, M. Rabinowitz. Natera, Inc., San
Carlos, CA.
05:00 PM O-96 VITRIFIED BLASTOCYSTS YIELD EQUIVALENT
PREGNANCY RATES AS COMPARED TO FRESH
BLASTOCYSTS. D. A. Kelk, E. L. Paganetti, M.
P. Leondires, M. E. Moore, C. M. Murdock,
S. S. Richlin. Reproductive Medicine
Associates of Connecticut, Norwalk, CT.
05:30 PM O-90 HOMOCYSTEIN (HCY), FOLIC ACID AND
VITAMIN (B12) LEVELS IN FOLLICULAR FLUID
(FF) AND SERUM OF PATIENT WHO BECAME
PREGNANT AND THOSE WHO DID NOT AFTER
CONTROLLED OVARIAN HYPERSTIMULATION
(COH) FOR ICSI. M. E. Hammadeh.
University of Saarland, Homburg/Saar,
Germany.
05:15 PM O-97 ADVANCES IN QUALITY CONTROL: MOUSE
EMBRYO MORPHOKINETICS ARE SENSITIVE
MARKERS OF IN VITRO STRESS. H. S. Wolff, J.
R. Fredrickson, D. L. Walker, D. E. Morbeck.
60
ORAL ABSTRACTS
Mayo Clinic, Rochester, MN.
05:30 PM O-98 TIME LAPSE OBSERVATION OF EMBRYO
DEVELOPMENT IDENTIFIES LATER STAGE
MORPHOLOGY BASED PARAMETERS
ASSOCIATED WITH BLASTOCYST QUALITY
BUT NOT CHROMOSOME CONSTITUTION.
J. Stevens1, M. Rawlins1, A. Janesch1,
N. Treff2, W. B. Schoolcraft1, M. G. KatzJaffe1. 1Colorado Center for Reproductive
Medicine, Lone Tree, CO; 2Reproductive
Medicine Associates of New Jersey,
Morristown, NJ.
05:45 PM O-99 OVERNIGHT SURVIVAL OF THAWED AND
TROPHECTODERM BIOPSIED BLASTOCYSTS.
C. F. Boylan, M. P. Portmann, L. S. Morrison,
S. M. Carney, G. Kovalevsky, R. F. Feinberg.
Reproductive Associates of Delaware,
Newark, DE.
06:00 PM O-100 PREDICTION OF EMBRYO VIABILITY
USING VALIDATED CELL DIVISION TIME
INTERVALS MEASURED BY TIME-LAPSE
IMAGING. A. A. Chen1, K. Loewke1, S. P.
Willman2, P. E. Chenette3, R. Boostanfar4,
S. Shen1. 1Auxogyn, Inc., Menlo Park, CA;
2
Reproductive Science Center of the
Bay Area, San Ramon, CA; 3Pacific Fertility
Center, San Francisco, CA; 4HRC Fertility,
Encino, CA.
__________________________________________________________
Environment and Reproduction
Moderators: Victor Y. Fujimoto
04:15 PM O-101
ENDOCRINE DISRUPTING CHEMICALS
LEAD TO EARLIER AGE OF MENOPAUSE:
A CROSS-SECTIONAL STUDY USING THE US
POPULATION-BASED NHANES DATABASE.
N. M. Grindler1, J. E. Allsworth2, K. A. Roehl2,
A. R. Cooper1. 1Obstetrics and
Gynecology, Division of Reproductive
Endocrinology and Infertility, Washington
University, St Louis, MO; 2Obstetrics and
Gynecology, Division of Clinical Research,
Washington University, St Louis, MO.
04:30 PM O-102
ASSOCIATION OF SHORT-TERM AND LONGTERM PHYSICAL ACTIVITY ON
IMPLANTATION IN IN VITRO FERTILIZATION
(IVF) CYCLES. K. C. Calhoun1, A. Z.
Steiner1, M. Wen2, A. Calingo1, K. Evenson2.
1
Obstetrics and Gynecology, UNC-Chapel
Hill, Chapel Hill, NC; 2Epidemiology, UNC
Chapel Hill Gillings School of Global Public
Health, Chapel Hill, NC.
04:45 PM O-103
DEVELOPMENTAL VITAMIN D3 DEFICIENCY
DIFFERENTIALLY AFFECTS OVARIAN
GENE EXPRESSION PATTERNS IN ADULT
FEMALE MICE. J. B. Davis1, Z. Merhi4, B.
Tolga-Suntay2, G. Neal-Perry3. 1OB/GYN,
Montefiore Medical Center, Bronx, NY;
2
OB/GYN, Bronx Lebanon Hospital, Bronx,
61
NY; 3OB/GYN, Albert Einstein College of
Medicine, Bronx, NY; 4OB/GYN, University
of Vermont College of Medicine,
Burlington, VT.
05:00 PM O-104
DEVELOPMENTAL DIOXIN EXPOSURE
PROMOTES A HYPER-INFLAMMATORY
PERITONEAL MICROENVIRONMENT WHICH
MAY CONTRIBUTE TO THE ENDOMETRIOSISLIKE PHENOTYPE. D. R. Glore1, K. L.
Bruner-Tran1, K. L. Boyd2, J. A. Lucas1, K. G.
Osteen1. 1Women’s Reproductive Health
Research Center, Vanderbilt University
Medical Center, Nashville, TN; 2Pathology,
Microbiology and Immunology, Vanderbilt
University Medical Center, Nashville, TN.
05:15 PM O-105
RELEVANCE OF “SCOTS’ PARADOX” FOR
REPRODUCTIVE BIOLOGY? L. Pal1, N.
Kidwai2, W. Grant3. 1Obstetrics,
Yale University School of Medicine, New
Haven, CT; 2University of Connecticut,
Storrs, CT; 3Sunlight, Nutrition, and Health
Research Center (SUNARC), San Francisco,
CA.
05:30 PM O-106
IN THE FETAL RHESUS MONKEY UTERUS,
IN UTERO EXPOSURE TO BISPHENOL A
(BPA) IS ASSOCIATED WITH CHANGES
IN GENE EXPRESSION AND ACCELERATED
ADENOGENESIS. K. Calhoun1, E. Padilla
Banks2, C. VandeVoort4, P. Hunt3, C. J.
Williams2. 1Ob/Gyn, Division of
Reproductive Endocrinology, UNC
Chapel Hill, Chapel Hill, NC; 2Reproductive
Medicine Group, National Institute for
Environmental Health Sciences, Research
Triangle Park, NC; 3Molecular BioSciences,
Washington State University, Pullman, WA;
4
Ob/Gyn, UC Davis, Davis, CA.
05:45 PM O-107
REPRODUCTIVE HAZARDS OF DI-(2
ETHYLHEXYL)-PHTHALATE: IN VITRO AND IN
VIVO EXPOSURE TO MOUSE. X.-f. Huang1,2,
Y. Li2, H.-Q. Zhang1,3, H.-J. Shi1,3.
1
Department of Gynecology and
Obstetrics, Medical School of Fudan
University, Shanghai, China; 2Reproductive
Medical Center, the First Affiliated Hospital
of Wenzhou Medical School, Wenzhou,
Zhejiang, China; 3Shanghai Institute of
Planned Parenthood Research, Shanghai,
China.
06:00 PM O-108
ASSOCIATION OF URINARY PHTHALATE
(P) METABOLITE CONCENTRATIONS WITH
OVARIAN RESPONSE AMONG PATIENTS
UNDERGOING OVULATION INDUCTION
INTRAUTERINE INSEMINATION (OI/IUI).
I. Souter1, K. W. Smith2, I. Dimitriadis1,2,
P. L. Williams3, J. B. Ford1,2, R. Hauser1,2.
1
Obstetrics/Gynecology-Reproductive
Endocrinology & Infertility Division,
Massachusetts General Hospital-Harvard
Medical School, Boston, MA; 2Department
of Environmental Health, Harvard School
of Public Health, Boston, MA; 3Department
of Biostatistics, Harvard School of Public
Health, Boston, MA.
ORAL ABSTRACTS
11:15 am - 1:00 pm
Prize Paper Candidates’ Oral Abstract Presentations and Special Research Presentation
Moderators: Margareta D. Pisarska and Nathan R. Treff
The first six papers are candidates for the ASRM Scientific Program Prize Paper Awards.
Six additional candidates will be presented during the Prize Paper Candidates’ session on Monday morning.
11:15 AM O-109
A LARGE DOUBLE-BLIND EFFICACY AND
SAFETY TRIAL OF CORIFOLLITROPIN ALFA
VERSUS DAILY RECOMBINANT FSH
IN WOMEN 35 TO 42 YEARS OF AGE
UNDERGOING OVARIAN STIMULATION
PRIOR TO IVF OR ICSI (PURSUE TRIAL). R.
Boostanfar1, T. Yeko2, B. Shapiro3, J. Elbers4,
H. Witjes4, B. Mannaerts4. 1Huntington
Reproductive Center, Encino, CA; 2The
Reproductive Medicine Group, Florida
Fertility, Tampa, FL; 3The Fertility Center of
Las Vegas, Las Vegas, NV; 4MSD, Oss,
Noord-Brabant, Netherlands.
11:30 AM O-110
CONTRACEPTIVE TRIAL TESTING A
PROSTAGLANDIN E2 RECEPTOR (EP2)
ANTAGONIST IN FEMALE MONKEYS. M.
C. Peluffo1,2, R. L. Stouffer2,3,4, J. Stanley2,3,
J. D. Hennebold2,3,4, M. B. Zelinski2,3, B.
Lindenthal5. 1Centro de Investigaciones
Endocrinológicas (CEDIE-CONICET),
Hospital de Niños Ricardo Gutierrez,
Ciudad Autónoma de Buenos Aires,
Argentina; 2Division of Reproductive &
Developmental Sciences, Oregon
National Primate Research Center,
Beaverton, OR; 3Contraceptive
Development and Research Center,
Oregon National Primate Research
Center, Beaverton, OR; 4Department of
Obstetrics and Gynecology, Oregon
Health & Science University, Portland, OR;
5
Global Drug Discovery, Bayer Pharma AG,
Berlin, Germany.
11:45 AM O-111
A COMPARISON OF PATIENT-REPORTED
SEXUAL DYSFUNCTION AFTER TREATMENT
FOR GYNECOLOGIC CANCERS VERSUS
NON-GYNECOLOGIC CANCERS. J. L.
Chan, R. L. Diaz, W. Salem, E. Niemasik,
M. Rosen, J. Letourneau. Department of
California, San Francisco, San Francisco,
CA.
62
12:00 PM O-112
A NON-INVASIVE DIAGNOSTIC METHOD
OF HUMAN ENDOMETRIAL RECEPTIVITY
BASED ON A SPECIFIC LIPIDOMIC PROFILE
IN ENDOMETRIAL FLUID. F. Vilella1, H.
Bradshaw2, L. B. Ramirez1, J. M. Stuart2,
S. Martinez1, C. Simon1. 1IVI Investigación,
Fundación Instituto Valenciano de
Infertilidad (FIVI), Valencia University and
Instituto Universitario IVI/INCLIVA, Paterna,
Valencia, Spain; 2Psychological and Brain
Sciences, Indiana University, Bloomington,
IN.
12:15 PM O-113
GRANULOCYTE COLONY-STIMULATING
FACTOR PRESERVES FERTILITY IN MICE
TREATED WITH HIGH-DOSE GONADOTOXIC
CHEMOTHERAPY. M. E. Skaznik-Wikiel,
M. Sukhwani, J. N. Donohue, K. E. Orwig.
and Reproductive Sciences, MageeWomens Research Institute, University of
Pittsburgh School of Medicine, Pittsburgh,
PA.
12:30 PM O-114
PRESERVATION OF FERTILITY. S. J. Silber1,
D. Z. Silber1, N. Kagawa2, M. Kuwayama3.
1
Infertility Center of St. Louis, St. Luke’s
Hospital, St. Louis, MO; 2Kato Ladies Clinic,
Tokyo, Japan; 3Repro Support Medical
Research Centre, Tokyo, Japan.
12:45 PM
Special Research Presentation
DHEA ALTERS OOCYTE METABOLISM VIA THE
PENTOSE PHOSPHATE PATHWAY
2010-2012 Society for Reproductive
Endocrinology and Infertility (T32) Grant
Patricia T. Jimenez, M.D.
University of Texas Southwestern Medical
Center at Dallas
ORAL ABSTRACTS
Tuesday, October 23, 2012 4:15 pm-6:15 pm
Abstract Sessions
• Reproductive Surgery
• Imaging and ART Imaging
• Male Reproduction and Urology: Traveling Scholars
• Menopause
• Mental Health
• Nutrition
• Sexuality
• Outcome Predictors – Clinical: ART
• Ovarian Stimulation – High Responders: ART
• Preimplantation Genetic Diagnosis
• Procedures and Techniques – Clinical: ART
• Reproductive Endocrinology: Fellows Research
__________________________________________________________
Reproductive Surgery
Moderators: Charles H. Koh and Liselotte Mettler
04:15 PM O-115
EVALUATION OF OVARIAN AND TESTICULAR
TISSUE CRYOPRESERVATION AND THEIR
BUNDLING WITH MEDICALLY-INDICATED
PROCEDURES IN CHILDREN UNDERGOING
GONADOTOXIC THERAPIES FOR BLOOD
DYSCRASIAS OR CANCER. S. Babayev1,
M. Karsy1, E. Arslan1,2, S. Kogan2,3, K. Oktay1.
1
Obstetrics and Gynecology, New York
Medical College, Valhalla, NY; 2Institute
Surgery of New York, Rye, NY; 3Urology,
New York Medical College, Valhalla, NY.
04:30 PM O-116
OVARY ALLOTRANSPLANTATION BETWEEN
NON-HOMOZYGOUS SISTERS: SUCCESS
AND FAILURE, AN IMMUNOLOGIC PUZZLE.
S. J. Silber1, D. Z. Silber1, M. DeRosa1, P.
Mennes2, R. Graff3, S. Pincus3. 1Infertility
Center of St. Louis, St. Luke’s Hospital, St.
Louis, MO; 2Department of Nephrology, St.
Luke’s Hospital, St. Louis, MO; 3Department
of Surgery HLA Laboratory and Oncology,
Saint Louis University, St. Louis, MO.
04:45 PM O-117
LAPAROSCOPIC TUBAL REANASTOMOSIS
VERSUS IN VITRO FERTILIZATION: COSTBASED DECISION ANALYSIS
INCORPORATING MULTIPLE PATIENT
AGES, LIGATION TECHNIQUE AND IMPACT
OF MULTIPLE GESTATION. J. A. Winter,
J. E. Hirshfeld-Cytron. Obstetrics and
Gynecology, University of Illinois Medical
Center, Chicago, IL.
05:00 PM O-118
MICROSCOPIC TUBAL REVERSAL:
ROBOT ASSISTED LAPAROSCOPY OR
MICROSURGERY? A. E. Owens, H. O.
Irobunda, M. B. Henne. Reproductive
Endocrinology and Infertility Department
of Obstetrics and Gynecology, Walter
Reed National Military Medical Center,
Bethesda, MD.
05:15 PM O-119
THE COMPLICATION RATE OF
TRANSVAGINAL HYDRO-LAPAROSCOPY
IS LOW. M. Bloechle, S. G. Marr.
Kinderwunschzentrum an der
Gedächtniskirche Berlin, Berlin, Germany.
05:30 PM O-120
COMPARISON OF LONG TERM FERTILITY
AND BLEEDING OUTCOMES AFTER ROBOTIC,
LAPAROSCOPIC, AND OPEN
MYOMECTOMY. R. Flyckt, E. Soto, B. Nutter,
T. Falcone. Obstetrics and Gynecology,
Cleveland Clinic, Cleveland, OH.
05:45 PM O-121
ASSESSMENT OF LONG TERM BOWEL
SYMPTOMS AFTER SEGMENTAL RESECTION
FOR DEEPLY INFILTRATING ENDOMETRIOSIS.
M. Catenacci, C. Bedient, J. E. Jelovsek,
B. Nutter, T. Falcone. Cleveland Clinic
Foundation, Cleveland, OH.
06:00 PM O-122 DETERMINING THE FERTILITY BENEFIT OF
(COH) AND INTRAUTERINE INSEMINATION
(IUI) AFTER OPERATIVE LAPAROSCOPY
IN PATIENTS WITH ENDOMETRIOSIS. A.
Gandhi1, L. Carvalho2, B. Nutter2, T.
Falcone2. 1Obstetrics and Gynecology;
Lerner College of Medicine of CWRU,
Cleveland Clinic Foundation, Cleveland,
OH; 2Obstetrics and Gynecology,
Cleveland Clinic Foundation, Cleveland,
OH.
__________________________________________________________
Imaging and ART Imaging
Moderators: Ilan Tur-Kaspa and Laurel Stadtmauer
63
04:15 PM O-123
NON-INVASIVE IMAGING FOR THE
DETECTION OF HUMAN EMBRYONIC
ANEUPLOIDY AT THE BLASTOCYST
STAGE. B. E. Friedman1,2, S. L. Chavez1,2,
B. Behr2, R. B. Lathi2, V. L. Baker2, R. A.
Reijo Pera1,2. 1Institute for Stem Cell Biology
and Regenerative Medicine, Stanford,
CA; 2Stanford Fertility and Reproductive
Medicine Center, Stanford, CA.
04:30 PM O-124
IS A LARGE ARCUATE MORE DETRIMENTAL
THAN A SMALL ONE? HOW IMPORTANT
IS AN ARCUATE UTERUS? A PROSPECTIVE
STUDY OF 1280 CONSECUTIVE PATIENTS
WITH SECONDARY INFERTILITY. M.
Hartman1, A. Hartman2. 1Obstetrics
and Gynecology, Memorial University of
Newfoundland, St. John’s, NF, Canada;
2
True North Imaging, Thornhill, ON,
Canada.
04:45 PM O-125
USING FIRST TRIMESTER CROWN-RUMPLENGTH AS AN EARLY PREDICTOR OF
INTRAUTERINE GROWTH RESTRICTION. R.
B. Makhijani, B. Hodes-Wertz, J. Grifo. NYU
Fertility Center, New York, NY.
ORAL ABSTRACTS
05:00 PM O-126
EVALUATION OF THE OVARIAN RESERVE:
IS THERE STILL A PLACE FOR ULTRASOUND?
J. Saumet1, F. Dzineku1, M. del p. Velez1,
W. Jamal2, P. Lehmann1, I.-J. Kadoch1.
1
Obstetrics and Gynaecology, Montreal
University, Montreal, QC, Canada;
2
Obstetrics and Gynaecology, Clinique
OVO, Montreal, QC, Canada.
05:15 PM O-127
DOES THE ANTRAL FOLLICLE COUNT (AFC)
PREDICT OVARIAN RESPONSE FOR IN
VITRO FERTILIZATION (IVF) IN A PROGRAM
THAT USES MULTIPLE SONOGRAPHERS? K.
P. Comerford, R. M. Pixley, M. L. Matthews,
P. B. Marshburn, R. S. Usadi, B. S. Hurst.
Obstetrics and Gynecology, Carolinas
Medical Center, Charlotte, NC.
05:30 PM O-128
COMPARISON OF 3D/4D ULTRASOUND TO
3D SALINE INFUSED SONOHYSTEROGRAPHY
FOR EVALUATION OF ENDOMETRIAL POLYPS
IN PRE AND POSTMENOPAUSAL WOMEN.
M. A. Rodriguez B., M. Gualtieri, Y.
Mouhayar, A. Mejia, K. F. Brookfield, F.
Cruz-Pachano. Obstetrics and
Gynecology, University of Miami- Jackson
Memorial Hospital, Miami, FL.
05:45 PM O-129
TO SPRAY OR NOT TO SPRAY, THAT
IS THE QUESTION. A RANDOMIZED
CONTROLLED TRIAL OF BENZOCAINE
VERSUS PLACEBO SPRAY FOR PAIN RELIEF
AT HYSTEROSALPINGOGRAM (HSG). E.
A. Bachman, S. Senapati, S. Kansal Kalra.
Gynecology, Hospital of the University of
Labhasetwar2, E. S. Sabanegh1. 1Glickman
Urological and Kidney Institute, Cleveland
Clinic, Cleveland, OH; 2Biomedical
Engineering, Cleveland Clinic, Cleveland,
OH.
04:45 PM O-133
INCREASED BODY MASS INDEX IN MEN
WITH VARICOCELE IS ASSOCIATED WITH
LARGER PERITESTICULAR VEIN DIAMETERS
WHEN SUPINE. B. B. Najari, P. S. Li, M.
Goldstein. Urology, Weill Cornell Medical
05:00 PM O-134
DAIRY FOOD INTAKE IN RELATION TO SEMEN
QUALITY AMONG ACTIVE YOUNG MEN.
M. Afeiche1, J. Mendiola2, N. Jørgensen3,
S. H. Swan4, J. E. Chavarro1. 1Department
of Nutrition, Harvard School of Public
Health, Boston, MA; 2Division of Preventive
Medicine and Public Health, University of
Murcia, Espinardo, Murcia, Spain;
3
University Department of Growth and
Reproduction, Copenhagen, Denmark;
4
Department of Preventive Medicine,
Mount Sinai School of Medicine, New York,
NY.
05:15 PM O-135
EFFICACY OF A NEW DEVICE FOR
INDUCING EJACULATION IN MEN WITH
SPINAL CORD INJURY (SCI). L. C. Jenkins1,
E. Ibrahim2, T. C. Aballa2, K. Tajkarimi3, C.
M. Lynne1,2, N. L. Brackett1,2. 1Department
of Urology, University of Miami Miller School
of Medicine, Miami, FL; 2Miami Project to
Cure Paralysis, Miami, FL; 3Summit Urology
Group, Chambersburg, PA.
05:30 PM O-136 TESTICULAR ULTRASOUND AS A NON
INVASIVE INDICATOR OF TESTICULAR
FUNCTION. E. Goldenberg1, J. Hillelsohn2,
B. Gilbert2. 1Division of Urologic Surgery,
Washington University School of Medicine,
St. Louis, MO; 2Arthur Smith Institute for
Urology, North Shore - Long Island Jewish
Health System, New Hyde Park, NY.
__________________________________________________________
06:00 PM O-130 MULLERIAN DUCT ANOMALIES (MDAs) AND
MISCARRIAGES IN SECONDARY INFERTILITY.
A PROSPECTIVE STUDY OF THE
ASSOCIATION BETWEEN MISCARRIAGES
AND MDAs USING STRICT CRITERIA. M.
Hartman1, A. Hartman2. 1Obstetrics
and Gynecology, Memorial University of
Newfoundland, St. John’s, NF, Canada;
2
True North Imaging, Thornhill, ON,
Canada.
__________________________________________________________
Menopause
Moderators: Melissa F. Wellons and Aimee Seungdamrong
Male Reproduction and Urology: Traveling Scholars
Moderators: Nancy L. Brackett and Grace M. Centola
04:15 PM O-131
04:15 PM O-137
SEMEN PARAMETERS IN YOUNG MALE
CANCER PATIENTS CHOOSING SPERM
CRYOPRESERVATION: DOES STANDARD
WORLD HEALTH ORGANIZATION (WHO)
CRITERIA APPLY? L. A. Ross, M. Rosario, C.
Ahrendsen, L. A. Kondapalli. Obstetrics
and Gynecology, University of Colorado
Denver Anschutz Medical Campus,
Aurora, CO.
04:30 PM O-132 NOVEL TECHNIQUE FOR NANOPARTICLE
DELIVERY TO THE TESTIS IN A RAT MODEL.
D. C. Snow-Lisy1, M. K. Samplaski1, V.
64
DECREASED OVARIAN FUNCTION IN
PREMENOPAUSAL WOMEN IS ASSOCIATED
WITH INCREASED CENTRAL ADIPOSITY OVER
TEN YEARS: THE CORONARY ARTERY RISK
DEVELOPMENT IN YOUNG ADULT WOMEN’S
STUDY. M. R. McLean1, G. W. Bates1, B.
Sternfeld2, P. Schreiner3, D. Siscovick4, M.
Wellons1. 1Reproductive Endocrinology
and Infertility, University of Alabama at
Birmingham, Birmingham, AL; 2Division of
Research, Kaiser Permanente, Oakland,
CA; 3Division of Epidemiology and
Community Health, University of
Minnesota, Minneapolis, MN; 4Department
of Medicine, University of Washington,
Seattle, WA.
ORAL ABSTRACTS
04:30 PM O-138
ABUSE IN CHILDHOOD IS RELATED TO
ACCELERATED OVARIAN FOLLICLE LOSS AT
MIDLIFE. M. E. Bleil1, N. E. Adler1, L. A.
Pasch1, S. E. Gregorich2, M. P. Rosen3,
M. I. Cedars3. 1Psychiatry, University of
California San Francisco, San Francisco,
CA; 2Medicine, University of California San
Francisco, San Francisco, CA; 3Obstetrics,
Gynecology, and Reproductive Sciences,
University of California San Francisco, San
Francisco, CA.
04:45 PM O-139
HIGH FSH LEVEL INCREASE FAT
ACCUMULATION BY DOWNREGULATING
AQP7 AND GLYCROL EFFLUX IN
ADIPOCYTES. L.-t. Chen1, S. Shi2, J.-y. Li1,
X.-m. Liu2, H.-F. Huang1. 1Reproductive
endocrinology, Women’s Hospital, School
of Medicine, Zhejiang University,
Hangzhou, Zhejiang, China;
2
Pathophysiology, School of Medicine,
Zhejiang University, Hangzhou, Zhejiang,
China.
05:15 PM O-141
DECLINE IN ANTI-MULLERIAN HORMONE
(AMH) IN A COHORT OF LATE
REPRODUCTIVE AGE WOMEN AND ITS
ASSOCIATION WITH TIME TO MENOPAUSE.
M. D. Sammel1, E. W. Freeman2, D.
Boorman3. 1Biostatistics and Epidemiology,
Perelman School of Medicien,
Univ. of Pennsylvania, Philadelphia,
PA; 2Department of Obstetrics and
Gynecology, Perelman School of
Medicien, Univ. of Pennsylvania,
Philadelphia, PA; 3Center for Research
on Reproduction and Women’s Health,
Perelman School of Medicien, Univ. of
05:30 PM O-142
DOES ACCELERATED REPRODUCTIVE
AGING UNDERLIE PREMENOPAUSAL RISK
FOR CARDIOVASCULAR DISEASE? M.
E. Bleil1, N. E. Adler1, S. E. Gregorich2,
B. Sternfeld3, M. P. Rosen4, M. I. Cedars4.
1
Psychiatry, University of California San
Francisco, San Francisco, CA; 2Medicine,
University of California San Francisco,
San Francisco, CA; 3Division of Research,
Kaiser Permanente Northern California,
Oakland, CA; 4Obstetrics, Gynecology,
and Reproductive Sciences, University of
CA.
05:45 PM O-143
THE EFFECT OF PRIOR HYSTERECTOMY
AND/OR OOPHORECTOMY ON CHANGES
IN BONE MINERAL DENSITY (BMD) AND
CAROTID INTIMA-MEDIA THICKNESS
(CIMT) IN POSTMENOPAUSAL WOMEN.
S. J. Mucowski1, W. J. Mack2,3, N. Kono2,3,
R. Paulson1, D. Shoupe1, H. N. Hodis2,3.
1
Division of Reproductive Endocrinology
and Infertility, Keck School of Medicine
of the University of Southern California, Los
Angeles, CA; 2Atherosclerosis Research
Unit, Keck School of Medicine of the
University of Southern California, Los
Angeles, CA; 3Department of Preventive
Medicine, Keck School of Medicine of
the University of Southern California, Los
Angeles, CA.
06:00 PM O-144 LEUKOCYTE TELOMERE LENGTH AND AGE
AT MENOPAUSE. K. E. Gray1, M. A. Schiff1,
A. L. Fitzpatrick1, J. R. Starr2. 1Epidemiology,
University of Washington, Seattle, WA;
2
Center for Clinical and Translational
Research, The Forsyth Institute, Cambridge,
MA.
__________________________________________________________
Mental Health
Moderators: Sharon N. Covington and Alice D. Domar
65
04:15 PM O-145
ARE DEPRESSED INFERTILITY PATIENTS
OFFERED AND DO THEY RECEIVE MENTAL
HEALTH SERVICES? L. A. Pasch1, S. R.
Holley2, M. E. Bleil1, D. Shehab3, R. D.
Nachtigall4, P. P. Katz3. 1Psychiatry,
Francisco, CA; 2Psychology, San Francisco
State University, San Francisco, CA;
3
Institute for Health Policy Studies, University
CA; 4Institute for Health and Aging,
Francisco, CA.
04:30 PM O-146
THE PREVALENCE OF ANTIDEPRESSANT
USE BY WOMEN UNDERGOING IVF. A.
D. Domar1, J. Gross1, D. Ryley1, V. A.
Moragianni2, A. Urato3. 1Boston IVF,
Waltham, MA; 2Division of Reproductive
Endocrinology and Infertility, Beth Israel
Deaconess Medical Center, Boston, MA;
3
Obstetrics and Gynecology, Tufts Medical
Center, Boston, MA.
04:45 PM O-147
PRACTICING COGNITIVE BEHAVIORAL
INTERVENTIONS (CBI) INCREASES
PREGNANCY RATES IN WOMEN
UNDERGOING IVF. J. Czamanski-Cohen1,
O. Sarid1, J. Cwikel1, A. Zeadna2, E.
Levitas1,2, I. Har-Vardi1,2. 1Ben Gurion
University of the Negev, Beer Sheeba,
Israel; 2Soroka University Medical Center,
Beer Sheeba, Israel.
05:00 PM O-148
REGRET AROUND FERTILITY CHOICES
IS DECREASED WITH PRETREATMENT
COUNSELING AND FERTILITY-SPARING
SURGERY IN GYNECOLOGIC CANCER
PATIENTS. J. L. Chan, R. L. Diaz, L.-m. Chan.
Gynecology, University of California, San
05:15 PM O-149
THE LONG-TERM PSYCHOLOGICAL HEALTH
OF SURROGATE MOTHERS AND THEIR
FAMILIES. S. Imrie, V. Jadva, S. Golombok.
Centre for Family Research, University of
ORAL ABSTRACTS
Cambridge, Cambridge, Cambridgeshire,
United Kingdom.
05:30 PM O-150
FERTILITY PRESERVATION COUNSELING AT
THE TIME OF CANCER DIAGNOSIS REDUCES
DISTRESS AND ANXIETY. E. E. Niemasik1,
J. M. Letourneau2, A. Katz1, J. Belkora3,
M. Cedars1, M. Rosen 1. 1Obstetrics,
Francisco, CA; 2Obstetrics and
Gynecology, University of North Carolina
at Chapel Hill, NC; 3Health Policy and
Surgery, University of California, San
05:45 PM O-151
WAITING FOR PREGNANCY TEST RESULTS
FOLLOWING IN VITRO FERTILIZATION AND
EMBRYO TRANSFER (IVF/ET) OR
INTRAUTERINE INSEMINATION (IUI): WILL
GIVING PATIENTS A CARD HELP THEM
COPE? L. S. Covington, C. B. Toll, P. Sachs,
E. J. Mindes, M. H. Deweese, K. S. Richter.
Shady Grove Fertility Reproductive
Science Center, Rockville, MD.
05:00 PM O-156 DO SERUM VITAMIN D LEVELS CORRELATE
WITH SEMEN ANALYSIS PARAMETERS AND
SPERM DNA FRAGMENTATION? L. Rubal1,
A. M. Hernandez2, S. Ingles3, M. Scrooc4, K.
Bendikson1,4. 1Obstetrics and Gynecology,
Keck School of Medicine, University of
Southern California, Los Angeles, CA;
2
Keck School of Medicine, University
of Southern California, Los Angeles, CA;
3
Preventive Medicine, Keck School of
Medicine, University of Southern California,
Los Angeles, CA; 4USC Fertility, Los Angeles,
CA.
__________________________________________________________
Sexuality
Moderators: Michael A. Thomas
06:00 PM O-152 PREDICTORS OF REPRODUCTIVE CONCERNS
FOR SURVIVORS OF REPRODUCTIVE AGE
CANCERS: TARGETING POST-TREATMENT
COUNSELING FOR HIGH-RISK POPULATIONS
M. Shah, J. Letourneau, E. Ebbel, E. E.
Niemasik, M. Cedars, M. Rosen. Obstetrics,
Francisco, CA.
__________________________________________________________
Nutrition
Moderators: Kevin G. Osteen and Alex J. Polotsky
04:15 PM O-153
DOES CHANGING A PATIENT’S DIETARY
CONSUMPTION OF PROTEINS AND
CARBOHYDRATES IMPACT BLASTOCYST
DEVELOPMENT AND CLINICAL PREGNANCY
RATES FROM ONE CYCLE TO THE NEXT?
J. B. Russell, C. Abboud, A. Williams, M.
Gibbs, S. Pritchard, D. Chalfant. Division of
Christiana Care Health Systems, Newark,
DE.
04:30 PM O-154
DIETARY FOLATE INTAKE AND EARLY
OUTCOMES. A. J. Gaskins1, D. S. Colaci1,
D. L. Wright2, T. L. Toth2, R. Hauser1, J.
E. Chavarro1. 1Harvard School of Public
Health, Boston, MA; 2Massachusetts
General Hospital, Boston, MA.
04:45 PM O-155
CARBOHYDRATE INTAKE AND SEMEN
QUALITY AMONG YOUNG MEN. J. E.
Chavarro1, M. Afeiche1, J. Mendiola3,
N. Jorgensen4, S. Swan5. 1Department of
Nutrition, Harvard School of Public Health,
Boston, MA; 2Preventitive Medicine and
Public Health Unit, University of Murcia,
Faculty of Medicine, Murcia, Spain;
University Department of Growth and
Reproduction, Rigshospitalet,
Copenhagen, Denmark; 4Department of
Preventive Medicine, Mount Sinai School
of Medicine, New York, NY.
3
05:15 PM O-157
SEXUAL FUNCTION IS REDUCED IN THE
FEMALE PATIENT AND SEXUALLY INTIMATE
PARTNERS FOLLOWING CANCER THERAPY.
A. M. Martinez, J. M. Sroga, I. B. Ressler, L.
Ayensu-Coker, M. A. Thomas, S. L.
Lindheim. Department of Obstetrics &
Gynecology, University of Cincinnati,
Cincinnati, OH.
05:30 PM O-158
ANALYSIS OF A COHORT OF GAY
MEN SEEKING HELP WITH THIRD-PARTY
REPRODUCTION. S. A. Grover1, Z.
Shmorgun1, J. Christensen1, A. Sojecki1,
S. I. Moskovtsev1,2, C. L. Librach1,2,3,4.
1
CReATe Fertility Centre, Toronto, ON,
Canada; 2Obstetrics and Gynaecology,
University of Toronto, Toronto, ON,
Canada; 3Reproductive Endocrinology
and Infertility, Obstetrics and
Gynaecology, Sunnybrook Health
Sciences Centre, Toronto, ON, Canada;
4
Reproductive Endocrinology and
Infertility, Obstetrics and Gynaecology,
Women’s College Hospital, Toronto, ON,
Canada.
05:45 PM O-159
EVALUATION OF THE SEXUALITY OF
BRAZILIAN INFERTILE WOMEN. N. E. Busso, L.
Leis, L. O. Tso, J. B. Soares, O. B. Duarte
Filho, E. Tognotti. Alfa Project, São Paulo,
SP, Brazil.
06:00 PM O-160 FEMALE SEXUAL FUNCTION DURING
PREGNANCY IN SAUDI WOMEN. S. Alsibiani,
A. Rouzi. Obstetrics and Gynecology, King
Abdulaziz University, Jeddah, Saudi Arabia.
__________________________________________________________
66
ORAL ABSTRACTS
05:15 PM O-165 WITHDRAWN
Outcome Predictors-Clinical: ART
Moderators: Elizabeth S. Ginsburgh and Fernando ZegersHochschild
04:15 PM O-161
BLASTOCYST EUPLOID SELECTIVE TRANSFER
(BEST): AN RCT OF COMPREHENSIVE
CHROMOSOME SCREENING-SINGLE
EMBRYO TRANSFER (CCS-SET) VS DOUBLE
EMBRYO TRANSFER (DET)-EQUIVALENT
PREGNANCY RATES, ELIMINATES TWINS.
E. J. Forman1,2, K. H. Hong1,2, K. M. Ferry1,2,
X. Tao1, N. R. Treff1,2,3, R. T. Scott, Jr.1,2.
1
Reproductive Endocrinology,
School, New Brunswick, NJ; 3Genetics,
Piscataway, NJ.
04:30 PM O-162
SHARED DONOR EGG CYCLES DO NOT
COMPROMISE RECIPIENT OUTCOMES. A.
D. Giovannetti, I. N. Cholst, N. Lourie, J. E.
Malmsten, N. Zaninovic, Z. Rosenwaks.
Weill Cornell Medical College, New York,
NY.
04:45 PM O-163
PROSPECTIVE COHORT STUDY OF AUTISM,
NEURODEVELOPMENT, AND BEHAVIOR IN
YOUNG CHILDREN CONCEIVED BY ASSISTED
REPRODUCTIVE TECHNOLOGY (ART):
CAUSE FOR CONCERN OR REASSURANCE?
L. A. Kondapalli1, T. A. Molinaro2, S. J.
Ratcliffe3, S. A. Lorch4, K. T. Barnhart5.
1
Infertility, University of Colorado
Anschutz Medical Campus, Aurora,
CO; 2Reproductive Medicine Associates
of NJ, Eatontown, NJ; 3Biostatistics
and Epidemiology, University of
Pennsylvania, Philadelphia, PA; 4Center
for Outcomes Research, Children’s
Hospital of Philadelphia, Philadelphia, PA;
5
Infertility, University of Pennsylvania,
Philadelphia, PA.
05:00 PM O-164
ALTERNATE METHODS OF ESTIMATING
GESTATIONAL AGE FROM NATIONAL
DATABASES MAY OVERESTIMATE RATES OF
PRETERM BIRTH FOLLOWING ART. J.
E. Stern1, M. Kotelchuck2, B. Luke3, E.
Declercq4, C. M. Belanoff4, H. Diop5.
1
Ob/Gyn, Dartmouth-Hitchcock Medical
Center, Lebanon, NH; 2Mass General
Hospital for Children, Harvard Medical
School, Boston, MA; 3Department of
Obstetrics, Gynecology, and Reproductive
Biology, and Department of Epidemiology,
Michigan State University, East Lansing,
MI; 4Community Health Sciences, Boston
University School of Public Health, Boston,
MA; 5Bureau of Family Health and Nutrition,
Department of Public Health, Boston, MA.
05:30 PM O-166
DOES DONOR AGE AFFECT RECIPIENT
OUTCOMES? D. S. Bitterman, C. V. Levens,
I. N. Cholst. The Ronald O. Perelman and
Claudia Cohen Center for Reproductive
Medicine, Weill Cornell Medical College,
New York, NY.
05:45 PM O-167
MOVING TOWARDS SINGLE EMBRYO
TRANSFER: A CAUTIONARY TALE. S. Ouhilal,
H. Lachgar, N. Mahutte. The Montreal
Fertility Centre, Montreal, QC, Canada.
06:00 PM O-168 CLINICAL OUTCOMES STRATIFIED BY SERUM
FOLLICLE STIMULATING HORMONE (FSH)
LEVEL IN WOMEN WITH LOW,
SATISFACTORY, AND HIGH SERUM ANTI
MULLERIAN HORMONE (AMH) LEVELS FROM
MULTIPLE FERTILITY CENTERS. B. Leader1,
A. Penzias3,4, K. Richter1, V. L. Baker5.
1
Clinical Research Division, ReproSource,
Inc, Woburn, MA; 2Boston IVF, Waltham,
MA; 3Associate Professor of Obstetrics,
Gynecology and Reproductive Biology,
Harvard Medical School, Boston, MA;
4
Obstetrics and Gynecology, Division of
Stanford University School of Medicine,
Stanford, CA.
__________________________________________________________
Ovarian Stimulation - High Responders: ART
Moderators: Manish Banker and Owen Davis
67
04:15 PM O-169
IVF/ICSI PATIENTS PREDICTED TO BE HIGH
RESPONDERS BY THEIR AMH LEVEL MAY
BENEFIT FROM HP-HMG TREATMENT. A. La
Marca1, A. Nyboe Andersen2, P. Devroey3,
B. M. Klein4, J.-C. Arce5. 1Mother-Infant
Department, Institute of Obstetrics and
Gynecology, University of Modena and
Reggio Emilia, Modena, Italy; 2Fertility
Clinic, Rigshospitalet, Copenhagen
University Hospital, Copenhagen,
Denmark; 3Centre for Reproductive
Medicine, University Hospital Brussels,
Brussels, Belgium; 4Biometrics, Global
Clinical R&D, Ferring Pharmaceuticals,
Copenhagen, Denmark; 5Reproductive
Health, Global Clinical R&D, Ferring
Pharmaceuticals, Copenhagen, Denmark.
04:30 PM O-170
(hCG) RE-TRIGGER FOLLOWING A POOR
RESPONSE TO LEUPROLIDE ACETATE (LA)
TRIGGER IS NOT ASSOCIATED WITH POOR
IN VITRO FERTILIZATION (IVF) TREATMENT
OUTCOMES. S. Beall1, K. Moon1, E. Widra2,
J. Segars1, F. Chang2, K. Richter1. 1Program
in Reproductive and Adult Endocrinology,
Eunice Kennedy Shriver National Institute
of Child Health and Human Development,
National Institutes of Health, Bethesda, MD;
2
Shady Grove Fertility Reproductive
ORAL ABSTRACTS
04:45 PM O-171
GnRH AGONIST TRIGGER WITH LOW DOSE
SUCCESSFULLY RESCUES LUTEAL PHASE,
PREVENTS OVARIAN HYPERSTIMULATION
SYNDROME AND IMPROVES IVF OUTCOMES.
H. S. Lee, H. J. Jeong, M. H. Kim, M. K.
Chung. Reproductive Endocrinology,
Seoul Rachel Fertility Center, Seoul, Korea.
05:00 PM O-172
IS THERE A ROLE OF ANTIMULLERIAN
HORMONE IN DIAGNOSIS OF
PCOS? A PROSPECTIVE COHORT
STUDY. A. Ray, A. Shah, R. Homburg.
Obstetrics&Gynaecology, Homerton
University Hospital, London, United
Kingdom.
05:15 PM O-173
HIGH ESTRADIOL LEVELS AND HIGH
OOCYTE YIELD ARE NOT DETRIMENTAL TO
IVF OUTCOME IN BLASTOCYST CYCLES. F.
I. Sharara1,2, G. Abdo1. 1Virginia Center for
Reproductive Medicine, Reston, VA; 2Dept
of OB/GYN, George Washington University,
Washington, DC.
05:30 PM O-174
LIPIDOMICS IN POLYCYSTYC OVARY
SYNDOME: A NOVEL APPROACH FOR
DIAGNOSIS. F. B. Cordeiro, R. C. Rochetti,
C. B. Lima, T. Regiani, R. Fraietta, E.
G. Lo Turco. Surgery/Urology-Human
Reproduction Section, São Paulo Federal
University, São Paulo, SP, Brazil.
05:45 PM O-175
MATCHED SAMPLES COMPARISON OF
IN VITRO FERTILIZATION (IVF) CLINICAL
OUTCOMES ASSOCIATED WITH LEUPROLIDE
ACETATE (LA) VERSUS HUMAN CHORIONIC
GONADOTROPIN (hCG) TRIGGER FOR
OOCYTE MATURATION. S. Beall1, K. Moon1,
E. Widra2, A. DeCherney1, F. Chang2, K.
Richter1. 1Program in Reproductive and
Adult Endocrinology, Eunice Kennedy
Shriver National Institute of Child Health
and Human Development, National
Institutes of Health, Bethesda, MD; 2Shady
Grove Fertility Reproductive Science
Center, Rockville, MD.
06:00 PM O-176 INFLUENCE OF GnRH ANTAGONIST
TREATMENT DURATION AND DOSE IN A
OOCYTE DONATION PROGRAM. J. A.
Agirregoikoa1,2, J. L. De Pablo1, C. Anarte1,
E. Abanto1, M. Gonzalez1, G.
Barrenetxea1,2. 1Quiron Bilbao, Bilbao,
Bizkaia, Spain; 2Universidad del País Vasco/
Euskal Herriko Unibertsitatea, Leioa, Bizkaia,
Spain.
__________________________________________________________
Moderators: Carlos Simon and Pasquale Patrizio
04:15 PM O-177
IDIOPATHIC RECURRENT PREGNANCY LOSS
IS MOSTLY CAUSED BY ANEUPLOID
EMBRYOS. J. Grifo1, H. Danzer2, T. Taylor3,
C. Laskin4, R. Lathi5, S. Munne6. 1Fertility
68
Center, NYU Langone School of Medicine,
New York, NY; 2ART Reproductive Center,
Beverly Hills, CA; 3Main Line Fertility and
Reproductive Medicine, Bryn Mawr, PA;
4
LifeQuest Centre for Reproductive
Medicine, Toronto, ON, Canada; 5Stanford
Fertility Clinic, Stanford University Medical
Center, Palo Alto, CA; 6Reprogenetics,
Livingston, NJ.
04:30 PM O-178
DEVELOPMENT AND VALIDATION OF NEXTGENERATION SEQUENCING (NGS) BASED
PGD. A. Fedick1,2, X. Tao1, B. Devkota1,
D. Taylor1,3, R. T. Scott, Jr.1,3, N. R. Treff1,3.
1
New Jersey, Morristown, NJ; 2Molecular
Genetics, Microbiology and Immunology,
UMDNJ- Robert Wood Johnson Medical
School, Piscataway, NJ; 3Obstetrics,
Gynecology, and Reproductive Sicences,
04:45 PM O-179
23-CHROMOSOME SINGLE NUCLEOTIDE
POLYMORPHISM (SNP) MICROARRAY
PREIMPLANTATION GENETIC SCREENING
(PGS) FOR RECURRENT PREGNANCY LOSS
(RPL) IN 687 IN VITRO FERTILIZATION (IVF)
CYCLES AND 5871 EMBRYOS. K. J. Tobler1,
P. R. Brezina1, A. T. Benner2, L. Du2, B. Boyd2,
W. G. Kearns1,2. 1Department of
Gynecology and Obstetrics, Division
Infertility, Johns Hopkins Medical
Institutions, Baltimore, MD; 2Genetics,
Center for Preimplantation Genetics,
LabCorp, Rockville, MD.
05:00 PM O-180
HIGH RATE OF MICRODELETIONS IN
MISCARRIAGE PRODUCTS OF CONCEPTION
(POC) SAMPLES SUGGESTS ROLE FOR
(PGD). M. Rabinowitz, S. Sigurjonsson,
J. Keller, M. Maisenbacher, Z. Demko, B.
Pettersen. Natera, Inc., San Carlos, CA.
05:15 PM O-181
BENEFITS OF PREIMPLANTATION GENETIC
SCREENING (PGS) IN ADVANCED
MATERNAL AGE (AMA) WOMEN
DEMONSTRATED BY CUMULATIVE LIVEBIRTH RATES (CLBR) CONSIDERING ALL
THE EMBRYOS REPLACED IN CONSECUTIVE
CYCLES. M. Milan1, N. Garrido2, C.
Rubio1, C. Simon1, J. Remohí2, A. Pellicer2.
1
PGD Molecular Cytogenetics, IVIOMICS,
Paterna, Valencia, Spain; 2Institut
Universitari IVI, Valencia, Spain.
05:30 PM O-182
CHANGING CULTURE CONDITIONS.
BLASTOCYST PLOIDY FOLLOWING
STANDARD INCUBATION AND
UNINTERRUPTED CULTURE IN THE
EMBRYOSCOPE (ES). N. Bowman1, A.
Campbell2, S. Duffy1, K. Gardner1, M.
Sedler1, S. Fishel2. 1CARE Fertility
Manchester, Manchester, Lancashire,
ORAL ABSTRACTS
United Kingdom; 2CARE Fertility,
Nottingham Business Park, Nottingham,
United Kingdom.
Sciences, Yale University School of
Medicine, New Haven, CT.
05:45 PM O-183
DOES DAY 5 EMBRYO MORPHOLOGY BETTER
PREDICT EUPLOIDY COMPARED TO DAY 6?
B. Hodes-Wertz, E. Ampeloquio, S. Morin, A.
Adler, J. Grifo. NYU Fertility Center, New
York, NY.
05:15 PM O-189
ASSISTED HATCHING DOES NOT IMPROVE
IMPLANTATION RATES WHEN KEY FACTORS
ARE CONTROLLED FOR: TIME TO STOP USING
IT? A. Obradors1, M. Durban1, A. Pujol1, R.
Vassena1, O. Coll1,2, V. Vernaeve1,2. 1Clínica
EUGIN, Barcelona, Spain; 2Fundació
EUGIN, Barcelona, Spain.
05:30 PM O-190
HIGH DOSE ESTROGEN IN ENDOMETRIUM
PREPARATION INCREASES PREGNANCY
RATES IN FRESH OOCYTE DONATION
CYCLES. L. Schelstraete1, R. Vidal1, F.
Rodríguez1, O. Coll1,2, R. Vassena1, V.
Vernaeve1,2. 1Clínica EUGIN, Barcelona,
Spain; 2Fundació EUGIN, Barcelona, Spain.
05:45 PM O-191
FOLLICULAR FLUSHING IN VERY POOR
RESPONDERS: A RANDOMIZED CONTROLLED
TRIAL. E. Mok-Lin, A. Aelion Brauer, S.
Spandorfer, Z. Rosenwaks. The Ronald
O. Perelman and Claudia Cohen Center
for Reproductive Medicine, Weill Cornell
Medical College, New York, NY.
06:00 PM O-184 USING INDUCED PLURIPOTENT STEM (iPS)
CELL MODEL TO STUDY SPECIFIC FEATURES
OF TROPHOBLASTS WITH GENOMIC
TRISOMY OF CHROMOSOMES 13 AND
18. M. J. Tschirhart, Y. Seita, C.-w. Lu.
Department of Obstetrics, Gynecology,
and Reproductive Sciences, UMDNJ
Robert Wood Johnson Medical School
Child Health Institute of New Jersey, New
Brunswick, NJ.
__________________________________________________________
Procedures and Techniques-Clinical: ART
Moderators: Eric A. Widra and Yoshiharu Morimoto
04:15 PM O-185
OUTCOME OF INTRACYTOPLASMIC
SPERM INJECTION (ICSI) WITH FRESH
SPERM OBTAINED ON THE DAY OF OR THE
DAY BEFORE OOCYTE COLLECTION, AND
CRYOPRESERVED TESTICULAR
SPERMATOZOA IN MEN WITH
AZOOSPERMIA. M. Karacan, M. Ulug, Z.
Cebi, M. Berberoglugil, S. Erkan, T.
Camlibel. Obstetrics and Gynecology,
FulyaJinemed Hospital, Istanbul, Turkey.
04:30 PM O-186
EMBRYO TRANSFER (ET) IN FELLOWSHIP
PROGRAMS: EFFICACY OF INTRAUTERINE
INSEMINATIONS (IUI) AS A TRAINING
MODALITY. D. K. Shah1, E. Ginsburg1, K. F.
B. Correia1, C. Racowsky1, S. A. Missmer1,2,3.
1
and Infertility, Department of Obstetrics,
Gynecology, and Reproductive Biology,
Brigham and Women’s Hospital and
2
Channing Laboratory, Department of
Medicine, Brigham and Women’s Hospital
and Harvard Medical School, Boston, MA;
3
Department of Epidemiology, Harvard
School of Public Health, Boston, MA.
04:45 PM O-187
INTRAMUSCULAR ADMINISTRATION OF
PROGESTERONE FOR LUTEAL PHASE
SUPPORT IN IVF CYCLE IMPROVE
MAINTENANCE OF PREGNANCY FROM
BIOCHEMICAL TO CLINICAL STATUS. S.
Menard1,2, M. P. Velez1,2, R. Antaki1,2, I.-J.
Kadoch1,2. 1Clinique de Fertilite OVO,
Montreal, QC, Canada; 2Universite de
Montreal, Montreal, QC, Canada.
05:00 PM O-188
THE ASSOCIATION BETWEEN ASSISTED
REPRODUCTIVE TECHNOLOGY (ART) CLINIC
SUCCESS RATES AND NUMBER OF EMBRYOS
TRANSFERRED PER CYCLE. D. Gong, E. Seli.
06:00 PM O-192 NO IMPACT OF LONG-TERM STORAGE
ON ASEPTICALLY VITRIFIED BLASTOCYSTS –
PREGNANCY RATE (PR), LIFE BIRTH RATE
(LBR) AND HEALTH OF CHILDREN. B.
Wirleitner, P. Vanderzwalmen, D.
Schwerda, M. Bach, A. Stecher, N. H. Zech.
IVF Centers Prof. Zech, Bregenz, Austria.
__________________________________________________________
Reproductive Biology: Human Studies
Moderators: Sangita K. Jindal
04:15 PM O-193 Withdrawn
69
04:30 PM O-194
TROPHECTODERM IS PREDICTIVE OF
THE INNER CELL MASS AND NEWBORN
MITOCHONDRIAL DNA MUTATION LOAD.
N. R. Treff1,2, X. Tao1, J. Campos1, K. M.
Ferry1, B. Levy3, R. Scott1. 1Reproductive
Medicine Assocaites of New Jersey,
Morristown, NJ; 2Obstetrics, Gynecology,
and Reproductive Sciences, UMDNJRobert Wood Johnson Medical School,
New Brunswick, NJ; 3Columbia University,
New York, NY.
04:45 PM O-195
DEVELOPMENT AND IMPROVEMENT
OF A NEW MULTI-GENETIC TEST FOR THE
DETECTION OF 221 OF THE MOST HIGHLY
PENETRANT MONOGENIC DISEASES. J. A.
Horcajadas1,2, J. Fischer3,4, K. Ketterson3,4, A.
Bisignano3. 1Recombine-EU, RecombineEU, Alicante, Spain; 2Laboratory of
Traslational Research, Hospital Miguel
Servet, Zaragoza, Spain; 3Recombine
LL, Recombine LLC, Livingston, NJ;
4
Reprogenetics, Reprogenetics, Livingston,
NJ.
ORAL ABSTRACTS
05:00 PM O-196
DEVELOPMENT OF A NOVEL NEXT-GEN
SEQUENCING (NGS) METHODOLOGY
FOR ACCURATE CHARACTERIZATION
OF GENOME-WIDE MITOCHONDRIAL
HETEROPLASMY IN HUMAN EMBRYOS. K.
H. Hong1,2, D. M. Taylor1,2, E. Forman1, X.
Tao1, N. R. Treff1,2,3, R. T. Scott, Jr.1,2, R. Scott1.
1
Piscataway, NJ.
05:15 PM O-197
DIMINISHED OVARIAN FUNCTION IS
ASSOCIATED WITH DISTINCTIVE DNA
METHYLOME CHANGES IN HUMAN
OVARIAN GRANULOSA CELLS. B.
Yu1, A. DeCherney1, J. Segars, Jr.1, A.
Ignaszewski2, V. Russanova3, B. Howard3.
1
Program in Reproductive and Adult
Endocrinology, NICHD, NIH, Bethesda,
MD; 2Embryology Laboratory, Shady Grove
Fertility Reproductive Science Center,
Rockville, MD; 3Program in Genomics of
Differentiation, NICHD, NIH, Bethesda, MD.
05:30 PM O-198
AGE RELATED PROBABILITY OF HAVING A
CHROMOSOMALLY NORMAL EMBRYO FOR
TRANSFER FOLLOWING TROPHECTODERM
BIOPSY AND COMPREHENSIVE
CHROMOSOME SCREENING. D. A. Kelk, J.
Lo, K. Reyes, M. P. Leondires, J. M. Hurwitz,
C. M. Murdock. Reproductive Medicine
05:45 PM O-199
MOLECULAR KARYOTYPE ANALYSIS OF
SINGLE NUCLEOTIDE POLYMORPHISM
MICROARRAY FOR EARLY SPONTANEOUS
MISCARRIAGE AFTER ASSISTED
REPRODUCTIVE TECHNOLOGY. G. Li, Y. Liu,
L. Hu, Y. Guo, Y. Su, Y. Sun. Reproductive
Medical Center, The First Affiliated Hospital
of Zhengzhou University, Zhengzhou,
Henan, China.
06:00 PM O-200 EXPRESSION OF CRITICAL DEVELOPMENTAL
GENES IS IMPACTED BY THE AGE OF THE
OOCYTE. A. Strieby, J. C. Parks, B. R.
McCallie, W. Schoolcraft, M. Katz-Jaffe.
National Foundation for Fertility Research,
Lone Tree, CO.
__________________________________________________________
Reproductive Endocrinology: Fellows Research
Moderators: Ann Steiner and Jared C. Robins
04:15 PM O-201
METFORMIN TREATMENT PREVENTS
THE DEVELOPMENT OF ENDOTHELIAL
DYSFUNCTION IN A RAT MODEL OF
POLYCYSTIC OVARY SYNDROME (PCOS).
A. K. Hurliman1,2, G. Osol1, P. R. Casson1,2,
N. Maille1. 1Obstetrics and Gynecology,
University of Vermont, Burlington, VT;
70
2
04:35 PM O-202
EMBRYO TRANSFER BY REPRODUCTIVE
ENDOCRINOLOGY FELLOWS VERSUS
ATTENDING PHYSICIANS: ARE LIVE BIRTH
RATES COMPARABLE? J. L. Eaton, X.
Zhang, R. B. Barnes. Division of
Gynecology, Northwestern University
Feinberg School of Medicine, Chicago, IL.
04:55 PM O-203
EMBRYOS WHOSE POLAR BODIES
HAD A RECIPROCAL CHROMOSOMAL
ABNORMALITY ARE ALMOST ALWAYS
EUPLOID: A RESULT OF CORRECTION
OF PREMATURE SEPARATION OF SISTER
CHROMATIDS (PSSC). E. J. Forman1,2, J. M.
Stevens3, M. Katz-Jaffe1, W. Schoolcraft1,
N. Treff1, R. Scott1. 1Reproductive
Endocrinology, Reproductive Medicine
Associates of New Jersey, Morristown, NJ;
2
Obstetrics, Gynecology & Reproductive
Sciences, UMDNJ-Robert Wood Johnson
Medical School, New Brunswick, NJ;
3
Colorado Center for Reproductive
Medicine, Lone Tree, CO.
05:15 PM O-204
BLOCKADE OF TRANSFORMING GROWTH
FACTOR β (TGF-β) RESTORES MARKERS
OF ENDOMETRIAL RECEPTIVITY IN FIBROIDEXPOSED ENDOMETRIAL STROMAL CELLS
(ESC). L. F. Doherty, H. S. Taylor. Obstetrics,
Yale School of Medicine, New Haven, CT.
05:30 PM O-205
BIRTH WEIGHT AND CHILDHOOD GROWTH
IN DAUGHTERS OF WOMEN WITH IRREGULAR
MENSTRUAL CYCLES. E. T. Wang1, P. M.
Cirillo2, C.-N. Kao1, B. A. Cohn2, M. Cedars1.
1
Obstetrics Gynecology & Reproductive
Francisco, San Francisco, CA; 2Child
Health and Development Studies, Center
for Research on Women’s and Children’s
Health, Berkeley, CA.
05:45 PM O-206
OVARIAN MORPHOLOGY IS ASSOCIATED
WITH INSULIN RESISTANCE: CAN OVARIAN
VOLUME IDENTIFY WOMEN WITH
METABOLIC RISK IN POLYCYSTIC OVARIAN
SYNDROME? S. R. Pittenger1, C.-N. Kao1,
L. Pasch1, K. Shinkai2, H. G. Huddleston1.
1
Center for Reproductive Health, University
of California at San Francisco, San
Francisco, CA; 2Dermatology, University of
California at San Francisco, San Francisco,
CA.
06:00 PM O-207
DOUBLE THE TRANSFER EQUALS DOUBLE
THE RISK: THE BENEFITS OF ELECTIVE SINGLE
EMBRYO TRANSFER (ESET) IN REDUCING
THE RISK OF MULTIPLES WHILE PRODUCING
A HIGH CUMULATIVE CLINICAL
PREGNANCY RATE. K. E. Melzer, C.
McCaffrey, A. S. Berkeley, J. A. Grifo. NYU
Fertility Center, NYU Langone Medical
Obstetrics and Gynecology, Fletcher
Allen Healthcare, Burlington, VT.
ORAL ABSTRACTS
11:15 pm-12:45 pm
Abstract Sessions
• Androgen Excess
• Cryopreservation and Frozen Embryo Transfer-Clinical: ART
• Endometriosis
• Fibroids
• Nursing
• Outcome Predictors – Clinical: ART
• Ovarian Stimulation – Poor Responders: ART
• Procedures and Techniques – Laboratory: ART
• Male Factor: ART
__________________________________________________________
Androgen Excess
Moderators: Antoni J. Duleba
11:15 AM O-209
VITAMIN D (VitD) STATUS PREDICTS PCOS
RELATED INFERTILITY TREATMENT SUCCESS:
RETROSPECTIVE COHORT ANALYSIS OF
25OHD LEVELS IN STORED SERA FROM A
RCT OF CLOMID (CC) VS.METFORMIN (M)
VS. CC+M) IN PCOS. L. Pal1, J. Williams1,
The Reproductive Medicine Network
Investigators2. 1Obstetrics, Gynecology
& Reproductive Sciences, Yale University,
New Haven, CT; 2Eunice Kennedy Shriver
National Institute of Child Health & Human
Development, Bethesda, MD.
11:30 AM O-210
THE PROINFLAMMATORY TNFα RESPONSE
TO GLUCOSE INGESTION IS INDEPENDENT
OF ABDOMINAL ADIPOSITY IN POLYCYSTIC
OVARY SYNDROME (PCOS). F. González1,
C. L. Sia1, M. K. Shepard1, N. S. Rote2, J.
Minium2. 1Obstetrics and Gynecology,
Indiana University School of Medicine,
Indianapolis, IN; 2Reproductive Biology,
Case Western Reserve University School of
Medicine, Cleveland, OH.
11:45 AM O-211
HUMAN FOLLICULAR FLUID CONTAINS
ABUNDANT MICRORNAS, SOME OF
WHICH ARE ALTERED IN EXPRESSION
WITH POLYCYSTIC OVARIAN SYNDROME.
L. W. Roth1, B. McCallie2, R. Alvero1, D.
Minjarez3, W. Schoolcraft1, M. G. KatzJaffe2. 1Obstetrics and Gynecology,
University of Colorado, Denver, Aurora,
CO; 2National Foundation for Fertility
Research, Lone Tree, CO; 3Colorado
Tree, CO.
12:00 PM O-212
TESTOSTERONE AND WESTERN-STYLE DIET
INDUCE CHANGES IN OVARIAN STRUCTUREFUNCTION OF YOUNG ADULT, FEMALE
RHESUS MONKEYS. C. V. Bishop1, W. K.
McGee1,2, M. B. Zelinski1, J. L. Cameron2,3, R.
L. Stouffer1,4. 1Division of Reproductive and
2
Department of Behavioral Neuroscience,
Oregon Health & Science University,
Portland, OR; 3Department of Cell Biology
and Physiology, University of Pittsburgh,
Pittsburgh, PA; 4Department of Obstetrics
and Gynecology, Oregon Health &
Science University, Portland, OR.
12:15 PM O-213
HYPERANDROGENEMIA PLUS WESTERN STYLE
DIET (WSD) ATTENUATES DECIDUALIZATION
IN RHESUS MACAQUES. O. D. Slayden1, W.
K. McGee1, C. V. Bishop1, J. L. Cameron2,
R. L. Stouffer1. 1Division of Reproductive
and Developmental Sciences, Oregon
National Primate Research Center, Oregon
Health & Sciences University, Beaverton,
OR; 2Department of Cell Biology and
Physiology, University of Pittsburgh,
Pittsburgh, PA.
12:30 PM O-214
RESVERATROL REDUCES STEROIDOGENESIS
IN RAT OVARIAN THECA-INTERSTITIAL
CELLS: THE ROLE OF INHIBITION OF AKT/
PKB SIGNALING PATHWAY. I. Ortega1,2, J.
A. Villanueva1, A. B. Cress1, A. Sokalska1,3,
S. D. Stanley4, A. J. Duleba1. 1Department
of Obstetrics and Gynecology, University
of California, Davis, Davis, CA; 2IVI-Madrid,
Madrid, Spain; 3Department of
Gynecology, Obstetrics and
Gynecological Oncology, Karol
Marcinkowski University of Medical
Sciences, Poznan, Poland; 4Department
of Molecular Biosciences, University of
California, Davis, Davis, CA.
12:45 PM O-215 WOMEN WITH PCOS ARE NO MORE
VITAMIN D DEFICIENT THAN THE GENERAL
US POPULATION. L. Pal1, J. Williams1, S.
Hailpern2, NICHD Reproductive Medicine
Network3. 1Obstetrics, Gynecology &
Reproductive Sciences, Yale University,
New Haven, CT; 2New Haven, CT;
3
Reproductive Medicine Network,
Bethesda, MD.
__________________________________________________________
Cryopreservation and Frozen Embryo Transfer Clinical: ART
Moderators: Bill Yee and David Wininger
71
11:15 AM O-216
COMPARISON OF TAKE HOME BABY RATE
BETWEEN 2600 AND 1099 IVF/ICSI FRESH
CYCLES PERFORMED DURING AND AFTER
THE 40/2004 ITALIAN LAW RESPECTIVELY.
M. G. Minasi, F. Scarselli, K. Litwicka, M. T.
Varricchio, S. Ferrero, E. Greco. Centre for
Reproductive Medicine, European
Hospital, Rome, Italy.
11:30 AM O-217
PERINATAL OUTCOME OF CHILDREN BORN
AFTER VITRIFICATION OF BLASTOCYSTS
(6467 CYCLES WITH 2059 BABIES IN 12
YEARS EXPERIENCES). T. Mukaida1, T. Goto2,
ORAL ABSTRACTS
T. Tajima2, C. Oka2, K. Takahashi1.
Hiroshima HART Clinic, Hiroshima,
Hiroshima, Japan; 2Tokyo HART Clinic,
Tokyo, Japan.
11:45 AM O-218
EVALUATION OF THE FIRST 338
INFANTS FROM 257 DELIVERIES USING
CRYOPRESERVED DONATED OOCYTES
FROM A SINGLE IVF PROGRAM BASED ON
A STANDARDIZED VITRIFICATION
TECHNIQUE. J. Kahn, D. P. Bernal, T. A.
Elliott, C.-C. Chang, D. Shapiro, Z. P. Nagy.
Reproductive Biology Associates, Atlanta,
GA.
12:00 PM O-219
EGG BANKING IN THE USA: CURRENT
STATUS OF COMMERCIALLY AVAILABLE
CRYOPRESERVED OOCYTES. A. M. Quaas,
A. Melamed, K. Chung, K. A. Bendikson, R.
J. Paulson. Reproductive Endocrinology
and Infertility, Keck School of Medicine of
USC, Los Angeles, CA.
12:15 PM O-220
HIGH CUMULATIVE PREGNANCY RATES
DEMONSTRATE THE EFFICIENCY OF AN
OOCYTE DONATION PROGRAM USING
VITRIFIED OOCYTES. D. P. Bernal, J. Kahn, T.
A. Elliott, C.-C. Chang, C. Moon, Z. P. Nagy.
GA.
12:30 PM O-221
IS THERE ANY BENEFIT IN ARTIFICIAL
COLLAPSE OF HUMAN BLASTOCYSTS PRIOR
TO VITRIFICATION? J. Liebermann, J. M.
Matthews, E. Pawlowska, S. R. Sanchez, E.
Feinberg, C. Sipe. Fertility Centers of Illinois,
Chicago, IL.
1
12:45 PM O-222 ECTOPIC PREGNANCY INCIDENCE IS
REDUCED FOLLOWING TRANSFER OF
BLASTOCYSTS DERIVED FROM THAWED
BIPRONUCLEAR OOCYTES WHEN
COMPARED TO FRESH BLASTOCYST
TRANSFER. B. S. Shapiro1,2, S. T.
Daneshmand1,2, L. De Leon2, F. C. Garner1,2,
M. Aguirre1, C. Hudson1. 1Fertility Center
of Las Vegas, Las Vegas, NV; 2Dept. of
Nevada School of Medicine, Las Vegas,
NV.
__________________________________________________________
Endometriosis
Moderators: Bruce A. Lessey and Pamela Stratton
11:15 AM O-223
SIMVASTATIN MODULATES ACTION OF
RETINOIC ACID ON HUMAN ENDOMETRIAL
STROMAL CELLS. A. Sokalska1,2, M.
Anderson1, J. Villanueva1, K. L. Bruner-Tran3,
K. G. Osteen3, A. J. Duleba1. 1Department
of California Davis, Sacramento, CA;
2
Department of Gynecology, Obstetrics
and Gynecological Oncology, Karol
Marcinkowski University of Medical
Sciences, Poznan, Poland; 3Women’s
72
Reproductive Health Research Center,
Vanderbilt University School of Medicine,
Nashville, TN.
11:30 AM O-224
A PROSPECTIVE STUDY OF ENDOMETRIOSIS
AND CORONARY HEART DISEASE RISK.
F. Mu1, J. Rich-Edwards2, E. Rimm3, K.
Mukamal4, S. Missmer5. 1Department of
Epidemiology, Harvard School of Public
Health, Boston, MA; 2Connors Center for
Women’s Health, Brigham and Women’s
Hospital, Boston, MA; 3Channing
Laboratory, Department of Medicine,
4
Department of Medicine, Beth Israel
5
and Reproductive Biology, Brigham and
Women’s Hospital and Harvard Medical
School, Boston, MA.
11:45 AM O-225
ASSESSMENT OF THE RELATIONSHIP AMONG
MULTIFOCAL PAIN, PAIN SEVERITY,
DISTURBED SLEEP, AND PSYCHOLOGICAL
SYMPTOMS IN WOMEN WITH CHRONIC
PELVIC PAIN ASSOCIATED WITH
ENDOMETRIOSIS. J. A. L. Gemmill1,
N. Sinaii2, D. Shanis1, G. Chrousos1, I.
Khachikyan1, P. Stratton1. 1Program in
Reproductive and Adult Endocrinology,
NICHD/NIH, Bethesda, MD; 2Biostatistics
and Clinical Epidemiology Service, CC/
NIH, Bethesda, MD.
12:00 PM O-226
FENRETINIDE AS A NOVEL TREATMENT
FOR ENDOMETRIOSIS. M. E. Pavone, S. Malpani, M. Dyson, D. Monsivais, S.
E. Bulun. Obstetrics and Gynecology,
Northwestern University, Feinburg School of
Medicine, Chicago, IL.
12:15 PM O-227
USE OF DEPOT GnRH ANTAGONIST
(DEGARELIX) IN THE TREATMENT
OF ENDOMETRIOSIS RECURRENCE. A
CONTROLLED TRIAL. F. Scarpellin, M.
Sbracia. CERM, Hungaria, Rome, Italy.
12:30 PM O-228
SIPPING FROM THE FIREHOSE: COMPLETE
GENOME SEQUENCING OF ENDOMETRIOSIS
PATIENTS. K. Ward, R. Chettier, P.
Farrington, H. Albertsen. Juneau
12:45 PM O-229
PREDICTIVE MODELS OF ENDOMETRIOSIS:
TOWARDS A SCREENING ASSESSMENT
TOOL TO PRIORITISE WOMEN FOR SURGERY.
K. E. Nnoaham1, L. Hummelshoj2, S. H.
Kennedy3, C. Jenkinson4, K. T. Zondervan3,5.
1
Public Health, University of Oxford,
Oxford, Oxfordshire, United Kingdom;
2
World Endometriosis Research Foundation,
London, United Kingdom; 3Nuffield
University of Oxford, Oxford, Oxfordshire,
United Kingdom; 4Health Services
ORAL ABSTRACTS
12:30 PM O-235
Research Unit, University of Oxford, Oxford,
Oxfordshire, United Kingdom; 5Wellcome
Trust Centre for Human Genetics, University
of Oxford, Oxford, Oxfordshire, United
Kingdom.
__________________________________________________________
12:45 PM O-236 THE PROTECTIVE MECHANISM OF
CETRORELIX ACETATE IN A
CHEMOTHERAPY-INDUCED MURINE
MODEL OF OVARIAN DAMAGE. C. M. P.
Duke1, I. Khachikyan2, A. Z. Rosenberg3,
X. C. Guo2, J. H. Segars2, A. Y. Armstrong2.
1
Gynecology and Obstetrics, Johns
Hopkins University, School of Medicine,
Baltimore, MD; 2Program in Reproductive
and Adult Endocrinology, Eunice Kennedy
Institutes of Health, Bethesda, MD;
3
Laboratory of Pathology, Clinical Center,
National Institutes of Health, Bethesda, MD.
__________________________________________________________
Moderators: Mitchell P. Rosen and Karen B. Glass
11:15 AM O-230
ANTI-MÜLLERIAN HORMONE (AMH)
ALTERS PREANTRAL FOLLICLE SURVIVAL
AND GROWTH, PLUS INHIBITS STEROID
PRODUCTION IN ANTRAL FOLLICLES DURING
ENCAPSULATED 3-DIMENSIONAL (3D)
CULTURE IN PRIMATES. J. Xu, M. Lawson,
R. Yeoman, R. Stouffer, M. Zelinski. Oregon
Health & Science University, Beaverton,
OR.
11:30 AM O-231
SPHINGOSINE-1-PHOSPHATE PREVENTS
HUMAN PRIMORDIAL FOLLICLE
DEATH INDUCED BY A DIVERSE SET OF
CHEMOTHERAPY AGENTS. F. Li1, K. Akula1,
E. Ozkaya1, P. De Sutter3, K. Oktay1,2.
1
Laboratory of Molecular Reproduction
and Fertility Preservation, Obstetrics
& Gynecology, New York Medical
of New York, Rye, NY; 3Department of
Reproductive Medicine, Ghent University,
Ghent, Belgium.
11:45 AM O-232
HETEROTOPIC TRANSPLANTS OF VITRIFIED
OVARIAN TISSUE IN MACAQUES:
ASSESSMENT OF FOLLICULAR FUNCTION,
EMBRYONIC DEVELOPMENT AND A
NOVEL MICROBUBBLE ASSAY FOR BLOOD
FLOW. D. M. Lee1, A. Ting2, C. Thomas2, C.
Bishop2, F. Xu2, M. B. Zelinski1,2. 1Obstetrics
& Gynecology, Oregon Health & Science
University, Portland, OR; 2Oregon National
Primate Research Center, Beaverton, OR.
12:00 PM O-233
AKT1 SIGNALING PATHWAY ACTIVATION
IMPROVES ANGIOGENESIS OF OVARIAN
GRAFTS. Y. Cohen1,2, H. Dafni1, K. Walsh3,
L. E. Benjamin4, T. Raz1, M. Neeman1.
1
Biological Regulation, Weizmann Institute
of Science, Rehovot, Israel; 2Obstetrics and
Gynecology, Lis Maternity Hospital, Tel Aviv
Sourasky Medical Center, Tel Aviv, Israel;
3
Department of Medicine, Boston University
School of Medicine, Boston, MA; 4Beth
Israel Deaconess Medical Center, Boston,
MA.
12:15 PM O-234
CHARACTERIZATION OF THE
GONADOTROPIN RELEASING HORMONE
RESPONSE IN THE OVARY. S. Torrealday,
O. Guzeloglu-Kayisli, M. Lalioti, E. Seli.
Sciences, Yale University, New Haven, CT.
FIFTEEN YEARS OF FERTILITY PRESERVATION
WITH OOCYTE STORAGE. E. Porcu, L.
Notarangelo, F. Fabbri, G. Damiano, C.
Zacà, L. Cipriani. IVF Center, Sant’orsola
Malpighi Hospital University, Bologna, Italy.
Fibroids
Moderators: Erica E. Marsh and Guillermo L. Marconi
11:15 AM O-237
LEIOMYOMA CELL REGULATION VIA
THE PROFIBROBLASTIC PROTEIN LAMININ,
RESULTS IN SPATIAL ORGANIZATION. M.
Malik1, J. Britten-Webb1, W. H. Catherino1,2.
1
Obstetrics and Gynecology, USUHS,
Bethesda, MD; 2Program in Reproductive
and Human Development, Bethesda, MD.
11:30 AM O-238 AKAP13 AUGMENTS PROGESTERONEDEPENDENT GENE ACTIVATION IN FIBROID
CELLS. S. Jorge1, P. H. Driggers1, M. Malik2,
J. H. Segars1. 1Program in Adult and
Reproductive Endocrinology, NICHD, NIH,
Bethesda, MD; 2Department of Ob/Gyn,
USUHS, Bethesda, MD.
73
11:45 AM O-239
UTERINE FIBROID-SPECIFIC STEM CELLS
ENHANCE SUBCUTANEOUS TUMOR
FORMATION IN A NOVEL MOUSE MODEL
(SHARAN-2). C. Sharan, S. Nair, S. Halder,
A. Al-Hendy. Obstetrics and Gynecology,
CWHR, Meharry Medical College,
Nashville, TN.
12:00 PM O-240
RACIAL DIFFERENCES IN FIBROID
PREVALENCE AND AWARENESS IN
ASYMPTOMATIC YOUNG WOMEN (18-30
YEARS OLD). G. E. Ekpo, E. R. Cardozo,
M. E. Brocks, T. J. Dune, L. Cohen, E.
E. Marsh. Obstetrics and Gynecology,
Feinberg School of Medicine Northwestern University, Chicago, IL.
12:15 PM O-241
TRANSFORMING GROWTH FACTOR
BETA UPREGULATES COLLAGEN VIA THE
SUPPRESSION OF microRNA-29 EXPRESSION
IN LEIOMYOMA. E. E. Marsh, J. B. Parker,
J. Wu, J. Dickens, D. Chakrvarti, S. E. Bulun.
ORAL ABSTRACTS
Obstetrics and Gynecology, Feinberg
School of Medicine - Northwestern
12:30 PM O-242
DIFFERENTIAL EXPRESSION OF CHROMATIN
MODIFYING PROTEINS BETWEEN NORMAL
MYOMETRIUM VERSUS MYOMETRIUM FROM
FIBROID UTERI SUGGESTS INVOLVEMENT OF
THE EPIGENOME IN FIBROID BIOLOGY. C.
Sharan, S. Nair, S. Halder, S. Maitra, A. AlHendy. Obstetrics and Gynecology,
CWHR, Meharry Medical College,
Nashville, TN.
12:45 PM O-243 TGFBETA MEDIATED FIBROSIS IN
LEIOMYOMA CELLS WORKS THROUGH THE
SMAD DEPENDENT SIGNALING AND NOT
THROUGH MAPK/ERK PATHWAY. M. Malik1,
J. Britten-Webb1, G. Levy1,2, M. Gilden1, W.
H. Catherino1,2. 1Obstetrics and
Gynecology, USUHS, Bethesda, MD;
2
Endocrinology, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, Bethesda, MD.
__________________________________________________________
New York, NY; 3RESOLVE: The National
Infertility Association, McLean, VA;
4
Health Services Consulting Corporation,
Boxborough, MA; 5Seattle Reproductive
Medicine, Seattle, WA.
12:15 PM O-248
A SURVEY OF THE EXPERIENCES AND
ATTITUDES OF HEALTHY FERTILE DONORS OF
OOCYTES USED FOR IN VITRO FERTILIZATION
(IVF) TREATMENTS OF INFERTILE PATIENTS.
M. J. Levy, D. L. Dagerman, K. S. Richter,
M. Purcell, K. Bugge. Shady Grove Fertility
MD.
12:30 PM O-249
POTENTIAL REASONS FOR PATIENTS NOT
PURSUING FERTILITY PRESERVATION
AFTER REFERRAL FOR CONSULTATION
AND COUNSELING. L. Pepin, J. Nulsen, C.
Benadiva, M. Rescildo, L. Engmann. Center
for Advanced Reproductive Services,
and Infertility, Department of Obstetrics
and Gynecology, Farmington, CT.
12:45 PM O-250 IS PARTNER CONSENT FOR A WOMAN’S
PARTICIPATION IN FERTILITY CLINICAL
TRIALS JUSTIFIED? THE REPRODUCTIVE
MEDICINE NETWORK EXPERIENCE. R.
G. Brzyski1, K. Barnhart2, N. Santoro3, E.
Eisenberg4. 1University of Texas HSC San
Antonio, TX; 2University of Pennsylvania
Medical Center, Philadelphia, PA;
3
University of Colorado Anschutz Medical
Campus, Aurora, CO; 4National Institute
Bethesda, MD.
__________________________________________________________
Nursing
Moderators: Shalini S. Gunawardena and Cynthia F.Willson
11:15 AM O-244
URSES MAKE THE DIFFERENCE: VIGILANT
COMMUNICATION MAY HELP PATIENTS
WITH SEVERE OHSS AVOID MEDICAL
INTERVENTION. H. I. G. Cotton1, M.
Acosta1, J. A. Lee1, M. Whitehouse1,
L. Grunfeld1,2, A. B. Copperman1,2.
1
York, New York, NY; 2Obstetrics,
Gynecology and Reproductive Science,
NY.
11:30 AM O-245
INTRAUTERINE INSEMINATION PREGNANCY
RATES DO NOT DIFFER BETWEEN PHYSICIANS
AND NURSES. W. R. Meyer1, A. Oddone2,
S. Berchuck2, J. K. Park1. 1Carolina
Conceptions, Raleigh, NC; 2Duke
University, Durham, NC.
11:15 AM O-251
MYO-INOSITOL: OVARIAN STIMULATION
AND IVF OUTCOMES. G. Carlomagno1,
M. Montanino Oliva2, S. J. Roseff3, V. Unfer1.
1
Agunco, Rome, Italy; 2Villa Mafalda,
Rome, Italy; 3South Florida Institute for
Reproductive Medicine, Jupiter, FL.
11:45 AM O-246
WHO DOES WHAT: A NATIONAL SURVEY
OF ROLES WITHIN OOCYTE DONATION
(OD) IVF PRACTICES. K. R. Hammond1, N.
A. Cataldo2, M. P. Steinkampf1. 1Alabama
Fertility Specialists, Birmingham, AL;
2
Birmingham, AL.
12:00 PM O-247
COMPARISON OF OBSTETRIC/
GYNECOLOGY (OB/GYN) NURSE
PRACTITIONER (NP) AND PHYSICIAN (MD)
PATTERNS OF FERTILITY-RELATED
DISCUSSIONS WITH PATIENTS: FINDINGS
FROM THE FERTILITY HCP 2012 SURVEY.
F. F. Velez1, E. Kramer2, B. L. Collura3,
N. C. Edwards4, M. C. Mahony1, T. M.
Tobias5. 1EMD Serono, Inc., Rockland, MA;
2
Healthcare Research, Harris Interactive,
11:30 AM O-252
IMPACT OF NUMBER OF OOCYTES THAWED
AND THE DAY OF EMBRYO TRANSFER ON
IVF SUCCESS RATES WITH VITRIFIED DONOR
OOCYTES: AN INDIVIDUAL PATIENT DATA
META-ANALYSIS FROM 508 THAW CYCLES.
A. P. Cil1,2, M. Rosen4, K. Oktay1,3. 1Institute
Specialists of New York, Rye, NY; 2Obstetrics
and Gynecology, Kirikkale University
School of Medicine, Kirikkale, Turkey;
3
Obstetrics and Gynecology, New York
Medical College, Valhalla, NY; 4University
CA.
Moderators: TBD
74
ORAL ABSTRACTS
11:45 AM O-253
MORE IS NOT BETTER: DAILY SERUM FSH
LEVELS DURING CONTROLLED OVARIAN
HYPERSTIMULATION (COH) IN WOMEN WITH
NORMAL (NOR) AND DIMINISHED OVARIAN
RESERVE (DOR) ACROSS A SPECTRUM OF
BODY MASS INDICES (BMI). D. Kulak1, S. K.
Jindal1,2, C. Hickmon2, A. Yu1, H. Lieman1,2,
E. Buyuk1,2. 1Obstetrics and Gynecology,
2
Montefiore’s Institute for Reproductive
Medicine and Health, Hartsdale, NY.
12:15 PM O-255
EFFECT OF ANTRAL FOLLICLE COUNT ON
CHANGE IN OOCYTE YIELD IN
CONSECUTIVE IVF CYCLES. E. E. Eppsteiner,
A. Sparks, D. Liu, E. H. Duran, B. Van
Voorhis. Obstetrics and Gynecology,
University of Iowa Hospitals and Clinics,
Iowa City, IA.
12:30 PM O-256
PERI-IMPLANTATION SERUM LEVEL OF
PREDICTS IVF OUTCOME. S. T.
Daneshmand1,2, B. S. Shapiro1,2, F. C.
Garner1,2, M. Aguirre1, C. Hudson1. 1Fertility
Center of Las Vegas, Las Vegas, NV; 2Dept
of Nevada School of Medicine, Las Vegas,
NV.
12:45 PM O-257 USING LINKED CYCLES OF ASSISTED
REPRODUCTIVE TECHNOLOGY (ART)
TO EVALUATE FACTORS ASSOCIATED
WITH MONOZYGOSITY AND THE RISK
OF RECURRENCE. B. Luke1, M. B. Brown2,
E. Wantman3, J. E. Stern4. 1Ob, Gyn, &
Reproductive Biology, Michigan State
University, East Lansing, MI; 2Biostatistics,
University of Michigan, Ann Arbor, MI;
3
Redshift Technologies, New York, NY;
4
Obstetrics & Gynecology, Dartmouth
Hitchcock Medical Center, Lebanon, NH.
__________________________________________________________
IN VITRO FERTILIZATION (IVF) YIELDS MUCH
HIGHER SUCCESS RATES THAN INTRAUTERINE
INSEMINATION (IUI) AMONG OLDER
WOMEN AGED 38-44 YEARS. C. M.
Eguiguren1, K. S. Richter2, J. A. Horne3, J.
E. Osheroff2, E. A. Widra2. 1Georgetown
University Hospital, Washington, DC; 2Shady
Center, Rockville, MD; 3Georgetown
University Medical School, Washington,
DC.
11:30 AM O-259
450IU VERSUS 600IU OF GONADOTROPINS
IN POOR RESPONDERS UNDERGOING IN
VITRO FERTILIZATION (IVF): PRELIMINARY
REPORT OF A RANDOMIZED CONTROLLED
TRIAL. E. Monceau1,2, M.-P. Velez1,2, N.
Dean1,2, I. J. Kadoch1,2, L. Lapensee1,2.
1
Clinique OVO, Montreal, QC, Canada;
2
11:45 AM O-260
LIVE BIRTH CHANCES IN WOMEN WITH
UNDETECTABLE ANTI-MULLERIAN HORMONE
(AMH) LEVELS. A. Aelion Brauer, E. MokLin, S. D. Spandorfer, Z. Rosenwaks. Ronald
for Reproductive Medicine/Weill Cornell
12:00 PM O-261
NUMBER OF EMBRYOS TRANSFERRED
DURING IN-VITRO FERTILIZATION CYCLES
IN WOMEN AT LEAST 40 YEARS-OLD AND
THE EFFECT ON PREGNANCY AND MULTIPLE
GESTATION RATES. M. H. Dahan, W. Y. Son,
S. L. Tan. McGill Repoductive Center,
McGill university, Montreal, QC, Canada.
12:15 PM O-262
ADDING LUTEINIZING HORMONE TO
FOLLICLE STIMULATING HORMONE
DURING OVARIAN STIMULATION INCREASES
PREGNANCY RATE IN IVF FOR POOR
OVARIAN RESPONDERS. C. Rongieres1,
V. Poirier1, C. Celebi1, O. Pirrello1, K.
Bettahar1, P. Lehert2. 1Gynecology and
Obstetric Centre of ART, CMCO Hopitaux
Universitaires de Strasbourg, Schiltigheim,
France; 2Faculty of Economics, Univertsity
of Louvain, Mons, Belgium.
12:30 PM O-263
LETROZOLE IN POOR RESPONDERS:
ASSOCIATION OF PRACTICAL, SAVING
AND GOOD RESULTS. A. G. Soligo1, R. S.
Rodrigues1, A. S. Setti2, D. P. A. F. Braga1,2,
A. Iaconelli Jr.1,2, E. Borges Jr.1,2. 1Fertility Assisted Fertilization Center, São Paulo, SP,
Brazil; 2Sapientiae Institute - Educational
and Research Center in Assisted
Reproduction, São Paulo, SP, Brazil.
Université de Montréal, Montreal, QC,
Canada.
12:45 PM O-264 CO-TREATMENT WITH GROWTH HORMONE
(GH) MAY INCREASE PREGNANCY RATE
IN POOR RESPONDERS UNDERGOING IVF/
ET. M.-S. Shen, C.-W. Wang, C.-H. Chen,
C.-J. Chen, H.-M. Wu, C.-R. Tzeng. Center
for Reproductive Medicine, Taipei Medical
University Hospital, Taipei, Taiwan.
__________________________________________________________
Ovarian Stimulation - Poor Responders: ART
Moderators: John C. Nulsen and Timothy N. Hickman
11:15 AM O-258
Procedures and Techniques-Laboratory: ART
Moderators: Catherine Racowsky and G. David Ball
11:15 AM O-265
75
DENSITY GRADIENT CENTRIFUGATION
PRIOR TO CRYOPRESERVATION AND
ANTIOXYDANT SUPPLEMENTATION BY
HYPOTAURINE IMPROVE POST-THAW
SPERM QUALITY OF INFERTILE MEN WITH
OLIGOASTHENOTERATOZOOSPERMIA. F.
Brugnon1,2, L. Ouchchane3,4,5, C. Artonne2,
H. Pons-Rejraji1,2, L. Janny1,2. 1Biologie
de la Reproduction, AMP, CECOS, CHU
Clermont Ferrand, CHU Estaing, Clermont
Ferrand, France; 2Génétique Reproduction
Développement,GReD, Université
d’Auvergne, INSERM U1103, CNRS UMR
ORAL ABSTRACTS
6393, Faculté de Médecine, Clermont
Ferrand, France; 3Pôle Santé Publique,
Médecine Légale, Qualité, Vigilances,
Unité de Biostatistique, Informatique
Médicale et Technologies de
Communication, CHU Clermont Ferrand,
Clermont Ferrand, France; 4Laboratoire
de Biostatistique, Informatique Médicale et
Technologies de Communication,
Université d’Auvergne, Clermont
Ferrand, France; 5ISIT, UMR6284, Université
d’Auvergne, Clermont Ferrand, France.
11:30 AM O-266
LIVE-CELL INTRA-OOCYTE LIPID ANALYSIS
AND QUANTIFICATION WITH
HYPERSPECTRAL IMAGING BY MULTIPLEX
COHERENT ANTI-STOCKES RAMAN
SCATTERING MICROSCOPY (CARS-M). J.
Jasensky1, A. Boughton1, A. Khmaladze2,
J. E. Swain3, Z. Chen1, G. D. Smith3.
1
Department of Biophysics, University of
Michigan, Ann Arbor, MI; 2Department
of Chemistry, University of Michigan,
Ann Arbor, MI; 3Department of OB/Gyn,
University of Michigan, Ann Arbor, MI.
11:45 AM O-267
LASER-ASSISTED HATCHING (LAH)
OF CRYOPRESERVED EMBRYOS – THE
SIGNIFICANCE OF HOLE SIZE. B. Link1, B.
Wong1, J. Mayer2, M. Sullivan1, J. Fleetham1,
C. Greene1. 1Regional Fertility Program
Inc., Calgary, AB, Canada; 2Eastern
Virginia Medical School, Norfolk, VA.
12:00 PM O-268
INTRACYTOPLASMIC MORPHOLOGICALLY
SELECTED SPERM INJECTION (IMSI)
BENEFITS IN THE PRESENCE OF UNEXPLAINED
INFERTILITY: A PROSPECTIVE RANDOMIZED
STUDY. A. S. Setti1, D. P. A. F. Braga1,2, R.
C. S. Figueira2, S. S. Colturato2, A. Iaconelli
Jr.1,2, E. Borges Jr.1,2. 1Sapientiae Institute
- Educational and Research Center in
Assisted Reproduction, Sao Paulo, SP, Brazil;
2
Fertility - Assisted Fertilization Center, Sao
Paulo, SP, Brazil.
12:15 PM O-269
SPINDLE EXAMINATION OF UNFERTILIZED
EGGS BETWEEN ICSI AND IVF WITH
POLSCOPE. J. H. Moon, J.-T. Chung, S.
Henderson, S. G. Jin, A. Garcia, H. Holzer.
Reproductive Center, Mcgill University
Health Center, Montreal, QC, Canada.
12:30 PM O-270
A HIGHLY SENSITIVE
ELECTROCHEMILUMINESCENCE
IMMUNOASSAY FOR DETECTING
EMBRYONIC HUMAN CHORIONIC
GONADOTROPIN IN EMBRYO CULTURE
MEDIA. J. Li1, X. Chen1, D. Jiang2, X. Liu2,
Y. Liu1, G. Zhuang1. 1Human Reproductive
Center, The First Affiliated Hospital of
Sun Yat-Sen University, Guangzhou,
Guangdong, China; 2Clinical Laboratory
Department, The First Affiliated Hospital
of Sun Yat-Sen University, Guangzhou,
Guangdong, China.
12:45 PM O-271 EVALUATION OF A MODIFIED RAPID
STAINING PROTOCOL FOR HUMAN SPERM
MORPHOLOGY ASSESSMENT. M. Lanham,
J. E. Swain. Obstetrics & Gynecology,
University of Michigan, Ann Arbor, MI.
__________________________________________________________
Male Factor: ART
Moderators: Denny Sakkas and Sergio C. Oehninger
76
11:15 AM O-272
ALTERATIONS IN THE SPERM PROTEOME
MAY IDENTIFY IDIOPATHIC INFERTILITY AND
POOR IVF OUTCOME. S. McReynolds1, M.
Dzieciatkowska2, K. C. Hansen2, M. KatzJaffe1,3. 1National Foundation for Fertility
Research, Lone Tree, CO; 2University of
Colorado Denver, Aurora, CO; 3Colorado
Tree, CO.
11:30 AM O-273
THE EFFECT OF PATERNAL AGE ON SHARED
RECIPIENT OOCYTE DONATION (OD)
CYCLES. L. Meyer, L. Zakarin, D. E.
Reichman, S. Spandorfer, Z. Rosenwaks.
Ronald O. Perelman and Claudia Cohen
Center for Reproductive Medicine and
Infertility, Weill Cornell Medical School,
New York, NY.
11:45 AM O-274
IS SPERM DNA DAMAGE EVALUATION
USEFUL BEFORE THE FIRST INTRAUTERINE
INSEMINATION (IUI) CYCLE? S. Belloc1, J.
de Mouzon2, M. Cohen-Bacrie1, A. Hazout3,
I. Lichtblau1, P. Cohen-Bacrie1. 1ART Unit
Eylau Unilabs, Paris, France; 2Service de
Gynécologie Obstétrique II et Médecine
de la Reproduction, CHU Cochin Port
Royal, APHP, Université Paris Descartes,
Paris, France; 3RDP Conseil, Paris, France.
12:00 PM O-275
TUNEL ASSAY ON SWIM UP SAMPLES AIDS IN
PREDICTING IVF OUTCOMES. D. A.
Paduch1, A. Bolyakov1, R. Stubbs2, M.
Murawski2, N. Zaninovic2, G. L. Schattman2.
1
Urology and Reproductive Medicine,
NY; 2Center for Reproductive Medicine
and Infertility, Weill Cornell Medical
College, New York, NY.
12:15 PM O-276
HIGHER LEVELS OF SPERM APOPTOSIS
AND LIPID PEROXIDATION ARE RELATED
TO INCREASING MALE AGE IN INFERTILE
PATIENTS. C. Alvarez Sedó, M. V. Gil, J.
Serna, F. Nodar, S. Papier, C. Chillik. CEGYR
(Centro de Estudios en Ginecología y
Reproducción), Capital Federal, Buenos
Aires, Argentina.
12:30 PM O-277
FERTILIZATION CAPACITY AND EMBRYO
OUTCOME USING microTESE SPERM
COMPARED TO THE EJACULATED SPERM
IN DONOR OOCYTE CYCLES. N. Zaninovic,
A. Bahia, J. Hariprashad, D. Weiss, C.-A.
Cook. Reproductive Medicine, Weill
Cornell Medical College, New York, NY.
ORAL ABSTRACTS
12:45 PM O-278 EVALUATION OF POTENTIAL CORRELATION
BETWEEN SPERM PARAMETERS AND IVF
OUTCOMES WHEN ICSI IS PERFORMED ON
VITRIFIED/WARMED DONOR EGGS. J. Kahn,
M. A. Witt, C.-C. Chang, T. A. Elliott, S. M.
Slayden, Z. P. Nagy. Reproductive Biology
Associates, Atlanta, GA.
__________________________________________________________
Moderators: Thomas G. Turner and Sue A. Gitlin
12:15 PM O-283
SERUM BIOMARKERS OF OVARIAN AGING
BUT NOT ANTRAL FOLLICLE COUNT VARY
WITH BMI: IS AFC A MORE VERSATILE
MARKER OF OVARIAN AGING? S.
R. Pittenger1, B. Sternfeld2, R. A. ReijoPera3. 1Center for Reproductive Health,
University of California, San Francisco,
Kaiser Permanente, Oakland, Oakland,
CA; 3Institute for Stem Cell Biology and
Regenerative Med, Stanford University,
Stanford, CA.
12:30 PM O-284
VALIDATION OF A NOVEL HIGH
THROUGHPUT SCREENING ASSAY TO
ASSESS CALCIUM RESPONSES IN HUMAN
SPERM. S. J. Martins da Silva1, A. G. Hope2,
D. W. Gray2, C. L. R. Barratt1. 1Reproductive
Medicine, University of Dundee, Dundee,
Scotland, United Kingdom; 2Division of
Biological Chemistry and Drug Discovery,
University of Dundee, Dundee, Scotland,
United Kingdom.
11:15 AM O-279
ZINC FINGER PROTEINS 36 (ZFP36s) FAMILY
AND LEUKEMIA INHIBITORY FACTOR (LIF)
EXPRESSION IN THE HUMAN ENDOMETRIAL
CYCLE: A PROSPECTIVE CASE-CONTROL
STUDY. E. Evans-Hoeker1, S. L. Young1, L.
Yuan1, B. Lessey3, K. Caron2, S. B. Ramos1.
1
North Carolina at Chapel Hill, NC; 2Cell
and Molecular Physiology, University
of North Carolina at Chapel Hill, NC;
3
Obstetrics and Gynecology, Greenville
Hospital, Greenville, SC.
11:30 AM O-280
EZRIN AND RADIXIN ARE EXPRESSED IN
GLANDULAR PINOPODES AND MICROVILLI
DURING THE SECRETORY PHASE IN HUMAN
ENDOMETRIUM. O. Tan1, K. S. Carrick2,
A. R. Word1, O. Bukulmez1, B. R. Carr1.
1
Gynecology, University of Texas
Southwestern Medical Center, Dallas, TX;
2
Department of Pathology, University of
Texas Southwestern Medical Center,
Dallas, TX.
11:45 AM O-281
ELEVATED SERUM PROGESTERONE
ON THE DAY OF HUMAN CHORIONIC
GONADOTROPIN (hCG) TRIGGER
NEGATIVELY IMPACTS IMPLANTATION
IN BOTH CLEAVAGE AND BLASTOCYST
EMBRY0 TRANSFERS. M. J. Hill1,2, G. Levy1,2,
K. Richter1, A. DeCherney2, G. Suthar1, M.
J. Levy1. 1Shady Grove Fertility
MD; 2Program in Reproductive and Adult
Human Development, National Institutes of
11:15 AM O-286
YOUNG CANCER SURVIVORS ACHIEVE
UNASSISTED PREGNANCIES AT A RATE
SIMILAR TO HEALTHY CONTROLS DESPITE
IMPAIRED MEASURES OF OVARIAN RESERVE.
K. E. Dillon1, M. D. Sammel2, M. Prewitt1, L.
Lechtenberg1, A. Schanne1, C. R. Gracia1.
1
Obstetrics and Gynecology, University
of Pennslyvania School of Medicine,
Philadelphia, PA; 2Biostatistics and
Epidemiology, University of Pennsylvania,
Philadelphia, PA.
12:00 PM O-282
PREECLAMPSIA-ASSOCIATED SOLUBLE
ENDOGLIN (sENG) IS DECREASED IN
POLYCYSTIC OVARIAN SYNDROME (PCOS)
LEADING TO TRANSFORMING GROWTH
FACTOR (TGF)-B1 DYSREGULATION DURING
CONTROLLED OVARIAN STIMULATION.
R. Tal1, D. B. Seifer1, A. Shohat-Tal2, R. V.
Grazi1, H. E. Malter1. 1Genesis Fertility &
Reproductive Medicine, Brooklyn, NY;
2
Department of Biology, Brooklyn College,
City University of New York, Brooklyn, NY.
11:30 AM O-287
AGE-RELATED NORMAL SERUM
CONCENTRATIONS OF ANTI-MÜLLERIAN
HORMONE AND COMPARISON OF
OVARIAN RESERVE TESTS IN A COHORT
OF HEALTHY KOREAN WOMEN. T. G. Jang1,
A. Lee2, Y. J. Kim2, K. Y. Lee2, J. H. Rhee1,
J. C. Park1. 1Department of Obstetrics and
Gynecology, School of Medicine,
Keimyung University, Daegu, Korea; 2Seoul
Medical Science Institute/Seoul Clinical
Laboratories, Seoul, Korea.
12:45 PM O-285 DIFFERENCES IN SPERM DNA
FRAGMENTATION BETWEEN HIGH- AND
LOW-CYCLING VOLUME TRIATHLETES:
PRELIMINARY RESULTS. D. Vaamonde1, M.
E. Da Silva-Grigoletto2, J. M. Garcia
Manso3, R. Vaamonde-Lemos1. 1School of
Medicine- University of Cordoba,
Cordoba, Spain; 2University of Seville,
Seville, Spain; 3University of Las Palmas de
Gran Canaria, Las Palmas, Gran Canaria,
Spain.
__________________________________________________________
Reproductive Endocrinology: Clinical
Moderators: H. Irene Su and Amber R. Cooper
77
ORAL ABSTRACTS
11:45 AM O-288
A SINGLE PRE-OVULATORY IUI AT 12 HOURS
AFTER hCG TRIGGER IS COMPARABLE
TO A TRADITIONAL IUI AT 36 HOURS. A.
M. Propst1,5, J. J. Thoppil1, J. M. Groll2, J. L.
Frattarelli3, R. D. Robinson1, M. G. Retzloff1,4.
1
San Antonio Military Medical Center, San
Antonio, TX; 2Wright-Patterson USAF
Medical Center, Dayton, OH; 3Tripler Army
Medical Center, Honolulu, HI; 4Keesler
USAF Medical Group, Biloxi, MS; 5Uniformed
Services University of the Health Sciences,
Bethesda, MD.
12:00 PM O-289
ECTOPIC PREGNANCIES IN DISGUISE:
(hCG) CURVES IN WOMEN WITH AN
ECTOPIC PREGNANCY MIMIC OTHER
OUTCOMES AND DIFFER BY RACE AND
ETHNICITY. K. E. Dillon1, V. D. Sioulas2,
K. Chung3, M. Sammel1, P. Takacs4, K. T.
Barnhart1. 1Obstetrics and Gynecology,
University of Pennslyvania School of
Medicine, Philadelphia, PA; 2Obstetrics
and Gynecology, University of Athens,
Athens, Haidari, Greece; 3Obstetrics
and Gynecology, University of Southern
California, Los Angeles, CA; 4Obstetrics
and Gynecology, University of Miami
School of Medicine, Miami, FL.
12:15 PM O-290
CLOMIPHENE CITRATE OR LETROZOLE AS
FIRST LINE OVULATION INDUCTION DRUG
IN INFERTILE PCOS WOMEN: A PROSPECTIVE
RANDOMISED TRIAL. S. Kar. Kar Clinic &
Hospital Pvt. Ltd., Bhubaneswar, Orissa,
India.
12:30 PM O-291
METABOLIC CHANGES TELOMERE LENGTH
AND IN WOMEN WITH POLYCYSTIC OVARY
SYNDROME. D. C. C. Pedroso1, M. Okuka2,
W. de P. Martins1, D. L. Keefe2, C. Silva2, R.
M. dos Reis1. 1Department of Obstetrics
and Gynecology, Medical School
of Ribeirão Preto, Ribeirao Preto, SP,
Brazil; 2Department of Obstetrics and
Gynecology, University of South Florida
College of Medicine, Tampa, FL.
12:45 PM O-292
PRE-TREATMENT ANTI-MULLERIAN
HORMONE (AMH) LEVEL DETERMINES
RATE OF POST-THERAPY OVARIAN
RESERVE RECOVERY: ACUTE CHANGES
IN OVARIAN RESERVE DURING AND
AFTER CHEMOTHERAPY. K. E. Dillon1, M. D.
Sammel2, J. P. Ginsberg3, J. E. Mersereau4,
Y. Gosiengfiao5, C. R. Gracia1. 1Obstetrics
and Gynecology, University of
Pennslyvania School of Medicine,
Epidemiology, University of Pennsylvania
School of Medicine, Philadelphia, PA;
3
Pediatrics, The Children’s Hospital of
Philadelphia, Philadelphia, PA; 4Obstetrics
Carolina, Chapel Hill, NC; 5Pediatrics,
Children’s Memorial Hospital, Chicago, IL.
3:45 pm- 5:30 pm
Abstract Sessions
• Male Reproduction and Urology: Clinical
• Cryopreservation and Frozen Embryo Transfer – Laboratory/
Basic: ART
• Endometriosis
• Health Disparities
• Other: ART-Laboratory/Basic
• Ovarian Stimulation: ART
• Procedures and Techniques – Laboratory: ART
__________________________________________________________
Male Reproduction and Urology: Clinical
Moderators: Erma Z. Drobnis
03:45 PM O-293
PERFORMANCE OF TESTICULAR VERSUS
EJACULATED SPERMATOZOA IN MEN
WITH EXTREME OLIGOZOOSPERMIA. D.
Monahan1, Q. V. Neri1, P. Schlegel, Z.
Rosenwaks, G. D. Palermo1. 1The Ronald
O. Perelman & Claudia Cohen Center
Medical College, New York, NY; 2Urology
Department, Weill Cornell Medical
78
04:00 PM O-294
SEMEN PARAMETERS DECLINING AMONG
YOUNG ADULT MALES IN THE BOSTON AREA
DURING THE PAST 6 YEARS. G. M. Centola1,
A. Blanchard1, J. Demick1, B. Blaney1, S. H.
Benoff2. 1New England Cryogenic Center,
Newton, MA; 2Formerly of The Feinstein
Institute, Manhasset, NY.
04:15 PM O-295
OBESE MEN WITH NONOBSTRUCTIVE
AZOOSPERMIA HAVE WORSE PREGNANCY
OUTCOMES FOLLOWING MICRODISSECTION
TESTICULAR SPERM EXTRACTION. R.
Ramasamy, C. F. Bryson, J. E. Reifsnyder, Q.
Neri, G. D. Palermo, P. N. Schlegel. Center
for Reproductive Medicine, New York
Presbyterian Hospital, Weill Cornell Medical
04:30 PM O-296
ASSESSMENT OF DNA DAMAGE AND
STRICT MORPHOLOGY. M. G. McIntyre, A.
Patuszack, P. Shah, T.-C. Hsieh, D. J. Lamb,
L. I. Lipshultz. Urology, Baylor College of
Medicine, Houston, TX.
04:45 PM O-297
SEMINAL INFECTION AND ABNORMAL
SPERM CHROMATIN PACKAGING. P.
Cohen-Bacrie1, M. Cohen-Bacrie1, J. de
Mouzon2, S. Belloc1, I. Lichtblau1, V.
ORAL ABSTRACTS
Napoly1. 1ART Unit Eylau Unilabs, Paris,
France; 2Service de Gynécologie
Obstétrique II et Médecine de la
Reproduction, CHU Cochin Port Royal,
APHP, Université Paris Descartes, Paris,
France.
05:00 PM O-298 THE NUMBER OF TOTAL MOTILE SPERM
INSEMINATED (TMSI) IS PREDICTIVE
OF PREGNANCY BY INTRAUTERINE
INSEMINATION (IUI) USING SPERM
FROM MEN WITH SPINAL CORD INJURY
(SCI). A. S. Q. Kathiresan1, E. Ibrahim2,
T. Aballa2, G. R. Attia1, C. M. Lynne3, N. L.
Brackett3. 1Department of Obstetrics and
Gynecology, University of Miami, Miami, FL;
2
Miami Project to Cure Paralysis, Miami, FL;
3
Department of Urology, University of
Miami, Miami, FL.
__________________________________________________________
Cryopreservation and Frozen Embryo Transfer Laboratory/Basic: ART
Moderators: Jeffrey P. Boldt and Jacob Mayer
03:45 PM O-299
ICE BLOCKERS IMPROVE VITRIFICATION
OUTCOME OF MOUSE EMBRYOS BY
ALLOWING LOWER CRYOPROTECTANT
CONCENTRATION IN VITRIFICATION MEDIA
WITHIN A CLOSED SYSTEM. T. A. Farghaly1,2,
S. Israel1, M. Marconi1, A. Loeb1, J.
Goldfarb1, A. Ahmady1. 1University
Hospitals Fertility Center, Ahuja Medical
Center, Beachwood, OH; 2Womens’ Health
Center, Assiut University, Assiut, Egypt.
04:00 PM O-300
OOCYTE VITRIFICATION DOES NOT RESULT
IN A DECREMENT IN MITOCHONDRIAL
DNA (mtDNA) COPY NUMBER IN RESULTING
EMBRYOS: A PAIRED RANDOMIZED
CONTROLLED TRIAL (RCT). E. J. Forman1,2,
J. Su1, D. Taylor1,3, B. Devkota1, N. Treff1,
Piscataway, NJ.
04:15 PM O-301
THE INTERCHANGEABILITY OF
HEPES (4-(2-hydroxyethyl)-1piperazineethanesulfonic ACID) AND
MOPS (3-(N-morpholino)propanesulfonic
ACID) BASED SOLUTIONS FOR
VITRIFICATION AND SUBSEQUENT
WARMING. M. J. Abeyta, Q. Zhao, J.
Gebhardt, M. Suarez, V. Reddy, B. R.
Behr. Obstetrics and Gynecology, Division
Infertility, Stanford Fertility and
Reproductive Medicine Center, Palo Alto,
CA.
04:30 PM O-302
IDENTIFICATION OF ALTERED PROTEIN
EXPRESSION AFTER CRYOPRESERVATION
OF HUMAN OVARIAN TISSUE. S. S.
Kim1, L. Collins1, L. He1, Y. Dong1, D.
Kim1, A. Artigues2. 1OB/GYN, Univesity
of Kansas Medical Center, Kansas City,
KS; 2Biochemistry and Molecular Biology,
Univesity of Kansas Medical Center, Kansas
City, KS.
04:45 PM O-303
EFFECTS OF VITRIFICATION ON
MITOCHONDRIAL DISTRIBUTION AND
SPINDLE CONFIGURATION DURING IN
VITRO MATURATION OF HUMAN GERMINAL
VESICLE-STAGE OOCYTES. R. Tsutsumi1,2,3,
T. Huang1,2. 1OB/GYN, University of Hawaii,
Honolulu, HI; 2Pacific In Vitro Fertilization
Institute, Honolulu, HI; 3Institute for
Biogenesis Research, University of Hawaii,
Honolulu, HI.
05:00 PM O-304
OUTCOME OF VITRIFIED DAY 7
BLASTOCYSTS IN THE ERA OF EXTENDED
CULTURE. S. M. Carney, M. P. Portmann,
L. S. Morrison, C. F. Boylan, G. Kovalevsky,
R. F. Feinberg. Reproductive Associates of
Delaware, Newark, DE.
05:15 PM O-305
PERMEABILITY OF OOCYTES TO
CRYOPROTECTANTS DEPENDING ON
UPREGULATION OF AQP7 EXPRESSION BY
HYPERTONIC CRYOPROTECTANTS DURING
CRYOPROSERVATION. Y. Tan1, Y. Xiong1, G.L. Ding2, Y. Meng2, H.-F. Huang2, J.-Z.
Sheng1. 1Department of Pathophysiology,
School of Medicine, Hangzhou, ZheJiang,
China; 2Department of Reproductive
Endocrinolog, Women’s Hospital, School of
Medicine, Hangzhou, ZheJiang, China.
05:30 PM O-306 OBESITY HAS LITTLE IMPACT ON
VITRIFICATION INJURY FOR MOUSE EMBRYO
OTHER THAN OBESITY PER SE. W. Ma, X.
Yang, X. Liang. Center for Reproductive
Medicine, The Sixth Affiliated Hospital
of Sun Yat-sen University, Guangzhou,
Guangdong, China.
__________________________________________________________
Endometriosis
Moderators: Steven L. Young and Kathy L. Timms
79
03:45 PM O-307
BAZEDOXIFENE AND CONJUGATED
ESTROGENS DECREASE LESION SIZE
AND STEM CELL RECRUITMENT IN MURINE
ENDOMETRIOSIS. S. H. Sakr, H. Naqvi,
H. Taylor. Obstetrics, Gynecology and
Reproductive Sciences, Yale University,
New Haven, CT.
04:00 PM O-308
DIFFERENCES IN RETINOID UPTAKE AND
METABOLISM CAUSES ALTERED PARACRINE
SIGNALING IN ENDOMETRIOSIS. M. E.
Pavone, S. Malpani, M. Dyson, D.
Monsivais, T. Kakinuma, S. E. Bulun.
Obstetrics and Gynecology, Northwestern
ORAL ABSTRACTS
University, Chicago, Il.
04:15 PM O-309
ENDOMETRIAL CXCL13 IS ABERRANTLY
EXPRESSED IN HUMANS AND MACAQUES
WITH ENDOMETRIOSIS. J. M. Franasiak1,
O. Slayden3, B. A. Lessey2, L. Yuan1, M. A.
Fritz1, S. L. Young1. 1Ob/Gyn, UNC School
of Medicine, Chapel Hill, NC; 2Ob/Gyn,
Greenville Hospital System, Greenville,
SC; 3Oregon National Primate Research
Center, Oregon Health & Science
University, Beaverton, OR.
04:30 PM O-310
INCREASED HAEMATOPOIETIC STEM
CELLS (HSCS) AND UTERINE NATURAL
KILLER (UNK) CELL PROGENITORS IN
EUTOPIC ENDOMETRIUM OF WOMEN
WITH ENDOMETRIOSIS. M. McMenamin1,2,
T. Lysakova-Devine3, C. O’Herlihy1, C.
O’Farrelly3, M. Wingfield1,2. 1UCD School
of Medicine and Medical Science, Dublin
2, Ireland; 2Merrion Fertility Clinic, Dublin
2, Ireland; 3School of Biochemistry and
Immunology, Trinity College Dublin, Dublin
1, Ireland.
05:30 PM O-314 INHIBITOR OF APOPTOSIS PROTEIN (IAP)
IS A NOVEL THERAPEUTIC TARGET FOR
ENDOMETRIOSIS. F. Taniguchi1, H. Higaki1,
M. Izawa2, T. Iwabe1, N. Terakawa1, T.
Harada1. 1Ob/Gyn, Tottori University
Faculty of Medicine, Yonago, Japan;
2
Biosignaling, Tottori University Faculty of
Medicine, Yonago, Japan.
__________________________________________________________
Moderators: Pasquale Patrizio and Barbara J. Stegmann
03:45 PM O-315
PROTECTION FROM CYLOPHOSFAMID
INDUCED OVARIAN DAMAGE WITH BONE
MARROW DERIVED MEZENCHYMAL STEM
CELLS. S. Kilic1, F. Pinarli1, C. Ozogul2, N.
Tasdemir3, G. N. Sarac2, T. Delibasi1. 1Stem
Cell Labarotory, Yildirim Beyazit
Educational and Research Hospital,
Ankara, Turkey; 2Histology and
Embryology, Gazi University, Ankara,
Turkey; 3Reproductive Endocrinology,
Namik Kemal University, Tekirdag, Turkey.
04:00 PM O-316 SUBPOPULATION OF MOUSE TESTICULAR
GERM CELLS WERE DIFFERENTLY AFFECTED
PERIPHERAL AND LOCAL CYTOKINES
FOLLOWING EXPERIMENTAL AUTOIMMUNE
INCLUDING IL-8, IL-9 AND IL-17 ARE
ORCHITIS. M. Huleihel1, M. Ganaiem1,
ELEVATED IN ENDOMETRIOSIS: AN IN VIVO
E. Lunenfeld2. 1The Shraga Segal Dept.
AND IN VITRO ANALYSIS BEFORE AND AFTER Microbiology and Immunology, BenSURGERY SUGGESTS A MECHANISM FOR
Gurion University of the Negev, BeerENDOMETRIAL DYSFUNCTION. B. A. Lessey1, Sheva, Israel; 2Obstetrics and Gynecology,
M. Nagarkatti2, J. Zhou2, S. L. Young3,
4
4 1
Soroka University Medical Center, BeerM. K. Adur , R. A. Nowak . Dept Obstet
Sheva, Israel.
Gynecol Div REI, Univ South Carolina SOM
Greenville, Greenville, SC; 2Dept
Pathology, Microbiology and Immunology, 04:15 PM O-317 SPERM PRESERVATION BY
ELECTROEJACULATION IN ADOLESCENT
Univ South Carolina School of Medicine
CANCER PATIENTS. I. Gat1, A. Toren2, A.
Columbia, Columbia, SC; 3Dept Obstet
Hourvitz1, M. Baum1, I. Madjar3, G. Raviv3.
Gynecology Div REI, University of North
1
IVF Unit, Department of Obstetrics and
Carolina, Chapel Hill, NC; 4Animal Gynecology, Sheba Medical Center,
Sciences, University of Illinois, Urbana, IL.
Ramat Gan, Israel; 2Pediatric Hemato Oncology Department, Sheba Medical
05:00 PM O-312 AUF-1 IS REGULATED IN THE MENSTRUAL
Center, Ramat Gan, Israel; 3Andrology Unit,
CYCLE AND REPRESSED IN ECTOPIC
Department of Urology, Sheba Medical
ENDOMETRIUM: IMPLICATIONS FOR
Center, Ramat Gan, Israel.
REGULATION OF CYTOKINE AND
GROWTH FACTOR EXPRESSION IN NORMAL
04:30 PM O-318 FERTILITY PRESERVATION WITH IVF OR
ENDOMETRIUM AND ENDOMETRIOSIS. H.
IVM FOR WOMEN WITH HEMATOLOGICAL
Karalok1, A. Torun1, O. Saglam2, E. Seli1.
1
MALIGNANCY – EXPERIENCES AND
Obstetrics, Gynecology and Reproductive EXPECTATIONS. J. H. Hyman, J.-T. Chung,
Sciences, Yale University School of
T. Sokal-Arnon, E. Shalom-Paz, A. Wiser,
Medicine, New Haven, CT; 2Pathology,
H. Holzer. MUHC Reproductive Centre,
Haven, CT.
Gynecology, McGill University, Montreal,
QC, Canada.
05:15 PM O-313 THE NFκB INHIBITOR PARTHENOLIDE
REDUCES CELL PROLIFERATION AND PGE2
04:45 PM O-319 A TWO-STEP SERUM-FREE CULTURE SYSTEMS
SYNTHESIS IN HUMAN ENDOMETRIOTIC
SUPPORTS DEVELOPMENT OF HUMAN
STROMAL CELLS AND INHIBITS
PREANTRAL FOLLICLES IN THE PRESENCE OF
DEVELOPMENT OF ENDOMETRIOSIS IN
GDNF. F. Dong, S. Shi, S. Dai, X. Liu, L. Ma,
MURINE MODEL E. Takai, F. Taniguchi,
Y. Sun. First Affiliated Hospital of Zhengzhou
T. Iwabe, N. Terakawa, T. Harada. Ob/
University, Zhengzhou, Henan, China.
Gyn, Tottori University Faculty of Medicine,
Yonago, Japan.
04:45 PM O-311
80
ORAL ABSTRACTS
05:00 PM O-320
COUNSELING PATIENTS REGARDING
MULTIPLE CYCLES OF ELECTIVE OOCYTE
CRYOPRESERVATION: WHAT HAVE WE
FOUND THE SECOND TIME AROUND? K.
E. Melzer, M. E. Fino, A. S. Berkeley, J.
M. Knopman. NYU Fertility Center, NYU
Langone Medical Center, New York, NY.
05:15 PM O-321
IMPACT OF CHEMOTHERAPY EXPOSURE
ON FERTILITY PRESERVATION CYCLE
OUTCOMES. K. Jeong1,2,3, M. Karsy1,
K. Oktay1,2. 1Laboratory of Molecular
Reproduction and Fertility Preservation,
Gynecology, New York Medical
Obstetrics and Gynecology, School of
Medicine, Ewha Womans University, Seoul,
Korea.
05:30 PM O-322 SUCCESSFUL PREGNANCY AND BIRTH
FOLLOWING AVASCULAR MICRO OVARIAN
TISSUE ORTHOTOPIC TRANSPLANTATION
IN A PATIENT WITH HODGKINS DISEASE.
F. Azem, A. Amit, I. Vagman, N. Mey Raz,
D. Ben-Yosef, J. Lessing. Racine IVF Unit,
Sourasky Medical Center, Tel Aviv, Israel.
__________________________________________________________
Health Disparities
Moderators: Ruben Alvero and Gloria Richard-Davis
03:45 PM O-323
EFFICACY OF ULIPRISTAL ACETATE FOR
THE TREATMENT OF SYMPTOMATIC UTERINE
LEIOMYOMAS IN AFRICAN AMERICANS. L.
J. Green1, G. Levy2, R. Wesley2, L. Nieman2,
A. Armstrong2. 1Obstetrics and
Gynecology, Howard University Hospital,
Washington, DC; 2Program in Reproductive
Institute of Health, Bethesda, MD.
04:00 PM O-324
HOW MUCH DOES AN IVF BABY COST?
THE BOSTON IVF EXPERIENCE. V. A.
Moragianni1,2, K. N. Aronis3, D. Sakkas2,
A. S. Penzias1,2, M. M. Alper1,2. 1Obstetrics
& Gynecology, Division of Reproductive
Endocrinology & Infertility, Beth Israel
Deaconess Medical Center, Harvard
Medical School, Boston, MA; 2Boston IVF,
Waltham, MA; 3Internal Medicine, Boston
Medical Center, Boston University, Boston,
MA.
04:15 PM O-325
“I WAS KIND OF TAKEN ABACK BECAUSE
IN MY MIND IT HAD ALWAYS BEEN A
PERSONAL AND NOT A PUBLIC HEALTH
ISSUE” – HOW PHYSICIAN EXPERIENCE
AND FRAMING IMPACTS ADVOCACY FOR
INFERTILITY CARE. G. L. Ryan1, A. M. Lewis2,
L. A. Shinkunas3, W. S. Lester2, S. P. Stuart4.
1
of Iowa Carver College of Medicine, Iowa
City, IA; 2Department of Psychological
and Quantitative Foundations, University
of Iowa, Iowa City, IA; 3Program in
Bioethics and Humanities, University of
Iowa Carver College of Medicine, Iowa
City, IA; 4Psychiatry, University of Iowa
Carver College of Medicine, Iowa City, IA.
04:30 PM O-326
ASSOCIATIONS BETWEEN IN VITRO
FERTILIZATION (IVF) INSURANCE COVERAGE
AND CUMULATIVE NUMBER OF CHILDREN.
E. S. Jungheim1, L. Pollack2, G. A.
Macones1, R. R. Odem1, K. Omurtag1, B.
Hamilton2. 1Obstetrics and Gynecology,
St. Louis, MO; 2Washington University Olin
School of Business, St. Louis, MO.
04:45 PM O-327
TIME TO TREATMENT AND DEMOGRAPHICS
PREDICT WHO WILL UNDERGO FERTILITY
PRESERVATION ONCE PRESENTED TO
A REPRODUCTIVE HEALTH CLINIC. E. E.
Niemasik1, J. M. Letourneau2, A. Katz1, J.
Belkora3, S.-w. Chan1, M. Rosen1.
1
Francisco, San Francisco, CA; 2Obstetrics
Carolina, Chapel Hill, NC; 3Health Policy
and Surgery, University of California, San
05:00 PM O-328
COST EFFECTIVE ANALYSIS OF TREATMENT
METHODS USED FOR UNEXPLAINED
INFERTILITY. H. Cottrell, B. Cooper, K. J.
Manahan, J. P. Geisler. Obstetrics and
Gynecology, University of Toledo College
of Medicine and Life Sciences, Toledo, OH.
05:15 PM O-329IVF INSURANCE COVERAGE INFLUENCES
FERTILITY TREATMENT AND DECISIONMAKING FOR AFRICAN AMERICAN WOMEN.
K. O. Omurtag, E. S. Jungheim. Obstetrics
and Gynecology, Division of Reproductive
Endocrinology and Infertility, Washington
University-St Louis, St Louis, MO.
05:30 PM O-330 THERE IS LESS AWARENESS OF INFERTILITY
BUT A STRONGER DESIRE FOR TREATMENT
IN PRIMARY CARE PATIENTS AT AN URBAN
COUNTY HOSPITAL. R. S. Gerhard, C. W. M.
Ritenour, W. Hsiao. Urology, Emory
University, School of Medicine, Atlanta,
GA.
__________________________________________________________
Other: ART - Laboratory/Basic
Moderators: Louis V. De Paolo and Nikica Zaninovic
03:45 PM O-331
81
TROPHECTODERM GRADE, BUT NOT
INNER CELL MASS GRADE, IS PREDICTIVE
OF OUTCOMES IN SINGLE BLASTOCYST
TRANSFERS. M. J. Hill1,2, E. D. Levens1,2, K.
Richter1, J. R. Graham1, A. H. DeCherney2,
P. E. Browne1. 1Shady Grove Fertility
ORAL ABSTRACTS
04:00 PM O-332
ART IS NOT A RISK FACTOR FOR
CHROMOSOMAL ABNORMALITY OF THE
EMBRYOS BASED ON THE ANALYSIS OF
533 ABORTED PRODUCTS OF CONCEPTION.
A. Yamamoto1, A. Fukuda1, A. Ohgaki1, Y.
Morimoto2. 1IVF Osaka Clinic, HigashiOsaka, Japan; 2IVF Namba Clinic, Osaka,
Japan.
04:15 PM O-333
DIMINISHED OOCYTE NUMBER IN WOMEN
UNDERGOING IVF IS ASSOCIATED WITH
ALTERED microRNA EXPRESSION IN
CUMULUS CELLS. C. Karakaya1, O.
Guzeloglu-Kayisli1, A. Uyar1, N. Bozkurt2,
O. Karabacak2, E. Seli1. 1Obstetrics,
Haven, CT; 2Obstetrics and Gynecology,
Gazi University, Ankara, Icanadolu, Turkey.
04:30 PM O-334
A NOVEL TESTIS-DERIVED STEM CELLS
(HTSCs) FROM HUMAN ADULT TESTIS
TISSUES WERE ABLE TO DIFFERENTIATE INTO
FUNCTIONAL NEURON CELLS IN A BILATERAL
CAVERNOUS NERVE CRUSH INJURY MODEL
IN RATS. W. Y. Choi1, D. H. Shin1, K. H.
Kwak1, S. H. Song1, J. Y. Hong2, Y. Kim1.
1
Fertility Center of CHA Gangnam
Medical Center, CHA Universiry College
of Medicine, Seoul, Korea; 2Department of
Urology, Bundang CHA General Hospital,
Seongnam-si, Gyeonggi-do, Korea.
04:45 PM O-335
CULTURE OF MOUSE EMBRYOS ON
SOFT ENVIRONMENT IMPROVES EMBRYO
DEVELOPMENT. K. S. Kolahi, A. Donjacour,
X. Liu, W. Lin, R. Simbulan, P. Rinaudo.
CA.
05:00 PM O-336
HATCHING OF HUMAN EMBRYOS
EVALUATED BY TIME-LAPSE ANALYSIS: THE
INFLUENCE OF FERTILIZATION METHOD. K.
Kirkegaard, J. J. Hindkjær, J. Ingerslev. The
Fertility Clinic, Aarhus University Hospital,
Aarhus N, Denmark.
05:15 PM O-337
QUALITY ENHANCEMENT OF BOVINE
BLASTOCYSTS USING DEFINED CULTURE
MEDIA SUPPLEMENTED WITH RECOMBINANT
HUMAN ALBUMIN, WITH OR WITHOUT
MYO-INOSITOL. M. Murakami, A. Egashira,
T. Kuramoto. Kuramoto Women’s Clinic,
Fukuoka, Japan.
05:30 PM O-338 THE EFFECT OF ALGINATE THREE
DIMENSIONAL CULTURE ON THE
DEVELOPMENT OF PREIMPLANTATION
MOUSE EMBRYOS. T. A. Farghaly1,2, B. V.
Rossi1, B. Peskin1, B. Hecht1, J. Goldfarb1,
A. Ahmady1. 1University Hospitals Fertility
Center, Ahuja Medical Center,
Beachwood, OH; 2Womens’ Health Center,
Assiut University, Assiut, Egypt.
__________________________________________________________
Moderators: Nancy Klein
82
03:45 PM O-339
WEIGHING THE EVIDENCE: ACCURACY
OF PERINATAL OUTCOMES REPORTED TO
THE SOCIETY FOR ASSISTED REPRODUCTIVE
TECHNOLOGIES (SART) DATABASE. C.
B. Morse1, M. D. Sammel2, A. Dokras1,
C. Coutifaris1, K. Barnhart1, S. Kansal
Kalra1. 1Department of Obstetrics and
Endocrinology and Infertility, University
of Pennsylvania, Philadelphia, PA;
2
Department of Biostatistics and
Epidemiology, University of Pennsylvania,
Philadelphia, PA.
04:00 PM O-340
EFFECTS OF WEIGHT ON OUTCOMES
WITHIN A COHORT OF POLYCYSTIC OVARY
SYNDROME (PCOS) PATIENTS UNDERGOING
IN VITRO FERTILIZATION (IVF). A. P. Bailey, L.
K. Hawkins, K. F. Correia, E. H. Yanushpolsky.
Center for Infertility and Reproductive
Surgery, Department of Obstetrics &
Gynecology, Brigham and Women’s
Hospital, Boston, MA.
04:15 PM O-341
PREGNANCY OUTCOME FOLLOWING IVF
CAN BE PREDICTED BY A GENE EXPRESSION
SIGNATURE IN HUMAN CUMULUS
CELLS. A. E. Iager1, A. M. Kocabas2, H.
H. Otu3,4, E. Fernández5, J. B. Cibelli1,6,7,
J. A. Crosby5. 1Gema Diagnostics, Ann
Arbor, MI; 2Laboratory of Developmental
Neurobiology, The Rockefeller
University, New York, NY; 3Department
of Bioengineering, Istanbul Bilgi University,
Eyüp, Istanbul, Turkey; 4Department
of Medicine, BIDMC Genomics Center,
5
Unidad de Medicina Reproductiva,
Clínica Las Condes, Las Condes, Santiago,
Chile; 6Departments of Physiology and
Animal Science, Michigan State University,
East Lansing, MI; 7Laboratorio Andaluz
de Reprogramación Celular (LARCEL),
Consejería de Salud, Junta de Andalucía,
Seville, Andalucía, Spain.
04:30 PM O-342
EMBRYOS TRANSFERRED IN FREEZE-THAW
CYCLES ARE MORE LIKELY TO IMPLANT
THAN MORPHOLOGICALLY EQUIVALENT
EMBRYOS TRANSFERRED IN FRESH CYCLES.
B. S. Shapiro1,2, S. T. Daneshmand1,2, F. C.
ORAL ABSTRACTS
04:45 PM O-343
Center of Las Vegas, Las Vegas, NV;
Nevada School of Medicine, Las Vegas,
NV.
2
ARE REPEATED “SALVAGE” STIMULTION
CYCLES IN POOR PROGNOSIS IVF PATIENTS
FUTILE? M. H. Papadakis, M. L. Matthews,
P. B. Marshburn, R. S. Usadi, B. S. Hurst.
Obstetrics and Gynecology, Carolinas
Medical Center, Charlotte, NC.
05:15 PM O-345
ADVANCED PATERNAL AGE DOES NOT
AFFECT BIRTH WEIGHT AND GESTATIONAL
OUTCOME IN SINGLETON PREGNANCIES
CONCEIVED BY ART. M. Zanirato, C.-N.
Kao, P. Caballero Campo, M. I. Cedars,
M. Rosen, P. Rinaudo. Repriductive
Endocrinology and Infertility, University of
CA.
05:30 PM O-346 THE NUMBER OF SUPERNUMERARY
VITRIFIED BLASTOCYSTS IS POSITIVELY
CORRELATED TO IMPLANTATION IN SINGLE
BLASTOCYST TRANSFERS. M. J. Hill1,2, R. J.
Heitmann1,2, K. Richter1, J. R. Graham1, A.
H. DeCherney2, M. J. Levy1. 1Shady Grove
Rockville, MD; 2Program in Reproductive
Institutes of Health, Bethesda, MD.
__________________________________________________________
Ovarian Stimulation: ART
Moderators: Guido de jesus Parra and Glenn Schattman
03:45 PM O-347
ROLE OF QUINAGOLIDE (NORPROLAC) IN
PREVENTING OVARIAN HYPERSTIMULATION
SYNDROME (OHSS) IN HIGH RISK
INTRACYTOPLASMIC SPERM INJECTION
(ICSI) PATIENTS. M. Alhalabi1,2, S. Samawi1,
N. Kafri1, J. Sharif1, A. Saker2, A. Othman2.
1
Assisted Reproduction Unit, Orient
Hospital, Damascus, Syrian Arab Republic;
2
Embryology & Reproductive Medicine,
Faculty of Medicine, Damascus University,
Damascus, Syrian Arab Republic.
DECLINE OF TRANSCRIPTIONAL ACTIVITY
IN HUMAN CUMULUS CELLS UNDER
IN VITRO COMPARED WITH IN VIVO
MATURATION CONDITIONS IN PCOS
PATIENTS. S. Hamamah1,2, S. Assou1,
D. Haouzi1, L. Hesters3, N. Frydman3, R.
Frydman3. 1CHU Montpellier, Institute
for Research in Biotherapy, Université
Montpellier1, INSERM U1040, Montpellier,
Hérault, France; 2Département de Biologie
de la Reproduction, UAM: AMP - DPI,
Montpellier, Hérault, France; 3Embryologie
Cytogénétique, Service de Gynécologie
Obstétrique, Clamart, Hauts de Seine,
France.
04:45 PM O-351
FOLLICLE-STIMULATING HORMONE
RECEPTOR GENE POLYMORPHISM AND
OVARIAN RESPONSES TO CONTROLLED
OVARIAN HYPERSTIMULATION. C. Peluso,
D. M. Christofolini, C. M. Trevisan, E. B.
Cordts, C. P. Barbosa, B. Bianco. Human
Reproduction and Genetics Center,
Faculdade de Medicina do ABC, Santo
Andre, SP, Brazil.
05:00 PM O-352
VARIATION WITHIN THE NORMAL RANGE
IN FRAGILE X MENTAL RETARDATION 1
(FMR1) GENE CGG REPEAT NUMBER IS NOT
PREDICTIVE OF OVARIAN RESPONSIVENESS
DURING IVF. M. D. Werner, K. Hong, L.
Duffy, E. Forman, B. Devkota, R. Scott.
05:15 PM O-353
GnRH ANTAGONIST (GnRHant) DOES NOT
HAVE A NEGATIVE EFFECT ON
ENDOMETRIAL RECEPTIVITY: A
COMPARISON OF OUTCOMES OF HIGH
QUALITY EUPLOID BLASTOCYSTS IN FRESH
ANTAGONIST VS. AGONIST CYCLES. K.
H. Hong1,2, E. Forman1, K. Ferry1, R. Scott1.
1
05:30 PM O-354 PROLONGED GONADOTROPIN
STIMULATION DURING ART IS DETRIMENTAL
FOR ALL ETIOLOGIES OF INFERTILITY EXCEPT
FOR WOMEN WITH PCOS: MULTIVARIABLE
ANALYSIS OF 663 CYCLES FROM 12 YEARS
OF FOLLOW-UP. A. R. Ryan, S. Wang,
R. Alvero, A. J. Polotsky. Obstetrics and
Gynecology, University of Colorado,
Aurora, CO.
__________________________________________________________
04:15 PM O-349
04:30 PM O-350
PROSPECTIVE RANDOMIZED STUDY ON
COMPLIANCE WITH CORIFOLLITROPIN
ALFA TREATMENT IN OOCYTE DONORS.
A. Requena1, D. Collado1, A. Izquierdo2,
A. Ballesteros2, M. Muñoz3, J. A. GarcíaVelasco1. 1IVI Madrid, Madrid, Spain; 2IVI
Barcelona, Barcelona, Spain; 3IVI Alicante,
Alicante, Spain.
83
ORAL ABSTRACTS
Procedures and Techniques-Laboratory: ART
Moderators: Judy E. Stern and Michael W. Vernon
03:45 PM O-355
BE CAREFUL WHAT YOU INJECT, AS LATE
MATURING OOOCYTES ONLY ABATE YOUR
RATES: DEVELOPMENTALLY YOUNG
OOCYTES ARE NOT READY FOR THE NEEDLE!
J. Lee1, M. Whitehouse1, A. B.
Copperman1,2, J. Barritt1,2. 1Reproductive
Medicine Associates of New York, New
York, NY; 2Obstetrics, Gynecology and
Reproductive Science, Mount Sinai School
of Medicine, New York, NY.
04:00 PM O-356
FACTORS AFFECTING IMPLANTATION
RATE AFTER TROPHECTODERM BIOPSY
AND VITRIFICATION. K. A. Ketterson1, C.
Wagner-Coughlin2, J. Grifo3, A. Coates4,
Z. P. Nagy5, B. Ripps6. 1Reprogenetics and
Tyho-Galileo Research Labs, Livingston,
NJ; 2Highland Park IVF, Highland Park,
IL; 3NYU Fertility Center, New York, NY;
4
Oregon Reproductive Medicine, Portland,
OR; 5Reproductive Biology Associates,
Atlanta, GA; 6Dept of Ob/Gyn - Division of
Reproductive Endocrinology, Florida State
University College of Medicine Pensacola, Pensacola, FL.
04:15 PM O-357
BLASTOCYST (blast) DEVELOPMENT OF
SIBLING EMBRYOS IN A SINGLE
CONTINUOUS EXTENDED CULTURE (CEC) VS.
SINGLE CULTURE MEDIA RENEWED ON DAY3
(CMR). S. R. Singh, E. JohnstonMacAnanny, T. Yalcinkaya, A. J. Carrillo.
Ob/Gyn, Wake Forest University Baptisit
Medical Center, Winston-Salem, NC.
04:30 PM O-358
DOES THE USE OF MAGNETIC ACTIVATED
CELL SORTING OF NON APOPTOTIC
SPERMATOZOA IMPROVE THE FERTILIZATION
RATES IN PATIENTS WITH SECOND IVF
CYCLES? A. Arnanz, F. Quintana, I.
Peñalva, F. Aspichueta, M. Ferrando, Z.
Larreategui. IVI Bilbao, Leioa, Vizcaya,
Spain.
04:45 PM O-359
THE PROGRESSION OF PGS:
TECHNOLOGICAL ADVANCEMENTS AND
APPLICATION IMPROVES IMPLANTATION
AND CLINICAL PREGNANCY RATES BY
ENHANCING DIAGNOSTIC ACCURACY
IN IDENTIFYING THE EUPLOID EMBRYO. J.
A. Lee1, J. Barritt1,2, M. Duke1,2, B. Sandler1,2,
T. Mukherjee1,2, A. B. Copperman1,2.
1
Reproductive Medicine Associates
of New York, New York, NY; 2Obstetrics,
Gynecology and Reproductive Science,
NY.
05:00 PM O-360
IMPROVED BLASTOCYST FORMATION
IS WITH REDUCED CULTURE VOLUME:
COMPARISON OF THREE DIFFERENT CULTURE
CONDITIONS ON 1128 SIBLING HUMAN
ZYGOTES. F. Scarselli, M. G. Minasi, V.
Casciani, A. Colasante, M. Lobascio, E.
Greco. Centre for Reproductive Medicine,
European Hospital, Rome, Italy.
05:15 PM O-361
THE ADDITION OF THE DHA ANTIOXIDANT
DOES NOT AFFECT EMBRYO KINETICS IN
THE MOUSE MODEL; A TIME-LAPSE STUDY.
A. Mifsud, S. Pérez, B. Vallejo, P. Campos,
M. J. de los Santos, M. Meseger. IVI
Valencia, Universidad Valencia, Valencia,
Spain.
05:30 PM O-362 PREGNANCY RATES OF VITRIFIED
BLASTOCYSTS ARE EQUAL TO FRESH
DAY 6 TRANSFERS FOR EUPLOID
EMBRYOS FOLLOWING COMPREHENSIVE
CHROMOSOMAL SCREENING (CCS). D.
A. Kelk, K. Reyes, J. Lo, M. P. Leondires,
S. S. Richlin, J. M. Hurwitz. Reproductive
Medicine Associates of Connecticut,
Norwalk, CT.
__________________________________________________________
Moderators: Amy E. Sparks and Zsolt P. Nagy
84
03:45 PM O-363
EFFECT OF MITOCHONDRIAL GENE
REPLACEMENT IN HUMAN OOCYTES ON
FERTILIZATION AND EMBRYO DEVELOPMENT.
M. Tachibana1, P. Amato2, M. Sparman1,
D. Battaglia2, P. Patton2, S. Mitalipov1,2.
1
Division of Reproductive & Developmental
Research Center, OHSU, Beaverton, OR;
2
Portland, OR.
04:00 PM O-364
ANEUPLOID EMBRYOS AS DETERMINED BY
23 SINGLE NUCLEOTIDE POLYMORPHISM
(SNP) MICROARRAY PREIMPLANTATION
GENETIC SCREENING (PGS) POSSESS THE
POTENTIAL TO GENETICALLY NORMALIZE
DURING EARLY DEVELOPMENT. P. R.
Brezina1, Y. Sun2, R. M. Anchan3, G. Li2,
Y. Zhao1, W. G. Kearns1,4. 1Gynecology
and Obstetrics; Division of Reproductive
Endocrinology and Infertility, Johns Hopkins
University School of Medicine, Baltimore,
MD; 2Reproductive Medical Center,
The First Affiliated Hospital of Zhengzhou
University, Zhengzhou, Henan, China;
3
Department of Gynecology and
Obstetrics; Division of Reproductive
Endocrinology and Infertility, Harvard
University School of Medicine: Brigham
and Women’s Hospital, Boston, MA;
4
Genetics, The Center for Preimplantation
Genetics, LabCorp., Rockville, MD.
ORAL ABSTRACTS
04:15 PM O-365
PROTEIN SECRETOME PROFILES
RELIABLY DISTINGUISH EMBRYONIC
STAGES OF DEVELOPMENT AND PREDICT
SUCCESSFUL IVF OUTCOME. M. G. KatzJaffe1,2, S. McReynolds1, J. Stevens2,
M. Dzieciatkowska3, K. Hansen3, W. B.
Schoolcraft2. 1National Foundation for
Fertility Research, Lone Tree, CO;
2
Colorado Center for Reproductive
Medicine, Lone Tree, CO; 3University of
Colorado, Denver, Aurora, CO.
04:30 PM O-366
SLOWER EARLY EMBRYO DEVELOPMENT
SYNDROME (PCOS) COMPARED TO
REGULARLY CYCLING WOMEN (CONTROLS).
M. L. Wissing, T. Hoest, A. L. Mikkelsen.
Fertility Clinic of Region Sjaelland, Holbaek
Sygehus, Holbaek, Region Sjaelland,
Denmark.
04:45 PM O-367
MORPHOKINETICS OF THE FIRST CELL CYCLE
IS RELATED WITH EMBRYO IMPLANTATION.
M. J. Escriba, Y. Motato, N. Grau, L. Escrich,
B. Aparicio, M. Meseguer. IVI Valencia,
Valencia, Spain.
05:00 PM O-368
ENDOMETRIAL INSULIN SIGNALING
PATHWAY DURING OVARIAN STIMULATION
FOR ASSISTED REPRODUCTIVE TECHNOLOGY
(ART). L. Detti1, R. A. Uhlmann1, N. M.
Fletcher2, M. P. Diamond2, G. M. Saed2.
1
Tennessee Health Science Center,
Memphis, TN; 2Obstetrics and Gynecology,
Wayne State University, Detroit, MI.
05:15 PM O-369
DEFINING THE BIOCHEMICAL CONTENT
OF THE HUMAN BLASTOCOEL USING
MASS SPECTROMETRY: A NOVEL TOOL
FOR IDENTIFYING BIOMARKERS OF EMBRYO
COMPETENCE. M. Poli1,3, A. Ori2, K. Turner1,3,
T. Child1,3, D. Wells1. 1Nuffield Department
of Obstetrics and Gynaecology, University
of Oxford, Oxford, United Kingdom;
2
Structural and Computational Biology
Unit, European Molecular Biology
Laboratory, Heidelberg, Germany; 3Oxford
Fertility Unit, Oxford, United Kingdom.
Reproductive Endocrinology: Clinical
Moderators: Suleena Kansal Kalra
05:30 PM O-370 PREDICTIVE VALUE OF GOOD
MORPHOLOGY ON DAYS 2, 3 AND 5 FOR
BLASTOCYST IMPLANTATION. D. R. Kinzer,
M. M. Alper, B. Milette, D. Sakkas, C. B.
Barrett. Boston IVF, Waltham, MA.
__________________________________________________________
85
03:45 PM O-371
DESPITE THE ADDITION OF RECOMBINANT
LH, RECOMBINANT FSH LEADS TO HIGHER
PROGESTERONE (P4) LEVELS OF THE DAY
OF hCG THAN FSH-hCG PREPARATIONS
BUT THIS PHENOMENON DOES NOT ALTER
IVF-ET OUTCOME. S. Sebag-Peyrelevade1,
M. Grynberg1, S. Le Parco1, V. Gallot1,
M. Poulain2, R. Fanchin1. 1Reproductive
Medicine, Hôpital Antoine Béclère,
Clamart, France; 2Reproductive biology,
Hôpital Antoine Béclère, Clamart, France.
04:00 PM O-372
ANALYSIS OF THE EARLIEST APPEARANCE
OF CELL FREE FETAL DNA IN MATERNAL
CIRCULATION. H. M. Garnsey, E. Forman,
A. A. Ruiz, A. Lonczak, N. Treff, R. Scott.
Reproductive Medicine Associates of NJ,
Morristown, NJ.
04:15 PM O-373
ONE-YEAR FOLLOW-UP OF SERUM ANTIMÜLLERIAN HORMONE LEVELS IN PATIENTS
WITH LAPAROSCOPIC CYSTECTOMY FOR
ENDOMETIOMAS. A. Iwase, A. Sugita, M.
Goto, T. Nakahara, T. Nakamura, F.
Kikkawa. Obstetrics and Gynecology,
Nagoya University Graduate School of
Medicine, Nagoya, Aichi, Japan.
04:30 PM O-374
ANTI-MULLERIAN HORMONE (AMH)
IS DIMINISHED IN FEMALE LYMPHOMA
PATIENTS EVEN BEFORE ONCOLOGICAL
TREATMENT. K. E. Dillon1, M. D. Sammel2,
J. P. Ginsberg3, J. E. Mersereau4, Y.
Gosiengfiao5, C. R. Gracia1. 1Obstetrics
and Gynecology, University of
Pennslyvania School of Medicine,
Epidemiology, University of Pennsylvania
3
Pediatrics, The Children’s Hospital of
Philadelphia, Philadelphia, PA; 4Obstetrics
Carolina, Chapel Hill, NC; 5Pediatrics,
Children’s Memorial Hospital, Chicago, IL.
04:45 PM O-375
EFFECTS OF RESISTED PHYSICAL
TRAINING ON MUSCLE STRENGTH GAIN,
BODY COMPOSITION AND METABOLIC
REPERCUSSIONS IN WOMEN WITH
POLYCYSTIC OVARY SYNDROME. G. S.
Kogure, F. K. Picchi, C. S. Vieira, M. F. Silva
de Sa, R. A. Ferriani, R. M. Reis.
Gynecology and Obstetric, Faculty of
Medicine of Ribeirao Preto, University of
Sao Paulo, Ribeirao Preto, SP, Brazil.
05:00 PM O-376
COMPARATIVE RISK OF ENDOMETRIAL
CANCER FROM ABLATION VERSUS MEDICAL
MANAGEMENT OF DYSFUNCTIONAL
UTERINE BLEEDING: VALIDATION IN A
POPULATION-BASED COHORT STUDY. S.
Senapati1, R. L. Dood2, C. R. Gracia1,
K. Haynes2, B. L. Strom2, M. Sammel.
ORAL ABSTRACTS
1
05:15 PM O-377
REPRODUCTIVE CHALLENGES IN WOMEN
WITH EHLERS-DANLOS SYNDROME: SURVEY
RESULTS FROM OVER 1350 RESPONDENTS
FROM THE EHLERS-DANLOS NATIONAL
FOUNDATION. B. S. Hurst, M. B. Lang, S.
M. Kullstam, R. S. Usadi, M. L. Matthews, P.
B. Marshburn. Obstetrics and Gynecology,
Carolinas Medical Center, Charlotte, NC.
05:30 PM O-378
TROPHECTODERM (TE) BIOPSY FOR
ANEUPLOIDY SCREENING RESULTS IN
LOWER INITIAL hCG LEVELS WITH ALTERED
PREDICTIVE VALUES: LOW INITIAL LEVELS
STILL HAVE HIGH DELIVERY RATES AND
NORMAL PREGNANCY OUTCOMES.
M. Olcha1, K. M. Ferry2, E. Forman1, K.
Hong1, N. Treff1, R. Scott1. 1Obstetrics,
School, New Brunswick, NJ; 2Reproductive
Pennsylvania, Philadelphia, PA; 2Center for
Epidemiology and Biostatistics, University of
__________________________________________________________
86
POSTER INFORMATION
87
POSTER HALL FLOORPLAN
88
POSTER PRESENTATIONS
Tuesday, October 23, 2012 Poster Presentations and Reception
Abstracts P-1 through P-300
7:00 AM – 9:00 AM
Continental Breakfast Provided
Menopause
ASRM invites you to meet the poster presenters of posters P-1
through P-300 on Tuesday morning and enjoy a continental
breakfast. Authors of posters P-301 through P-600 will present
their posters Wednesday morning.
P-1
PERSISTENCE OF OVARIAN FUNCTION
AND VASCULAR MAINTENANCE IN
POSTMENOPAUSAL FEMALES. R. Maruoka,
A. Tanabe, A. Watanabe, K. Nakamura,
M. Takai, M. Ohmichi. Obstetrics and
Gynecology, Osaka Medical College,
Takatsuki, Osaka, Japan.
P-2
ASSOCIATIONS BETWEEN LEVELS OF SEX
STEROID HORMONES AND INFLAMMATORY
CYTOKINES BY HORMONE REPLACEMENT
THERAPY (HRT) STATUS IN ETHNIC MINORITY
POSTMENOPAUSAL WOMEN. K. M.
Brennan1,2, B. Chen1, A. Goto1, S. Liu1,2,3.
1
Epidemiology, UCLA, Los Angeles, CA; 2OB/
GYN, UCLA, Los Angeles, CA; 3Medicine,
UCLA, Los Angeles, CA.
Please note that on Monday, posters will be open from 12:00
pm until 5:00 pm. On Tuesday, posters will be open from 7:00
am until 5:00 pm. On Wednesday, posters will be open at
7:00 am and will conclude at 2:00 pm.
ASRM cannot be responsible for removing and/or returning
posters. All posters not removed will be discarded.
__________________________________________________________
TUESDAY TOPICS AND POSTER NUMBERS:
Menopause: P-1 thru P-3
Nursing: P-4 thru P-5
Ovarian Reserve: P-6 thru P-15
Male Reproduction Endocrinology: P-106 thru P-110
ASSOCIATION OF BRCA-1 AND -2
MUTATIONS WITH FMR1 GENOTYPES: EFFECTS
ON MENARCHE AND MENOPAUSE AGE.
M.-K. M. Tea1, A. Weghofer1,2, A. Kim2, K.
Wagner3, C. F. Singer1. 1Department of
Obstetrics and Gynecology, Medical
University of Vienna, Vienna, Austria;
2
Center for Human Reproduction, New York,
NY; 3Department for Genetics, Medical
University of Graz, Graz, Steiermark, Austria.
__________________________________________________________
Male Reproductive Urology: P-111 thru P-130
Nursing
Sperm Biology: P-131 thru P-146
P-4
P-5
Cancer: P-16 thru P-19
Fertility Preservation: P-20 thru P-39
Cryopreservation: P-40 thru P-64
Genetic Counseling: P-65 thru P-70
Preimplantation Genetic Diagnosis: P-71 thru P-105
P-3
Oocyte Maturation: P-147 thru P-158
Fertilization: P-159 thru P-167
Embryo Biology: P-168 thru P-184
Embryo Culture: P-185 thru P-199
PREGNANCY SPECIFIC STRESS EXPERIENCED
BY WOMEN WHO CONCEIVED PREGNANCIES
VIA IN-VITRO FERTILIZATION: A MIXEDMETHODS APPROACH. E. L. Stevenson1,
C. M. Bergh2. 1School of Nursing, Duke
University, Durham, NC; 2Reproductive
Morristown, NJ.
THE EFFECT OF GUIDED IMAGERY TO REDUCE
PAIN AT THE TIME OF IN VITRO FERTILIZATION
EGG RETRIEVAL: A RANDOMIZED
CONTROLLED TRIAL. Y. Nagaoka. Ibaraki
Prefectural University of Health Sciences,
Inashiki-County, Ibaraki, Japan.
__________________________________________________________
Ovarian Stimulation: P-200 thru P-226
Embryo Transfer: P-227 thru P-241
Implantation: P-242 thru P-262
Luteal Phase Support: P-263 thru P-266
Pregnancy Loss and Termination: P-267 thru P-272
Ovarian Reserve
Contraceptions/Family Planning: P-273 thru P-285
Female Reproductive Endocrinology: P-286 thru P-300
__________________________________________________________
89
P-6
ANDROGEN RECEPTOR POLYMORPHISMS
ARE ASSOCIATED WITH POOR OVARIAN
RESPONSE. J. Llacer1, J. A. Ortiz2, J.
Guerrero1, B. Lledo2, J. Ten1, R. Bernabeu1.
1
Reproductive Medicine, Instituto Bernabeu,
Alicante, Spain; 2IB Biotech, Instituto
Bernabeu, Alicante, Spain.
P-7
P-8
P-9
S. K. Nurudeen1, M. V. Sauer1, R. Lobo1, N.
C. Douglas1. 1Obstetrics and Gynecology,
Columbia University College of Physicians
& Surgeons, New York, NY; 2Pediatric
Rheumatology, Columbia University College
of Physicians & Surgeons, New York, NY.
CORRELATION BETWEEN ANTI-MULLERIAN
HORMONE AND NUMBER OF CGG
REPEATS. E. Cervantes1, M. Luna1, G.
Vela1, M. Whitehouse1, B. Sandler1,2, A. B.
Copperman1,2. 1Reproductive Medicine
Associates of New York, New York, NY;
2
Obstetrcis, Gynecology and Reproductive
Science, Mount Sinai School of Medicine,
New York, NY.
OVEREXPRSSION OF UROMODULIN-LIKE
1 ACCELERATES OVARIAN AGING. W.
Wang, Y. Tang, L. Ni, E. J. Kim, H.-C. Liu,
Z. Rosenwaks. CRMI Endocrine Research
Laboratory, Weill Medical College of Cornell
University, New York, NY.
P-15 THE EFFECT OF OOCYTE RESERVE ON
PREGNANCY RATES (PRs) PER OOCYTE
HARVEST IN WOMEN AGED £35. J. H.
Check1,2, A. Whetstone3, C. Wilson1, J.
K. Choe1. 1Dept. OB/GYN, Division of
Repro. Endo. & Infertility, UMDNJ, Robert
Wood Johnson Med. School at Camden,
Camden, NJ; 2Dept. OB/GYN, Division of
School of Rowan University, Camden,
NJ; 3Dept. OB/GYN, UMDNJ-School of
Osteopathic Medicine, Stratford, NJ.
__________________________________________________________
AGE RELATED DECLINE IN THE RATIO OF
ANTI-MULLERIAN HORMONE TO ANTRAL
FOLLICLE COUNT. S. R. Pittenger1, C.N. Kao1, B. Sternfeld2, R. A. Reijo-Pera3.
1
Center for Reproductive Health,
University of California, San Francisco,
Kaiser Permanente, Oakland, Oakland,
CA; 3Institute for Stem Cell Biology and
Regenerative Medicine, Stanford University,
Stanford, CA.
P-10 IS THERE A DIFFERENCE IN MORPHOKINETICS
ACCORDING TO OVARIAN RESERVE? T.
Freour, J. Lammers, C. Splingart, S. Lattes,
P. Barriere. Médecine et Biologie de la
Reproduction, University Hospital of Nantes,
Nantes, France.
P-11 A STUDY TO ESTABLISH OPTIMAL VITRIFIED
FREEZING-THAWING PROTOCOL OF
HUMAN OVARY TISSUE WITH VITRIFICATION:
COMPARISON BETWEEN CRYOPROTECTANT
AND TEMPERATURE. E.-A. Kim1, E. K. Kim1,
S. H. Cha2, H. Kwon1, N. K. An1, D. H. Choi1.
1
Fertility Center, CHA Bundang Medical
Center, CHA University, Seongnam-si,
Gyenggi-do, Republic of Korea; 2Ob&Gyn,
CHA Bundang Medical Center, CHA
University, Seongnam-si, Gyenggi-do,
Republic of Korea.
P-12 ANTI-MÜLLERIAN HORMONE (AMH): A
RELIABLE BIOMARKER OF OOCYTES QUALITY
IN STIMULATED IN VITRO FERTILIZATION (IVF).
P. Lehmann, M. Del P. Vélez, J. Saumet,
L. Lapensée, F. Bissonnette, J. Kadoch.
Obstetric and Gynecology, Clinic OVO
and University of Montreal, Montréal, QC,
Canada.
P-13 CYCLOPHOSPHAMIDE (CYC) EXPOSURE IN
PEDIATRIC PATIENTS WITH SYSTEMIC LUPUS
ERYTHEMATOSUS (pSLE) IS ASSOCIATED WITH
REDUCED SERUM ANTI-MULLERIAN HORMONE
(AMH) LEVELS. L. C. Grossman1, J. Isgro2,
P-14 WOMEN WITH POLYCYSTIC OVARY
SYNDROME EXPERIENCE MORE RAPID
DECLINE IN ANTI-MULLERIAN HORMONE
LEVELS. F. J. Roca1, A. K. Schutt2, E. C.
Mazur1, W. E. Gibbons1, E. Kovanci1.
1
Ob&Gyn, Baylor College of Medicine,
Houston, TX; 2Ob&Gyn, University of Virginia,
Charlottesville, VA.
Cancer
90
P-16 THE PROTECTIVE EFFECT OF FIBRATE AGAINST
ENDOTHELIAL DYSFUNCTION INDUCED
BY PLATINUM-BASED CHEMOTHERAPY IN
GYNECOLOGICAL CANCER PATIENTS.
A. Watanabe, A. Tanabe, Y. Tanaka, S.
Tsunetoh, Y. Terai, M. Ohmichi. Obstetrics
and Gynecology, Osaka Medical College,
Takatsuki, Osaka, Japan.
P-17 A RANDOMIZED OPEN LABEL CLINICAL TRIAL
OF FIXED VS.TITRATED DOSE LETROZOLE
FOR OVARIAN STIMULATION IN BREAST
CANCER PATIENTS: AN INTERIM ANALYSIS.
E. R. Rauch1,2, R. Stubbs1, P. Christos1, M.
Costantini-Ferrando1,3, G. Schattman1.
1
The Center for Reproductive Medicine
and Infertility, New York Presbyterian- Joan
and Sanford Weill Medical College, New
York, NY; 2IVFNJ, Somerset, NJ; 3RMANJ,
Morristown, NJ.
P-18 THE INFLUENCE OF THE ANTICANCER DRUG
CYCLOPHOSPHAMIDE ON FERTILIZATION
AND EMBRYO GROWTH IN A MOUSE
MODEL. M. Koike1, Y. Kumasako1, E. Otsu1,
Y. Araki2, Y. Araki2, T. Utsunomiya1. 1St. Luke
Clinic, Oita City, Oita, Japan; 2The Institute
for Advanced Reproductive Medical
Technology, Maebashi, Gunma, Japan.
P-19 ANTI-MULLERIAN HORMONE DRAWN
FOR INFERTILITY ASSESSMENT ALERTS TO
OVARIAN TUMOR. B. J. Hill1, T. J. Morrell1,
S. Fong2, M. Zhang3, K. H. Wong2, J. M.
Norian4. 1Obstetrics & Gynecology, Loma
Linda University School of Medicine, Loma
Linda, CA; 2Obstetrics & Gynecology,
Division of REI, Kaiser Permanente Fontana
Medical Center, Fontana, CA; 3Obstetrics
& Gynecology, Division of Gynecologic
Oncology, Kaiser Permanente Fontana
Medical Center, Fontana, CA; 4Obstetrics
& Gynecology, Section of REI, Loma Linda
University School of Medicine, Loma Linda,
CA.
__________________________________________________________
G. Wessel2, S. Carson1. 1Obstetrics and
Gynecology, Women & Infants Hospital,
The Warren Alpert Medical School of Brown
University, Providence, RI; 2Department
of Molecular Biology, Cell Biology and
Biochemistry, Brown University, Providence,
RI.
P-28 A NOVEL PROTOCOL OF OVARIAN
STIMULATION FOR FERTILITY PRESERVATION
IN BREAST CANCER PATIENTS. M. Cavagna,
A. Dzik, N. F. Donadio, G. C. Freitas, F.
Cavagna, L. H. Gebrim. Women’s Health
Reference Center - Hospital Perola
Byington, Sao Paulo, SP, Brazil.
P-29 ACTIVATION AND SUBSEQUENT GROWTH
OF DORMANT PRIMORDIAL FOLLICLES
COMPLETELY IN VITRO. R. L. Krisher1,
M. Paczkowski1, K. Maruniak2, W. B.
Schoolcraft2. 1National Foundation for
Tree, CO.
P-30 RESPONSE TO OVARIAN STIMULATION
IN PATIENTS FACING GONADOTOXIC
THERAPY. L. N. C. Johnson1, K. E. Dillon1, M.
D. Sammel2, M. A. Mainigi1, C. R. Gracia1.
1
University of Pennsylvania, Philadelphia, PA;
2
Biostatistics and Epidemiology, University of
P-31 SOCIODEMOGRAPHIC DISPARITIES AFFECT
ACCESS TO REPRODUCTIVE HEALTH
COUNSELING AMONG REPRODUCTIVE AGE
WOMEN UNDERGOING GYNECOLOGIC
CANCER TREATMENT. J. M. Letourneau1,2, L.
Diaz2, E. Niemasik2, J. Chan2. 1Department
of North Carolina at Chapel Hill, NC;
2
CA.
P-32 TARGETED ANTIAPOPTOTIC AGENTS
FOR OVARIAN PROTECTION FROM
CHEMOTHERAPEUTIC AGENT-INDUCED
OVARIAN TOXICITY. C.-H. Chen1, C.-W.
Wang1, M.-I. Hsu2, C.-R. Tzebg1. 1Center for
Reproductive Medicine & Sciences, Taipei
Medical University Hospital, Taipei, Taiwan;
2
Wan Fang Hospital, Taipei Medical
University, Taipei, Taiwan.
P-33 UTILITY OF SERUM FSH MONITORING IN
LETROZOLE-GONADOTROPIN CYCLES IN
WOMEN WITH BREAST CANCER. E. Ozkaya1,
F. Moy1,3, J. Reddy1,2, K. Oktay1,2. 1Obstetrics
P-20 COMPARISON OF LEUPROLIDE VS hCG
TRIGGER IN LETROZOLE-GONADOTROPIN
FERTILITY PRESERVATION CYCLES. K. Oktay1,2,
E. Ozkaya1, J. Reddy1, F. Moy1,3. 1Obstetrics
of New York, Rye, NY; 3Clinical Pathology,
New York Medical College, Valhalla, NY.
P-21 VITRIFICATION OF BOVINE OOCYTES
SUBSTANTIALLY IMPAIRS THEIR REPRODUCTIVE
CAPACITY INDEPENDENTLY OF MATURATION
STAGE. D. L. Bulgarelli, A. A. Vireque, C.
P. Pitangui, M. P. Bernuci, M. F. Silva-deSá, A. C. Sá Rosa-e-Silva. Department of
Obstetrics and Gynecology, Faculty of
Medicine of Ribeirão Preto, University of São
Paulo, Ribeirão Preto, SP, Brazil.
P-23 ONCOFERTILITY PROGRAM FOR
ADOLESCENTS AND YOUNG WOMEN
WITH CANCER: EARLY EXPERIENCES AND
TRENDS IN A UNIQUE POPULATION. S. C.
Cardamone, N. Noyes, K. Melzer, M. E.
Fino. Obstetrics and Gynecology, New York
University Fertility Center, New York, NY.
P-24 EFFECTS OF CANCER ON OVARIAN
RESPONSE IN CONTROLLED OVARIAN
STIMULATION FOR FERTILITY PRESERVATION.
B. Almog, I. Eldar, Y. Hasson, G. Barkan, J.
Lessing, R. Gamzu. Tel Aviv University, Tel
Aviv, Israel.
P-25 SERUM FSH LEVELS ON TRIGGER-DAY CAN
PREDICT OOCYTE MATURITY RATE IN IN
VITRO FERTILIZATION CYCLES. E. Ozkaya1,
J. Reddy2, F. Moy1,3, K. Oktay1,2. 1Obstetrics
Pathology, New York Medical College,
Valhalla, NY.
P-26 MULTIDRUG RESISTANT TRANSPORT ACTIVITY
IS ASSOCIATED WITH MATURATIONAL
STAGE AND OOCYTE SUSCEPTIBILITY TO
CHEMOTHERAPEUTIC AGENTS. L. M.
Brayboy1, N. Oulhen2, J. Robins1, J. Witmyer1,
91
Pathology, New York Medical College,
Valhalla, NY.
Aurora, CO; 2Fertile Action, Los Angeles,
CA; 3Oncofertility Consortium, Northwestern
__________________________________________________________
P-34 CRYOPRESERVATION RATES IN SPERM
SAMPLES COLLECTED ONSITE AND REMOTELY
USING THE NextGenSM HOME SPERM
BANKING KIT. A. Agarwal, R. Sharma,
S. Gupta, A. J. Hamada, E. Sabanegh
Jr. Center for Reproductive Medicine,
Glickman Urological and Kidney Institute,
Cryopreservation
P-35 IT COMES DOWN TO MONEY: WHY
WOMEN DECIDE NOT TO UNDERGO
FERTILITY PRESERVATION. E. E. Niemasik1,
J. M. Letourneau2, A. Katz1, J. Belkora3, M.
Cedars1, M. Rosen1. 1Obstetrics, Gynecology
CA; 2Obstetrics and Gynecology, University
of North Carolina at Chapel Hill, NC; 3Health
Policy and Surgery, University of California,
San Francisco, San Francisco, CA.
P-36 ESTROGEN THERAPY TO RESTORE
CYCLOPHOSPHAMIDE (CTX)-INDUCED BONE
AND UTERINE CHANGES IN PRE-PUBERTAL
MICE. C. C. Ogwo1, R. A. Uhlmann1, L. J.
Williams1, S. E. Osborne1, R. W. Williams2,
L. Detti1. 1Obstetrics and Gynecology,
University of Tennessee Health Science
Center, Memphis, TN; 2Anatomy and
Neurobiology, University of Tennessee
Health Science Center, Memphis, TN.
P-37 OVARIAN TISSUE CRYOPRESERVATION:
ANALYZING OVARIAN TISSUE WITH
DIFFERENT TECHNIQUES TO RULE OUT
MICROMETASTASES IN PATIENTS WITH
DIFFERENT KINDS OF PRIMARY TUMORS.
E. J. Hoekman1,2, V. T. H. B. M. Smit2, L. A.
Louwe1, G.-J. Fleuren2, C. G. J. M. Hilders1,3.
1
Gynecology, Leiden University Medical
Center, Leiden, South Holland, Netherlands;
2
Pathology, Leiden University Medical
Center, Leiden, South Holland, Netherlands;
3
Gynecology, Reinier de Graaf Gasthuis,
Delft, South Holland, Netherlands.
P-38 PREGNANCY FOLLOWING ALLOGENEIC
UTERINE TRANSPLANTATION IN A RABBIT
MODEL. S. Saso1, J. Chatterjee1, Y. Thum2,
S. Ghaem-Maghami1, G. Del Priore3, J. R.
Smith1. 1Imperial College London, London,
United Kingdom; 2The Lister Hospital,
London, United Kingdom; 3Indiana
University, School of Medicine, Indianapolis,
IN.
P-39 TRENDS IN ONCOFERTILITY SERVICES AND
COSTS ACROSS THE NATION: HAVE WE
OVERCOME THE FINANCIAL BARRIERS TO
ACCESS? L. A. Kondapalli1, A. Crisci1,2, K. W.
Timmerman3, C. Ahrendsen1, T. K. Woodruff3.
1
of Colorado Anschutz Medical Campus,
92
P-40 A CLOSED VITRIFICATION SYSTEM ENABLES
A SAFE AND AN ASEPTIC VITRIFICATION
WITHOUT IMPAIRING THE DEVELOPMENTAL
COMPETENCE OF HUMAN EMBRYOS. A.
Amo, S. Hashimoto, S. Hama, K. Oosumi, Y.
Nakaoka, Y. Morimoto. IVF Namba Clinic,
Osaka, Japan.
P-41 THE VITRIFICATION METHOD IS
SIGNIFICANTLY BETTER FOR THAWING OF
SLOW-FREEZING EMBRYOS. E. Kojima1,2, N.
Fukunaga1,2,3, R. Nagai1,2, H. Kitasaka1,2, H.
Ohno1,2, Y. Asada1,2,3. 1Asada Ladies Nagoya
Clinic, Nagoya, Aichi, Japan; 2Asada Ladies
Kachigawa Clinic, Kasugai, Aichi, Japan;
3
The Asada Institute for Reproductive
Medicine, Kasugai, Aichi, Japan.
P-42 PREGNANCY POTENTIAL AND PERINATAL
OUTCOMES OF WARMED BLASTOCYSTS:
THE INFLUENCE OF DELAYED BLASTULATION
PRIOR TO VITRIFICATION. F-c. Hung. City
Fertility Centre, Brisbane, QLD, Australia.
P-43 IS SPONTANEOUS NATURAL CYCLE THE IDEAL
METHOD FOR PLANNING VITRIFIED/THAWED
BLASTOCYST TRANSFER IN NORMOVULATORY
PATIENTS? D. Kyrou, H. M. Fatemi, D.
Stoop, H. Tournaye, P. Devroey. Centre
for Reproductive Medicine, Universitair
Ziekenhuis Brussel, Vrije Universiteit Brussel,
Brussels, Belgium.
P-44 COMPREHENSIVE CHROMOSOMAL
SCREENING (CCS) IN COMPARISON TO
CONVENTIONAL CRYOPRESERVATION OF
BLASTOCYST TRANFERS. A. R. Anderson,
T. Gibson, S. B. Hudson, A. Browne, F.
S. Arredondo. Reproductive Medicine
Associates of Texas, San Antonio, TX.
P-45 CLINICAL OUTCOMES AFTER TRANSFER OF
VITRIFIED-WARMED DAY-3 IVM EMBRYOS
VERSUS EMBRYOS GENERATED AFTER
CONVENTIONAL ART. L. Guzman1, C.
Ortega-Hrepich2, L. Van Landuyt2, H.
Tournaye2, J. Smitz1, M. De Vos2. 1Laboratory
of Follicular Biology, UZ Brussel, Brussel,
Belgium; 2Centre for Reproductive
Medicine, UZ Brussel, Brussel, Belgium.
P-46 LYOPHILIZATION AND REHYDRATION OF
BOVINE OOCYTES AFTER VITRIFICATION: A
NEW TECHNOLOGICAL BREAKTHROUGH.
P. Patrizio1, L. Loi2, A. Arav3. 1Obstetrics/
Yale Fertility Center, New Haven, CT;
2
Comparative Biomedical Sciences,
Veterinary Medicine, Teramo, Italy;
3
Coredynamics, Nes Zyona, Israel.
P-47 REPRODUCTIVE TECHNOLOGY: THE EFFECTS
OF CONTEXT ON ATTITUDES. B. A. Dooley,
J. D. Hans. Family Sciences, University of
Kentucky, Lexington, KY.
P-48 CUMULATIVE PREGNANCY AND BIRTH RATES
WITH THE USE OF FRESH AND VITRIFIED/
THAWED OOCYTES. R. E. Nakamo1, C. G.
Almodin2, V. C. M. Camara2, L. S. Fujihara1,
C. M. O. Filho4, A. P. Ceschin3. 1Human
Reproduction, Ferticlin, São Paulo, SP,
Brazil; 2Human Reproduction, Materbaby
Reprodução Humana, Maringá, PR,
Brazil; 3Human Reproduction, Feliccita
Instituto de Fertilidade, Curitiba, PR, Brazil;
4
Human Reproduction, Nucleo Santista de
Reprodução Humana, Santos, SP, Brazil.
Laboratorio de Patologia de Maringá,
Maringá, PR, Brazil; 3Urology, Santa Casa de
Misericórdia de São Paulo, SP, Brazil.
P-49 LOWER INTRACELLULAR CONCENTRATION
OF CRYOPROTECTANT (ICCP) AFTER
VITRIFICATION (VIT) THAN SLOW FREEZING
(SF) DESPITE EXPOSURE TO HIGHER
CONCENTRATION OF CRYOPROTECTANT
SOLUTIONS (CPS). P. Vanderzwalmen1, L.
Grobet2, N. H. Zech1, F. Puissant3, F. Ectors2.
1
IVF Centers Prof. Zech, Bregenz, Austria;
2
GIGA Research, University of Liege, Liege,
Belgium; 3Centre Hospitalier Inter Régional
Cavell Chirec, Bruxelles, Belgium.
P-50 COMPARISON OF CLINICAL OUTCOMES
BETWEEN SINGLE AND DOUBLE FROZENTHAWED BLASTOCYST EMBRYO TRANSFER
ACCORDING TO THE DAY OF VITRIFICATION.
K. E. Lee1, S. M. Kang1, H. J. Jeong1, J. C.
Kim1, S. G. Lee1, J. H. Lim2. 1Maria Fertility
Clinic, Daegu, Republic of Korea; 2Maria
Fertility Hospital, Seoul, Republic of Korea.
P-51 IMPORTANCE OF ENDOMETRIAL THICKNESS
IN FROZEN-THAWED EMBRYO TRANSFER:
DIFFERENCE BETWEEN HORMONE
REPLACEMENT PROTOCOL AND NATURAL
CYCLE PROTOCOL. I. H. Park1, K. H. Lee1,
H. G. Sun1, S. K. Kim1, J. H. Lee1, G.-H.
Jeon2. 1Mamapapa & Baby OB&GY, Ulsan,
Republic of Korea; 2OB/GY, Inje University,
Haeundae Paik Hospital, Busan, Republic of
Korea.
P-52 DOES ARTIFICIAL COLLPASE OF HUMAN DAY
6 BLASTOCYSTS PRIOR TO THE COOLING
STEPS OF VITRIFICATION IMPROVE THEIR
PROBABILITY OF INCREASED OUTCOME? J.
Liebermann, E. J. Pelts, J. M. Matthews, S.
R. Sanchez, J. Rapisarda, K. Lederer. Fertility
Centers of Illinois, Chicago, IL.
P-53 COMPARISON OF TWO DIFFERENT
PROTOCOLS FOR THE CRYOPRESERVATION
OF TESTICULAR TISSUE IN RATS. M. R.
M. Radaelli1, C. G. Almodin1, P. M.
Almodin1, V. C. M. Camara1, H. Meisler2,
A. J. Gonçalves3. 1Human Reproduction,
Materbaby Reprodução Humana, Maringá,
PR, Brazil; 2Clinical Pathology, Lapam 93
P-54 TWICE-FROZEN EMBRYOS HAVE
IMPLANTATION POTENTIAL SIMILAR
TO ONCE-FROZEN EMBRYOS. S. T.
Daneshmand1,2, B. S. Shapiro1,2, F. C.
Center of Las Vegas, Las Vegas, NV; 2Dept
of Obstetrics and Gynecology, University of
Nevada School of Medicine, Las Vegas, NV.
P-55 CRYOPRESERVATION OF OOCYTES:
OUTCOME OF 2409 FREEZING CYCLES.
E. Porcu, L. Notarangelo, F. Fabbri, G.
Damiano, C. Zacà, L. Cipriani. IVF Center,
Sant’orsola Malpighi Hospital University,
Bologna, Italy.
P-56 THE LATE CLEAVED EMBRYOS, FROZEN CYCLE
IS BETTER THAN FRESH CYCLE. J. H. Lee, K. H.
Lee, I. H. Park, H.-G. Sun, S. G. Kim, Y. Y. Kim.
Infertility Lab, Mamapapa & Baby OB&GY,
Ulsan, Republic of Korea.
P-57 ALTERATION OF HIGH-POLARIZED
MITOCHONDRIA DISTRIBUTION BY
VITRIFICATION OF MOUSE IMMATURE
OOCYTE MAY AFFECT EMBRYONIC
DEVELOPMENT. S. Y. Yoon, S. K. Cha, N. J.
Yang, J. H. Eum, W. S. Lee, D. R. Lee. Fertility
Center of CHA Gangnam Medical Center,
CHA University, College of Medicine, Seoul,
Korea.
P-58 SUCCESS OF OOCYTE CRYOPRESERVATION
IN NON-DONOR IVF CYCLES: A
RANDOMIZED TRIAL OF SIBLING OOCYTES. J.
Kim, S. B. Ramos, M. A. Fritz, J. E. Mersereau.
North Carolina, Chapel Hill, NC.
P-59 COST ANALYSIS OF VITRIFICATION DEVICES
RELATED TO PREIMPLANTATION GENETIC
SCREENING (PGS) AND CRYOPRESERVATION
OF BLASTOCYSTS (BLs). M. C. Schiewe,
J. Whitney, S. Zozula, I. Hatch, R. E.
Anderson. Southern California Institute for
Reproductive Sciences, Newport Beach,
CA.
P-60 THE NEW RAPID i CLOSED VITRIFICATION
SYSTEM IS TECHNICALLY EASY TO USE
AND GIVES EXCELLENT OUTCOMES WITH
BOTH BLASTOCYST AND CLEAVAGE
STAGE EMBRYOS. N. Desai, J. Goldberg,
C. Austin. Obstetrics and Gynecology/
Women’s Health Institute, Cleveland Clinic,
Beachwood, OH.
P-61 ESET AND VITRIFICATION GIVE HIGH
CUMULATIVE PREGNANCY AND
DELIVERY RATES REDUCING THE NEED
FOR TRANSFER OF MULTIPLE EMBRYOS IN
GOOD PROGNOSIS PATIENTS. E. Fischer,
J. Conaghan. Pacific Fertility Center, San
Francisco, CA.
P-62 VITRIFICATION APPARENTLY WEAKEN THE
HATCHING CAPABILITY OF THE EMBRYOS.
A. Hossain, J. Y. Phelps. Obstetrics and
Gynecology, The University of Texas Medical
Branch, Galveston, TX.
P-63 THE SUCCESS OF A FROZEN BLASTOCYST
TRANSFER CYCLE IS PREDICTED BY THE
OUTCOME OF THE CORRESPONDING FRESH
BLASTOCYST TRANSFER CYCLE. L. F. Doherty,
J. R. Martin, U. Kayisli, D. Sakkas, P. Patrizio.
Sciences, Yale Fertility Center, New Haven,
CT.
Sciences, Yale University, New Haven, CT;
2
Counsyl, South San Francisco, CA.
1
P-70 COMPARING APPLES AND ORANGES:
MOLECULAR PATHOGENESIS OF
ENDOMETRIOSIS VARIES BY PATIENT
ANCESTRY. R. Chettier, H. Albertsen, K.
Ward. Juneau Biosciences, LLC, Salt Lake
City, UT.
__________________________________________________________
P-64 VITRIFICATION VERSUS SLOW FREEZING:
WHAT IS THE BETTER METHOD TO
PRESERVE HUMAN OVARIAN TISSUE
QUALITY? S. Sanfilippo1,2, M. Canis2,3, P.
Déchelotte4, C. Artonne1, L. Janny1,3, F.
Brugnon1,3. 1Laboratoire de Biologie de
la Reproduction, Université d’Auvergne,
UFR Médecine, Clermont-Ferrand,
France; 2Centre International de Chirurgie
Endoscopique (CICE), Clermont-Ferrand,
France; 3Pôle Gynécologie obstétrique et
Reproduction humaine, AMP, CECOS, CHU
Clermont-Ferrand, CHU Estaing, ClermontFerrand, France; 4Anatomie Pathologique,
CHU Clermont-Ferrand, CHU Estaing,
Clermont-Ferrand, France.
__________________________________________________________
P-71 SHOULD REBIOPSY BE PERFORMED ON
HEALTHY-LOOKING BLASTOCYSTS DEEMED
CHROMOSOMALLY ABNORMAL BASED ON
D3 BLASTOMERE RESULTS? K. Xu, A. R. Victor,
C. Zhang, Z. Rosenwaks. CRM, Weill Cornell
P-72 ISOLATION OF TROPHOBLAST CELLS FROM
TRANSCERVICAL SPECIMENS FOR PRENATAL
DETERMINATION OF FETAL SEX BY SINGLECELL ANALYSIS. J. M. Bolnick1, B. A. Kilburn1,
S. Bajpayee1, N. Reddy1, M. P. Diamond1,
D. R. Armant1,2. 1Department of Obstetrics
and Gynecology, Wayne State University,
Detroit, MI; 2Program in Reproductive and
Adult Endocrinology, NICHD,NIH,DHHS, NIH,
Bethesda, MD.
P-73 PREIMPLANTATION GENETIC DIAGNOSIS
(PGD) FOR CHROMOSOMAL
REARRANGEMENTS (CR) USING aCGH.
RISK ASSESSMENT DEPENDING ON THE TYPE
OF CR, THE MATERNAL AGE AND THE SEX
OF THE CARRIER. S. Munne1, P. Colls1, P.
Lopez2, M. Roche3, E. Garcia-Guixe4, M.
Sandalinas4. 1Reprogenetics LLC, Livingston,
NJ; 2Reprogenetics Latinoamerica, Lima,
Peru; 3Reprogenetics Japan, Kobe, Japan;
4
Reprogenetics Spain, Barcelona, Spain.
P-74 DEVELOPMENT OF A 4 HOUR PROTOCOL
FOR SIMULTANEOUS SINGLE GENE
DISORDER (SGD) AND COMPREHENSIVE
CHROMOSOMAL ANEUPLOIDY SCREENING
(CCS) FROM A SINGLE TROPHECTODERM (TE)
BIOPSY. R. Pepe, X. Tao, J. Su, J. Stevens,
N. Treff, R. Scott. Reproductive Medicine
P-75 THE APPLICATION OF MODIFIED MULTIPLE
DISPLACEMENT AMPLIFICATION
COMBINED WITH SHORT TANDEM REPEATS
POLYMORPHISM IN 23 PREIMPLANTATION
GENETIC DIAGNOSIS CYCLES. X. Shen, Y.
Xu, C. Zhou, Y. Zhong, Y. Zeng, C. Ding.
Center for Reproductive Medicine, First
Genetic Counseling
P-65 SINGLE NUCLEOTIDE POLYMORPHISM (SNP)
MICROARRAYS (MA) MAY BE VALUABLE IN
DETECTING SMALL GENOMIC IMBALANCES
AND DISTINGUISHING BALANCED FROM
NORMAL EMBRYOS FOR CARRIERS OF
RECIPROCAL TRANSLOCATIONS. M. D.
Werner, J. Campos, E. Forman, K. Hong,
N. Treff, R. Scott. Reproductive Medicine
Associates of NJ, Morristown, NJ.
P-66 GENETIC HETEROGENEITY OF
ENDOMETRIOSIS. P. Farrington. Juneau
P-69 THE RELATIONSHIP BETWEEN REPRODUCTIVE
HISTORY AND HORMONES AND BRCA
MUTATIONS. J. Kim, J. E. Mersereau.
North Carolina, Chapel Hill, NC.
P-67 FMR1 GENE ALLELES IN INFERTILE WOMEN
WITH PRIMARY OVARIAN INSUFFICIENCY,
DIMINISHED OVARIAN RESERVE AND POOR
RESPONSE TO OVARIAN STIMULATION. I.
Streuli, S. Bouba, V. Gayet, C. Chapron,
G. Viot, D. de Ziegler. Department of
Medicine, APHP CHU Cochin, Université
Paris Descartes, Paris Sorbonne Cité, Paris,
France.
P-68 PREVALENCE OF SINGLE GENE DISORDERS
AMONG PATIENTS SEEKING INFERTILITY
TREATMENT. T. Saioa1, G. Lazarin2, P. Patrizio1.
94
Affiliated Hospital of Sun Yat-sen University,
Guangzhou, Guangdong, China.
2
P-76 TROPHECTODERM (TE) BIOPSY, BLASTOCYST
VITRIFICATION, AND SIMULTANEOUS
SINGLE GENE DISORDER (SGD) AND
COMPREHENSIVE CHROMOSOME
SCREENING (CCS) RESULTS IN EXCELLENT
ONGOING PREGNANCY RATES. E. J.
Forman1,2, K. Ferry1, M. Katz-Jaffe1,
W. Schoolcraft1, N. Treff1, R. Scott1.
1
Reproductive Endocrinology, Reproductive
Morristown, NJ; 2Obstetrics, Gynecology
& Reproductive Sciences, UMDNJ-Robert
Brunswick, NJ.
P-78 TROPHECTODERM (TE) BIOPSY WITH
VITRIFICATION ON DAY 5/6 FOLLOWED BY
A FROZEN EMBRYO TRANSFER (FET) RESULTS
IN HIGH IMPLANTATION RATE (IR), CLINICAL
PREGNANCY RATE (CPR) AND IS SUPERIOR
TO DAY 3 BIOPSY. H.-L. Lee, A. Adler, E.
Ampeloquio, T.-L. Lee, A. Berkeley, J. Grifo.
NYUFC, New York Langone Medical Center,
New York, NY.
P-79 SUCCESSFUL APPLICATION OF
SIMULTANEOUS CHROMOSOMAL
MICROARRAY ANALYSIS (CMA) AND
GENETIC DISEASE DIAGNOSIS FROM DAY
5 TROPHECTODERM (TE) EMBRYO BIOPSIES
WITH DAY 6 EMBRYO TRANSFER. K. D. Tran,
B. D. Mariani, S. L. Shrestha, M. C. Sands, V.
Novik, H. J. Stern. Genetics and IVF Institute,
Fairfax, VA.
P-80 DELIVERY OF A CHROMOSOMALLY
NORMAL BABY AFTER THE TRANSFER OF
AN EMBRYO DIAGNOSED AS ANEUPLOID
BY 24-CHROMOSOME PREIMPLANTATION
GENETIC SCREENING. C. A. Guerrero, A.
Fleming, J. S. Goldstein. Fertility Specialists of
Texas, Frisco, TX.
P-81 INCIDENCE OF ANEUPLOIDY IS INCREASED
IN PATIENTS WITH ADVANCED MATERNAL
AGE AND RECURRENT PREGNANCY LOSS.
L. Guzman1,2, B. Acacio3, B. S. Shapiro4,
M. Perloe5, W. Venier6, T. Escudero7.
1
Reprogenetics Latinoamerica, Lima, Peru;
2
Grupo Pranor, Lima, Peru; 3Acacio Fertility,
California; 4Fertility Center of Las Vegas,
Las Vegas, NV; 5Georgia Reproductive
Specialists, Atlanta, GA; 6San Diego Fertility
Center, San Diego, CA; 7Reprogentics,
Livingston, NJ.
P-82 DEVELOPMENTAL MORPHOLOGY AND
CONTINUOUS TIME-LAPSE MICROSCOPY
(TLM) OF HUMAN EMBRYOS: CAN WE
PREDICT EUPLOIDY? K. E. Melzer1, C.
McCaffrey1, A. Adler1, P. Colls2, S. Munne2,
J. A. Grifo1. 1NYU Fertility Center, NYU
Langone Medical Center, New York, NY;
95
Reprogenetics, Livingston, NJ.
P-83 HIGH IMPLANTATION RATES WITH
BLASTOCYST BIOPSY, ARRAY COMPARATIVE
GENOME HYBRIDIZATION (aCGH) AND
DAY-6 (D6) REPLACEMENT. B. R. Behr1, S.
Tormasi3, S. H. Anderson2, M. J. Glassner2,
C. Welch3, D. B. Smotrich1. 1La Jolla
IVF, La Jolla, CA; 2Main Line Fertility &
Reproductive Medicine, Ltd., Bryn Mawr, PA;
3
Reprogenetics, Los Angeles, CA.
P-84 CLINICAL VALIDATION FOR MOSAICISM
DETECTED IN TROPHECTODERM BIOPSY
SAMPLES ANALYZED BY CHROMOSOMAL
MICROARRAYS. V. Novik, E. B. Morris, K. D.
Tran, H. J. Stern, B. D. Mariani, W. S. Stanley.
Genetics & IVF Institute, Fairfax, VA.
P-85 A FASTER GROWING EUPLOID EMBRYO HAS
GREATER PREGNANCY POTENTIAL. S. Morin,
B. Hodes-Wertz, H.-L. Lee, E. Ampeloquio, J.
Grifo. NYU Fertility Center, New York, NY.
P-86 THE RATE OF EUPLOID EMBRYOS IN EGG
DONORS COMPARED TO INFERTILE PATIENTS.
A. Botes, D. Smotrich, W. Sherri, C. Kettler,
R. MacAdam, B. Behr. La Jolla IVF, La Jolla,
CA.
P-87 RESULTS OF ARRAY COMPARATIVE GENOMIC
HYBRIDIZATION (aCGH) COMBINED WITH
MULTIPLEX PCR FOR PREIMPLANTATION
GENETIC DIAGNOSIS (PGD) OF BOTH SINGLE
GENE DISORDERS AND ANEUPLOIDY. R.
Prates1, A. Kung1, J. M. Fischer1, J. Grifo2,
B. Kaplan3, T. Escudero1. 1Reprogenetics,
Livingston, NJ; 2NYU Fertility Center, New
York, NY; 3FCI, Highland Park, IL; 4Georgia
Reproductive Specialist, Atlanta, GA.
P-88 SIGNIFICANTLY HIGHER IMPLANTATION AND
PREGNANCY RATES WITH DAY 5 BIOPSY AND
DAY 6 FRESH TRANSFER FOLLOWING ARRAY
COMPARATIVE GENOMIC HYBRIDIZATION
WHEN COMPARED TO DAY 5 TRANSFER
ALONE. T. H. Taylor, T. L. Stankewicz, K.
K. Hanshew, J. J. Orris, M. J. Glassner, S.
H. Anderson. IVF, Main Line Fertility and
Reproductive Medicine, Bryn Mawr, PA.
P-89 DOES FIRST POLAR BODY ARRAY CGH
ANALYSIS CORRELATE WITH A CLEAVAGE
STAGE EMBRYO BIOPSY IN IVF-ICSI
CYCLES AND PREIMPLANTATION GENETIC
SCREENING. T. Singer, K. Xu, G. L.
Schattman, A. R. Victor, C. Zhang, Z.
Rosenwaks. The Center for Reproductive
Medicine and Infertility -Obstetrics and
Gynecology, Weill Cornell Medical College,
New York, NY.
P-90 AN ARRAY CGH STUDY ON RELATIONSHIP
BETWEEN BLASTOCYST MORPHOLOGY,
PLOIDY AND IMPLANTATION. Z. Yang1, J.
Liu2, S. Salem1, X. Liu2, S. Sills1, R. Salem1. 1ART
and PGD Program, Pacific Reproductive
Center, Torrance, CA; 2IVF Division, Jia En De
Yun Hospital, Beijing, China.
P-91 COMPREHENSIVE GENOMIC SCREENING
REANALYSIS OF DAY 5 AND DAY 6
HUMAN BLASTOCYSTS DIAGNOSED WITH
ANEUPLOIDY ON DAY 3. E. Littman, A. La,
D. Harris, C. Lopez, K.-V. Phan. Red Rock
Fertility Center, Las Vegas, NV.
P-92 EFFECT OF BIOPSY DAY ON DONOR OOCYTE
24 CHROMOSOME PREIMPLANTATION
GENETIC SCREENING (PGS) PREGNANCY
RATES WITH FRESH EMBRYO TRANSFERS (ET).
B. R. Behr, A. Botes, C. Kettler, M. Gaona, S.
Wang, D. B. Smotrich. La Jolla IVF, La Jolla,
CA.
P-93 EXPLORING THE INCIDENCE OF
TROPHECTODERM MOSAICISM IN A
POPULATION OF PREVIOUSLY DIAGNOSED
EMBRYOS. K. E. Shelly, D. S. Johnson, L.
S. Morrison, S. M. Carney, C. F. Boylan, R.
F. Feinberg. Reproductive Associates of
Delaware, Newark, DE.
P-94 WOMEN UNDERGOING MULTIPLE IVF
ATTEMPTS HAVE HIGHER INCIDENCE OF
CHROMOSOMALLY NORMAL EMBRYOS
THAN IN WOMEN SUFFERING FROM
REPETITIVE MISCARRIAGES. J. R. Alegretti1,
L. Freitas1, M. Riboldi1, C. Gomes1,2, E.
L. Motta1,3, P. Serafini1,2. 1Huntington
Medicina Reprodutiva, Sao Paulo, SP, Brazil;
2
Ginecologia, Universidade de Sao Paulo
- USP, Sao Paulo, SP, Brazil; 3Ginecologia,
Universidade Federal de Sao Paulo UNIFESP, Sao Paulo, SP, Brazil.
P-95 BLASTOCYST RATES ACCORDING TO EMBRYO
FRAGMENTATION AND ANEUPLOIDY
ASSESSED BY ARRAY-CGH. M. Vera1, L.
Rodrigo1, A. Mercader2, V. Peinado1, C.
Simón1,2, C. Rubio1,2. 1IVIOMICS, Paterna,
Valencia, Spain; 2Instituto Valenciano de
Infertilidad (IVI), Valencia, Spain.
P-96 DAY 2 EMBRYO GRADING IS USEFUL IN
CHOOSING DAY 3 VS. DAY 5 BIOPSY FOR
ANEUDPLOIDY ASSESSMENT. D. R. Kinzer, M.
A. Alper, D. Sakkas, C. B. Barrett. Boston IVF,
Waltham, MA.
P-97 QUANTITATIVE REAL-TIME (q)PCR BASED
EMBRYONIC DNA FINGERPRINTING
SUCCESSFULLY DISTINGUISHES SIBLING
HUMAN EMBRYOS: A PRACTICAL TOOL FOR
BIOMARKER DEVELOPMENT. X. Tao, R. T.
Scott III, J. Su, E. Forman, D. Taylor, N. Treff.
P-98 TROPHECTODERM BIOPSY. A SIMPLIFIED
MECHANICAL METHOD. O. Perez, A.
Hannalie, L. Ku, B. Barnett. Dallas IVF, Frisco,
TX.
P-99 DAY 4 EMBRYO BIOPSY FOR
PREIMPLANTATION GENETIC SCREENING. A.
E. Jones, J. Miller, G. A. Hill, C. M. Whitworth,
G. A. Weitzman, A. C. Eblen. Nashville
Fertility Center, Nashville, TN.
P-100100% PREGNANCY RATE PER TRANSFER WITH
EGG DONATION AND PGD. D. Smotrich1,
S. Wang1, C. Welch2, S. Tormasi2, A. Kung2,
A. Botes1. 1La Jolla IVF, La Jolla, CA;
2
Reprogenetics, Livingston, NJ.
P-101THE MAJORITY OF WOMEN UNDERGOING
PREIMPLANTATION GENETIC SCREEINING
(PGS) USING 23 CHROMOSOME SINGLE
NUCLEOTIDE POLYMORPHISM (SNP)
MICROARRAYS WILL HAVE EUPLOID
EMBRYOS AVAILABLE FOR UTERINE TRANSFER.
P. R. Brezina1, K. J. Tobler1, A. T. Benner2, L.
Du2, B. Boyd2, W. G. Kearns1,2. 1Gynecology
and Obstetrics, Division of Reproductive
Endocrinology and Infertility, Johns
Hopkins Medical Institutions, Baltimore,
MD; 2Genetics, Center for Preimplantation
Genetics, LabCorp, Rockville, MD.
P-102BLASTOCYST MORPHOLOGY HOLDS CLUES
CONCERNING THE CHROMOSOMAL STATUS
OF THE EMBRYO. R. C. S. Figueira1, A. S.
Setti2, D. P. A. F. Braga1,2, R. C. Ferreira1,
A. Iaconelli Jr.1,2, E. Borges Jr.1,2. 1Fertility Assisted Fertilization Center, Sao Paulo, SP,
Reproduction, Sao Paulo, SP, Brazil.
P-103PGD OR NATURAL CONCEPTION? WHAT
IS RECOMMENDED FOR COUPLES WITH
RECURRENT MISCARRIAGES CAUSED
BY TRANSLOCATION CHROMOSOMAL
ABERRATIONS? A. Tanaka, M. Nagayoshi, I.
Tanaka. Saint Mother Hospital, Kitakyushu,
Fukuoka, Japan.
P-104TIME-LAPSE TECHNOLOGY REVEALS NO
DIFFERENCE BETWEEN EMBRYO QUALITY
AND THE CHROMOSOMAL STATUS OF DAY
3 EMBRYOS. N. Basile1, F. Bronet1, M. del
C. Nogales1, E. Martínez1, M. Ariza1, M.
Meseguer2. 1IVI Madrid, Madrid, Spain; 2IVI
Valencia, Valencia, Spain.
P-105IMPROVED IMPLANTATION WITH
SINGLE EMBRYO TRANSFER (SET) OF
GOOD MORPHOLOGY EMBRYOS AND
24-CHROMOSOME SNP MICROARRAY PREIMPLANTATION GENETIC SCREENING (PGS).
D. Potter1,2, T. Morgan3, C. Khoury1, J. Keller2,
Z. Demko2, M. Rabinowitz2. 1HRC Fertility,
Newport Beach, CA; 2Natera, San Carlos,
CA; 3Joint Educational Project, University of
Southern California, Los Angeles, CA.
__________________________________________________________
96
Male Reproductive Endocrinology
SA, Australia; 3School of Paediatrics &
Reproductive Health, University of Adelaide,
Adelaide, SA, Australia; 4School of
Pharmacy & Medical Sciences, University of
South Australia, Adelaide, SA, Australia.
P-106FSH LIGAND TARGETS SERTOLI CELL UPTAKE
OF NANOPARTICLES. D. C. Snow-Lisy1,
M. K. Samplaski1, V. Labhasetwar2, E.
S. Sabanegh1. 1Glickman Urological
and Kidney Institute, Cleveland Clinic,
Cleveland, OH; 2Biomedical Engineering,
P-107CHARACTERIZATION OF EXPRESSION AND
DNA METHYLATION PATTERNS OF H19 GENE
IN HUMAN SERTOLI CELLS (HSEC LINE). M.
A. Ribeiro1, M. B. dos Reis2, F. D. Oliveira1, C.
Briton-Jones3, C. A. Rainho2, W. R. Scarano1.
1
Department of Morphology, Institute
of Biosciences, University of Sao Paulo
State, Botucatu, SP, Brazil; 2Department of
Genetics, Institute of Biosciences, University
of Sao Paulo State, Botucatu, SP, Brazil; 3ART
Reproductive Center, Beverly Hills, CA.
P-108A RECREATION OF A SEMINIFEROUS TUBULELIKE ENVIRONMENT FOR SPERMATOGONIA
STEM CELLS. Q. V. Neri, T. Fields, Z.
Rosenwaks, G. Palermo. The Ronald O.
Perelman & Claudia Cohen Center for
Reproductive Medicine, Weill Cornell
P-109CORRELATION OF VITAMIN D AND LH LEVELS.
J. K. Knopf, E. Scosyrev, J. O’Brien. Urology,
University of Rochester Medical Center,
Rochester, NY.
P-114
PRM1 VARIANT RS35576928 (R34S)
WAS ASSOCIATED WITH DEFECT
SPERMATOGENESIS IN THE CHINESE HAN
POPULATION. X. He1, J. Ruan2, W. Du2,3,
G. Chen2, X. Zuo2, Y. Cao1. 1Reproductive
Medicine Center, The First Affiliated
Hospital of Anhui Medical University,
Hefei, Anhui, China; 2State Key Laboratory
Incubation Base of Dermatology, Ministry
of National Science and Technology, Anhui
Medical University, Hefei, Anhui, China;
3
Sektion Experimentelle Anaesthesiologie,
Universitaetsklinikum, Tübingen, BadenWürttemberg, Germany.
P-110THE SUCCESS OF REPEATED
MICRODISSECTION SPERM RETRIEVAL
(M-TESE) AND INTRACYTOPLASMIC
SPERM INJECTION (ICSI) FOLLOWING A
CONVENTIONAL TESTICULAR BIOPSY IN MEN
WITH NONOBSTRUCTIVE AZOOSPERMIA.
M. Karacan1, F. A. Alwaeely2, M. Ulug1, A.
Arvas1, S. Erkan1, T. Camlibel1. 1FulyaJinemed
Hospital, Istanbul, Turkey; 2Almanar Fertility
and Endoscopy Center, Basra, Iraq.
__________________________________________________________
P-115AN IMPROVED MODEL OF VARICOCELE IN
RATS USING MICROSURGICAL TECHNIQUE.
B. B. Najari, R. Ramasamy, M. Katz, P. N.
Schlegel, P. S. Li, M. Goldstein. Urology, Weill
P-116NEW QUANTITATIVE, MOLECULAR METHOD
FOR THE SIMULTANEOUS DIAGNOSIS OF
CHLAMYDIA, MYCOPLASMA, UREAPLASMA,
AND NEISSERIA IN SEMEN SAMPLES. A.
Mehta, A. Mielnik, D. A. Paduch. Urology,
NY.
P-117NOVEL MICRO-ULTRASOUND PROBE TO
IDENTIFY MICROVESSELS IN THE SPERMATIC
CORD. A. Gudeloglu, J. Brahmbhatt, K.
Priola, S. Parekattil. Urology, Winter Haven
Hospital and University of Florida, Winter
Haven, FL.
P-118VASECTOMY REVERSAL: ROBOTIC ASSISTED
VS. PURE MICROSURGICAL. A. Gudeloglu, J.
Brahmbhatt, K. Priola, S. Parekattil. Urology,
Winter Haven Hospital and University of
Florida, Winter Haven, FL.
P-119LIPID FINGERPRINTING PROFILE OF SEMINAL
PLASMA OF PATIENTS PERFOMING
SUBINGUINAL MICROSURGERY OF
VARICOCELECTOMY. M. Camargo1, D.
A. Montani1, F. C. Gozzo2, E. G. Lo Turco1,
R. Fraietta1, R. P. Bertolla1. 1Department
of Surgery, Division of Urology, Human
Reproduction Section, Sao Paulo Federal
University, Sao Paulo, SP, Brazil; 2Institute
Male Reproductive Urology
P-113LOCALIZATION OF SPERM DURING
MICRODISSECTION TESICULAR
SPERM EXTRACTION FOR MEN WITH
NONOBSTRUCTIVE AZOOSPERMIA. R.
Ramasamy, E. C. Osterberg, J. E. Reifsnyder,
B. J. Otto, P. N. Schlegel. Urology, New York
Presbyterian Hospital, Weill Cornell Medical
P-111MODELS FOR PREDICTING SPERM RETRIEVAL
PRIOR TO MICRODISSECTION TESTICULAR
SPERM EXTRACTION IN MEN WITH
NONOBSTRUCTIVE AZOOSPERMIA. E. C.
Osterberg1, R. Ramasamy1, W. O. Padilla2,
J. Reifsnyder1, C. Niederberger2, P. N.
Schlegel1. 1New York Presbyterian Hospital
- Weill Cornell, New York, NY; 2University of
Illinois - Chicago, IL.
P-112FERTILIZATION RATES FOLLOWING IVF
VERSUS ICSI IN A SIBLING OOCYTE MODEL:
IS CONCENTRATION THE BEST PREDICTOR
OF IVF FERTILIZATION RATES? H. W. Bakos1,2,
M. Lane1,3, K. P. Tremellen1,4. 1Repromed,
Adelaide, SA, Australia; 2School of
Medicine, University of Adelaide, Adelaide,
97
of Chemistry, University of Campinas,
Campinas, SP, Brazil.
P-120DOES EXTENSIVE SPERM SEARCH AND
RECOVERY AFFECT ICSI OUTCOMES IN MEN
WITH NON-OBSTRUCTIVE AZOOSPERMIA?
M. Serdarogullari1, A. Bayram1, M. E.
Bakircioglu1, U. Ulug1, H. Erden2, M. Bahceci2.
1
Bahceci Umut IVF Center, Istanbul, Turkey;
2
Bahceci Fulya IVF Center, Istanbul, Turkey.
P-121THE USE OF A “WET PREP” FOR THE POST
VASECTOMY SEMEN ANALYSIS (PVSA).
A. Norcross, A. Bollendorf, J. L. Marmar.
Surgery/Urology, Cooper IVF, Cooper
Medical School of Rowan University,
Camden, NJ.
Federal University, Sao Paulo, SP, Brazil;
Fleury Group, Sao Paulo, SP, Brazil.
2
P-122ROBOTIC ASSISTED LEGO ® CONSTRUCTION
AS A MODEL FOR ROBOTIC MICROSURGERY
SKILLS TRAINING. A. Gudeloglu, J.
Brahmbhatt, K. Priola, S. Parekattil. Urology,
Winter Haven Hospital and University of
Florida, Winter Haven, FL.
P-128PROTEOMIC PATHWAYS OF SEMINAL
PLASMA OF ADULT MEN BEFORE AND
AFTER VARICOCELECTOMY. M. Camargo1,
P. Intasqui1, P. T. Del Giudice1, K. H. M.
Cardozo2, V. M. Carvalho2, R. P. Bertolla1.
1
Department of Surgery, Division Of Urology,
Human Reproduction Section, Sao Paulo
Federal University, Sao Paulo, SP, Brazil;
2
Fleury Group, Sao Paulo, SP, Brazil.
P-129CONCURRENT SPERM DNA FRAGMENTATION
AND OXIDATIVE STRESS ASSESSMENT ON
2,281 MALE SEMEN SAMPLES. E. Tirado1,
B. Barrett2, B. Leader1. 1Clinical Research
Division, ReproSource, Woburn, MA; 2Boston
IVF, Waltham, MA.
P-130EVALUATION OF SPERM DNA AND
CHROMATIN INTEGRITY IN SEMEN SAMPLES
OF MEN ENROLLED IN IUI TREATMENT
PROGRAM. A. Alkhayal, M. San Gabriel, N.
Alhathal, K. Zeidan, A. Zini. Urology, McGill
University, Montreal, QC, Canada.
__________________________________________________________
P-1232-DIMENSIONAL DIFFERENTIAL IN-GEL
ELECTROPHORESIS-BASED PROTEOMICS OF
MALE GAMETE IN RELATION TO OXIDATIVE
STRESS. A. J. Hamada1, A. Agarwal1, S.
S. Du Plessis2, B. Willard1, E. Sabanegh Jr1,
R. Sharma1. 1Center for Reproductive
Medicine, Cleveland Clinic, Cleveland, OH;
2
Medical Physiology, Stellenbosch University,
Tygerberg, Cape Town, South Africa.
Sperm Biology
P-124PROTEOMIC ANALYSIS OF SPERMATOZOA
PROTEINS IN MEN WITH OXIDATIVE STRESS.
A. J. Hamada1, A. Agarwal1, S. S. Du Plessis2,
S. Yadav1, E. Sabanegh Jr1, R. Sharma1.
1
Center of Reproductive Medicine,
Cleveland Clinic, Cleveland, OH; 2Division of
Medical Physiology, Stellenbosch University,
Tygerberg, South Africa.
P-125FATHERHOOD AND PROSTATE CANCER RISK
IN A POPULATION-BASED CASE-CONTROL
STUDY. T. J. Walsh, J. L. Wright, J. L.
Stanford. University of Washington School of
Medicine, Seattle, WA.
P-126PROTEOMIC ANALYSIS OF SEMINAL PLASMA
PROTEINS IN MEN WITH VARIOUS SEMEN
PARAMETERS. R. Sharma1, A. Agarwal1, A.
J. Hamada1, R. Jesudasan2, S. Yadav1, E.
Sabanegh Jr1. 1Center of Reproductive
Medicine, Cleveland Clinic, Cleveland, OH;
2
Center for Cellular and Molecular Biology,
Hyderabad, Andhra Pradesh, India.
P-127UNRAVELLING SPERM DNA FRAGMENTATION
MECHANISMS: THE SPERM AND SEMINAL
PLASMA PROTEOME. P. Intasqui1, M.
Camargo1, D. M. Spaine1, V. M. Carvalho2,
K. H. M. Cardozo2, R. P. Bertolla1.
1
Department of Surgery, Division of Urology,
Human Reproduction Section, Sao Paulo
98
P-131THE ARYL-HYDROCARBON RECEPTOR (AHR)
PLAYS A ROLE IN MEDIATING SPERMATOCYTE
HEXOSE TRAFFICKING. K. Omurtag, B.
DeBosch, P. Esakky, E. Schoeller, K. Moley.
Obstetrics and Gynecology, Washington
University St Louis School of Medicine, St
Louis, MO.
P-132AUTOMATED SEMEN ANALYSIS...THE NEW
GOLD STANDARD? A COMPREHENSIVE
STUDY COMPARING MANUAL AND
AUTOMATED SEMEN ANALYSIS. J. Lammers,
W. Mansour, S. Lattes, M. Jean, P. Barriere,
T. Freour. Médecine et Biologie de la
Reproduction, University Hospital of Nantes,
Nantes, France.
P-133SPERM DEOXYRIBONUCLEIC ACID
FRAGMENTATION LEVEL, AS MEASURED
BY TUNEL TEST, IS NOT RELATED WITH THE
IVF OUTCOME IN GOOD PROGNOSIS
WOMEN. J. Llacer1, B. Lledo2, R. Morales2,
A. Rodriguez1, J. Ten1, R. Bernabeu1.
1
Reproductive Medicine, Instituto Bernabeu,
Alicante, Spain; 2IB Biotech, Instituto
Bernabeu, Alicante, Spain.
P-134INFLUENCE OF HUMAN SPERM MOTILITY
AND CRYOPRESERVATION ON THE OOCYTE
ACTIVATING FACTOR PHOSPHOLIPASE C
ZETA. B. Heindryck1, D. Nikiforaki1, F. Vanden
Meerschaut1, W. De Vos2, S. Lierman1, P.
De Sutter1. 1Department for Reproductive
Medicine, Ghent University Hospital, Ghent,
Flanders, Belgium; 2Cell Systems and Cellular
Imaging Group, Department of Molecular
Biotechnology, Ghent University, Ghent,
Flanders, Belgium.
Argentina; 3Indiana University School of
Medicine, Evansville, IN.
P-135ROLE OF BACTERIAL CONTAMINATION
ON SPERM DNA INTEGRITY. T. Fields, D.
Monahan, Q. V. Neri, Z. Rosenwaks, G.
D. Palermo. The Ronald O. Perelman &
Claudia Cohen Center for Reproductive
New York, NY.
P-143INHIBITION OF FATTY ACID OXIDATION
(FAO) DURING IN VITRO MATURATION
ALTERS EXPRESSION OF GLYCOLYTIC, FAO
AND REDOX GENES IN MURINE AND BOVINE
OOCYTES. M. Paczkowski, R. Krisher, W.
Schoolcraft. National Foundation for Fertility
Research, Lone Tree, CO.
P-136THE STUDY OF THE MUTATION OF USP26
RELATED TO SPERM FERTILIZATION FAILURE.
J. Zhang1, X.-G. Shao1, L. Wang1, Y.-W.
Huo2. 1Dalian Obstetrics and Gynecology
Hospital, Dalian, LiaoNing, China; 2Medical
College of Xi’an Jiaotong University, Xi’an,
Shaanxi, China.
P-144EFFECT OF MII ARREST ON IN VITRO-MATURED
HUMAN GV OOCYTES. M. J. Escribá1, N.
Grau1, L. Escrich1, A. Belén1, R. José1, M.
Messeguer1. 1IVI Valencia, Valencia, Spain;
2
IVI Valencia, Valencia, Spain.
P-145OOCYTE EFFICIENCY IS SUPERIOR WITH
NATURAL CYCLE IVF. B. A. Levine1, J. J.
Zhang2, J. Grifo1. 1Obstetrics & Gynecology,
College of Physicians & Surgeons, Columbia
University, New York, NY; 2New Hope Fertility
P-137ACROSOME BIOGENESIS AND PERINUCLEAR
THECA DEFECTS IN GLOBOZOOSPERMIA.
C. Alvarez Sedó1, G. Alvarez1, V. Y. Rawe2,
H. Chemes3. 1CEGYR (Centro de Estudios
en Ginecología y Reproducción), Capital
Federal, Buenos Aires, Argentina; 2Reprotec,
Capital Federal, Buenos Aires, Argentina;
3
CEDIE - CONICET (Center for Research in
Endocrinology, National Research Council),
Capital Federal, Buenos Aires, Argentina.
P-146OOCYTE STRESS: GENE EXPRESSION
STUDY IN OOCYTES AND CUMULUS CELLS
FROM GONADOTROPIN-STIMULATED AND
UNSTIMULATED OVARIES. C. Alvarez Sedó,
M. Baronio, M. Lavolpe, F. Nodar, S. Papier.
CEGYR (Centro de Estudios en Ginecología
y Reproducción), Capital Federal, Buenos
Aires, Argentina.
__________________________________________________________
P-139CUMULUS CELL CoQ10 SYNTHESIS AND
MITOCHONDRIAL FUNCTION IN AGED MICE:
EFFECT OF CoQ10 SUPPLEMENTATION.
R. Casper1, A. Ben-Meir1, Y. Bentov1, N.
Esfandiari1, A. Jurisicova2. 1Toronto Center
for Advanced Reproductive Technology,
Toronto, ON, Canada; 2Samuel Lunenfeld
Research Istitute, Toronto, ON, Canada.
P-140GONADOTROPIN REGULATION OF
NATRIURETIC PEPTIDE PRECURSOR TYPE C AS
A TRIGGER TO OOCYTE MATURATION. A. M.
Zamah, F. Xie, L. Xiong, M. Conti. Obstetrics,
Medical Center, San Francisco, CA.
P-141MASS SPECTROSCOPY ANALYSIS OF THE
HUMAN FOLLICULAR FLUID PROTEOME. A. M.
Zamah1, M. Hassis2, K. Williams2. 1Obstetrics,
Medical Center, San Francisco, CA;
2
Francisco Medical Center, San Francisco,
CA.
Oocyte Maturation
P-142PROTEASOME DYNAMICS DURING OOCYTE
MATURATION AND THEIR RELATIONSHIP WITH
CYTOPLASMIC MORPHOLOGY. C. Alvarez
Sedó1, M. Baronio1, F. Nodar1, I. Mancisidor1,
C. Wojcik3, V. Rawe2. 1CEGYR (Centro de
Estudios en Ginecología y Reproducción),
2
Reprotec, Capital Federal, Buenos Aires,
99
P-147MATERNAL AGE AFFECTS TRANSCRIPTIONAL
AND PROTEASOMAL ACTIVITIES OF HUMAN
CUMULUS CELLS ISOLATED FROM MATURE
MII OOCYTE. S. Assou1, H. Dechaud1, E.
Van den Abbeel2, J. C. Arce3, S. Amamah1.
1
CHU Montpellier, Institute for Research
in Biotherapy, Université Montpellier1,
INSERM U1040, Montpellier, Hérault,
France; 2Département de Biologie de la
Reproduction, UAM: AMP - DPI, Montpellier,
Hérault, France; 3Reproductive Medicine,
Global Clinical Research & Development,
Gent, Flanders, Belgium; 4Ferring
P-148LOW OOCYTE MATURITY AT THE TIME OF
RETRIEVAL WOULD NOT AFFECT THE OOCYTE
QUALITY AND SUBSEQUENT CLINICAL
OUTCOMES AFTER OOCYTE VITRIFICATION.
C.-C. Chang, T. A. Elliott, D. P. Bernal,
A. A. Toledo, D. B. Shapiro, Z. P. Nagy.
GA.
P-149CYTOPLASMIC IMMATURE METAPHASE II
OOCYTES: IMPACT ON REPRODUCTIVE
OUTCOME IN ART. M. Huerta Lorenzetti1, A.
Nabel1, C. Sueldo2, F. Noblia1, S. Kopelman1,
C. Alvarez Sedó1. 1CEGYR (Centro de
Estudios en Ginecología y Reproducción),
2
UCSF (University of California, San
Francisco, Fresno), Fresno, CA.
P-150IN VITRO MATURATION (IVM) OF OOCYTES
IN HUMANS BEFORE AND AFTER PUBLIC
FUNDING. W.-Y. Son, J.-T. Chung, E.
Demirtas, M. Dahan, S. Reinblatt, H. Holzer.
Dept OB/GYN, MUHC Reproductive Center,
Montreal, QC, Canada.
P-151EFFECT OF HEPARIN EXPOSURE BEFORE IN
VITRO MATURATION CULTURE ON OOCYTE
MATURATION. L. Guzman1, C. OrtegaHrepich2, G. Verheyen2, H. Tournaye2, M.
De Vos2, J. Smitz1. 1Laboratory of Follicular
Biology, UZ Brussel, Brussel, Belgium; 2Centre
for Reproductive Medicine, UZ Brussel,
Brussel, Belgium.
P-152IS EMBRYO QUALITY SUPERIOR WHEN
TRIGGERING OF OVULATION OCCURS BY
THE ADMINISTRATION OF GnRH AGONIST
ANALOG OVER CONVENTIONAL hCG TO
TRIGGER OVULATION? T. S. Domingues1,3,
A. Torres1, S. P. De Caldas1, P. C. Da Silva1,
E. L. A. Motta1,3, P. Serafini1,2. 1Huntington
2
P-153DUAL TRIGGER WITH GONADOTROPIN
RELEASING HORMONE AGONIST (GnRHa)
AND HUMAN CHORIONIC GONADOTROPIN
(HCG) FOR THE TREATMENT OF ‘IMMATURE
OOCYTE SYNDROME’ (IOS). D. Griffin, L.
Engmann, T. Budinetz, N. Kummer, J. Nulsen,
C. Benadiva. Obstetrics and Gynecology,
University of Connecticut Health Center,
Farmington, CT.
P-154OPTIMAL RECOMBINANT hCG DOSE FOR
FINAL OOCYTE MATURATION TRIGGERING
IN POOR RESPONDERS. K. E. Park1, B. C.
Jee1, C. S. Suh1,2, K. C. Kim3, W. D. Lee4, S.
H. Kim1,2. 1Department of Obstetrics and
Gynecology, College of Medicine, Seoul
National University, Seoul, Korea; 2Institute
of Reproductive Medicine and Population,
Medical Rresearch Center, Seoul National
University, Seoul, Korea; 3Hamchoon
Women’s Clinics, Seoul, Korea; 4Maria
Infertility Hospital, Seoul, Korea.
P-155CHANGES IN MITOCHONDRIAL DISTRIBUTION
DURING DIFFERENT STAGES OF HUMAN
OOCYTES MATURATION. A. Ellenbogen1, G.
Paz2, S. Hantisteanu2, T. Shavit1, M. Michaeli1,
O. Fainaru1,2. 1IVF Unit, Department of
Obstetrics and Gynecology, Hadera, Israel;
2
Laboratory for Reproductive Immunology,
Hadera, Israel.
P-156THE EFFECT OF BODY MASS INDEX (BMI)
ON THE RESCUE IN VITRO MATURATION
(IVM) OUTCOME IN STIMULATED IN VITRO
FERTILIZATION CYCLES. E.-A. M. Khalifa2, T. A.
Farghaly1,2, S. Mostafa2, M. A. Bedaiwy1, J.
Goldfarb1, A. Ahmady1. 1University Hospitals
Fertility Center, Ahuja Medical Center,
Beachwood, OH; 2Womens’ Health Center,
Assiut University Hospitals, Assiut, Egypt.
P-157IN VITRO MATURED HUMAN OOCYTES
DISPLAY LOW Ca2+ STORE CONTENT, LOW
IP3R1 SENSITIVITY AND REQUIRE HIGH
PLCzeta1 ACTIVITY TO INITIATE [Ca2+]
OSCILLATIONS. T. Jellerette-Nolan1, H.
i
C. Lee2, M. Arny1, D. Grow1, R. Fissore2.
1
Reproductive Biology and Infertility
Research, Department of Obstetrics and
Gynecology, Baystate Medical Center,
Springfield, MA; 2Animal Biotechnology
and Biomedical Sciences, Department of
Veterinary and Animal Sciences, University
of Massachusetts, Amherst, MA.
P-158NOVEL BIOMATERIAL FOR THREE
DIMENSIONAL CULTURE OF MOUSE
PRE-ANTRAL FOLLICLES. N. Desai1, A.
Suryanarayana1, A. Calabro2. 1Obstetrics
and Gynecology/Women’s Health Institute,
Cleveland Clinic, Beachwood, OH;
2
Biomedical Engineering, Cleveland Clinic,
Cleveland, OH.
__________________________________________________________
Fertilization
P-159THE EFFECT OF INTRACYTOPLASMIC SPERM
INJECTION (ICSI) ON THE TIMING OF
EMBRYONIC PROGRESSION IN CYCLES
WHERE OOCYTES WERE SPLIT INTO BOTH
ICSI AND CONVENTIONAL INSEMINATION.
H. Cook1, G. Ambartsumyan1, Y. Mahller2,
M. Pisarska2, C. Briton-Jones3, D. Hill3.
1
Obstetrics and Gynecology, UCLA David
Geffen School of Medicine, Los Angeles,
CA; 2Obstetrics and Gynecology, Cedars
Sinai Medical Center, Los Angeles, CA; 3ART
Reproductive Center, Beverly Hills, CA.
P-160CONVENTIONAL IVF ON AN OOCYTE
DONATION PROGRAM: PROS AND CONS. M.
Esbert, M. Florensa, M. Riqueros, J. Molina,
A. Ballesteros, G. Calderón. IVI-Barcelona,
Barcelona, Spain.
P-161CLINICAL EFFICIENCY OF PIEZO-ICSI WITH
ULTRA-THIN MICROPIPETTE. K. Hiraoka, T.
Tamaki, Y. Nada, C. Kiriake, S. Kitamura.
IVF Section, NIJI Clinic, Suginami-ku, Tokyo,
Japan.
P-162CLINICAL APPLICATION OF Hg-FREE PIEZOICSI USING FLUORINERT. H. Morita1, M.
Kamihata1, T. Hirosawa1, A. Kuwahata2,
M. Ochi2, T. Horiuchi3. 1IVF laboratory,
Ochi Yume Clinic, Nagoya, Aichi, Japan;
100
Department of Reproductive Medecine,
3
Faculty of Life and Environmental Sciences,
Prefectural University of Hiroshima,
Shoubara-shi, Hiroshima, Japan.
Jones1, M. Surrey1, H. Danzer1, X. Zheng2,
S. Munne2. 1South California Reproductive
Center, Beverly Hills, CA; 2Reprogenetics,
Livingston, NJ.
2
P-163MORPHOKINETIC DIFFERENCES ON
EMBRYO DEVELOPMENT AFTER NORMAL
OR ABNORMAL FERTILIZATION. M. Boada1,
Y. Gil1, S. Mateo1, L. Joda1, P. N. Barri1, A.
Veiga1,2. 1Obstetrics, Gynecology and
Reproduction, Institut Universitari Dexeus,
Barcelona, BCN, Spain; 2Stem Cell Bank,
Center for Regenerative Medicine,
Barcelona, BCN, Spain.
P-164ROLE OF THE DEUBIQUITINATING ENZYME
UBIQUITIN C-TERMINAL HYDROLASE
L1 (Uch-l1) IN THE PREVENTION OF
POLYSPERMIC FERTILIZATION IN MOUSE
EGGS. M. S. Christianson1, B. C. Turner2,
A. Wilkinson2, J. P. Evans2. 1Department
of Gynecology and Obstetrics; Divison
Infertility, Johns Hopkins Medical
Institutions, Lutherville, MD; 2Department of
Biochemistry and Molecular Biology, Johns
Hopkins Bloomberg School of Public Health,
Baltimore, MD.
P-165OVULATION ASSESSMENT BY VAGINAL
TEMPERATURE ANALYSIS (THE OVUSENSE
ADVANCED FERTILITY MONITORING SYSTEM)
IN COMPARISON TO ORAL TEMPERATURE
MEASUREMENT. S. Papaioannou1, M.
Aslam2, B. H. Al Wattar1, R. C. Milnes2, T. G.
Knowles3. 1Obstetrics and Gynaecology,
Heart of England NHS Foundation Trust,
Birmingham, West Midlands, United
Kingdom; 2Fertility Focus Ltd., Warwick,
West Midlands, United Kingdom; 3School
of Veterinary Science, University of Bristol,
Bristol, Avon, United Kingdom.
P-169EMBRYO CLASSIFICATION METHOD BASED IN
TIME-LAPSE ANALYSIS IS ASSOCIATED WITH
BLASTOCYST QUALITY. M. Cruz1, M. Munoz1,
B. Gadea1, M. Roldan1, I. Perez-Cano1,
M. Meseguer2. 1IVI Alicante, Alicante,
Spain; 2Instituto Univestitario IVI Valencia,
Universidad de Valencia, Valencia, Spain.
P-170PREGNANCY OUTCOME AFTER TE BIOPSY
WITH FRESH TRANSFER OR VITRIFICATION. S.
Munne1, D. Smotrich2, D. Hill3, B. Kaplan4,
J. Grifo5, S. Anderson6. 1Reprogenetics,
Livingston, NJ; 2La Jolla IVF, La Jolla, CA;
3
South California Reproductive Center,
Beverly Hills, CA; 4Fertility Centers of Illinois,
Highland Park, IL; 5NYU Fertility Center, NYU
Langone School of Medicine, New York,
NY; 6Main Line Fertility and Reproductive
Medicine, Bryn Mawr, PA.
P-171OXYGEN UPTAKE IS CLEAVAGE TIMING
DEPENDENT IN HUMAN EMBRYOS; A TIMELAPSE AND MICROSENSOR COMBINED
ANALYSIS. A. Tejera, J. Herrero, I. Rubio,
C. Albert, M. De los Santos, M. M. Escriva.
Clinical Embryology Laboratory, IVI
P-172PROGESTERONE LEVELS ON THE DAY OF
FINAL OOCYTE MATURATION DO NOT
CORRELATE WITH EMBRYO KINETICS OF
DEVELOPMENT. M. Munoz1, N. Galindo1, V.
Legidos1, M. Mar1, L. Muela1, N. Garrido1.
1
IVI Alicante, Alicante, Spain; 2Instituto
Universitario IVI Valencia, Universidad de
P-173IMPACT OF ABNORMAL EMBRYONIC
MOLECULAR KARYOTYPE DETERMINED
BY SINGLE NUCLEOTIDE POLYMORPHISM
(SNP) MICROARRAY PREIMPLANTATION
GENETIC DIAGNOSIS (PGD) ON EMBRYO
DEVELOPMENT AND BLASTOCYST
FORMATION. G. Li, H. Jin, Z. Xin, Y. Guo, Y.
Su, Y. Sun. Reproductive Medical Center,
University, Zhengzhou, Henan, China.
P-174CORRELATION BETWEEN EMBRYO
MORPHOLOGY AND CHROMOSOMAL
ARRANGEMENT: PRELIMINARY DATA. P.
Rubino1, C. P. Rocio1, F. Fiorentino2, G.
Pierluigi1, C. Antonio1, G. Ermanno1.
1
FertiClinic s.r.l., Rome, Lazio, Italy;
2
’GENOMA’ - Molecular Genetics
Laboratory, Rome, Lazio, Italy.
P-175FOR HOW LONG DOES THE SECOND POLAR
BODY OF THE MOUSE-FERTILIZED EGG RETAIN
GENETIC STABILITY? T. Hino, H. Kusakabe,
H. Tateno. Biological Sciences, Asahikawa
P-166PREDICTIVE FACTORS FOR CLINICAL
PREGNANCY IN 354 UNEXPLAINED INFERTILE
COUPLE IN THEIR FIRST INTRAUTERINE
INSEMINATION CYCLE. H. Hassa, Y. Aydin, T.
Oge, O. Ozatik, F. Taplamacioglu. Obstetrics
and Gynecology Department, Eskisehir
Osmangazi University, Eskisehir, Turkey.
P-167SPERM MORPHOLOGY DOES NOT AFFECT
NORMAL FERTILIZATION, EMBRYONIC
DEVELOPMENT AND CLINICAL OUTCOME.
N. Zhang, H. Sun, Y. Hu, L. Chen. Tower
Hospital, Affiliated to Nanjing University
Medical School, Nanjing, Jiangsu, China.
__________________________________________________________
Embryo Biology
P-168BLASTULATION AND IMPLANTATION RATES
OF MICROARRAY CGH-DEFINED NORMAL
EMBRYOS COMPARED TO ABNORMAL AND
NON-BIOPSIED EMBRYOS. D. Hill1, C. Briton-
101
Medical University, Asahikawa, Hokkaido,
Japan.
P-176WHAT MAKES THEM SPLIT? IDENTIFYING
IVF RISK FACTORS THAT MAY LEAD TO
MONOZYGOSITIC TWINING (MZT). J. M.
Knopman1, L. C. Krey1, C. McCaffrey1, H.-L.
Lee1, C. Oh2, N. Noyes1. 1OB/GYN, NYU
2
Biostatistics, NYU Langone Medical Center,
New York, NY.
P-177TELOMERE DNA LENGTH IS NOT PREDICTIVE
OF EMBRYONIC REPRODUCTIVE POTENTIAL.
N.-A. Gueye1, J. Su2, R. T. Scott III2, M.
Lebiedzinski2, N. Treff1, R. Scott1. 1Obstetrics,
School, New Brunswick, NJ; 2Reproductive
Morristown, NJ.
P-178DYNAMIC ANALYSIS OF THE RELATIONSHIP
BETWEEN THE TIMING OF SYNGAMY AND
HUMAN EMBRYONIC DEVELOPMENT USING
TIME-LAPSE CINEMATOGRAPHY. M. Ueda,
K. Iwata, A. Imajo, K. Yumoto, Y. Iba, Y. Mio.
Reproductive Centre, Mio fertility clinic,
Yonago, Tottori, Japan.
P-179THE EFFECT OF ANEUPLOIDY ON EMBRYO
MORPHOLOGY AND PREIMPLANTATION
DEVELOPMENT FROM THE CLEAVAGE TO
THE BLASTOCYST STAGE. S. Jaroudi1, S.
Alfarawati1,2, M. Poli2, D. Wells1,2, E. Fragouli1,2.
1
Reprogenetics UK, Oxford, Oxfordshire,
United Kingdom; 2Nuffield Department of
Obstetrics and Gynaecology, University
of Oxford, Oxford, Oxfordshire, United
Kingdom.
P-180DOES SEMEN CRYOPRESERVATION HAVE
INFLUENCE ON EMBRYO KINETICS? L.
Muela García1, M. Martínez Morales1,
B. Gadea Navaro1, I. Pérez Cano1, M.
Muñoz Cantero1, M. Meseguer Escrivá2.
1
IVI Alicante, Alicante, Spain; 2IVI Valencia,
Valencia, Spain.
P-181UNFOLDED PROTEIN RESPONSE IS A KEY
REGULATOR OF OXYGEN DEPENDANT
TROPHOBLAST DIFFERENTIATION. J. C.
Robins, L. A. Underhill, B. Bhagavath, S.
A. Carson. Obstetrics and Gynecology,
Women and Infants Hospital/Warren Alpert
School of Medicine at Brown University,
Providence, RI.
Montpellier, Montpellier, France.
P-183COMPARISON AMONG DIFFERENT
HUMAN EMBRYO MORPHOLOGICAL
CLASSIFICATIONS REGARDING PREGNANCY
PROGNOSTIC IN IN VITRO FERTILIZATION
(IVF) CYCLES. G. M. Gindri, C. L. V.
Werneck, A. S. Aguiar, M. C. E. C. Martins, P.
G. Sá, M. C. A. Cardoso. Laboratory, Vida
Centro de Fertilidade da Rede D’Or, Rio de
Janeiro, RJ, Brazil.
P-184IDENTIFICATION OF DISPLACED
ENDOMETRIAL GLANDS AND EMBRYONIC
DUCT REMNANTS IN FEMALE FOETAL
REPRODUCTIVE TRACT: POSSIBLE
PATHOGENETIC ROLE IN ENDOMETRIOTIC
AND PELVIC NEOPLASTIC PROCESSES. J.
Bouquet de la Joliniere1, J. M. Ayoubi2,
L. Gianaroli1, J. B. Dubuisson1, A. Feki1, J.
Gogusev3. 1Gynecology, HFR Fribourg Hôpital cantonal, Fribourg, Switzerland;
2
Gynecology, Foch Hospital, Suresnes,
France; 3Inserm U 567, Hopital Necker, Paris,
France.
__________________________________________________________
Embryo Culture
P-185TROPHECTODERM GRADE IS A BETTER
PREDICTOR THAN INNER CELL MASS GRADE
FOR SELECTING BLASTOCYSTS FOR EMBRYO
TRANSFER. H. Ohno1,2, N. Fukunaga1,2,3,
R. Nagai1,2, H. Kitasaka1,2, M. Kato1,2, Y.
Asada1,2,3. 1Asada Ladies Nagoya Clinic,
Nagoya, Aichi, Japan; 2Asada Ladies
3
P-186SINGLE-STEP VS. TWO-STEP MEDIA: ARE
THERE ANY DIFFERENCES IN OUTCOME AND
IMPLANTATION? J. Liebermann, E. J. Pelts, R.
Brohammer, Y. Wagner, C. Sipe, K. Lederer.
Fertility Centers of Illinois, Chicago, IL.
P-187EFFECT OF LIF ON HUMAN EMBRYOS. A.
Zhioua1, N. Mami1, S. Fourati1, H. Elloumi1, M.
Khrouf2, F. Zhioua2. 1Center of Reproductive
Biology, Center of Reproductive Biology,
Tunis, Tunisia; 2Department of Gynecology
Obstetrics, Department of Gynecology
Obstetrics, Tunis, Tunisia.
P-188AN OOCYTE SPECIFIC MEDIUM FOR THE
FIRST 24 HOURS OF CULTURE IMPROVES
DEVELOPMENT OF GOOD QUALITY
BLASTOCYSTS. R. L. Krisher1, J. Stevens2, A.
Janesch2, S. D. Degelos3, G. Koulianos3, W.
B. Schoolcraft2. 1National Foundation for
Lone Tree, CO; 3Center for Reproductive
Medicine, Mobile, AL.
P-182DEVELOPMENTAL REGULATION OF
APOPTOSIS PHENOMENA DURING EARLY
EMBRYONIC DEVELOPMENT IN MOUSE AND
HUMAN SPECIES: ROLES OF Bcl2 FAMILY
GENES. I. Boumela1, S. Assou1, D. Haouzi1,
H. Dechaud2, S. Hamamah1,2. 1IRB-Inserm
U1040, Montpellier, France; 2Département
de Biologie de la Reproduction, CHRU
102
P-189OPTIMIZING THE TEMPERATURE FOR
EMBRYO CULTURE IN IVF: A RANDOMIZED
CONTROLLED TRIAL (RCT) COMPARING
STANDARD CULTURE TEMPERATURE OF 37C
TO THE REDUCED MORE PHYSIOLOGIC
TEMPERATURE OF 36C. K. H. Hong1,2, E. J.
Forman1,2, H. Lee1, K. M. Ferry1, N. Treff1,
Piscataway, NJ.
P-190GENE EXPRESSION AS BIOMARKERS OF
QUALITY TO COMPARE CULTURE OF SYSTEM:
SINGLE MEDIUM AND SEQUENTIAL MEDIA
SYSTEM. J. Polisseni1,2,3, F. Polisseni2, M. M.
Pereira3, M. O. Guerra1, L. S. A. Camargo3, V.
M. Peters1. 1Center of Biology Reproduction,
Federal University of Juiz de Fora, Juiz de
Fora, MG, Brazil; 2Assisted Reproduction,
Clínica Pró-Criar/Monte Sinai, Juiz de Fora,
MG, Brazil; 3Animal Reproduction, Embrapa
Dary Catlle, Juiz de Fora, MG, Brazil.
P-191BLASTOCYST DEVELOPMENT IN VITRO IS
INFLUENCED BY COLONY STIMULATING
FACTOR 3 (CSF3). G. A. Thouas, M. Truong,
N. J. Hannan, D. K. Gardner. Department of
Zoology, Faculty of Science, The University
of Melbourne, Melbourne, VIC, Australia.
P-192USE OF TIMELAPSE AND KINETIC MARKERS
TO COMPARE TWO DIFFERENT ONESTEP IVF CULTURE. T. Trinh, N. Desai, J.
Goldberg. Obstetrics and Gynecology/
Women’s Health Institute, Cleveland Clinic,
Beachwood, OH.
P-193SINGLE-STEP VS. TWO-STEP MEDIA: ARE
THERE ANY DIFFERENCES IN EMBRYONIC
DEVELOPMENT? J. Liebermann, E. J. Pelts,
J. M. Matthews, S. R. Sanchez, M. Uhler, A.
Beltsos. Fertility Centers of Illinois, Chicago,
IL.
P-194EFFECT OF MATERNAL FACTORS AND
CULTURE CONDITIONS ON IN VITRO
EMBRYO DEVELOPMENT – A MULTICENTER
RETROSPECTIVE STUDY. C. Pribenszky1, E.
Losonczi1, B. Kuron2, A. Reichart3, G. Palmer4,
D. Hlinka5. 1Dep. of Animal Breeding,
Nutrition and Laboratory Animal Science,
Szent Istvan University, Budapest, Hungary;
2
Semmelweis Medical University, Budapest,
Hungary; 3Forgacs Institute, Budapest,
Hungary; 4Mitera Maternity Clinic, Athens,
Greece; 5Prague Fertility Centre, Prague,
Czech Republic.
SELECTION. S. Verza Jr, D. T. Schneider, S. C.
Esteves. Androfert, Campinas, SP, Brazil.
P-196IMPORTANCE OF MULTINUCLEATION AT
2-CELL STAGE: STUDY IN A TIME-LAPSE
INCUBATOR. J. Muñoz Ramirez, F. Galera
Fernandez, A. Silván Bueno, M. Brandt, J. A.
Garcia Fernandez, E. Garijo Lopez. Instituto
Madrileño de Fertilidad (IMF), Madrid,
Spain.
P-197LOW LEVELS OF AMMONIUM DETECTED IN
SPENT MEDIA FROM MOUSE OR HUMAN
EMBRYOS CULTURED IN CONTINUOUS
SINGLE CULTURE™ (CSC) MEDIUM ARE
NOT DETRIMENTAL TO DEVELOPMENT. R.
S. Gilbert1, S. F. Hwan1, M. D. Vermilyea2,
J. R. Graham2, M. J. Tucker2. 1Research &
Development, Irvine Scientific, Santa Ana,
CA; 2Shady Grove Fertility Reproductive
P-198EARLY BLASTOMERE MULTINUCLEATION
EVALUATED IN 2-CELLS EMBRYOS BY
TIME-LAPSE SYSTEM IS NOT AFFECTING
IMPLANTATION RATE. J. Aguilar1, M.
Perez1, M. Ojeda1, E. Taboas1, E. Munoz1,
M. M. Escriva2. 1IVF Lab, IVI Vigo, Vigo,
Pontevedra, Spain; 2IVF Lab, IVI Valencia,
Valencia, Spain.
P-199USE OF A DRAWER-TYPE TRI-GAS INCUBATOR
FOR BLASTOCYST CULTURE AMONG PATIENTS
UNDERGOING DAY 3 OR 5 EMBRYO
TRANSFER. C. M. Sueldo1, E. Kelly2, J. Borba2,
K. Graff2, M. Synn1,2, C. E. Sueldo1,2. 1Ob/Gyn,
University of California San Francisco-Fresno,
Fresno, CA; 2IVF Program, Women Specialty
Center, Clovis, CA.
__________________________________________________________
Ovarian Stimulation
P-200OVULATORY RATE IN SUBSEQUENT
CLOMIPHENE CITRATE(CC) CYCLE AFTER
‘STAIR-STEP’(SS) CLOMIPHENE CITRATE
PROTOCOL. T. H. Budinetz, D. W. Griffin, L.
L. Engmann, C. A. Benadiva, J. C. Nulsen,
A. J. DiLuigi. Obstetrics and Gynecology,
University of Connecticut Health Center,
Farmington, CT.
P-201EFFECTIVE METHOD FOR EMERGENCY
FERTILITY PRESERVATION: RANDOM-START
CONTROLLED OVARIAN HYPERSTIMULATION.
H. Cakmak, A. M. Zamah, A. Katz,
M. Cedars, M. P. Rosen. Division of
CA.
P-195NUCLEAR STATUS ASSESSMENT OF HUMAN
EMBRYOS ON DAY 2: A POWERFUL TOOL
IN IVF CYCLES FOR EMBRYO TRANSFER
103
P-202RANDOMIZED CONTROLLED TRIAL
COMPARING HIGHLY PURIFIED (HP-hCG)
AND RECOMBINANT HCG (r-hCG) FOR
TRIGGERING OVULATION IN ART. D. De
Ziegler1,2,4, M. Bellavia2, C. De Geyter3, I. M.
Streuli1,4, V. Ibecheole4, M. H. Birkhäuser5.
1
Dept of Ob Gyn II, Reproductive Endocr.
and Infertility, Université Paris Descartes –
Hôpital Cochin, Paris, France; 2Maternity,
CHUV (Centre Hospitalier Universitaire
Vaudois), Lausanne, Vd, Switzerland;
3
Frauenklinik, Universitätsspital Basel,
Basel, BS, Switzerland; 4Hôpital Cantonal
Universitaire, Geneva, GE, Switzerland;
5
Frauenklinik Inselspital, Bern, Switzerland.
P-203DOES METHOTREXATE ADMINISTRATION
FOR ECTOPIC PREGNANCY FOLLOWING
IN-VITRO FERTILIZATION IMPACT OVARIAN
RESERVE OR OVARIAN RESPONSIVENESS? C.
E. Boots1, R. L. Gustofson2, E. C. Feinberg3.
1
Obstetrics & Gynecology, University of
Chicago, Chicago, IL; 2Colorado Center
3
Fertility Centers of Illinois, Chicago, IL.
P-204DRAMATIC PROGRAM-WIDE REDUCTION
IN THE INCIDENCE OF SEVERE OVARIAN
HYPERSTIMULATION SYNDROME (OHSS)
REQUIRING PARACENTESIS WITH SELECTIVE
USE OF GONADOTROPIN-RELEASING
HORMONE (GnRH) AGONIST TRIGGER. S.
Beall1, G. Betz2, J. Segars1, F. Chang1, K.
Richter1. 1Program in Reproductive and
Adult Endocrinology, Eunice Kennedy
Health, Bethesda, MD; 2Shady Grove Fertility
MD.
P-205HIGH OVARIAN STIMULATION DOESN’T
IMPAIR EMBRYO QUALITY. CLINICAL
EVIDENCE USING COMPARATIVE MODEL
WITH SHARED EGG DONORS. J. Llacer1, B.
Moliner1, A. Rodriguez1, J. Guerrero1, J. Ten1,
R. Bernabeu1. 1Reproductive Medicine,
Instituto Bernabeu, Alicante, Spain; 2IB
Biotech, Instituto Bernabeu, Alicante, Spain.
P-206EFFECT OF PERTUBATION ON PREGNANCY
RATES BEFORE INTRAUTERINE INSEMINATION
TREATMENT IN UNEXPLAINED INFERTILE
PATIENTS. F. Yildiz, N. Bozkurt, A. Erdem,
M. Erdem, M. Oktem, O. Karabacak. Gazi
Üniversity, Ankara, Turkey.
P-207CHARACTERISTICS PREDICTIVE OF FAILED
LEUPROLIDE ACETATE (LA) TRIGGER AMONG
PATIENTS UNDERGOING GONADOTROPINRELEASING HORMONE (GnRH) ANTAGONIST
SUPPRESSION FOR VITRO FERTILIZATION (IVF).
S. Beall1, K. Moon1, E. Widra2, A. DeCherney1,
F. Chang2, K. Richter1. 1Program in
National Institutes of Health, Bethesda, MD;
2
Shady Grove Fertility Reproductive Science
P-208THE EFFECTS OF RESVERATROL ON AN
OVARIAN HYPERSTIMULATION SYNDROME
MODEL IN RATS. M. Oktem1, S. Ozgur1,
O. Erdem2, S. Elbeg3, C. Cenksoy1, A.
Helvaci2. 1Obstetrics & Gynecology, Gazi
University Faculty of Medicine, Ankara,
Turkey; 2Pathology, Gazi University Faculty
of Medicine, Ankara, Turkey; 3Biochemistry,
Gazi University Faculty of Medicine, Ankara,
Turkey.
P-209INCREASING FSH DOSAGE BEYOND
PHYSIOLOGICAL RANGE FAILS TO
UPREGULATE ESTRADIOL PRODUCTION BY
GRANULOSA CELLS IN VITRO. M. D. Lalioti, E.
Seli, T. Gerasimova. Obstetrics, Gynecology
and Reproductive Sciences, Yale University,
New Haven, CT.
P-210USE OF GnRH ANTAGONISTS VS AGONISTS
PROTOCOL FOR IVF/ICSI IN THE REAL WORLD
– EXPERIENCE OF OVER 11,000 CYCLES.
E. Bosch1, S. Crespi2, N. Garrido1, M.
Meseguer1, H. Hu2. 1IVI Valencia, Valencia,
Spain; 2Merck & Co., Inc., Whitehouse
Station, NJ.
P-211CAN THE OVULATION INDUCTION PROTOCOL
IMPROVE THE OUTCOME OF OOCYTE
DONATION TREATMENTS? P. Feetback1,2,
R. Miranda1, T. Domingues1,3, M. A. Peres1,
M. Riboldi1, E. L. A. Motta1,3. 1Huntington
2
P-212A NOVEL THERAPY WITH SITAGLIPTIN
FOR METFORMIN-INEFFECTIVE AGED
ART REPEATERS: DRAMATICAL INCREASE
IN PREGNANCY RATE BY DECREASING
POSTPRANDIAL GLYCEMIC LEVELS AND
ADVANCED GLYCATION END-PRODUCTS.
M. Jinno1, M. Takeuchi2, A. Watanabe1, J.
Hirohama1, R. Hiura1, N. Suciu3. 1Women’s
Clinic Jinno, Choufu City, Tokyo, Japan;
2
Department ofAdvanced Medicine,
Medical Research Institute, Kanazawa
Medical University, Kahoku, Ishikawa,
Japan; 3Department of Obstetrics and
Gynecology, Polizu Maternity Hospital,
Bucharest, Romania.
P-213GRANULOCYTE-COLONY STIMULATION
FACTOR (G-CSF): AN OPTION TO IMPROVE
IN VITRO FERTILIZATION (IVF) OUTCOMES IN
POOR RESPONDERS. A. S. Cambiaghi, R. B.
F. Leao. Reproduction, IPGO, Sao Paulo, SP,
Brazil.
104
P-214LATE START OF GONADOTROPIN-RELEASING
HORMONE ANTAGONIST DOES NOT
COMPROMISE IVF-ET OUTCOMES IN
MULTIPLE-DOSE FLEXIBLE PROTOCOL. J. H.
Kim1, J. R. Lee1,2, B. C. Jee1,2, C. S. Suh1,2,
S. H. Kim2. 1Department of Obstetrics
and Gynecology, Seoul National
University Bundang Hospital, Seongnam,
Korea; 2Department of Obstetrics and
Gynecology, Seoul National University
College of Medicine, Seoul, Korea.
P-215LETROZOLE INDUCED OVULATION AND
PREGNANCIES IN ANOVULATORY
CLOMIPHENE CITRATE-RESISTANT WOMEN.
F. S. Chuong, A. Nardandrea, C. Silva, S.
Plosker. Department of Obstetrics and
Gynecology, University of South Florida,
Tampa, FL.
P-216OUTCOMES OF PROTRACTED IVF CYCLES
IN POOR RESPONDERS UNDERGOING
CLOMIPHENE CITRATE PROTOCOLS. E. MokLin, A. Aelion Brauer, O. Davis, Z. Rosenwaks.
The Ronald O. Perelman and Claudia
Cohen Center for Reproductive Medicine,
NY.
P-217TREATMENT OUTCOMES IN WOMEN
RECEIVING IVF/ICSI IN REAL-WORLD
SETTING – FSH ALONE VS. LH-CONTAINING
GONADOTROPIN REGIMENS. E. Bosch1, S.
Crespi2, N. Garrido1, M. Meseguer1, H. Hu2.
1
IVI Valencia, Valencia, Spain; 2Merck & Co.,
Inc., Whitehouse Station, NJ.
P-218TREATMENT OF POOR OVARIAN RESPONDERS
WITH CORIFOLLITROPIN ALPHA FOLLOWED
BY rFSH IN AN ANTAGONIST PROTOCOL. AN
OBSERVATIONAL PILOT STUDY. N. P. Polyzos1,
M. De Vos1, P. Humaidan2, C. OrtegaHrepich1, P. Devroey1, H. Tournaye1. 1Centre
for Reproductive Medicine, Universitair
Ziekenhuis Brussel, Vrije Universiteit Brussel,
Brussels, Belgium; 2The Fertility Clinic,
Department D, Odense University Hospital,
Odense, Denmark.
P-219SUPPRESSION OF OVARIAN RENIN
ANGIOTENSIN SYSTEM CAN BE USEFUL TO
PREVENT OVARIAN HYPERSTIMULATION
SYNDROME. B. Ata1,2, H. Clarke2, S. L. Tan2,
W. Buckett2. 1Obstetrics and Gynecology,
Uludag University, Bursa, Turkey; 2Obstetrics
and Gynecology, McGill University,
P-220EARLY GnRH ANTAGONIST INITIATION
INCREASE FOLLICULAR SYNCHRONIZATION
AND NO. OF MATURE OOCYTE. Y. I. Hwang1,
M. H. Choi1, K. M. Yang1, M. K. Koong1, J. S.
Lee2, C. W. Park1. 1Division of Reproductive
Endocrinology and Infertility, Cheil General
Hospital and Women’s Healthcare Center,
Seoul, Korea; 2Department of Urology, Cheil
General Hospital and Women’s Healthcare
Center, Seoul, Korea.
P-221GONADOTROPIN-RELEASING HORMONE
AGONIST VERSUS HCG FOR OOCYTE
TRIGGERING IN MILD OVARIAN STIMULATION
CYCLES IN PATIENTS WITH DIMINISHED
OVARIAN RESERVE. R. Huang, C. Fang, X.
Liang, X. Yang. Reproductive Medicine
Center, 6th Affiliated Hospital of Sun Yat-sen
University, Guangzhou, Guangdong, China.
P-222SAFE AND EFFECTIVE FIRST LINE THERAPY
FOR WOMEN WITH UNEXPLAINED INFERTILITY
IN REAL CLINIC PRACTICE. A. Fukui1, R.
Fukuhara1, H. Kimura2, S. Fujii3, H. Mizunuma1.
1
Obstetrics and Gynecology, Hirosaki
University Graduate School of Medicine,
Hirosaki, Aomori, Japan; 2Obstetrics and
Gynecology, National Hirosaki Hospital,
Hirosaki, Aomori, Japan; 3Tachizaki Ladies
Clinic, Aomori, Japan.
P-223SHORT GnRH-a PROTOCOL EVERY OTHER
DAY VERSUS DAILY LONG GnRH-a
PROTOCOL IN PATIENTS UNDERGOING IN
VITRO FERTILIZATION. C. A. R. Iaconelli1,
R. S. Rodrigues1, A. S. Setti2, S. Resende3,
A. Iaconelli Jr.1,2, E. Borges Jr.1,2,3. 1Fertility Assisted Fertilization Center, Sao Paulo, SP,
Reproduction, Sao Paulo, SP, Brazil; 3Fertility
- Assisted Fertilization Center, Campo
Grande, MS, Brazil.
P-224ANTI-MULLERIAN HORMONE
EVALUATION AND INITIAL OVARIAN
RESPONSE IN AN APPARENTLY GOOD
PROGNOSIS POPULATION TREATED BY
INTRACYTOPLASMIC SPERM INJECTION. G.
Agnani1, R. Ramanah1, A.-S. Tholozan1,
A.-L. Dubourdeau1, A. Berdin1, F. Mauny2.
1
Gynaecology and Obstetrics, University
of Besançon, Besançon Cedex,
Doubs, France, Metropolitan; 2Statistics
Department, University of Besançon,
Besançon Cedex, Doubs, France,
Metropolitan.
P-225IVF OUTCOMES IN PCO AND NONPCO PATIENTS. K. Sorby1, S. Roberts3, A.
Talmor1,2, C. Beyer1, B. Vollenhoven1,2,3, T.
Osianlis1. 1Monash IVF, Melbourne, VIC,
Australia; 2Department of Obstetrics
and Gynaecology, Monash University,
Melbourne, VIC, Australia; 3Women’s and
Children’s Program, Southern Health,
Melbourne, VIC, Australia.
P-226FIXED VERSUS FLEXIBLE GnRH ANTAGONIST
PROTOCOLS: WHO MAKES THE DIFFERENCE?
A. Weissman, S. Tannus, E. Horowitz,
A. Ravhon, J. Barkat, D. Levran. IVF
Unit, Department of Obastetrics and
Gynecology, Edith Wolfson Medical Center,
105
Sackler Faculty of Medicine, Tel Aviv
University, Holon, Israel.
__________________________________________________________
P-234DELAYED EMBRYO PROGRESSION ON DAY 5
DOES NOT IMPACT PREGNANCY RATES. M.
R. Maduro, M. Frank, P. Pasquale. Obstetrics,
Yale University, New Haven, CT.
P-235VIABILITY OF VITRIFIED-THAWED
BLASTOCYSTS OBTAINED ON DAY 7 OF
CULTURE. M. Takeuchi1,2, N. Fukunaga1,2,3,
R. Nagai1,2, H. Kitasaka1,2, T. Yoshimura1,2, Y.
Asada1,2,3. 1Asada Ladies Nagoya Clinic,
Nagoya, Aichi, Japan; 2Asada Ladies
3
P-236UNDERSTANDING THE INCIDENCE, ETIOLOGY
AND EFFECT OF RETAINED EMBRYOS
FOLLOWING EMBRYO TRANSFER. J. A. Lee1,
S. Akber3, P. Y. Beim3, M. Whitehouse1,
L. Grunfeld1,2, A. B. Copperman1,2.
1
York, New York, NY; 2Obstetrics, Gynecology
and Reproductive Science, Mount
Sinai School of Medicine, New York, NY;
3
Celmatix, Inc., New York, NY.
P-237EMBRYO QUALITY AND PATIENT AGE, BUT
NOT NUMBER OF TRANSFERRED EMBRYOS,
ARE ASSOCIATED WITH A CLINICAL
PREGNANCY IN AN ELECTIVE SINGLE
BLASTOCYST TRANSFER POLICY WITHOUT
COMPROMISING THE PREGNANCY RATE. T.
Hara1, T. Kodama1, K. Sato1, Y. Kikkawa1,
T. Muneto1, J. Tanaka2. 1Reproductive
Medicine, Hiroshima Prefectural Hospital,
Hiroshima, Japan; 2Epidemiology, Infectious
Disease Control and Prevention, Graduate
School of Biomedical Sciences, Hiroshima
University, Hiroshima, Japan.
P-238SEVEN MONOZYGOTIC TWINNING (MZT)
CASE SERIES OF VARIOUS TYPES OF
CHORIONICITY AND AMNIOSITY IN THE
COMPULSORY SINGLE EMBRYO TRANSFER
(cSET) PROGRAM BASED ON THE TIMELAPSE OBSERVATION FOR EACH EMBRYO.
H. Ando, Y. Teranishi, H. Moroi, M. Okada,
T. Takayanagi, N. Suzuki. Center for
Reproductive Medicine and Surgery,
Toyohashi Municipal Hospital, Toyohashi,
Aichi, Japan.
P-239PERFORMANCE OF EMBRYO TRANSFER IS
CRITICAL TO OUTCOME OF IVF ESPECIALLY
IN SET AND FET. A. Fukuda, A. Haruki, H.
Matsumoto, M. Ida, R. Mori. The Centre for
Reproductive Medicine and Infertility, IVF
Osaka Clinic, The Centre for Reproductive
Medicine and Infertility, Higashi-Osaka City,
Osaka Prefecture, Japan.
P-240EFFECT OF CLINICAL OUTCOMES ON SERUM
LH MONITORING IN NATURAL FET CYCLES. E.
M. Choi, Y. Y. Kim, S. G. Kim, J. H. Lee, H. I.
Park, K. H. Lee. Infertility Lab, Mamapapa &
Baby OB&GY, Ulsan, Republic of Korea.
Embryo Transfer
P-227MEIOTIC SPINDLE AREA IS A STRONG
INDICATOR OF HUMAN EMBRYO
DEVELOPMENTAL POTENTIAL. H. Tomari,
K. Honjou, K. Kunitake, K. Uchimura, K.
Ikebe, Y. Nagata. Center for Reproductive
Medicine, IVF Nagata Clinic, Fukuoka,
Japan.
P-228ARE FIRST TRIMESTER PREGNANCIES SMALLER
THAN EXPECTED AFTER THAWED EMBRYO
TRANSFER? A. M. Page, K. Hertler, R. W. Ke,
W. Kutteh. Obestetrics and Gynecology,
Reproductive Endocrinology, University of
Tennessee Health Science Center, Memphis,
TN.
P-229TIME-LAPSE IMAGING AND THE IDEAL TIME
FOR EMBRYO CLEAVAGE ON THE THIRD DAY
OF DEVELOPMENT: PRELIMINARY RESULTS. L.
Semião-Francisco, M. Samama, J. Ueno.
GERA- Instituto de Medicina Reprodutiva,
São Paulo, Brazil.
P-230OUTCOME OF FROZEN-THAWED EMBRYO
TRANSFER IN NATURAL CYCLES WITH
SPONTANEOUS OVULATION VERSUS hCG
TRIGGERING AND HORMONE REPLACEMENT
THERAPY. C. Martínez1, B. Calzada1, H.
Grassa1, M. Figueroa1, M. Pérez1, J. A.
García-Velasco1,2. 1IVI-Madrid, Madrid,
Spain; 2Rey Juan Carlos University, Móstoles,
Madrid, Spain.
P-231IMPACT OF THE NEW BRAZILIAN LAW IN THE
REDUCTION OF MULTIPLE PREGNANCIES.
D. T. Schneider, S. C. Esteves. Androfert,
P-232ULTRASOUND-GUIDED EMBRYO TRANSFER
– AN UPDATED META-ANALYSIS. H. N.
Sallam1,2, N. H. Sallam2, A. N. Sallam1, F.
Ezzeldin2. 1Department of Obstetrics and
Gynaecology, Alexandria University,
Alexandria, Egypt; 2Assisted Reproduction
Unit, Alexandria Fertility Center, Alexandria,
Egypt.
P-233PRE-IMPLANTATION GENETIC SCREENING
WITH ARRAY COMPARATIVE GENOMIC
HYBRIDIZATION: EVALUATION OF FRESH AND
FROZEN IMPLANTATION AND PREGNANCY
RATES AFTER BLASTOCYST BIOPSY. T. S.
Criscuolo1, M. M. Piccolomini1, B. C. Barros1,
M. B. Chehin1,2, P. Serafini1,3, E. L. A. Motta1,2.
1
Huntington Medicina Reprodutiva, Sao
Paulo, SP, Brazil; 2Ginecologia, Universidade
Federal de Sao Paulo - UNIFESP, Sao Paulo,
SP, Brazil; 3Ginecologia, Universidade de
Sao Paulo - USP, Sao Paulo, SP, Brazil.
106
P-241INFLUENCE OF FRAGMENTATION ON
TROPHECTDERM. K. Nakayama1,2, N.
Fukunaga1,2,3, R. Nagai1,2, H. Kitasaka1,2,
E. Kojima1,2, Y. Asada1,2,3. 1Asada Ladies
Nagoya Clinic, Nagoya, Aichi, Japan;
2
Asada Ladies Kachigawa Clinic, Kasugai,
Aichi, Japan; 3The Asada Institute for
Reproductive Medicine, Kasugai, Aichi,
Japan.
__________________________________________________________
UNICAMP, Campinas, SP, Brazil; 4Fertility Assisted Fertilization Center, Sao Paulo, SP,
Brazil.
P-246ELECTIVE CRYOPRESERVATION OF ALL
EMBRYOS WITH INTERVAL CRYOTHAW
TRANSFER IN PATIENTS AT RISK FOR
OHSS REDUCES THE RISK OF SGA AND
PREECLAMPSIA COMPARED TO SIMILAR
GROUP OF PATIENTS WITH FRESH TRANSFER.
A. N. Imudia1, A. O. Awonuga2, A. J.
Kaimal3, D. L. Wright1, A. K. Styer1, T. L.
Toth1. 1Vincent Department of Obstetrics
and Gynecology, Massachusetts General
Hospital Fertility Center, Boston, MA; 2Division
Infertility, Wayne State University School of
Medicine, Detroit, MI; 3Vincent Department
of Obstetrics and Gynecology, Division of
Maternal Fetal Medicine, Boston, MA.
P-247hCG ADMINISTRATION FOR OOCYTE
MATURATION IMPAIR ENDOMETRIAL
DIFFERENTIATION AND POST-IMPLANTATION
EMBRYO DEVELOPMENT. K. Ezoe, A.
Yabuuchi, K. Kato, F. Aono, Y. Takehara, O.
Kato. Kato Ladies Clinic, Tokyo, Japan.
P-249CONTROLLED OVARIAN HYPERSTIMULATION
(COH) CYCLES MAY BENEFIT FROM
VITRIFICATION OF ALL DAY 5 PGS-BIOPSIED
BLASTOCYSTS. J. Whitney, N. Nugent, K.
Duggan, S. Zozula, R. E. Anderson, M. C.
Schiewe. Southern California Institute for
Reproductive Science, Newport Beach, CA.
P-250TRANSFER OF BLASTOCYSTS VITRIFIED
USING THE MICROSECURE VITRIFICATION
METHOD YIELDS ONGOING IMPLANTATION
AND PREGNANCY RATES COMPARABLE TO
TRANSFER OF FRESH EMBRYOS. H. Dinnie,
C. Dowling, P. St. Marie, K. Lynch, M. Arny.
Obstetrics and Gynecology, Baystate
Medical Center, Springfield, MA.
P-251THE EARLY OOCYTE DONATION PREGNANCY
PRODUCES INCREASING AMOUNTS OF
PREGNENOLONE: ELUCIDATION THE
LUTEOPLACENTAL SHIFT AND IDENTIFICATION
OF A POTENTIAL PRENATAL DIAGNOSTIC
MARKER. F. Licciardi1, C. Oh2. 1OB/GYN, NYU
2
Biostatistics, NYU Langone Medical Center,
New York, NY.
P-252DECREASE OF DEVELOPMENTAL
COMPETENCE AND INCREASE OF
ABNORMAL SPINDLE OF GROWTHRETARDED EMBRYO AFTER VITRIFICATION.
S. Hashimoto, A. Amo, S. Hama, K. Ito, Y.
Nakaoka, Y. Morimoto. IVF Namba Clinic,
Osaka, Japan.
Implantation
P-242EFFECTS OF BARUSIBAN, A SELECTIVE
OXYTOCIN ANTAGONIST, ON UTERINE
CONTRACTILITY IN THE LUTEAL PHASE AFTER
CONTROLLED OVARIAN STIMULATION. H.
Visnova1, R. A. Pierson2, M. Mrázek3, J.
A. García-Velasco4, C. Blockeel5, J.-C.
Arce6. 1Clinic for Assisted Reproduction,
IVF CUBE, Prague, Czech Republic;
2
Obstetrics Gynecology and Reproductive
Sciences, College of Medicine, University
of Saskatchewan, Saskatoon, SK, Canada;
3
Lighthouse, ISCARE IVF, Prague, Czech
Republic; 4Reproductive Endocrinology,
IVI Madrid, Madrid, Spain; 5Centre for
Reproductive Medicine, University Hospital
Brussels, Brussels, Belgium; 6Reproductive
Health, Global Clinical R&D, Ferring
P-243THE EFFECT OF TRANSVAGINAL ENDOMETRIAL
PERFUSION WITH GRANULOCYTE COLONYSTIMULATING FACTOR(G-CSF). Y. Y. Kim, Y.
H. Jung, J. D. Jo, M. H. Kim, Y. J. Yoo, S. Kim.
Ellemedi OB/GYn, Changwon, Gyoung
Nam, Republic of Korea.
P-244EFFECT OF TAKING A ONE TIME INJECTION
OF 1MG LEUPROLIDE ACETATE 3 DAYS
AFTER EMBRYO TRANSFER ON PREGNANCY
OUTCOME AND LEVEL OF FIRST BETA HUMAN
CHORIONIC GONADOTROPIN (b-hCG)
LEVEL. J. H. Check1,2, J. K. Choe1, D. Brasile1,
R. Cohen3, D. Summers-Chase1. 1Dept. OB/
GYN, Div. Repro. Endo. & Infertility, UMDNJ,
Robert Wood Johnson Med. School at
Camden, Camden, NJ; 2Dept. OB/GYN, Div.
School of Rowen University, Camden, NJ;
3
Dept. OB/GYN, Philadelphia College of
Osteopathic Medicine, Philadelphia, PA.
P-245PREDICTION OF BLASTOCYST IMPLANTATION
POTENTIAL BY CULTURE MEDIA
FINGERPRINTING AND MULTIVARIATE
STATISTICAL MODEL – A PILOT STUDY. S. S.
Cortezzi1, M. G. Trevisan2, E. C. Cabral3, E.
M. Schmidt3, M. N. Eberlin3, E. Borges Jr.1,4.
1
Sapientiae Institute - Educational and
Research Center in Assisted Reproduction,
Sao Paulo, SP, Brazil; 2Institute of Chemistry,
Federal University of Alfenas, Alfenas,
MG, Brazil; 3ThoMSon Mass Spectrometry
Laboratory - Institute of Chemistry,
107
P-253DELAY OF LUTEAL SUPPORT START IMPROVES
THE CLINICAL PREGNANCY RATE IN FRESH
SINGLE-BLASTCYST TRANSFER CYCLE. K. Ito,
Y. Nakaoka, S. Hashimoto, T. Maezawa, T.
Himeno, Y. Morimoto. IVF Namba Clinic,
Osaka, Japan.
P-254GRANULOCYTE-COLONY STIMULATION
FACTOR (G-CSF) MAY IMPROVE
PREGNANCY RATE IN PATIENTS WITH
REPEATED IMPLANTATION FAILURES. A. S.
Cambiaghi, R. B. F. Leao. Reproduction,
IPGO, Sao Paulo, SP, Brazil.
P-255MicroRNA 31 IS UPREGULATED IN SERUM
DURING THE WINDOW OF IMPLANTATION. J.
D. K. Kresowik, E. J. Devor, B. J. Van Voorhis,
K. K. Leslie. Obstetrics & Gynecology,
University of Iowa Hospitals & Clinics, Iowa
City, IA.
P-256SERUM ESTRADIOL LEVELS IN EGG DONORS
ON THE DAY OF hCG DO NOT CORRELATE
WITH PREGNANCY RATES AND OUTCOMES.
L. Gonzalez-Berchelmann, R. SantosHaliscak, J. Rosales-DeLeon, I. ObesoMontoya, P. Diaz-Spindola, P. GalacheVega. IECH Fertility Center, Monterrey, NL,
Mexico.
P-257THE ROLE OF LUTEAL PHASE ESTRADIOL:
LESSONS FROM A NATURAL CYCLE FET
MODEL. G. Vela1, E. Cervantes1, M. Luna1,
M. C. Whitehouse1, J. Lee1, B. Sandler1,2, A.
B. Copperman1,2. 1Reproductive Medicine
Associates of New York, New York, NY;
2
Science, Mount Sinai School of Medicine,
New York, NY.
P-258INTRAUTERINE GLUCOSAMINE HAS
A REVERSIBLE INHIBITORY EFFECT ON
PREGNANCY IN MICE. K. E. O’Neill, M. B.
Schulte, J.-H. Tsai, K. Moley. Obstetrics and
Gynecology, Washington University in St.
Louis, Saint louis, MO.
P-259WHAT TIME SHOULD BE BETTER FOR THE NEXT
IVF CYCLE? Y. Bayoglu Tekin1, S. T. Ceyhan1,
S. Kilic2, C. Korkmaz3. 1IVF, Gynecology
and Obstetrics, Ankara, Turkey; 2IVF,
Gynecology and Obstetrics, Ankara, Turkey;
3
Epidemiology, Ankara, Turkey; 4Embriology,
Ankara, Turkey.
P-260IS INNER CELL MASS OR TROPHOBLAST
QUALITY MORE IMPORTANT IN PREDICTING
THE ABILITY OF A BLASTOCYST TO IMPLANT
WITH AN ONGOING HEARTBEAT? C.
Dowling, H. Dinnie, S. LaBrie, P. St. Marie,
K. Lynch, M. Arny. Baystate Reproductive
Medicine, Springfield, MA.
P-261EFFECT OF THE PRESENCE OF
MICRONUCLEATED BLASTOMERES ON DAY
2 IN THE EMBRYOS COHORT. J. M. Molina
Sabater1, M. Riqueros Arévalo1, J. Teruel
López1, A. Ballesteros Boluda1, A. Pellicer
Martínez2, G. Calderón de Oya1. 1IVF
Laboratory, IVI Barcelona, Barcelona, Spain;
2
Reproductive Unit, IVI Valencia, Valencia,
Spain.
P-262PREIMPLANTATION GENETIC SCREENING
(PGS) USING COMPARATIVE GENOMIC
HYBRIDIZATION (CGH) ON DAY 3 EMBRYO
BIOPSIES DOUBLES THE IMPLANTATION,
CLINICAL PREGNANCY AND ONGOING
PREGNANCY RATE PER TRANSFER. M.
Vega2, K. Martin1, I. Sirota2, E. Gonzales1,
D. Stein1. 1Department of Obstetrics and
Gynecology, Continuum Reproductive
Center, St.Lukes-Roosevelt Hospital Center,
Columbia College of Physicians and
Surgeons, New York, NY; 2Department of
Obstetrics and Gynecology, St. LukesRoosevelt Hospital Center, New York, NY.
__________________________________________________________
Luteal Phase Support
P-263SATISFACTION WITH PROGESTERONE
VAGINAL RING (PGN VR): SURVEY OF
WOMEN PARTICIPATING IN A RANDOMIZED
TRIAL OF WEEKLY PGN VR VS 8% PGN
GEL AS LUTEAL SUPPORT AFTER IN VITRO
FERTILIZATION (IVF). K. M. Silverberg1, B.
Howard2. 1Texas Fertility Center and Austin
IVF, Austin, TX; 2Teva Global Branded
Products R&D, Inc, Frazer, PA.
P-264BENEFICIAL EFFECTS OF GnRH AGONIST IN
LUTEAL PHASE: AGE-DEPENDENT DIFFERENCE.
I. H. Park1, K. H. Lee1, H. G. Sun1, S. G. Kim1,
Y. Y. Kim1, G.-H. Jeon2. 1Mamapapa & Baby
OB&GY, Ulsan, Republic of Korea; 2OB/GY,
Inje University, Haeundae Paik Hospital,
Busan, Republic of Korea.
P-265LUTEAL SUPPLEMENTATION IN DONOR EGG
AND FROZEN EMBRYO TRANSFER CYCLES:
SHOULD THE ROUTE OF ADMINISTRATION
INFLUENCE THE TIME OF INITIATION? R. H.
Fogle1, A. R. Gumer2, J. P. Toner1. 1Atlanta
Center for Reproductive Medicine, Atlanta,
GA; 2The George Washington University
School of Medicine and Health Sciences,
Washington, DC.
P-266RECOMBINANT LH RESCUES THE LUTEAL
PHASE AFTER GnRH AGONIST TRIGGERING
OF OVULATION. A COMPARATIVE STUDY.
E. Munoz1, E. Taboas1, B. Martinez1, I.
Fernandez1, J. Aguilar1, J. Remohí2.
1
Reproductive Medicine, IVI Vigo, Vigo,
Pontevedra, Spain; 2Reproductive
Medicine, Instituto Valenciano de
Infertilidad, Valencia University, Valencia,
Spain.
__________________________________________________________
108
Pregnancy Loss and Termination
Contraception/Family Planning
P-267LOW MOLECULAR WEIGHT HEPARIN
(LMWH) FOR TREATMENT OF RECURRENT
MISCARRIAGE NEGATIVELY TESTED FOR ANTI
PHOSPHOLIPID ANTIBODIES: A RANDOMIZED
CONTROLLED TRIAL. S. A. Salman, O. M.
Shaaban, K. M. Zahran, M. M. Fathalla, M.
A. Anan. Obstetrics and Gynecology, Assiut
University, Assiut, Egypt.
P-268ANEUPLOIDY IN ABORTUSES FOLLOWING IN
VITRO FERTILIZATION, INTRACYTOPLASMIC
SPERM INJECTION AND NATURAL
CONCEPTION. J. Cai1,2,3, B. Yin1,2,3, T. Wu1,2,3,
G. Li1,2,3, P. Liang1,2,3, Y. Zeng1,2,3. 1Shenzhen
Zhongshan Institute for Reproductive
Medicine and Genetics, Shenzhen
Zhongshan Urology Hospital, Shenzhen,
Guangdong, China; 2Clinical Center
for Recurrent Miscarriage & Recurrent
Implantation Failure, Shenzhen Zhongshan
Urology Hospital, Shenzhen, Guangdong,
China; 3Fertility Center, Shenzhen Zhongshan
Urology Hospital, Shenzhen, Guangdong,
China.
P-273COMPARISON OF SHORT-TERM EFFICACY,
SIDE EFFECTS, BENEFITS OF TWO
DROSPIRENONE CONTAINING COMBINED
ORAL CONTRACEPTIVES: 21/7-DAY3MG/30MCG VS 24/4-DAY-3MG/20 MCG.
A. Tekeli1, B. Dilbaz1, S. Kiykac Altinbas1, Y.
Bayoglu Tekin2. 1Department of Obstetrics
& Gynecology, Ministry of Health, Etlik
Zubeyde Hanim Women’s Health Teaching
and Research Hospital, Ankara, Turkey;
2
Rize University School of Medicine, Rize,
Turkey.
P-274PRE-CLINICAL EVALUATION FOR
FUNCTIONAL REVERSAL WITH DMSO
AND NAHCO3 FOLLOWING LONG-TERM
CONTRACEPTION WITH RISUG IN RATS. A. S.
Ansari, M. Hussain, S. R. Khan, I. Alam, N. K.
Lohiya. Department of Zoology, University of
Rajasthan, Jaipur, Rajasthan, India.
P-275TRANSCERVICAL ADMINISTRATION OF
POLIDOCANOL FOAM BLOCKS THE
FALLOPIAN TUBES OF RHESUS MACAQUES
WITHOUT ADVERSE NONTARGET EFFECTS.
J. Jensen1,2, E. Micks1, A. Edelman1,2, C.
Hanna2, S. Yao2, O. Slayden2. 1Obstetrics
& Gynecology, Oregon Health & Science
University, Portland, OR; 2Division of
Reproductive and Developmental
Research Center, Beaverton, OR.
P-276INAPPROPRIATE USE OF COMBINED
HORMONAL CONTRACEPTIVES AMONG
ADULT REPRODUCTIVE-AGE WOMEN IN THE
UNITED STATES. J. Yu, H. X. Hu. Global Health
Outcomes, Merck & Co., Inc., Whitehouse
Station, NJ.
P-277BLEEDING PROFILES OF TWO LOWDOSE LEVONORGESTREL-RELEASING
INTRAUTERINE SYSTEMS (LNG-IUSs) USED
FOR CONTRACEPTION IN NULLIPAROUS AND
PAROUS WOMEN: RESULTS OF A GLOBAL,
RANDOMIZED, PHASE III STUDY. A. Nelson1,
B. Hauck2, D. Apter3, S. Rybowski4, K. Rosen5,
K. Gemzell-Danielsson6. 1Los Angeles
Biomedical Research Institute, Torrance,
CA; 2Department of Obstetrics and
Gynecology, Calgary, AB, Canada; 3Sexual
Health Clinic, Väestöliitto, Helsinki, Finland;
4
Bayer Pharma AG, P300, Berlin, Germany;
5
Bayer HealthCare Pharmaceuticals,
Montville, NJ; 6Department of Women’s
and Children’s Health, Karolinska University
Hospital, Stockholm, Sweden.
P-269INFORMATICS-BASED MOLECULAR
KARYOTYPING OF PRODUCTS OF
CONCEPTION (POC) PRESERVED IN PARAFFIN
WITH MATERNAL CELL CONTAMINATION
(MCC) DETECTION: REPORT ON 46
CONSECUTIVE ANALYSES. R. B. Lathi1, M.
Maisenbacher2, S. Sigurjonsson2, J. Keller2, Z.
Demko2, M. Rabinowitz2. 1Stanford Fertility
& Reproductive Medicine Center, Stanford
University Medical Center, Palo Alto, CA;
2
Natera, Inc., San Carlos, CA.
P-270QUANTITATIVE METHYLATION ANALYSIS OF
DEVELOPMENTALLY IMPORTANT IMPRINTED
GENES IN HUMAN STILLBIRTHS FROM ART
AND SPONTANEOUS CONCEPTION. S.-L.
Chen, H.-Y. Zheng, X. Chen, D.-S. Ye, Y.
Tang, X.-H. Yang. Center for Reproductive
Medicine, Gynecology and Obstetrics
Department, Nanfang Hospital, Southern
Medical University, Guangzhou,
Guangdong, China.
P-271MISCARRIAGE CHROMOSOME TESTING:
UTILITY OF COMPARATIVE GENOMIC
HYBRIDIZATION (CGH) WITH SELECTIVE
MICROSATELLITE ANALYSIS (MSA) IN
RECURRENT EARLY PREGNANCY LOSS (RPL).
N. Mathur, L. Triplett, M. M. Harper, M. D.
Stephenson. Obstetrics and Gynecology,
University of Chicago Medical Center,
Chicago, IL.
P-272
WITHDRAWN
__________________________________________________________
109
P-278
USER SATISFACTION, EASE OF PLACEMENT,
AND DISCOMFORT DURING PLACEMENT
OF TWO LOW-DOSE LEVONORGESTREL
CONTRACEPTIVE INTRAUTERINE SYSTEMS
(LNG-IUS) IN A MULTICENTER, RANDOMIZED,
PHASE 3 STUDY. A. L. Nelson1, K. Gemzell
Danielsson2, L. Borgatta3, B. Hauck4, R.
Lynen5, K. Rosen6. 1Los Angeles BioMedical
Research Institute at Harbor-UCLA Medical
Center, Torrance, CA; 2Department of
Women’s and Children’s Health, Division
of Obstetrics and Gynecology, Karolinska
Institutet, Stockholm, Sweden; 3Department
of Obstetrics & Gynecology, Boston
University School of Medicine, Boston,
MA; 4Department of Obstetrics and
Gynecology, Foothills Hospital, University
of Calgary, Calgary, AB, Canada; 5Bayer
HealthCare Pharmaceuticals, Inc., Wayne,
NJ; 6Bayer HealthCare Pharmaceuticals,
Inc., Montville, NJ.
P-279A COMPARISON OF ARRAY TECHNOLOGIES
AND NEXT GENERATION SEQUENCING
TECHNOLOGIES IN PRECONCEPTION
GENETIC DIAGNOSIS. A. Bisignano1,
K. Ketterson2, J. Fischer2, D. Wells3, J.
Horcajadas4, E. Bush1. 1Recombine, New
York, NY; 2Recombine and Reprogenetics,
Livingston, NJ; 3Institute for Reproductive
Sciences, University of Oxford, Cowley,
Oxford, Oxfordshire, United Kingdom;
4
Recombine-EU, Alicante, Spain.
P-280UNPLANNED PREGNANCY AND USE
OF CONTRACEPTIVE METHODS IN TWO
DIFFERENT SOCIOECONOMIC LEVEL
POPULATION. S. Ciarmatori1, S. Gogorza1, A.
Belardo1, L. Bozza2, C. Cardenas3, R. Pesce1.
1
Gynecology, Hospital Italiano de Buenos
Aires, Ciudad Autonoma de Buenos Aires,
Argentina; 2Gynecology, Hospital Gral. de
Agudos Donación Francisco Santojanni,
Ciudad Autonoma de Buenos Aires,
Argentina; 3Gynecology, Unidad Sanitaria
Los Alamos, Almirante Brown, Buenos Aires,
Argentina.
P-281MODELING COST-SAVINGS THROUGH
INCREASE UTILIZATION OF INTRAUTERINE
CONTRACEPTION AND IMPLANT. J. L.
Pocoski1, N. Henry2, F. Hassan2, A. Filonenko3,
A. Law1, J. Trussell4. 1Health Economics, and
Outcomes Research, Bayer HealthCare
Pharmaceuticals Inc., Wayne, NJ; 2Health
Economics and Outcomes Research, IMS
Health, London, United Kingdom; 3Bayer
Pharma AG, Berlin, Germany; 4Office of
Population Research, Princeton University,
Princeton, NJ.
VS NON-OBESE WOMEN. A. M. Kaunitz1,
D. F. Archer2, M. Foegh3. 1Department of
Florida College of Medicine, Jacksonville,
FL; 2Obstetrics and Gynecology, Eastern
Virginia Medical School, Norfolk, VA;
3
Clinical Research & Development, Agile
Therapeutics, Inc., Princeton, NJ.
P-283USING CHANGES IN BINDING GLOBULINS
TO ASSESS ORAL CONTRACEPTIVE PILL
COMPLIANCE IN CLINICAL TRIALS. C.
L. Westhoff1, K. A. Petrie1,2, S. Cremers3.
1
Gynecology, Columbia University Medical
Center, New York, NY; 2Mailman School of
Public Health, Columbia University, New
York, NY; 3Irving Institute for Clinical and
Translational Research, Columbia University
Medical Center, New York, NY.
P-284A MULTICENTER, RANDOMIZED, PHASE 3
STUDY OF TWO LOW-DOSE LEVONORGESTREL
CONTRACEPTIVE INTRAUTERINE SYSTEMS
(LNG-IUS): A SUBGROUP ANALYSIS IN
NULLIPAROUS WOMEN. A. L. Nelson1, K.
Gemzell-Danielsson2, S. R. Drosman3, R.
Lynen4, K. Rosen5. 1Los Angeles BioMedical
Research Institute at Harbor-UCLA Medical
Center, Torrance, CA; 2Department of
Women’s and Children’s Health, Karolinska
Institutet, Stockholm, Sweden; 3Genesis
Center for Clinical Research, San Diego,
CA; 4Bayer HealthCare Pharmaceuticals,
Wayne, NJ; 5Bayer HealthCare
Pharmaceuticals, Inc., Montville, NJ.
P-285MULTICENTER OPEN-LABEL STUDY TO
EVALUATE EFFICACY AND SAFETY OF AN
ASCENDING-DOSE, EXTENDED-REGIMEN
ETHINYL ESTRADIOL/LEVONORGESTREL
COMBINATION ORAL CONTRACEPTIVE FOR
PREVENTING PREGNANCY IN WOMEN. D.
J. Portman1, B. Howard2, H. Weiss3, A. M.
Kaunitz4, N. Ricciotti2. 1Columbus Center for
Women’s Health Research, Columbus, OH;
2
Teva Global Branded Products R&D, Inc,
Frazer, PA; 3Teva Global Branded Products
R&D, Inc, Petach Tikva, Central District,
Israel; 4University of Florida College of
Medicine-Jacksonville, Jacksonville, FL.
__________________________________________________________
Female Reproductive Endocrinology
P-282SAFETY AND TOLERABILITY OF THE AGILE
PATCH, A CONTRACEPTIVE PATCH WITH
LOW-DOSE ETHINYL ESTRADIOL (EE) AND
LEVONORGESTREL (LNG), VS COMBINATION
ORAL CONTRACEPTIVES (COCs) IN OBESE
110
P-286THE EFFECT OF PROGESTERONE
SUPPLEMENTATION ON PREGNANCY RATES
IN CONTROLLED OVARIAN STIMULATION
AND INTRAUTERINE INSEMINATION CYCLES:
A RANDOMIZED PROSPECTIVE TRIAL. A.
Alleyassin1, M. Agha Hosseini1, F. Sarvi1, L.
Safdarian1, H. Rahmanpour2, A. A. Kokab1.
1
Infertility, Tehran University of Medical
Sciences, Shariati Hospital, Tehran, Islamic
Republic of Iran; 2Zanjan University of
Medical Sciences, Ayatollah Mosavi
Hospital, Zanjan, Islamic Republic of Iran.
P-287ADDITIONALTHYROID HORMONE
SUPPLEMENTATION MAY BE NECESSARY FOR
PREGNANT WOMEN WHO HAVE DEVELOPED
AFTER UNDERGOING IN-VITRO FERTILIZATION.
D. Perisic1, S. Carter2, T. Kim3. 1Ob/Gyn,
Morristown Medical Center, Morristown,
NJ; 2Horizon Blue Cross Blue Shield of New
Jersey, Newark, NJ; 3Reproductive Medicine
School of Medicine, Winston-Salem, NC;
Pathology/Comparative Medicine, Wake
Forest School of Medicine and Primate
Center, Winston-Salem, NC.
4
P-288OOCYTE RETRIEVAL SCHEDULING BASED
ON THE OCCURRENCE OF SPONTANEOUS
LH SURGE DURING NATURAL CYCLE IVF
TREATMENT: A RETROSPECTIVE ANALYSIS OF
1138 CYCLES FROM A SINGLE CENTER. D.
Bodri, S. Kawachiya, R. Kato, T. Matsumoto.
Kobe Motomachi Yume Clinic, Kobe,
Hyogo, Japan.
P-289IS THERE A CORRELATION BETWEEN
HYPOTHYROIDISM AND FRAGILE X REPEAT
NUMBER? P. D. O’Toole1, K. E. Wright1, N. S.
John3, M. A. Bray2, J. R. Stelling2. 1OB Gyn,
Good Samaritan Hospital, West Islip, NY;
2
Reproductive Specialists of NY, Mineola,
NY; 3SUNY Stoneybrook School of Medicine,
Stoney Brook, NY.
P-290DIFFERENCES IN OVARIAN AGING
PATTERNS BETWEEN RACES ARE, LIKELY,
RELATED TO OVARIAN GENOTYPES AND
SUB-GENOTYPES OF THE FMR1 GENE. D. H.
Barad1,2, E. Lazzaroni1, A. Kim1. 1Center for
Human Reproduction (CHR), New York, NY;
2
Foundation for Reproductive Medicine,
New York, NY.
P-291CLINICAL EFFECTS OF NORMALIZING
TESTOSTERONE LEVELS DURING ORAL
CONTRACEPTION. Y. X. Zimmerman, H. J.
T. Coelingh Bennink. Pantarhei Bioscience,
Zeist, Utrecht, Netherlands.
P-292PREVENTION OF OSTEOPOROSIS IN
HYPOESTROGENIC WOMEN IN THE
REPRODUCTIVE AGE RANGE. C. J. Haines1,
A. W. Y. Wong1, G. Kong1, L. P. Cheung1,
D. Choy2, P. C. Leung2. 1Obstetrics and
Gynaecology, The Chinese University of
Hong Kong, Shatin, NT, Hong Kong; 2Hong
Kong Jockey Club Centre for Osteoporosis
Care and Control, The Chinese University of
Hong Kong, Shatin, NT, Hong Kong.
P-293LUTEINIZING HORMONE PULSATILITY
IN VERVET MONKEYS (CHLOROCEBUS
AETHIOPS): NORMATIVE DATA FOR
MODELING THE IMPACT OF BODY MASS
ON PITUITARY FUNCTION. S. M. Stephens1,
K.-Y. F. Pau2, T. M. Yalcinkaya3, S. L. Berga3,
S. E. Appt4, A. J. Polotsky1. 1Reproductive
Endocrinology, University of Colorado
Denver, Aurora, CO; 2Oregon National
3
Obstetrics and Gynecology, Wake Forest
111
P-294CHANCES OF PREGNANCY AT EXTREME OF
AGE: DOES ANTI-MULLERIAN HORMONE
(AMH) MATTER? A. Aelion Brauer, E. Mok-Lin,
L. Meyer, S. D. Spandorfer, Z. Rosenwaks.
Ronald O. Perelman and Claudia Cohen
Center for Reproductive Medicine/Weill
P-295FALLING HUMAN CHORIONIC
GONADOTROPIN (hCG) CURVES IN
PREGNANCIES OF UNKNOWN LOCATION:
DEFINING THE WINDOW OF CONCERN. K. E.
Dillon1, M. Sammel1, S. Senapati1, P. Takacs2,
K. Chung3, K. T. Barnhart1. 1Obstetrics and
Gynecology, University of Pennslyvania
2
of Miami School of Medicine, Miami, FL;
3
P-296PLACENTAL-LIKE GROWTH FACTOR (PIGF)
AS A MARKER OF ECTOPIC PREGNANCY:
VALIDATION IN A CASE CONTROL STUDY.
S. Senapati1, P. Takacs2, K. Chung3, A.
Shaunik1, K. T. Barnhart1, M. Sammel.
1
Obstetrics and Gynecology & Center for
Clinical Epidemiology and Biostatistics,
University of Pennsylvania, Philadelphia,
PA; 2Obstetrics and Gynecology, University
of Miami School of Medicine, Miami, FL;
3
P-297BONE MORPHOGENETIC PROTEIN-7(BMP-7)
MIGHT CONTRIBUTE TO FOLLICULOGENESIS
BY PROMOTING ANGIOGENESIS. I. Akiyama,
O. Yoshino, Y. Osuga, T. Yano. UniverSity of
Tokyo, Tokyo, Japan.
P-298MATERNAL CHARACTERISTICS AND
PREGNANCY OUTCOMES AFTER ASSISTED
REPRODUCTIVE TECHNOLOGIES (ART)
BY INFERTILITY DIAGNOSIS: OVULATORY
DYSFUNCTION (OD) VERSUS TUBAL
OBSTRUCTION (TO). V. Grigorescu, Y. Zhang,
D. Kissin, E. Sauber-Schatz, M. Sunderam, D.
Jamieson. Centers for Disease Control and
Prevention, Atlanta, GA.
P-299ANDROGEN DYNAMICS IN WOMEN WITH
DIMINISHED FUNCTIONAL OVARIAN RESERVE
(DOR) AFTER DEHYDROEPIANDROSTERONE
(DHEA) SUPPLEMENTATION. N. Gleicher1,2,
A. Shohat-Tal1, E. Lazzaroni1, T. Michaeli1,
H.-J. Lee1, D. H. Barad1,2. 1Center for
2
New York, NY.
P-300IS THERE A CORRELATION BETWEEN CYCLE
DAY 3 FOLLICLE STIMULATING HORMONE
AND FRAGILE X REPEAT NUMBER? K.
E. Wright1, P. D. O’Toole1, N. S. John3,
J. R. Stelling2, M. A. Bray2. 1Obstetrics
& Gynecology, Good Samaritan
Hospital Medical Center, West Islip, NY;
2
Reproductive Specialists of NY, Mineola,
NY; 3Stonybrook School of Medicine,
Stonybrook, NY.
Wednesday, October 24, 2012 Poster Presentations and Reception
Abstracts P-301 through P-600
7:00 AM – 9:00 AM
Continental Breakfast Provided
ASRM invites you to meet the poster presenters of posters
P-301 through P-600 on Wednesday morning and enjoy a
continental breakfast.
Sperm Preparation: P-467 thru P-470
Please note that on Monday, posters will be open from 12:00
pm until 5:00 pm. On Tuesday, posters will be open from 7:00
am until 5:00 pm. On Wednesday, posters will be open at
7:00 am and will conclude at 2:00 pm.
ART-Clinical: P-472 thru P-531
ASRM cannot be responsible for removing and/or returning
posters. All posters not removed will be discarded.
__________________________________________________________
WEDNESDAY TOPICS AND POSTER NUMBERS:
Reproductive Hormones: P-301 thru P-304
Obesity and Metabolism: P-305 thru P-317
Ovarian Function: P-318 thru P-325
Polycystic Ovary Syndrome: P-326 thru P-345
Endometriosis: P-346 thru P-365
Stem Cells: P-471
ART-Laboratory/Basic: P-532 thru P-534
Outcome Predictors-Clinical: ART: P-535 thru P-557
Outcome Predictors-Lab:ART: P-558 thru P-568
Ovarian Stimulation – Poor Responders: ART: P-569 thru P-570
ART – In Vitro Fertilization: P-571 thru P-600
__________________________________________________________
Poster Session
Reproductive Hormones
P-301DYSMENORRHEA AS A RISK FACTOR
FOR HYPEREMESIS GRAVIDARUM. C. A.
Enakpene1,2, S. Arya1,2, M. Dalloul1, C.
Petterkin2, J. Anopa1, O. MuneyyirciDelale1,2. 1OB/GYN, SUNY Downstate
Medical Center, Brooklyn, NY; 2OB/GYN,
Kings County Hospital Center, Brooklyn, NY.
P-302TESTOSTERONE PROMOTES SURVIVAL AND
GROWTH OF PRIMATE PREANTRAL FOLLICLES
CULTURED INDIVIDUALLY IN A THREEDIMENSIONAL MATRIX. J. K. Rodrigues1,3,
J. Xu1, R. R. Yeoman1, M. B. Zelinski1,2, R.
L. Stouffer1,2. 1Division of Reproductive &
Primate Research Center, Oregon Health
& Sciences University, Beaverton, OR;
2
Portland, OR; 3Faculty of Medicine of
Ribeirao Preto, University of Sao Paulo,
Ribeirao Preto, SP, Brazil.
P-303DETERMINATION OF 17β-HYDROXYSTEROID
DEHYDROGENASE TYPES 1 AND 2 ACTIVITIES
IN HUMAN PLACENTA BY ION TRAP GC/
MS/MS. L. Dhariwal1, S. Arya1, M. Dalloul1,
Reproductive Immunology: P-366 thru P-371
Female Reproductive Tract: P-373 thru P-374
Imaging: P-375 thru P-379
Endometrium: P-381 thru P-388
Female Reproductive Surgery: P-389 thru P-395
Leiomyoma: P-396 thru P-408
Sexuality: P-409
Nutrition: P-410 thru P-411
Mental Health: P-412 thru P-417
Practice Management: P-418 thru P-425
Environment and Toxicology: P-426
Oxidative Stress: P-427 thru P-434
Male Factor: P-435 thru P-466
112
V. Nacharaju1, O. Muneyyirci-Delale1, J. G.
Kral2. 1Obstetrics and Gynecology, SUNY
Downstate Medical Center, Brooklyn, NY;
2
Surgery, SUNY Downstate Medical Center,
Brooklyn, NY.
and Laboratory Medicine, King Faisal
Specialist Hospital and Research Center,
Riyadh, Saudi Arabia.
P-310EFFECTS OF PATERNAL OBESITY ON IN
VITRO FERTILIZATION (IVF) PREGNANCY
AND LIVE BIRTH RATES. M. H. Link1, K. C.
Schliep2, R. Deshmukh2, C. A. Porucznik2,
D. Carrell3, A. O. Hammoud1. 1Obstetrics
and Gynecology, University of Utah, Salt
Lake City, UT; 2Family and Preventive
Medicine, University of Utah, Salt Lake City,
UT; 3Andrology and IVF Laboratory, Utah
Center for Reproductive Medicine, Salt
Lake City, UT.
P-311LEPTIN SUPPRESSES ANTI-MULLERIAN
HORMONE GENE EXPRESSION IN HUMAN
LUTEINIZED GRANULOSA CELLS THROUGH
JAK2/STAT3 PATHWAY. Z. O. Merhi1, E.
Buyuk2, D. Berger2, A. Zapantis2, S. Chua,
Jr3, S. Jindal2. 1Obstetrics and Gynecology,
and Infertility, University of Vermont College
of Medicine, Burlington, VT; 2Division of
Albert Einstein College of Medicine/
3
Medicine, Division of Endocrinology, Albert
Einstein College of Medicine, Bronx, NY.
P-312DOES THE PLACENTA PROTECT THE FETUS
FROM 5-ANDROSTENEDIOL IN OBESITY?
PLACENTAL 17β-HSD-1 ACTIVITY. L.
Dhariwal1, S. Arya1, M. Dalloul1, V.
Nacharaju1, O. Muneyyirci-Delale1, J. G.
Kral2. 1Obstetrics and Gynecology, SUNY
2
Surgery, SUNY Downstate Medical Center,
Brooklyn, NY.
P-313DOES OBESITY INCREASE THE RATE OF
EUPLOID MISCARRIAGE IN WOMEN WITH
RECURRENT EARLY PREGNANCY LOSS (RPL):
A CASE-CONTROL STUDY. C. E. Boots, M.
M. Harper, M. D. Stephenson. Obstetrics
& Gynecology, University of Chicago,
Chicago, IL.
P-314INCREASED BODY MASS INDEX IS A
RISK FACTOR FOR POOR FERTILIZATION
AMONG WOMEN UNDERGOING IN VITRO
FERTILIZATION (IVF). B. A. Malizia3, L. E.
Dodge1,2, J. S. Sisti2, A. S. Penzias4,5, M. R.
Hacker1,2,5. 1Obstetrics and Gynecology,
Beth Israel Deaconess Medical Center,
Boston, MA; 2Epidemiology, Harvard School
of Public Health, Boston, MA; 3Alabama
Fertility Specialists, Birmingham, AL; 4Boston
IVF, Waltham, MA; 5Obstetrics, Gynecology
and Reproductive Biology, Harvard Medical
School, Boston, MA.
P-315PUBLIC OPINION REGARDING UTILIZATION
OF ASSISTED REPRODUCTIVE TECHNOLOGY
(ART) IN OBESE WOMEN. D. K. Shah1, S. A.
P-304GONADOTROPIN RELEASING HORMONE
(GnRH) REDUCES LIGAND-INDUCED
ESTROGEN RECEPTOR (ER) DIMERIZATION IN
GT1-7 CELLS. R. J. Chason, P. K. Leung, A.
H. DeCherney, J. H. Segars, K. J. Catt. NIH/
NICHD, Bethesda, MD.
__________________________________________________________
Obesity and Metabolism
P-305MAPPING OF EPIGASTRIC VESSELS IN FEMALE
PATIENTS OF REPRODUCTIVE AGE STRATIFIED
BY BODY MASS INDEX. A. Garza-Cavazos1,
S. Lay2, J. Buedefeldt-Pollard1, K. Groesch1,3,
M. E. McAsey1, S. A. Siddique1. 1Obstetrics
and Gynecology, Southern Illinois University
School of Medicine, Springfield, IL;
2
Radiology, Southern Illinois University School
of Medicine, Springfield, IL; 3Center for
Clinical Research, Southern Illinois University
School of Medicine, Springfield, IL.
P-306OBESITY AND IN VITRO FERTILIZATION (IVF)
WITH DONOR OOCYTES: A SYSTEMATIC
REVIEW AND META-ANALYSIS. M. Schulte1,
S. Schon1, M. G. Tuuli1, D. DeUgarte2, E. S.
Jungheim1. 1Obstetrics and Gynecology,
St. Louis, MO; 2Pediatric Surgery, David
Geffen School of Medicine at UCLA, Los
Angeles, CA.
P-307HgbA1c SCREENING IN A GENERAL
INFERTILITY POPULATION REVEALS A HIGH
PREVALENCE OF PRE-DIABETES. J. M. Hurwitz,
C. R. Gundell, M. Moore, S. S. Richlin, C. M.
Murdock, M. P. Leondires. Reproductive
Medicine Associates of Connecticut,
Norwalk, CT.
P-308MONOCYTE CHEMOTACTIC PROTEIN-1
(MCP1): SOLE MEDIATOR OF INFLAMMATORY
RESPONSE IN THE OVARIES OF OBESE
WOMEN UNDERGOING CONTROLLED
OVARIAN HYPERSTIMULATION (COH)-IVF?
O. A. Asemota1, S. K. Jindal1, G. Neal-Perry1,
M. J. Charron1,2,3, E. Buyuk1. 1Obstetrics &
Gynecology and Women’s Health, Albert
Einstein College of Medicine/Montefiore
Medical Center, Bronx, NY; 2Biochemistry,
Albert Einstein College of Medicine, Bronx,
NY; 3Endocrinology, Albert Einstein College
of Medicine, Bronx, NY.
P-309EFFECT OF WEIGHT LOSS IN MORBIDLY OBESE
INFERTILE WOMEN ON IVF OUTCOME. K. A.
Awartani1, N. Al-Sahan1, S. H. Al-Hassan1,
S. Coskun2. 1Obstetrics/Gynecology & IVF,
King Faisal Specialist Hospital and Research
Center, Riyadh, Saudi Arabia; 2Pathology
113
Missmer1,2,3, K. F. B. Correia1, E. A. Ginsburg1.
1
Division of Reproductive Medicine,
School, Boston, MA; 2Channing Laboratory,
Department of Medicine, Brigham and
Epidemiology, Harvard School of Public
Health, Boston, MA.
P-322THE PRESENCE OF MATURE DENDRITIC CELLS
WITHIN HUMAN OVARIAN FOLLICULAR FLUID
CORRELATES WITH INCREASED BLOOD FLOW
TO THE FOLLICLE. O. Fainaru, M. Geva,
S. Hantisteanu, M. Michaeli, M. Hallak, A.
Ellenbogen. IVF Unit and Laboratory for
Reproductive Immunology, Obstetrics and
Gynecology, Hillel Yaffe Medical Center,
Hadera, Israel.
P-323NON-SYNONYMOUS SINGLE NUCLEOTIDE
POLYMORPHISM IN MCM8 DECREASED IN A
COHORT OF PREMATURE OVARIAN FAILURE
PATIENTS. E. M. Munch1, Q. Liu1, A. Balasa1,
W. E. Gibbons1, J. L. Simpson2, E. Kovanci1.
1
Obstetrics & Gynecology, Baylor College
of Medicine, Houston, TX; 2Obstetrics &
Gynecology, Florida International University,
Miami, FL.
P-324MECHANISM OF BENZO[a]PYRENE-INDUCED
INHIBITION OF FOLLICLE GROWTH. J.
C. Sadeu, W. Foster. Obstetrics and
Gynecology, McMaster University, Hamilton,
ON, Canada.
P-316HIGH PREVALENCE OF HYPOGONADISM,
OBESITY AND HYPERTENSION IN PATIENTS
PRESENTING TO AN ANDROLOGY CLINIC. A.
Mehta, P. Stahl, D. A. Paduch. Urology, Weill
P-317EMBRYO MORPHOKINETICS IS NOT AFFECTED
BY FEMALE OBESITY. J. Bellver, A. Mifsud,
N. Grau, J. M. De los Santos, L. Privitera,
M. Meseguer. Instituto Valenciano de
Infertilidad, Valencia, Spain.
__________________________________________________________
Ovarian Function
P-318EFFECTS OF PIOGLITAZONE ON FOLLICULAR
DEVELOPMENT AND STEROIDOGENESIS IN IN
VITRO MOUSE PREANTRAL FOLLICLE CULTURE.
S. Hara, T. Takahashi, K. Matsuo, H. Igarashi,
H. Kurachi. Department of Obstetrics and
Gynecology, Yamagata University Faculty
of Medicine, Yamagata, Japan.
P-319POST-GENOMIC MOLECULAR FINGERPRINTS
AND THEIR ASSOCIATION TO POOR
OVARIAN RESPONSE IN WOMEN SUBMITTED
TO IVF. T. Regiani1, L. do V. T. da Costa1,
E. J. Pilau2, R. P. Bertolla2, F. C. Gozzo2, E.
G. Lo Turco1. 1Surgery/Urology-Human
Reproduction Section, São Paulo Federal
University, São Paulo, SP, Brazil; 2Organic
Chemistry, Institute of Chemistry, Campinas,
SP, Brazil.
P-320RADIXIN REGULATES GAMMAAMINOBUTYRIC ACID-A RECEPTORS IN
HUMAN GRANULOSA CELLS. L. Hou, T.
M. Yalcinkaya. Dept. of Obstetrics and
Gynecology, Wake Forest School of
Medicine, Winston-Salem, NC.
P-321FMR1 GENE CGG REPEAT NUMBER
VARIATION WITHIN THE NORMAL RANGE
IS NOT PREDICTIVE OF EMBRYONIC
ANEUPLOIDY RATE (AR) IN IVF. K. H. Hong1,2,
B. Devkota1, E. Forman1, O. Bendarsky1,
N. Treff1, R. Scott1. 1Reproductive
2
Medical School, New Brunswick, NJ.
P-325MUTATIONS IN MITOCHONDRIAL HISTIDYL
tRNA SYNTHETASE (HARS2) IS NOT
ASSOCIATED WITH PREMATURE OVARIAN
FAILURE IN A COHORT OF 69 PATIENTS. Q.
Liu1, S. K. Mahadevan1, W. E. Gibbons1, J.
L. Simpson2, E. Kovanci1. 1Ob&Gyn, Baylor
College of Medicine, Houston, TX; 2March of
Dimes Foundation, White Plains, NY.
__________________________________________________________
Polycystic Ovary Syndrome
P-326EFFECT OF CALCIUM AND VITAMIN D
SUPPLEMENTATION ON FOLLICULAR
FLUID TUMOR NECROSIS-ALPHA AND
INTERLEUKIN-6 AND IVF/ICSI OUTCOMES IN
INFERTILE PATIENTS WITH POLYCYSTIC OVARY
SYNDROME. S.-Y. Choi1, C. H. Kim1, J.-W.
Ahn2, S.-K. Kwon1, K.-H. Lee1, B.-M. Kang1.
1
Obstetrics and Gynecology, College of
Medicine, University of Ulsan, Asan Medical
Center, Seoul, Korea; 2Obstetrics and
Gynecology, College of Medicine, Ulsan
University Hospital, Ulsan, Korea.
P-327ESTROGEN RECEPTOR AND TGFbeta
SIGNALING PATHWAYS ARE ALTERED IN
CUMULUS CELLS ISOLATED FROM MATURE MII
OOCYTES FROM PATIENTS WITH POLYCYSTIC
OVARY SYNDROMEβ. H. Dechaud, D.
Haouzi, S. Assou, C. Monzo, S. Hamamah.
CHU Montpellier-Hôpital St-Eloi, IRB-Inserm
U1040, Montpellier, Lanquedoc-Roussillon,
France.
P-328A COMPARISON OF IN-VITRO MATURATION
VERSUS ANTAGONIST PROTOCOLS FOR
IN-VITRO FERTILIZATION IN WOMEN WITH
POLYCYSTIC OVARIAN SYNDROME. T.
Shavit, O. Fainaru, R. Atamny, M. Michaeli,
114
University, Tekirdag, Turkey; 3Obstetrics and
Gynecology, Harvard Medical School,
Boston, MA; 4Family Health, Nakim Kemal
University, Tekirdag, Turkey; 5Obstetrics and
Gynecology, Istanbul University, Istanbul,
Turkey.
E. Kartchovsky, A. Ellenbogen. IVF Unit,
Obstetrics and Gynecology Department,
Hillel-Yaffe Medical Center, Hadera, Israel.
P-329EXERCISE TRAINING IMPROVES CUTANEOUS
MICROVASCULAR NITRIC OXIDE
DYSFUNCTION IN WOMEN WITH POLYCYSTIC
OVARIAN SYNDROME. V. S. Sprung1, D. J.
Green1, D. J. Cuthbertson2, N. M. D. Aziz3,
N. T. Cable1, H. Jones1. 1Research Institute
for Sport and Exercise Sciences, Liverpool
John Moores University, Liverpool, United
Kingdom; 2Department of Obesity &
Endocrinology, University Hospital Aintree,
Liverpool, United Kingdom; 3Department of
Gynaecology, Liverpool Women’s Hospital,
Liverpool, United Kingdom.
P-330IVF COMPARISON OF ART OUTCOMES
IN INFERTILE PCOS WOMEN; IN VITRO
MATURATION (IVM) VS. GnRH AGONIST vs.
GnRH ANTAGONIST CYCLES. M. H. Choi,
H. O. Kim, S. W. Cha, M. K. K. Koong, J. Y.
Kim, C. W. Park. Division of Reproductive
Endocrinology and Infertility, Department
Obstetrics and Gynecology, Cheil General
Hospital, Kwandong University College of
Medicine, Seoul, Korea.
P-331ANGIOGENIC FACTOR DYSREGULATION
IN POLYCYSTIC OVARIAN SYNDROME
(PCOS) DURING CONTROLLED OVARIAN
STIMULATION. R. Tal1, D. B. Seifer1, A.
Shohat-Tal2, R. V. Grazi1, H. E. Malter1.
1
Genesis Fertility & Reproductive Medicine,
Maimonides Medical Center, Brooklyn, NY;
2
Department of Biology, Brooklyn College,
City University of New York, Brooklyn, NY.
P-332NOVEL CARDIOVASCULAR DISEASE (CVD)
RISK FACTORS ELEVATED IN YOUNG WOMEN
WITH PCOS – POSSIBLE LINK BETWEEN
NEFA AND ANDROGENS IDENTIFIED. A.
Roe1, S. Butts1, M. Smith1, D. Rader2, A.
Dokras1. 1Department of Obstetrics and
Endocrinology, Philadelphia, PA; 2Division
of Translational Medicine and Human
Genetics, Philadelphia, PA.
P-333ANTI-MULLERIAN HORMONE IS ELEVATED
SYNDROME BUT IS UNALTERED FOLLOWING
hCG STIMULATION. H. Cook-Andersen, S.
S. Chuan, H. I. Su, R. J. Chang. Department
of Reproductive Medicine, University of
California, San Diego, La Jolla, CA.
P-334THE RELATIONSHIP BETWEEN COPPER,
HOMOCYSTEINE AND EARLY VASCULAR
DISEASE IN NON-OBESE WOMEN WITH
POLYCYSTIC OVARY SYNDROME. C.
Celik1, E. Bastu5, R. Abali1, S. Alpsoy2,
E. C. Guzel4, J. Yeh3. 1Obstetrics and
Gynecology, Nakim Kemal University,
Tekirdag, Turkey; 2Cardiology, Nakim Kemal
P-335THE UTILITY OF ANTI-MULLERIAN HORMONE
(AMH) MEASUREMENTS IN THE ASSESSMENT
OF OVARIAN RESERVE IN WOMEN WITH
POLYCYSTIC OVARIES (PCO). S. Keyhan1,
K. Ziebell1, R. Paulson2, S. Jabara1.
1
Kaiser Permanente LAMC, Los Angeles,
CA; 2University of Southern California, Los
Angeles, CA.
P-336EXPLORING THE ASSOCIATION OF VITAMIN
D3 DEFICIENCY WITH CLINICAL AND
BIOCHEMICAL PARAMETERS IN INDIAN
POLYCYSTIC OVARY SYNDROME (PCOS)
PATIENTS. S. M. Bhattacharya1,3, A. Jha2,
R. R. Roy3, N. Nandi3. 1Obstetrics and
Gynecology, S.C. DAS Memorial Medical
and Research Center, Kolkata, West
Bengal, India; 2Division of Epidemiology and
Communicable Diseases, Indian Council
of Medical Research, New Delhi, India;
3
Obstetrics and Gynecology, KPC Medical
College, Kolkata, West Bengal, India.
P-337TRANSVAGINAL OVARIAN DRILLING (TVOD)
FOR SEVERE POLYCYSTIC OVARY SYNDROME
(PCOS) PRIOR TO IN VITRO FERTILIZATION
(IVF) DRAMATICALLY IMPROVES IVF
OUTCOMES. A. K. Breborowicz2, M. D.
Keltz1, P. Chau2, D. Stein1, M. Lederman1,
E. Gonzales1. 1Continuum Reproductive
Center, Department of Obstetrics and
Gynecology, St. Lukes-Roosevelt Hospital
Center, Columbia College of Physicians
and Surgeons, New York, NY; 2Department
of Obstetrics and Gynecology, St. LukesRoosevelt Hospital Center, New York, NY.
P-338EFFECT OF OVARIAN PUNCTURE ON
CIRCULATING AMH LEVELS IN PATIENTS WITH
PCO/PCOS UNDERGOING IVM. C. OrtegaHrepich1, N. P. Polyzos1, E. Anckaert2, H.
Tournaye1, J. Smitz2, M. De Vos1. 1Center for
Reproductive Medicine, UZ Brussel, Brussels,
Belgium; 2Laboratory of Follicular Biology, UZ
Brussel, Brussels, Belgium.
P-339INCREASED PREVALENCE OF ENDOMETRIAL
POLYPS IN A VENEZUELAN POPULATION OF
PCOS WOMEN. L. A. Sanchez, M. Perez,
S. Valentina. Caracas Fertility Center.
Policlinica Metropolitana, Caracas,
Miranda, Venezuela.
P-340EPIGENETIC ALTERATION IN THE OFFSPRING
OF WOMEN WITH POLYCYSTIC OVARY
SYNDROME (PCOS) IS ASSOCIATED
WITH THE DOWN-REGULATION OF
DNA METHYLTRANSFERASES BY
115
HYPERANDROGENISM IN FOLLICLES. S. Tian,
X.-H. Lin, G.-F. Xu, W. Zhao, H.-F. Huang.
Reproductive Endocrinology, Women’s
Hospital, School of Medicine, Zhejiang
University, Hangzhou, Zhejiang, China.
P-341SERUM ANTI-MÜLLERIAN HORMONE LEVELS
(AMH) DECREASE AFTER METFORMIN
ADMINISTRATION IN WOMEN WITH BOTH
LEAN AND OVERWEIGHT POLYCYSTIC
OVARY SYNDROME (PCOS). M. SauerbrunCutler2, M. Lederman1, M. Keltz1, M. Lee2,
D. Stein1. 1Department of Obstetrics and
Gynecology, Continuum Reproductive
Center, St.Lukes-Roosevelt Hospital Center,
Columbia College of Physicians and
Surgeons, New York, NY; 2Department of
Obstetrics and Gynecology, St. LukesRoosevelt Hospital Center, New York, NY.
P-347EXPRESSION OF ENZYMES INVOLVED IN
LOCAL REGULATION OF SULFONATED
ESTROGENS IS DYSREGULATED IN
ENDOMETRIUM OF WOMEN WITH
ENDOMETRIOSIS VERSUS CONTROLS. C.
A. Piccinato1,2, R. M. Neme1,3, N. Torres1, H.
F. Brudniewski1,3, J. C. Rosa-e-Silva2, R. A.
Ferriani2. 1Hospital Albert Einstein, São Paulo,
SP, Brazil; 2Departamento de Ginecologia
e Obstetrícia, Faculdade de Medicina
de Ribeirão Preto - USP, Ribeirão Preto, SP,
Brazil; 3Centro de Endometriose São Paulo,
São Paulo, SP, Brazil.
P-348A SMALL-MOLECULE TRIPTOLIDE REGULATES
SURVIVAL AND MIGRATION OF STROMAL
CELLS FROM PATIENTS WITH ENDOMETRIOSIS.
J. Li, X. Liang. Reproductive Medicine
Research Centre, 6th Affiliated Hospital,
Sun Yat-sen University, Guangzhou,
Guangdong, China.
P-349EXPRESSION AND REGULATION OF
P21-ACTIVATED KINASE IN HUMAN
ENDOMETRIUM AND ENDOMETRIOSIS. S.
H. Kim, H. D. Chae, C. H. Kim, B. M. Kang.
Obstetrics & Gynecology, University of Ulsan
College of Medicine, Asan Medical Center,
Songpa-gu, Seoul, Korea.
P-350EFFECTS OF SMALL MOLECULE ANTAGONISTS
OF Tcf/BETA-CATENIN COMPLEX IN VITRO
ON ENDOMETRIOSIS. S. Matsuzaki1,2,3, C.
Darcha1, G. Mage1,2,3. 1CHU ClermontFerrand, Clermont-Ferrand, France;
2
Clermont Université, Université d’Auvergne,
ISIT UMR6284, Clermont-Ferrand, France;
3
CNRS, ISIT UMR6284, Clermont-Ferrand,
France.
P-351CHANGES IN EUTOPIC ENDOMETRIAL GENE
EXPRESSION DURING THE DEVELOPMENT
OF EXPERIMENTAL ENDOMETRIOSIS IN
THE BABOON. Y. Afshar1, J. Hastings2, D.
Roqueiro3, J.-W. Jeong4, L. Giudice5, A. T.
Fazleabas4. 1Department of Obstetrics and
Gynecology, Cedars-Sinai Medical Center,
Los Angeles, CA; 2Human Reproductive
Sciences Unit, Medical Research Council
Institute, Edinburgh, United Kingdom;
3
Department of Bioengineering, University
of Illinois, Chicago, IL; 4Center for Women’s
Health and Reproduction, Michigan
State University, Grand Rapids, MI;
5
CA.
P-342SERUM PLASMINOGEN-ACTIVATOR
INHIBITOR TYPE I (PAI-1) LEVEL IS INCREASED
IN PCOS WOMEN. C. W. Park, M. H. Choi,
M. K. Koong, H. O. Kim, J. Y. Kim, K. M. Yang.
and Infertility, Department Obstetrics
and Gynecology, Cheil General Hospital,
Kwandong University College of Medicine,
Seoul, Korea.
P-343RELATIONSHIP OF BODY MASS INDEX
AND INSULIN RESISTANCE TO DEGREE
OF HIRSUTISM IN POLYCYSTIC OVARY
SYNDROME (PCOS). E. I. Lewis1,2, T.
Hartshorn1,2, C. Holschneider1,2, K. M.
Brennan1,2. 1Obstetrics and Gynecology,
University of California Los Angeles, Los
Angeles, CA; 2Obstetrics and Gynecology,
Olive View UCLA, Sylmar, CA.
P-344INCREASED INSULIN-RESISTANCE AND
ß-CELL FUNCTION IN POLYCYSTIC OVARY
SYNDROME WOMEN STRATIFIED BY BODY
MASS INDEX AND WAIST-TO-HIP RATIO. I.
Sirota, D. E. Stein. Department of Obstetrics
and Gynecology, St. Luke’s Roosevelt
Hospital, New York, NY.
Clinical Center, Bethesda, MD; 4Program
NICHD/NIH, Bethesda, MD.
P-345THE IMPORTANCE OF FOLLICULAR
DISTRIBUTION IN THE POLYCYSTIC OVARY ON
MENSTRUAL IRREGULARITY. M. H. Dahan, B.
Goorah. McGill Repoductive Center, McGill
Unversity, Montreal, QC, Canada.
__________________________________________________________
Endometriosis
P-346CHANGES IN SELF-REPORTED SYMPTOMS
OF WOMEN WITH ENDOMETRIOSIS DURING
TREATMENT. O. Muneyyirci-Delale1,2, C.
Charles1, N. Sinaii3, J. Anopa1, M. Dalloul1, P.
Stratton4. 1Obstetrics and Gynecology, SUNY
2
Obstetrics and Gynecology, Kings County
Hospital Center, Brooklyn, NY; 3Biostatistics
& Clinical Epidemiology Service, NIH
116
P-352COMPARABILITY OF ENDOMETRIOSIS
DIAGNOSIS AND STAGING BY OPERATING
SURGEON AND EXPERT REVIEWER DURING
REAL-TIME LAPAROSCOPY IN THE ENDO
STUDY. J. B. Stanford1, K. C. Schliep1, Z.
Chen2, Y. Xie2, G. M. Buck Louis2, C. M.
Peterson3. 1Family and Preventive Medicine,
University of Utah, Salt Lake City, UT; 2Division
of Epidemiology, Statistics, and Prevention
Research, National Institute of Child Health
and Human Development, Rockville, MD;
3
Utah, Salt Lake City, UT.
P-353TYK2 VARIANT IS ASSOCIATED WITH
PROTECTION AGAINST ENDOMETRIOSISRELATED INFERTILITY IN BRAZILIAN WOmen.
C. Peluso, C. S. Goldman, F. A. Mafra, D.
M. Christofolini, C. P. Barbosa, B. Bianco.
Human Reproduction and Genetics Center,
Faculdade de Medicina do ABC, Santo
Andre, SP, Brazil.
P-354KRAS AND LCS6 SHOW NO EVIDENCE OF
ASSOCIATION WITH ENDOMETRIOSIS. K.
Ward, R. Chettier, P. Farrington, H. Albertsen.
Juneau Biosciences, LLC, Salt Lake City, UT.
P-355THE EXPRESSION STATUS OF G-PROTEIN
COUPLED ESTROGEN RECEPTOR
1 IS ASSOCIATED WITH CLINICAL
CHARACTERISTICS OF ENDOMETRIOSIS.
A. Tanabe, H. Yuguchi, A. Hayashi,
Y. Yamashita, K. Okuda, M. Ohmichi.
Obstetrics and Gynecology, Osaka Medical
College, Takatsuki, Osaka, Japan.
P-356PLASMA miRNAS AS NON-INVASIVE
BIOMARKERS FOR ENDOMETRIOSIS. V.
Nisenblat1,2, S. A. Robertson1, S. F. Evans3,
L. M. Hull1,2. 1Obstetrics and Gynaecology,
The Robinson Institute, Research Centre for
Reproductive Health, University of Adelaide,
Adelaide, SA, Australia; 2Obstetrics and
Gynaecology, The Women’s and Children’s
Hospital, North Adelaide, SA, Australia;
3
Obstetrics and Gynaecology, University of
Adelaide, Adelaide, SA, Australia.
P-357COMPARISON OF POST-OPERATIVE USE OF
LEVONORGESTREL-INTRAUTERINE SYSTEM
AND CYCLIC ORAL CONTRACEPTIVE
FOR PREVENTION OF ENDOMETRIOMA
RECURRENCE. Y. E. Jeon, J. A. Jung, S. K.
Seo, Y. S. Choi, S. Cho, B. S. Lee. Obstetrics
and Gynecology, Yonsei University College
of Medicine, Seoul, Korea.
P-359ABUSE IN CHILDHOOD AND RISK OF
ENDOMETRIOSIS. F. Wieser1, A. Vitonis2, J.
Rich-Edwards3, S. A. Missmer2. 1Gynecology
and Obstetrics, Emory University School
of Medicine, Atlanta, GA; 2Obstetrics,
Gynecology, and Reproductive Biology,
3
Connors Center for Women’s Health and
Gender Biology, Brigham and Women’s
Hospital and Harvard Medical School,
Boston, MA.
P-360THE COSTS OF ENDOMETRIOSIS: IT’S THE
ECONOMY, STUPID. T. D’Hooghe1, C.
D. Dirksen2, G. A. J. Dunselman3, A. de
Graaff3, W. E. R. F. EndoCost Consortium4,
S. Simoens5. 1Leuven University Fertility
Centre, University Hospitals Leuven,
Leuven, Belgium; 2Department of
Clinical Epidemiology and Medical
Technology Assessment, Maastricht
University Medical Centre, Maastricht,
Netherlands; 3Department of Obstetrics and
Gynaecology GROW - School for Oncology
and Developmental Biology, Maastricht
University Medical Centre, Maastricht,
Netherlands; 4World Endometriosis Research
Foundation, Endocost Consortium, London,
United Kingdom; 5Research Centre for
Pharmaceutical Care and Pharmacoeconomics, KU Leuven, Leuven, Belgium.
P-361HIGH PREVALENCE OF DEEP INFILTRATING
ENDOMETRIOSIS IN INFERTILE WOMEN
ATTENDING A TERTIARY INFERTILITY
CENTER – EVALUATION BY TRANSVAGINAL
ULTRASOUND. L. Chamié1, C. Gomes2,3, P.
Feetback2,3, M. Riboldi2, E. L. A. Motta2,4,
S. Paulo2,3. 1Chamié Imagem da Mulher,
Sao Paulo, SP, Brazil; 2Huntington Medicina
Reprodutiva, Sao Paulo, SP, Brazil;
3
Universidade de Sao Paulo - USP, Sao
Paulo, SP, Brazil; 4Universidade Federal de
Sao Paulo - UNIFESP, Sao Paulo, SP, Brazil.
P-362ABERRANT FOXP3 GENE EXPRESSION IN
EUTOPIC AND ECTOPIC ENDOMETRIUM OF
INFERTILE WOMEN WITH ENDOMETRIOSIS.
C. P. Barbosa, F. A. Mafra, E. B. Cordts, C.
Peluso, D. M. Christofolini, B. Bianco. Human
Reproduction and Genetics, Faculdade de
Medicina do ABC, Santo Andre, SP, Brazil.
P-363EXPRESSION AND POSSIBLE ROLE OF
RIBONUCLEOTIDE REDUCTASE SUBUNIT M2
(RRM2) IN ENDOMETRIOSIS. Y. E. Jeon1,
Y. Lee1, J. A. Jung2, S. K. Seo2, Y. S. Choi2,
S. Cho1. 1Obstetrics and Gynecology,
Gangnam Severance Hospital, Yonsei
Korea; 2Obstetrics and Gynecology,
Severance Hospital, Yonsei University
P-358MTHFR GENE POLYMORPHISMS (C677T,
A1298C AND G1793A) IN INFERTILE WOMEN
WITH ENDOMETRIOSIS AND ITS CORRELATION
WITH FOLLICULAR FLUID AND SERUM
HOMOCYSTEINE: PILOT STUDY. J. Teles, A.
dos Santos, J. Christofolini, A. Brandes, C.
Maftoum. Human Reproduction, FMABC,
Santo André, SP, Brazil.
117
P-364PROGNOSTIC VALUE OF THE REVISED
AMERICAN FERTILITY SOCIETY
CLASSIFICATION SYSTEM AND
PREOPERATIVE SERUM CA-125 LEVEL FOR
THE FIRST RECURRENCE OF ADVANCED
ENDOMETRIOSIS AFTER CONSERVATIVE
LAPAROSCOPY. B. R. Choi, Y. E. Jeon1, H. Y.
Kim3, S. K. Seo2, Y. S. Choi2, S. Cho1, B. S. Lee1.
1
Obstetrics and Gynecology, Gangnam
College of Medicine, Seoul, Republic
of Korea; 2Obstetrics and Gynecology,
College of Medicine, Seoul, Republic of
Korea; 3Obstetrics and Gynecology, Yongin
College of Medicine, Gyeonggi-Do,
Republic of Korea.
P-365REPLICATION OF ENDOMETRIOSIS GWAS
SIGNAL ACROSS MULTIPLE STUDIES SUPPORT
INVOLVEMENT OF WNT4. H. Albertsen, R.
Chettier, P. Farrington, K. Ward. Juneau
__________________________________________________________
P-371CLINICAL OUTCOME OF IVF-ET WITH
CONVENTIONAL COS IS UNALTERED BY THE
PRESENCE OF SERUM ANA WHEN LOW-DOSE,
SHORT-TERM CORTICOSTEROID REGIMEN IS
ADMINISTERED. C. Liao, X. Liang, R. Huang,
C. Fang, X. Yang, Y. Deng. Reproductive
Medicine Research Center, 6th Affiliated
Hospital, Sun Yat-sen University, Guangzhou,
Guangdong, China.
__________________________________________________________
Female Reproductive Tract
P-372DYSREGULATION OF MITOCHONDRIAL
DYNAMICS AND ACTIVATION OF THE
AUTOPHAGY CASCADE OCCUR IN A MOUSE
MODEL OF CIGARETTE SMOKE-INDUCED
OVARIAN FOLLICLE LOSS. A. M. Gannon1,2,
M. R. Stampfli1,3, W. G. Foster1,2. 1Faculty
of Health Sciences, McMaster University,
Hamilton, ON, Canada; 2Obstetrics and
Gynecology, McMaster University, Hamilton,
ON, Canada; 3Pathology and Molecular
Medicine, McMaster University, Hamilton,
ON, Canada.
P-373OBSTRUCTED HEMIVAGINA AND IPSILATERAL
RENAL ANOMALY (OHVIRA): DIAGNOSTIC
FEATURES AND MANAGEMENT OF A
FREQUENTLY MISDIAGNOSED SYNDROME.
M. S. Christianson1, M. M. Yates1, I. Woo1,
A. Khafagy2, J. E. Garcia1, L. A. Kolp1.
1
Gynecology and Obstetrics, Division
Infertility, Johns Hopkins Medical Institutions,
Lutherville, MD; 2Population, Family and
Reproductive Health, Johns Hopkins
Bloomberg School of Public Health,
Baltimore, MD.
P-366INCREASED CHEMERIN EXPRESSION IN
THE PERITONEAL FLUID AND ECTOPIC
ENDOMETRIUM OF WOMEN WITH
ENDOMETRIOSIS. K. W. Yi, H. T. Park, J.-H.
Shin, T. Kim, J.-Y. Hur, S. H. Kim. Obstetrics
and Gynecology, Korea university College
of medicine, Seoul, Korea.
P-367MYELOID CELL ALTERATIONS IN THE MOUSE
PLACENTA PRECEDE THE ONSET OF LABOR
AND DELIVERY. O. Fainaru, G. Paz, S.
Hantisteanu, M. Hallak, A. Ellenbogen.
IVF Unit and Laboratory for Reproductive
Immunology, Hadera, Israel.
P-368ALTERED SEX RATIO AMONGST WOMEN
PRESENTING WITH UNEXPLAINED
SECONDARY INFERTILITY. K. G. Phung,
C. Jones, G. Cheng, H. G. Huddleston.
P-369PRO-INFLAMMATORY EFFECTS OF SEMINAL
PLASMA ON HUMAN ENDOMETRIUM:
IMPLICATIONS FOR IMPLANTATION AND
HUMAN IMMUNODEFICIENCY VIRUS (HIV)
TRANSMISSION. B. A. Johnson1, J. Chen1, N.
Roan2, F. Barragan1, J. Irwin1, L. C. Giudice1.
1
Center for Reproductive Sciences,
University of California San Francisco,
San Francisco, CA; 2Gladstone Institute
of Virology, University of California San
P-370CHANGES IN CERVICAL NEUTROPHIL
ELASTASE LEVELS DURING THE MENSTRUAL
CYCLE. F. Tawara1, T. Nakayama2, N.
Kanayama3. 1Tawara IVF Clinic, ShizuokaCity, Shizuoka-ken, Japan; 2Shizuoka Kosei
Hospital, Shizuoka-City, Shizuoka-ken,
Japan; 3Obstetrics and Gynecology,
Hamamatsu University School of Medicine,
Hamamatsu-City, Shizuoka-ken, Japan.
P-374HUMAN OVIDUCTAL LACTOFERRIN SHOWS
A CYCLE-DEPENDENT EXPRESSION AND
MODULATES GAMETE INTERACTION IN VITRO.
S. Ghersevich1, C. Zumoffen1, M. Munuce1,
C. Morente2, A. Caille1. 1Laboratory of
Reproductive Studies, Area of Clinical
Biochemistry, School of Biochemical
and Pharmaceutical Sciences, National
University of Rosario, Rosario, Santa Fe,
Argentina; 2PROAR – Rosario Assisted
Reproduction Program, Rosario, Santa Fe,
Argentina.
__________________________________________________________
118
Imaging
P-375QUANTIFICATION OF BLOOD VOLUME AND
VASCULAR PERFUSION IN THE CORPUS
LUTEUM OF RHESUS MACAQUES DURING
THE MENSTRUAL CYCLE. C. V. Bishop1,
T. A. Molskness1, O. D. Slayden1,2, R. L.
Stouffer1,2. 1Division of Reproductive and
Primate Research Center, Beaverton,
OR; 2Department of Obstetrics and
Gynecology, Oregon Health & Science
University, Portland, OR.
P-376THE VALUE OF THREE-DIMENSIONAL
ULTRASOUND IN PREDICTION OF POOR
OVARIAN RESPONSE IN IN-VITRO
FERTILIZATION CYCLES. W. Y. Wong, C.
Haines. Obstetrics and Gynaecology,
Prince of Wales Hospital, Hong Kong.
P-377HOW REPRODUCIBLE ARE 2D FOLLICULAR
MEASUREMENTS? K. Servaes, D. Van
Schoubroeck, M. Welkenhuysen, T. M.
D’Hooghe, D. De Neubourg. Obstetrics and
Gynaecology, UZ Leuven, Leuven, Vlaams
Brabant, Belgium.
P-379HYSTEROSALPINGO-FOAM SONOGRAPHY
(HyFoSy), A NEW TECHNIQUE TO CONFIRM
PROXIMAL TUBAL OCCLUSION AFTER
TREATMENT OF A HYDROSALPINX BY
AN ESSURE® DEVICE PRIOR TO IN VITRO
FERTILIZATION (IVF). K. Dreyer1, V. Mijatovic1,
M. H. Emanuel2, P. G. A. Hompes1.
1
Department of Reproductive Medicine,
VU University Medical Center, Amsterdam,
Noord-Holland, Netherlands; 2Department
of Gynaecology and Obstetrics, Spaarne
Hospital, Hoofddorp, Noord-Holland,
Netherlands.
__________________________________________________________
College of Medicine, University of
Saskatchewan, Saskatoon, SK, Canada;
2
Lighthouse, ISCARE IVF, Prague, Czech
Republic; 3Center for Reproductive
Medicine, KRIOBANK, Bialystok, Poland;
4
Biometrics, Global Clinical R&D, Ferring
Pharmaceuticals, Copenhagen, Denmark;
5
Reproductive Health, Global Clinical R&D,
Ferring Pharmaceuticals, Copenhagen,
Denmark.
P-383PERSONALIZING EMBRYO TRANSFER (pET)
USING AN ENDOMETRIAL CUSTOMIZED
ARRAY AS DIAGNOSTIC AND THERAPEUTIC
STRATEGY IN PATIENTS WITH IMPLANTATION
FAILURE. M. Ruiz-Alonso1,2, D. Blesa1,2, P. DiazGimeno1, F. Vilella1, A. Pellicer1,2, C. Simon1,2.
1
IVI Investigación, Fundación IVI, Paterna,
Valencia, Spain; 2Product Development,
IVIOMICS S.L., Paterna, Valencia, Spain.
P-384ENDOMETRIAL THYROID AND VITAMIN D
SIGNALING PATHWAYS DURING OVARIAN
STIMULATION FOR ASSISTED REPRODUCTIVE
TECHNOLOGY (ART). L. Detti1, R. A.
Uhlmann1, N. M. Fletcher2, M. P. Diamond2,
G. M. Saed2. 1Obstetrics and Gynecology,
University of Tennessee Health Science
Center, Memphis, TN; 2Obstetrics and
Gynecology, Wayne State University,
Detroit, MI.
P-385INCREASED LEVELS OF INSULIN RESISTANCE,
PROLACTIN LEVELS, BMI AND ABDOMINAL
CIRCUMFERENCE IN INFERTILE WOMEN WITH
ENDOMETRIAL POLYPS; A CONTROLLED
CLINICAL TRIAL. L. A. Sanchez, V. Siero, M.
Perez. OB/GYN, Caracas Fertility Center.
Policlinica Metropolitana, Caracas,
Miranda, Venezuela.
P-386HIGH PROGESTERONE LEVEL ON hCG DAY
IMPAIRS GENE EXPRESSION PROFILE SHIFT
BETWEEN PRE-RECEPTIVE AND RECEPTIVE
SECRETORY PHASE OF ENDOMETRIAL
CELLS. C. Monzo1, D. Haouzi1, S. Assou1,
C. Vincens2, H. Dechaud1, S. Hamamah1.
1
CHU Montpellier-Hôpital St-Eloi, IRB-Inserm
U1040, Montpellier, Lanquedoc-Roussillon,
France; 2CHU Montpellier - Hôpital Arnaud
de Villeneuve, Service de GynécologieObstétrique, Montpellier, LanguedocRoussillon, France.
P-387TRANSCRIPTOMIC AND PROTEOMIC
ANALYSES OF HUMAN ENDOMETRIAL
RECEPTIVITY UNDER NATURAL CYCLE. D.
Haouzi, C. Hirtz, H. Dechaud, L. Tiers, S.
Lehmann, S. Hamamah. CHU MontpellierHôpital St-Eloi, IRB-Inserm U1040, Montpellier,
Lanquedoc-Roussillon, France.
Endometrium
P-381ENDOMETRIAL ACTIONS OF SELECTIVE
PROGESTERONE RECEPTOR MODULATOR
CDB-4124 (CDB). B. A. McAvey1, L. Zhu2,
S. Kuokkanen1, J. W. Pollard2. 1Obstetrics
and Gynecology & Women’s Health,
& Infertility, Montefiore Medical Center,
Bronx, NY; 2Developmental and Molecular
Biology, Specialized Cooperative Center
for the Study of Reproduction and Infertility
Research, Albert Einstein College of
Medicine, Bronx, NY.
P-382ENDOMETRIAL QUALITY AT THE END OF
CONTROLLED OVARIAN STIMULATION
PREDICTS ONGOING PREGNANCY RATE
AFTER TRANSFER OF A SINGLE EXPANDED
OR HATCHING/HATCHED BLASTOCYST
ON DAY 5 IN A FRESH CYCLE. R. A.
Pierson1, M. Mrázek2, W. Kuzcynski3,
B. M. Klein4, J.-C. Arce5. 1Obstetrics
119
P-388METALLOTHIONEIN-1 AND -3 EXPRESSION
IN HUMAN ENDOMETRIUM IS REGULATED
BY ZINC AND CADMIUM CHLORIDE. M.
S. Krause1, M. Li2, A. Garza-Cavazos2,
J. R. Loret de Mola2, M. E. McAsey2.
1
Obstetrics, Gynecology and Women’s
Health, University of Louisville, Louisville,
KY; 2Obstetrics and Gynecology, Southern
Illinois University, Springfield, IL.
__________________________________________________________
Female Reproductive Surgery
P-389IMPACT OF A WARM, HUMIDIFIED CO2
PNEUMOPERITONEUM ON THE SURGICAL
PERITONEAL ENVIRONMENT. S. Matsuzaki1,2,3,
R. Botchorishvili1,2,3. 1CHU Clermont-Ferrand,
Clermont-Ferrand, France; 2Clermont
Université, Université d’Auvergne, ISIT
UMR6284, Clermont-Ferrand, France; 3CNRS,
ISIT UMR6284, Clermont-Ferrand, France.
P-390STATE-MANDATED INSURANCE
COVERAGE IMPACTS THE APPROACH TO
HYDROSALPINGES PRIOR TO IVF. K. R.
Omurtag1, N. M. Grindler1, G. W. Bates2,
A. Beltsos3, R. R. Odem1, E. Jungheim1.
1
Obstetrics and Gynecology, Division of
Washington University St. Louis School of
Medicine, St Louis, MO; 2Obstetrics and
Endocrinology and Infertility, University
Alabama-Birmingham School of Medicine,
Birmingham, AL; 3Fertility Centers of Illinois,
Chicago, IL.
P-391RCT – COMPARING BUPIVICAINE
ADMINISTRATION IN LAPAROSCOPIC
GYNECOLOGIC SURGERY USING EITHER A
PRE-INCISION OR POST-CLOSURE INJECTION.
T. Singer, J. Y. Huang, M. Joseph, R. E.
Stubbs, G. L. Schattman, Z. Rosenwaks. The
Infertility -Obstetrics and Gynecology, Weill
P-392EFFECTS OF VAGINAL MISOPROSTOL
APPLICATION BEFORE OFFICE
HYSTEROSCOPY. E. Bastu1, C. Celik2, A.
Nehir1, M. Dogan1, F. Gungor-Ugurlucan1,
B. Ergun1. 1Department of Obstetrics and
Gynecology, Istanbul University School of
Medicine, Istanbul, Turkey; 2Department of
Obstetrics and Gynecology, Namik Kemal
University School of Medicine, Tekirdag,
Turkey.
P-393SINGLE PORT LAPAROSCOPIC
MYOMECTOMY: CLINICAL EXPERIENCE AND
FEASIBILITY. H. J. Ahn1, C. S. Suh1,2, S. H. Kim2.
1
Obstetrics and Gynecology, Seoul National
University Bundang Hospital, Seongnam,
Gyeonggido, Republic of Korea; 2Obstetrics
and Gynecology, Seoul National University
College of Medicine, Seoul, Republic of
Korea.
P-394WHAT IS A POWDER BURN? A. M. Page,
L. Detti, D. C. Martin, V. M. Feldbaum, A.
Azari. Obstetrics and Gynecology, University
of Tennessee Health Science Center,
Germantown, TN.
P-395PREGNANCY OUTCOMES FOLLOWING
MYOMECTOMY WITH PLACEMENT OF
POLYTETRAFLUOROETHYLENE ADHESION
BARRIER. J. L. Eaton, M. P. Milad. Division of
Northwestern University Feinberg School of
Medicine, Chicago, IL.
__________________________________________________________
Leiomyoma
P-396EXPRESSION AND PHOSPHORYLATION OF
KEY FOCAL ADHESION PROTEINS DIFFERS IN
UTERINE LEIOMYOMATA AND MYOMETRIUM,
AND IS ALTERED BY TREATMENT WITH
ULIPRISTAL ACETATE. S. Chang1, P. H.
Driggers1, M. Malik2, Q. Wei1, J. H. Segars1.
1
Human Development, National Institutes
of Health, Bethesda, MD; 2Obstetrics and
Gynecology, Uniformed Services University
of the Health Sciences, Bethesda, MD.
P-397IS PRE-ART HYSTEROSCOPIC MYOMECTOMY
COST-EFFECTIVE IN WOMEN WITH
SUBMUCOUS (SM) FIBROIDS SEEKING
ART? K. Devine1, S. Mumford2, J. Segars1,
A. Y. Armstrong1. 1Program in Adult and
Reproductive Endocrinology, NICHD,
National Institutes of Health, Bethesda,
MD; 2Epidemiology Branch, Division of
Epidemiology, Statistics, and Prevention
Research, NICHD, National Institutes of
P-398LONG-TERM MORTALITY FOLLOWING
HYSTERECTOMY FOR UTERINE LEIOMYOMAS:
A COHORT STUDY FROM THE ROCHESTER
EPIDEMIOLOGY PROJECT. Z. Khan1, S. K.
Laughlin-Tommaso1, A. L. Weaver2, C. L.
Schleck2, W. A. Rocca3, E. A. Stewart1.
1
& Infertility, Department of Obstetrics &
Gynecology, Mayo Clinic, Rochester,
MN; 2Department of Biomedical Statistics
& Informatics, Mayo Clinic, Rochester,
MN; 3Department of Neurology and
Epidemiology, Mayo Clinic, Rochester, MN.
P-399DIFFERENTIAL EXPRESSION OF CHROMATIN
MODIFYING PROTEINS BETWEEN FIBROID
TUMOR LESIONS VERSUS ADJACENT
MYOMETRIUM SUGGESTS INVOLVEMENT OF
THE EPIGENOME IN FIBROID BIOLOGY. C.
Sharan, S. Nair, S. Halder, S. Maitra, A. AlHendy. Obstetrics and Gynecology, CWHR,
Meharry Medical College, Nashville, TN.
120
P-400
AFRICAN AMERICAN WOMEN HAVE
SIGNIFICANTLY INCREASED FIBROID
SYMPTOMS: RESULTS OF A NATIONAL
SURVEY. E. A. Stewart1, W. K. Nicholson2,
L. Bradley3, B. J. Borah1. 1Obstetrics and
Gynecology and Health Sciences Research,
Mayo Clinic, Rochester, MN; 2Obstetrics
Carolina, Chapel Hill, NC; 3Obstetrics and
Gynecology, Cleveland Clinic, Cleveland,
OH.
P-401LIAROZOLE REDUCES TGF-b3 MEDIATED
FIBROSIS IN 2-DIMENSIONAL AND
3-DIMENSIONAL LEIOMYOMA CULTURES.
G. Levy1,2, M. Malik2, J. Britten2, M. Gilden2,
J. H. Segars1, W. H. Catherino1,2. 1Program
in Reproductive and Adult Endocrinology
Bethesda, MD; 2Department of Ob/Gyn,
Uniformed Services University of the Health
Sciences, Bethesda, MD.
P-402EPIGENOME & UTERINE FIBROIDS: DISTINCT
PATTERNS OF CHROMATIN MODIFYING
GENES IN HUMAN MYOMETRIAL STEM
CELLS FROM NORMAL VERSUS FIBROID
UTERI. S. Nair, C. Sharan, S. Halder, S.
Maitra, W. Khoder, A. Al-Handy. Obstetrics
Gynecology, CWHR, Meharry Medical
College, Nashville, TN.
P-403UTERINE FIBROIDS ARE CHARACTERIZED
BY AN IMPAIRED ANTIOXIDANT CELLULAR
SYSTEM: POTENTIAL ROLE OF HYPOXIA IN
THE PATHOPHYSIOLOGY OF FIBROIDS. N. M.
Fletcher1, A. Al-Hendy2, M. Diamond1, G. M.
Saed1. 1Obstetrics and Gynecology, Wayne
State University School of Medicine, Detroit,
MI; 2Obstetrics and Gynecology, Meharry
Medical College, Nashville, TN.
G. Osteen2, W. Khoder1, A. Chaudhry1, A.
Al-Hendy1. 1Department of Obstetrics and
Gynecology, CWHR, Meharry Medical
College, Nashville, TN; 2Department of
Obstetrics and Gynecology, Vanderbilt
University Medical Center, Nashville, TN.
P-408MIFEPRISTONE, A CLINICALLY EFFECTIVE
LEIOMYOMA THERAPY, DIRECTLY REGULATES
FIBROSIS IN HUMAN 3-DIMENSIONAL
CULTURES. W. H. Catherino1,2, M. Malik1, J.
Britten1, G. Levy1,2, M. Gilden1. 1Obstetrics
and Gynecology, Uniformed Services
University of the Health Sciences, Bethesda,
__________________________________________________________
Sexuality
P-409WOMEN’S VIEWS ON FERTILITY AND
CONCEPTION IN FIVE COUNTRIES. S.
Johnson1, L. Foster2, F. Humberstone1.
1
Scientific and Medical Affairs, SPD
Development Company Ltd, Bedford,
Beds, United Kingdom; 2SPD Swiss Precision
Diagnostics GmbH, Geneva, Switzerland.
__________________________________________________________
P-404THE EFFECT OF TIME INTERVAL BETWEEN
HYSTEROSCOPIC SUBMUCOUS FIBROID
RESECTION (SMR) AND SUBSEQUENT IN VITRO
FERTILIZATION (IVF) CYCLE ON PREGNANCY
OUTCOMES. L. Meyer, M. Noel, D. E.
Reichman, G. Schattman, Z. Rosenwaks.
Ronald O Perelman and Claudia Cohen
Infertility, Weill Cornell Medical College,
New York, NY.
Nutrition
P-405TREATMENT OF UTERINE FIBROIDS
WITH HIGHLY PURIFIED CLOSTRIDIAL
COLLAGENASE. F. L. Jayes1,2, X. Ma1, P. C.
Leppert1,2. 1Obstetrics and Gynecology,
Duke School of Medicine, Durham, NC;
2
Pathology, Duke School of Medicine,
Durham, NC.
P-406VITAMIN D3 REGULATES BETA-CATENIN
PROTEIN EXPRESSION IN HUMAN FIBROID
CELLS: IMPLICATIONS FOR Med12 ROLE IN
FIBROID PATHOGENESIS. S. K. Halder1, K.
P-407RAPAMYCIN, WHICH INHIBITS ESTRADIOLMEDIATED LEIOMYOMA CELL PROLIERATION,
HAS MINIMAL IMPACT ON FIBROSIS IN
HUMAN 3-DIMENSIONAL CULTURES. W. H.
Catherino1,2, M. Malik1, J. Britten1, M. Gilden1.
1
Obstetrics and Gynecology, Uniformed
Services University of the Health Sciences,
Bethesda, MD; 2Program in Reproductive
P-410DOES DIETARY PROTEIN AND
CARBOHYDRATE INTAKE INFLUENCE
BLASTOCYST DEVELOPMENT AND
PREGNANCY RATES? J. B. Russell, C.
Abboud, A. Williams, M. Gibbs, S. Pritchard,
D. Chalfant. Division of Reproductive
Endocrinology and Infertility, Christiana
Care Health Systems, Newark, DE.
P-411PROTEIN INTAKE AND EARLY IN-VITRO
FERTILIZATION OUTCOMES. D. S. Colaci1,
A. J. Gaskins1, D. Wright2, J. C. Petrozza2, R.
Hauser1, J. E. Chavarro1. 1Harvard School of
Public Health, Boston, MA; 2Massachusetts
__________________________________________________________
121
Mental Health
P-412RATES OF MAJOR DEPRESSION FOLLOWING
IVF FAILURE. S. R. Holley1, M. R. Passoni1, R.
D. Nachtigall2, M. E. Bleil3, N. E. Adler3, L. A.
Pasch3. 1Psychology, San Francisco State
University, San Francisco, CA; 2Obstetrics,
Francisco, CA; 3Psychiatry, University of
CA.
P-413AN UNACKNOWLEDGED LOSS: THE
EXPERIENCE OF PERMANENT, UNINTENTIONAL
CHILDLESSNESS FOR WOMEN WHO DELAYED
CHILDBEARING. E. Koert. Educational and
Counselling Psychology, University of British
Columbia, Vancouver, BC, Canada.
P-414THE INFLUENCE OF WORKING STATUS
AND REGULAR EXERCISE ON IN VITRO
FERTILIZATION OUTCOMES. H.-G. Sun1, K. H.
Lee1, I. H. Park1, S. G. Kim1, Y. Y. Kim1, G.-H.
Jeon2. 1Mamapapa & Baby OB&GY, Ulsan,
Republic of Korea; 2OB/GY, Inje University,
Haeundae Paik Hospital, Busan, Republic of
Korea.
P-415PSYCHOSOCIAL ISSUES IN FEMALE FERTILITY
PRESERVATION PATIENTS. A. K. Lawson1,
S. C. Klock1, M. E. Pavone1, J. HirshfeldCytron2, K. N. Smith1, R. R. Kazer1. 1Obstetrics
and Gynecology, Northwestern University,
Chicago, IL; 2Obstetrics and Gynecology,
University of Illinois-Chicago, IL.
P-420FERTILITY DISCUSSIONS IN THE US: PATIENT
AND OBSTETRICIAN/GYNECOLOGIST (OB/
GYN) PERSPECTIVES. F. F. Velez1, C. Link2,
A. Baxter-Bendus1, N. C. Edwards3, B. L.
Collura4, B. Kaplan5. 1EMD Serono, Inc.,
Rockland, MA; 2Healthcare Research, Harris
Interactive, New York, NY; 3Health Services
Consulting Corporation, Boxborough, MA;
4
RESOLVE: The National Infertility Association,
McLean, VA; 5Fertility Centers of Illinois,
Highland Park, IL.
P-421WHO ARE THE PEDIATRIC AND ADOLESCENT
GYNECOLOGIC (PAG) PATIENTS PRESENTING
TO AN ACADEMIC UNIVERSITY-BASED
REPRODUCTIVE ENDOCRINOLOGY
AND INFERTILITY (REI) PRACTICE? B.
McAvey1, J. Younger1, E. Hawkins2, S. E.
Pollack1. 1Obstetrics and Gynecology &
Women’s Health, Division of Reproductive
Endocrinology & Infertility, Montefiore
Medical Center and Albert Einstein College
of Medicine, Bronx, NY; 2Obstetrics and
Gynecology, North Shore University Hospital,
Manhasset, NY.
P-422SUCCESFUL MANAGEMENT OF
NONTUBAL ECTOPIC PREGNANCIES WITH
CONSERVATIVE AND MINIMALLY INVASIVE
TREATMENT. M. Gualtieri, D. English, K.
F. Brookfield, U. Verma. Obstetrics and
Gynecology, University of Miami- Jackson
Memorial Hospital, Miami, FL.
P-423A SHARED RISK (SR) REFUND PROGRAM FOR
IN VITRO FERTILIZATION (IVF) TREATMENT
RECEIVES STRONG ENDORSEMENT FROM
PARTICIPANTS. L. L. Libfraind1, K. S. Richter2,
E. F. Wolff1, K. Geddes2, M. J. Levy2. 1National
Institute of Health, Bethesda, MD; 2Shady
P-424REAPPRAISAL OF BASAL BODY TEMPERATURE
(BBT) MEASUREMENT IN INFERTILITY
TREATMENT – DOES IT HAVE ANY EFFCTS
ON COUPLES SEEKING PREGNANCY? A
PROSPECTIVE COHORT STUDY. S. Furuya,
T. Kagawa. Obstetrics & Gynecology,
Kubonoya Ob/Gyn Clinic, Kashiwa City,
Chiba Prefecture, Japan.
P-416DISCLOSURE PATTERNS OF FAMILIES
CONFORMED BY OOCYTE DONATION IN
ARGENTINA. A. Nabel, D. O. Fernandez, B.
Riestra Marteleur, M. F. Ugozzoli Llugdar, S. D.
Papier, C. E. Sueldo. CEGyR, Buenos Aires,
Argentina.
P-417TICK TOCK: CAN THE CLOCK BE
STOPPED? THE USE OF ELECTIVE OOCYTE
CRYOPRESERVATION (EOC) AS A MEANS
TO PRESERVE FERTILITY (PF). B. Hodes-Wertz,
S. Druckenmiller, M. Smith, N. Noyes. NYU
Fertility Center, New York, NY.
__________________________________________________________
Practice Management
P-418USING SOCIAL MEDIA IN AN INFERTILITY
POPULATION: A PRELIMINARY REPORT. L. G.
Mickey, R. L. Flyckt, E. Soto, M. Catenacci, J.
Goldberg. Reproductive Endocrinology and
Infertility, Cleveland Clinic Fertility Center,
Beachwood, OH.
P-419THE REPRODUCTIVE ENDOCRINOLOGY AND
INFERTILITY MATCH: A SURVEY OF THE 2011
APPLICANT POOL. A. S. Q. Kathiresan1, Y.
Cruz-Almeida2, R. Valthaty1, D. I. Hoffman3,
W. S. Maxson3, S. J. Ory3. 1Department of
of Miami, Miami, FL; 2University of Florida,
Gainesville, FL; 3IVF Florida, Margate, FL.
P-425IVF INSURANCE COVERAGE AND DONOR
OOCYTE RECIPIENTS. S. B. Schon1, M. M.
B. Schulte1, B. Hamilton2, R. R. Odem1, E. S.
Jungheim1. 1Department of Obstetrics and
Gynecology, Washington University in St.
Louis, Saint Louis, MO; 2Olin Business School,
Washington University in St. Louis, Saint Louis,
MO.
__________________________________________________________
122
Environment and Toxicology
P-432INCREASED CIRCULATING LEVELS OF
OXIDATIVE STRESS MARKERS IN THE DAY OF
OOCYTE RETRIEVAL OF INFERTILE WOMEN
WITH AND WITHOUT ENDOMETRIOSIS
SUBMITTED TO OVARIAN STIMULATION. M.
G. Da Broi, V. S. I. Giorgi, M. B. Palhares
Jr, W. P. Martins, L. A. Dib. Department of
Obstetrics and Gynecology, Faculty of
Medicine of Ribeirao Preto, University of Sao
Paulo, Ribeirão Preto, SP, Brazil.
P-433OXIDATIVE STRESS ADDUCTS (OSA): IMPACT
ON SPERM DNA INTEGRITY. R. Sethi1, E.
Tirado2, K.-H. N. Nguyen1, B. Barret1, D.
Sakkas1. 1Boston IVF, Harvard Medical
School, Waltham, MA; 2ReproSource,
Woburn, MA.
P-426EFFECT OF FEMALE SMOKING STATUS ON
ZONA PELLUCIDA THICKNESS. T. Freour, J.
Lammers, C. Splingart, S. Lattes, P. Barriere.
Medecine et Biologie de la Reproduction,
University Hospital of Nantes, Nantes,
France.
__________________________________________________________
Oxidative Stress
P-427EXPRESSION OF LIPID OXIDATIVE STRESSRELATED GENE ALDH3A2 (ALDEHYDE
DEHYDROGENASE 3 FAMILY, MEMBER A2)
IN HUMAN GRANULOSA-LUTEIN (GL) CELLS
CORRELATES WITH FSH RESPONSE AND
PREGNANCY. A. Palumbo2,3, R. GonzalezFernandez1, O. Peña1, J. Hernandez2, J.
Avila1. 1Bioquimica y Biologia Molecular,
Universidad de La Laguna, La Laguna,
Santa Cruz de Tenerife, Spain; 2Centro de
Asistencia a la Reproducción Humana
de Canarias, La Laguna, Santa Cruz
de Tenerife, Spain; 3Obstetrics and
Gynecology, New York University, New York,
NY.
P-428SPHINGOSINE-1-PHOSPHATE INHIBITS
HYDROGEN PEROXIDE-INDUCED
GRANULOSA CELL APOPTOSIS VIA THE PI3K/
AKT SIGNALING PATHWAY. T. Nakahara, A.
Iwase, M. Kondo, T. Nakamura, M. Goto, F.
Kikkawa. Departments of Obstetrics and
Gynecology, Nagoya University Graduate
School of Medicine, Nagoya, Aichi, Japan.
P-429IDENTIFICATION OF SEMINAL PLASMA
PROTEINS IN MEN WITH OXIDATIVE STRESS
UTILIZING PROTEOMIC TOOLS. R. Sharma1,
A. Agarwal1, A. J. Hamada1, S. S. Du Plessis2,
S. P. Yadav1, E. Sabanegh Jr1. 1Center
of Reproductive Medicine, Cleveland
Clinic, Cleveland, OH; 2Division of Medical
Physiology, Stellenbosch University,
Tygerberg, South Africa.
P-430SPINDLE TRANSFER CAN RESTORE
DEVELOPMENTAL CAPABILITY OF
MAMMALIAN OOCYTES DAMAGED BY
OXIDATIVE STRESS. M. Kobayashi, T.
Takeuchi, A. Yoshida. Kiba Park Clinic
Research Center, Koto, Tokyo, Japan.
P-431WHAT IS THE PLACE OF OXIDATIVE
STRESS TEST IN PREDICTION OF CLINICAL
PREGNANCY IN ART CYCLES? O. Ozatik1,
Y. Aydin1, H. Hassa1, D. Ulusoy Karatopuk2,
S. Ogut2, F. Mutlu1. 1Eskisehir Osmangazi
University, Eskisehir, Turkey; 2Isparta Suleyman
Demirel University, Isparta, Turkey.
P-434SERUM AND FOLLICULAR OXIDATIVE STRESS
BIOMARKERS LEVELS AND RESPONSE TO
(COH) IN IVF CYCLES. M. B. Palhares Junior1,
G. S. Romão2, M. G. Da Broi1, W. de P.
Martins1, A. A. Jordão Junior1. 1Obstetrics
and Gynecology, Faculty of Medicine of
Ribeirão Preto - University of São Paulo,
Riberião Preto, SP, Brazil; 2Medicine, Federal
University of São Carlos, São Carlos, SP,
Brazil.
__________________________________________________________
Male Factor
P-435EXPRESSION OF PARP1 IN INFERTILE MEN AND
CORRELATION WITH DNA FRAGMENTATION
INDEX. S. Mishra1, K. Mohanty1, J. Pani1, T.
Hasan1, R. Kumar2, R. Dada1. 1Anatomy, All
India Institute of Medical Sciences, New
Delhi, Delhi, India; 2Urology, All India Institute
of Medical Sciences, New Delhi, Delhi,
India.
P-436EFFECTS OF MICROSURGICAL
VARICOCELECTOMY ON HUMAN SPERM
DNA FRAGMENTATION, DISTRIBUTION OF
NUCLEAR SULFHYDRYL GROUPS AND SPERM
MATURATION: A PROSPECTIVE TRIAL. N.
Alhathal, M. San Gabriel, A. Zini. Division
of Urology, Department of Surgery, McGill
University, Montreal, QC, Canada.
P-437MEN OLDER THAN 34 HAVE INCREASED
RISK OF SPERM CHROMATIN DAMAGE
IN EJACULATED SPERM AS MEASURED
USING TUNEL ASSAY. D. A. Paduch1,2, A.
Bolyakov1,2, J. Kiper1, J. Bazarnik1. 1Urology
and Reproductive Medicine, Weill Cornell
Medical College, New York, NY; 2Consulting
Research Services, Inc, Jersey City, NJ.
P-438COMPUTER-ASSISTED OBJECTIVE
EVALUATION OF SPERM-CONTAINING
SEMINIFEROUS TUBULE IN TESTICULAR SPERM
RETRIEVALS. S. Verza Jr, S. C. Esteves.
Androfert, Campinas, SP, Brazil.
123
P-439PATERNAL AGE AND SPONTANEOUS
ABORTION AFTER IVF WITH DONOR EGGS. R.
Medina, M. T. Urbina, I. Benjamín, J. LernerBiber, M. T. Alvarez. Unifertes, Caracas,
Miranda, Venezuela.
P-440CHANGES IN DNA FRAGMENTATION DURING
SPERM PREPARATION FOR ICSI AT VARIABLE
TIME PERIODS. N. Rougier1,2, H. Uriondo1, F.
Nodar1, S. Papier1, C. Sueldo3, C. Alvarez
Sedó1. 1CEGYR (Centro de Estudios en
Ginecología y Reproducción), Capital
Federal, Buenos Aires, Argentina; 2UAB
(Autonomous University of Barcelona),
Cerdanyola del Vallès, Barcelona,
Spain; 3UCSF (University of California, San
Francisco, Fresno), Fresno, CA.
P-446CORRELATION BETWEEN NUCLEAR (nDNA)
AND MITOCHONDRIAL DNA (mDNA)
INTEGRITY OF FERTILE AND SUBFERTILE
MALE PATIENTS AND THEIR EFFECT ON ICSI
RESULTS. M. E. Hammadeh1, A. Al Marby1,
E. Solomayer1. 1Department of Obstetrics
& Gynecology, University of Saarland,
Homburg/Saar, Germany; 2Department
of Obstetrics & Gynecology, University
of Saarland, Homburg/Saar, Germany;
3
University of Saarland, Homburg/Saar,
Germany.
P-447DONOR OOCYTES COULD RESCUE THE
REPRODUCTIVE POTENTIAL OF TESTICULAR
SPERM, CELLS IN THE OBSTRUCTIVE
AZOOSPERMIA? D. Pabón, J. L. Romero,
T. Viloria, A. Galan, J. Remohí, M. J. de los
Santos. IVI-Valencia, Valencia, Spain.
P-448LIPID FINGERPRINTING PROFILE OF SEMINAL
PLASMA ASSOCIATED TO SPERM DNA
FRAGMENTATION. P. Intasqui1, C. B. de
Lima1, M. Camargo1, E. J. Pilau2, E. G.
Lo Turco1, R. P. Bertolla1. 1Department
of Surgery, Division of Urology, Human
Reproduction Section, Sao Paulo Federal
University, Sao Paulo, SP, Brazil; 2Institute
of Chemistry, University of Campinas,
P-443SPATIAL AND TEMPORAL TRENDS IN MALE
INFERTILITY THROUGHOUT THE UNITED STATES,
1995-2009. A. Y. Odisho1, A. K. Nangia2, J.
F. Smith1. 1Department of Urology, University
CA; 2Department of Urology, University of
Kansas Medical Center, Kansas City, KS.
P-449DIABETES MELLITUS AND RISK OF
SEMINOPATHY: ANOTHER PROBLEM TO
BE INVESTIGATED IN MALE INFERTILITY.
S. M. Bhattacharya1,3, M. Ghosh2, N.
Nandi3. 1Obstetrics and Gynecology, S.C.
DAS Memorial Medical and Research
Center, Kolkata, West Bengal, India;
2
Pharmacology, Murshidabad Medical
College, Murshidabad, West Bengal, India;
3
Obstetrics and Gynecology, KPC Medical
College, Kolkata, West Bengal, India.
P-444ABSTINENCE MAKES THE HEART
GROW FONDER: AN ANALYSIS OF
EJACULATORY ABSTINENCE INTERVALS
IN RELATIONSHIP TO SPERM PARAMETERS
AND CLINICAL PREGNANCY RATES AFTER
INTRAUTERINE INSEMINATION. S. M.
Thompson, M. Gonzaga, S. Morelli, A.
Seungdamrong, M. Cho, P. G. McGovern.
Obstetrics,Gynecology and Women’s
Health, UMDNJ-New Jersey Medical School,
Newark, NJ.
P-450IMPAIRED SPERMATOGENESIS AND GR/GR
DELETIONS RELATED TO Y CHROMOSOME
HAPLOGROUPS IN KOREAN MEN. J. Choi1,
S.-H. Song2, J. E. Park1, W. S. Lee3, T. K. Yoon3,
S. H. Shim1,4. 1Genetics Laboratory, Fertility
Seoul, Korea; 2Department of Urology, CHA
University, Seoul, Korea; 3Department of
Obstetrics and Gynecology, CHA University,
Seoul, Korea; 4Department of Biomedical
Science, CHA University, Seoul, Korea.
P-451NOT INFERTILE: A SOCIOLOGICAL LOOK
AT HOW MALE INFERTILITY PATIENTS SEE
THEMSELVES. L. E. Barnes. Sociology, UCSD,
San Diego, CA.
P-452DOUBLE INTRAUTERINE INSEMINATION
VERSUS SINGLE INTRAUTERINE INSEMINATION
FOR MALE FACTOR INFERTILITY. S. M.
Thompson, M. Gonzaga, A. Seungdamrong,
M. Cho, S. S. Morelli, P. G. McGovern.
P-441SEMINAL HYPERVISCOSITY IS NOT
ASSOCIATED WITH SEMENOGELIN
DEGRADATION AND SPERM DNA DAMAGE:
A PROSPECTIVE STUDY OF INFERTILE MEN. N.
Esfandiari1,4, E. de Lamirande3, A. Gokturk1,
M. San Gabriel2, R. F. Casper1,4, A. Zini3.
1
IVF, Toronto Centre for A.R.T., Toronto, ON,
Canada; 2IVF, OVO Fertility Clinic, Montreal,
QC, Canada; 3Urology, Department of
Surgery, Montreal, QC, Canada; 4Ob/Gyn,
University of Toronto, Toronto, ON, Canada.
P-442EFFECT OF POLYMORPHISM IN THE
PROMOTER ESTROGEN RECEPTOR ALPHA ON
SPERM COUNT. B. Lledo2, A. M. Fabregat2,
R. Morales2, J. A. Ortiz2, J. Llacer1, R.
Bernabeu1. 1IB Biotech, Instituto Bernabeu,
Alicante, Spain; 2Reproductive Medicine,
Instituto Bernabeu, Alicante, Spain.
P-445Micro TESE DAY Of VS. Micro TESE DAY
BEFORE: OPTIMAL TREATMENT AND CLINICAL
OUTCOME. N. Zaninovic1, J. Hariprashad1,
A. Bahia1, P. Schlegel2. 1Reproductive
New York, NY; 2Department of Urology, Weill
124
Obstetrics, Gynecology and Womens
Health, UMDNJ-New Jersey Medical School,
Newark, NJ.
P-453PREDICTIVE VARIABLES OF SUCCESS IN
MICROSURGICAL SPERM RETRIEVAL IN
AZOOSPERMIC MEN. T. Y. Tan1, M. Lau1, C.
Tan2, S. Nadarajah1, S. F. Loh3, H. H. Tan1.
1
KKIVF Centre, Department of Reproductive
Medicine, KK Women’s and Children’s
Hospital, Singapore, Singapore; 2National
University of Singapore, Singapore,
Singapore; 3Thomson Fertility Centre, The
O&G Specialist Clinic, Thomson Medical
Centre, Singapore, Singapore.
P-454SPERM TRANSCRIPTS IN iRPL. K. Kumar1, D.
Deka2, R. Dada3. 1Anatomy, AIIMS, New
Delhi, Delhi, India; 2Obst. and Gynae., AIIMS,
New Delhi, Delhi, India; 3Anatomy, AIIMS,
New Delhi, Delhi, India.
P-455MALE FACTOR INFERTILITY IN UGANDA:
RESULTS OF A QUALITATIVE STUDY OF MEN’S
BELIEFS. T. E. Fisher1, J. Mugisha2, P. Klatsky1.
1
Obstetrics & Gynecology and Women’s
Health, Albert Einstein College of Medicine,
Bronx, NY; 2St. Francis Mutolere Hospital,
Kisoro, Uganda.
P-456RELATIONSHIP OF DNA INTEGRITY OF MOTILE
HUMAN SPERMATOZOA AND ICSI OUTCOME.
B. K. Seo, Q. V. Neri, D. Monahan, Z.
Rosenwaks, G. Palermo. The Ronald O.
Perelman & Claudia Cohen Center for
Reproductive Medicine, Weill Cornell
P-457OXIDATIVE STRESS AND SPERM DNA QUALITY
IN COUPLES EXPERIENCING RECURRENT IVF
FAILURE. R. Dada1, M. B. Shamsi1, R. Kumar2.
1
Laboratory for Molecular Reproduction
and Genetics, Department of Anatomy,
All India Institute of Medical Science, New
Delhi, India; 2Department of Urology, All
India Institute of Medical Science, New
Delhi, India.
P-458TRENDS IN SPERM MORPHOLOGY
AFTER IMPLEMENTATION OF A QUALITY
IMPROVEMENT INITIATIVE. A. N. Hokenstad,
P. H. Leonard, A. L. Weaver, C. C.
Coddington, D. E. Morbeck. Obstetrics and
Gynecology, Mayo Clinic, Rochester, MN.
P-459TESTICULAR BIOPSIES FROM NONOBSTRUCTIVE AZOOSPERMIC PATIENTS
EXPRESSED DIFFERENT PRE-MEIOTIC CELL
MARKERS. M. Huleihel1, M. Azab1, B. Fisch2,
J. Younis3, R. Orvieto4, E. Lunenfeld5. 1The
Shraga Segal Dept. Microbiology and
Immunology, Ben-Gurion University of the
Negev, Beer-Sheva, Israel; 2Infertility and
IVF Unit, Rabin Medical Center, Petach
Tikva, Israel; 3Dep. OB/GYN, Poriya Medical
Center, Tiberias, Israel; 4Dep. OB/GYN,
Barzilai Medical Center, Ashkelon, Israel;
5
Obstetrics and Gynecology, Soroka
University Medical Center and Faculty of
Health Sciencres, Beer-Sheva, Israel.
P-460THERE IS A LACK OF AWARENESS OF
INFERTILITY IN A PRIMARY CARE POPULATION
IN THE UNITED STATES. R. S. Gerhard, C.
W. M. Ritenour, W. Hsiao. Urology, Emory
University, School of Medicine, Atlanta, GA.
P-461ASSOCIATION BETWEEN LOW MOTILITY AND
SPERM DNA FRAGMENTATION DESPITE SPERM
COUNT IN MEN. D. Kvitko, R. Azambuja,
V. Reig, H. De Martin, M. Badalotti, A.
Petracco. Fertilitat - Centro de Medicina
Reprodutiva, Porto Alegre, RS, Brazil.
P-462REJECTION TRESHHOLDS AND SEASONAL
VARIABILITY OF EPIFLUORESCENT SPERM
TUNEL ASSAY. D. Paduch1,2, A. Bolyakov1,2, J.
Kiper1, J. Bazarnik1, A. Mehta1, M. Goldstein1.
1
Urology and Reproductive Medicine, Weill
Cornell Medical College, New York, NY;
2
Consulting Research Services, Inc, Jersey
City, NJ.
P-463EARLY FERTILITY TRIALS OF A SEMEN
COLLECTION DEVICE PREVIOUSLY
DEMONSTRATED TO IMPROVE SEMEN
PARAMETERS AND PREGNANCY RATES IN
ANIMAL MODELS. R. P. Kauffman1, L. Welch2,
S. D. Prien2, J. Phy1. 1Ob/Gyn, Texas Tech
University Health Science Center, Amarillo,
TX; 2Ob/Gyn, Texas Tech University Health
Science Center, Lubbock, TX.
P-464THE CONTENT OF DNA FRAGMENTED
SPERMATOZOA IN PATIENTS WITH THE
DIFFERENT KINDS OF PATHOSPERMIA. I.
Zhylkova, O. Feskov, I. Feskova, O. Zozulina.
IVF Department, Clinic of Professor Feskov
A.M., Kharkov, Ukraine.
P-465PATERNAL SPERM DNA DAMAGE INCREASED
MUTATION FREQUENCY IN THE RESULTING
OFFSPRING. X.-f. Huang1,2, Y. Li2, H.-Q.
Zhang1,3, H.-J. Shi1,3. 1Gynecology and
Obstetrics, Medical School of Fudan
University, Shanghai, China; 2Reproductive
Medical Center, the First Affiliated Hospital
of Wenzhou Medical School, Wenzhou,
Zhejiang, China; 3Shanghai Institute of
Planned Parenthood Research, Shanghai,
China.
P-466HYALURONAN BINDING ASSAY AS
A DIAGNOSTIC TOOL IN PATIENTS
UNDERGOING IUI. R. Lafuente1, G. Lopez1,
M. A. Checa1,2, M. Brassesco1. 1Andrology
Laboratory, CIRH, Barcelona, Spain;
2
Obstetrics and Gynaecology, Hospital del
Mar, Barcelona, Spain.
__________________________________________________________
125
Sperm Preparation
P-467EFFECT OF DOSE OF MOTILE SPERM FOR
INTRAUTERINE INSEMINATION ON FECUNDITY
USING FRESH PARTNER OR CRYOPRESERVED
DONOR SAMPLES. T. J. Kuehl, J. L. Wu,
T. J. Wincek, J. F. Pliego. Obstetrics and
Gynecology, Scott & White Healthcare and
Texas A&M Health Science Center College
of Medicine, Temple, TX.
Center, Los Angeles, CA; Reproductive
Endocrinology and Infertility, CedarsSinai Medical Center, Los Angeles, CA;
Maternal Fetal Medicine, Cedars-Sinai
Medical Center, Los Angeles, CA; Maternal
Fetal Medicine, Obstetrix Medical Group,
Overland Park, KS.
P-474EFFECTS OF LONG-ACTING GnRH-a
COMBINED WITH TRANSVAGINAL
ULTRASOUND-GUIDED OVARIAN
ENDOMETRIAL CYST ASPIRATION ON THE
PREGNANCY OUTCOMES OF IN VITRO
FERTILIZATION OF EMBRYO TRANSFER. Y.
Guo1, N. Lu2, Y. Sun3. 1Reproductive Medical
Center, The First Affiliated Hospital of
Zhengzhou University, Zhengzhou, Henan,
China; 2Reproductive Medical Center,
University, Zhengzhou, Henan, China;
3
Reproductive Medical Center, The First
Affiliated Hospital of Zhengzhou University,
Zhengzhou, Henan, China.
P-475THE ASSOCIATION OF SOME
THROMBOPHILIC GENES MUTATIONS WITH
PREGNANCY LOSSES IN MOLDAVIAN
WOMEN POPULATION. V. Mosin1, N. Usurelu1,
D. Badicean1, S. Garaeva2, N. Sorici1, V.
Sacara1. 1National Center of Reproductive
Health and Medical Genetics, Chisinau,
Republic of Moldova; 2Institute of Physiology
and Sanocreatology of Academy of
Science of Republic of Moldova, Chisinau,
Republic of Moldova.
Stem Cells
P-471CD34, CD73-DOUBLE POSITIVE AND HIGHLY
PROLIFERATIVE AND POTENT TESTIS-DERIVED
STEM CELLS (HTSCs) OBTAINED FROM HUMAN
TESTIS TISSUES WERE ABLE TO DIFFERENTIATE
INTO INSULIN-SECRETING CELLS IN VITRO. W.
Y. Choi1, J. K. Park1, S. H. Song1, J. E. Han1, H.
K. Kim2, D. R. Lee1. 1Fertility Center of CHA
Gangnam Medical Center, CHA University
College of Medicine, Seoul, Korea; 2Seoul
Women’s University, Seoul, Korea.
__________________________________________________________
P-476GENETIC PREDICTION OF ENDOMETRIOSIS IN
WOMEN SEEKING ASSISTED REPRODUCTIVE
TECHNOLOGIES. K. Ward, R. Chettier,
P. Farrington, H. Albertsen. Juneau
P-477EFFECT OF SEASONAL VARIATIONS IN THE
ASSISTED REPRODUCTION (IVF± ICSI): A
META-ANALYSIS. S. Vitthala1, P. Makwana1,
M. Nissar1, S. V. Iliani2, K. P. Vasundhara1.
1
Fertility Centre, Kamineni Fertility Centre,
Hyderabad, AP, India; 2Fertility Centre, Surya
Fertility Centre, Hyderabad, AP, India.
P-478PREVENTING OOCYTE AGING BY ASEPTIC
VITRIFICATION FOR PATIENTS WITH
UNEXPECTED DELAY OF SPERM PRODUCTION.
B. Wirleitner1, P. Vanderzwalmen2, B.
Lejeune2, N. H. Zech1. 1IVF Centers Prof Zech,
Bregenz GmbH, Bregenz, Austria; 2CHIREC,
Braine-l’Alleud, Belgium.
P-479LOCALISED ASSISTED HATCHING EFFECT IN
CRYOPRESERVED BLASTOCYST TRANSFERS.
D. Gumbao1, B. Amorocho1, A. Sánchez
León1, J. Marcos1, M. Mollá1, J. Landeras2.
1
IVF Laboratory, IVI Murcia, Murcia, Spain;
2
Department of Gynecology, IVI Murcia,
Murcia, Spain.
P-468BROMELASE – A SIMPLE WAY TO REDUCE
VISCOSITY OF HUMAN SEMEN FOR
BETTER PREPARATION. N. Saymé, T.
Krebs, K. Sollmann, D. H. A. Maas. Team
Kinderwunsch Hannover, Hannover,
Niedersachsen, Germany.
P-469CATHETER FLUSHING DOES NOT IMPROVE
PREGNANCY RATE FOLLOWING
INTRAUTERINE INSEMINATION (IUI). I.
Lichtblau1, P. Cohen-Bacrie1, M. CohenBacrie1, A. Hazout3, J. de Mouzon2, S.
Belloc1. 1ART Unit Eylau Unilabs, Paris,
France; 2Service de Gynécologie
Obstétrique II et Médecine de la
Reproduction, CHU Cochin Port Royal,
APHP, Université Paris Descartes, Paris,
France; 3RDP Conseil, Paris, France.
P-470IMPROVING POST-THAW QUALITY
MANAGEMENT STANDARDS IN SPERM
CRYOBANKING TO ENHANCE CLIENT
SATISFACTION. M. C. Schiewe, C. A. Sims,
C. Rothman. QC/R&D Lab, California
Cryobank, Inc, Los Angeles, CA.
__________________________________________________________
ART - Clinical
P-472DO SMOKERS WITH NORMAL OVARIAN
RESERVE HAVE ADVERSE IVF OUTCOMES?
DATA FROM THE FASTT AND FORT-T TRIALS.
E. H. Goldstein, M. B. Goldman, J. L. Fung,
R. H. Reindollar. Obstetrics & Gynecology,
Dartmouth-Hitchcock Medical Center,
Lebanon, NH.
P-473PREGNANCY OUTCOMES IN VERY
ADVANCED MATERNAL AGE PREGNANCY.
C. J. Chung, S. Jackson, M. Pisarska, C.
Alexander, K. Gregory. Obstetrics and
Gynecology, Cedars-Sinai Medical
126
P-480EFFECT OF PIOGLITAZONE ON TUMOR
NECROSIS-ALPHA AND INTERLEUKIN-6 IN
FOLLICULAR FLUID AND IVF/ICSI OUTCOMES
IN INFERTILE PATIENTS WITH ENDOMETRIOSIS.
C. H. Kim1, S.-K. Kwon1, J.-W. Ahn2, S.-Y.
Choi1, K.-H. Lee1, B.-M. Kang1. 1Obstetrics
and Gynecology, College of Medicine,
University of Ulsan, Asan Medical Center,
Seoul, Korea; 2Obstetrics and Gynecology,
College of Medicine, University of Ulsan,
Ulsan University Hospital, Ulsan, Korea.
P-481THE IMPACT OF HEALTH CARE REFORM ON
ACCESS TO ART IN THE U.S. A. Y. Armstrong,
H. Eltoukhi, J. H. Segars. Program in
NICHD/NIH, Bethesda, MD.
P-482ARE THE ANNEXIN V MICROBEADS, A REAL
SOLUTION TO SPERM DNA FRAGMENTATION?
A. Domingo, C. Anarte, J. A. Agirregoikoa,
I. Calvo, J. L. De Pablo, G. Barrenetxea.
Quirón Bilbao Assisted Reproduction Center,
Bilbao, Bizkaia, Spain.
P-483PREGNANCY RATES AND MISCARRIAGES
IN ICSI CYCLES WITH VERY HIGH DNA
DAMAGED SPERM (>50%). S. Dar1,2, S. A.
Grover1, S. I. Moskovtsev1,2, D. Dacanay1,
C. L. Librach1,2,3,4. 1CReATe Fertility Centre,
Toronto, ON, Canada; 2Obstetrics and
Gynaecology, University of Toronto, Toronto,
ON, Canada; 3Reproductive Endocrinology
and Infertility, Obstetrics and Gynaecology,
Sunnybrook Health Sciences Centre,
Toronto, ON, Canada; 4Reproductive
Endocrinology and Infertility, Obstetrics and
Gynaecology, Women’s College Hospital,
Toronto, ON, Canada.
P-484RECIPIENT INFLUENCE ON PREGNANCY
OUTCOMES IN DONOR OOCYTE CYCLES. K.
A. Wyckoff, M. Arny, P. St. Marie, K. A. Lynch,
C. Sites, H. Wiczyk. Baystate Reproductive
Medicine, Springfield, MA.
P-485LOW UTILIZATION OF EXTRA EMBRYOS IN
DONOR OOCYTE IN VITRO FERTILIZATION
(IVF) CYCLES: AN ETHICAL DILEMMA TO
DONOR MANAGEMENT. H. Cook1, C. BritonJones2, D. Hill2. 1Obstetrics and Gynecology,
UCLA David Geffen School of Medicine,
Los Angeles, CA; 2ART Reproductive Center,
Beverly Hills, CA.
P-487CUMULATIVE LIVEBIRTH RATES (CLBR) PER
TOTAL NUMBER OF OOCYTES EMPLOYED
IN 11652 CONSECUTIVE OVUM DONATION
(OD) CYCLES IN A SINGLE CENTER (20062011). N. Garrido1, J. A. Garcia-Velasco2, J.
Remohí1, A. Pellicer1. 1Instituto Universitario
IVI Valencia, Valencia, Spain; 2IVI Madrid,
Madrid, Spain.
P-488DIFFERENT OVARIAN AGING PATTERNS
ARE ALREADY APPARENT AT YOUNG AGES:
AMH DISTRIBUTIONS ACCORDING TO FMR1
GENOTYPES IN YOUNG OOCYTE DONORS.
A. Weghofer1,2, H.-J. Lee1. 1Center for
2
Medical University Vienna, Vienna.
P-489THE ASSOCIATION BETWEEN ASSISTED
REPRODUCTIVE TECHNOLOGY (ART) CLINIC
PERFORMANCE AND CYCLE VOLUME:
IMPLICATIONS FOR PUBLIC REPORTING
OF PROVIDER PERFORMANCE DATA. D.
Gong, E. Seli. Obstetrics, Gynecology and
Reproductive Sciences, Yale University
School of Medicine, New Haven, CT.
P-490AMONG PATIENTS OF SIMILAR AGES, A LOW
SERUM ANTI-MULLERIAN HORMONE(AMH)
DOES NOT PREDICT A HIGHER INCIDENCE
OF ANEUPLOIDY IN EMBRYOS TESTED
WITH COMPREHENSIVE CHROMOSOMAL
SCREENING (CCS). S. Cummings2, B.
Devkota1, D. Taylor1, T. A. Molinaro1.
1
New Jersey, Morristown, NJ; 2Department
of OBGYN, Morristown Memorial Hospital,
Morristown, NJ.
P-491ROLE OF ESTROGEN AS LUTEAL PHASE
SUPPORT (LPS) IN NORMAL AND
EXPECTED POOR RESPONDERS IN LONG
AGONIST IN-VITRO FERTILIZATION (IVF)/
INTRA-CYTOPLASMIC SPERM INJECTION
(ICSI) CYCLES. A. Chakravarty, S.
Sharma Palchaudhuri, P. Chakraborty,
S. K. Goswami, R. Chattopadhyay, B.
Chakravarty. ART, Institute of Reproductive
Medicine, Kolkata, West Bengal, India.
P-492THE EFFECT OF THE THICKNESS OF THE ZONA
PELLUCIDA USING LAH (Laser Assisted
Hatching) OR NOT IN IVF/ICSI CYCLES
FOR TWO AGE GROUPS. B. Amorocho1, G.
Calderón2, D. Gumbao1, A. Sánchez1, M.
Mollá1, J. Landeras3. 1IVF Laboratory, IVI
Murcia, Murcia, Spain; 2IVF Laboratory, IVI
Barcelona, Barcelona, Spain; 3Gynecology,
Murcia, Spain.
P-493OBSTETRIC OUTCOME IN 1228 WOMEN
HOSPITALIZED DUE TO OVARIAN HYPER
STIMULATION SYNDROME (OHSS), A
RETROSPECTIVE SWEDISH COHORT STUDY
1998-2008 IN COMPARISON IN VITRO
FERTILISATION (IVF ) WITHOUT OHSS. K.
V. Rova, P. G. Lindqvist. Fertility United,
Clintec, Stockholm, Sweden.
P-494LETROZOLE ALONE OR LETROZOLE
GONADOTROPIN COMBINATION AS
FIRST LINE FOR SUPEROVULATION IN
WOMEN WITH UNEXPLAINED INFERTILITY
UNDERGOING INTRAUTERINE INSEMINATION
(IUI): A PROSPECTIVE RANDOMIZED TRIAL.
127
N. Malhotra, D. Karmakar, S. Kumar.
All India Institute of Medical Sciences, New
Delhi, Delhi, India.
P-495FIRST TRIMESTER SCREENING MARKERS IN ART
PREGNANCIES. A. P. Melnick, A. Kruczek,
S. N. Lin, A. Grunebaum. Obstetrics and
Gynecology, New York Presbyterian Hospital
- Weill Cornell Medical Center, New York,
NY.
P-496ART OUTCOME IN SEROPOSITIVE
FEMALES FOR HEPATITIS C AND HUMAN
IMMUNODEFICIENCY VIRUSES COMPARED
WITH MATCHED HEALTHY INFERTILE PATIENTS
AND DEPENDING ON THE BLOOD VIRAL
LOAD. J. Giles1, F. Cruz1, C. Vidal1, A.
Pellicer1, N. Garrido2. 1Reproductive
Medicine, Instituto Universitario IVI Valencia,
Valencia, Spain; 2Andrology, Instituto
Universitario IVI Valencia, Valencia, Spain.
P-497TRIGGERING FINAL OOCYTE MATURATION
WITH GnRH AGONIST IN PATIENTS WITH
POLYCYSTIC OVARIES UNDERGOING IVF. E.
M. Kolibianakis1, D. Kyrou1, C. A. Venetis1, I.
Sfontouris2, T. G. Lainas2, B. C. Tarlatzis1. 1Unit
for Human Reproduction, 1st Dept of Ob/
Gyn, Medical School, Aristotle University of
Thessaloniki, Thessaloniki, Greece; 2Eugonia
Unit of Assisted Reproduction, Athens,
Greece.
P-498IMPROVEMENT OF IN VITRO MATURATION
OUTCOMES DURING FOUR PHASES DIVIDED
BY APPLYING OF THE NOVEL SYSTEM SINCE
1995. M. K. Kim1, E. A. Park2, D. R. Lee2, H.
J. Won1, W. S. Lee1, T. K. Yoon1. 1Obsterics
and Gynecology, Fertility Center of CHA
Gangnam Medical Center, College of
Medicine, CHA University, Seoul, Republic
of Korea; 2Fertility Center of CHA Gangnam
Medical Center, College of Medicine, CHA
University, Seoul, Republic of Korea.
P-499COMPARATIVE ANALYSIS OF THE OBSTETRIC
AND PERINATAL OUTCOME OF CHILDREN
BORN FROM OOCYTE IN VITRO MATURATION
AND CONTROLLED OVARIAN STIMULATION
CYCLES. M. Dal Canto1, G. Coticchio1, M.
Mignini Renzini1, T. Guarnieri1, E. De Ponti2, R.
Fadini1. 1Istituti Clinici Zucchi - Department
of Gynaecology, Biogenesi Reproductive
Medicine Centre, Monza, MB, Italy;
2
Department of Medical Physics, Ospedale
S. Gerardo, Monza, MB, Italy.
P-501IMMUNE MODULATION TREATMENT DOES
NOT IMPROVE IVF OUTCOMES BUT INCREASE
EARLY PREGNANCY LOSSES IN PATIENTS
WITH UNKNOWN CAUSE OF REPEATED IVFET FAILURE. H. Y. Kim1, J. Kwak-Kim2, B. S.
Lee3, J. W. Kim4, I. S. Kang4. 1Obstetrics and
Gynecology, Yongin Severance Hospital,
Yonsei University, College of Medicine,
Yongin City, Kyunggi-do, Korea; 2Obstetrics
and Gynecology, The Chicago Medical
School at Rosalind Franklin University of
Medicine and Science, North Chicago, IL;
3
Obstetrics and Gynecology, Gangnam
College of Medicine, Seoul, Korea;
4
Obstetrics and Gynecology, Cheil General
Hospital and Women’s Healthcare Center,
Seoul, Korea.
P-502COMPARISON OF MEASURES IN SART
DATABASE AND MASSACHUSETTS VITAL
STATISTICS. B. Luke1, H. Cabral2, B. B.
Cohen3, L. Hoang2, K. Plummer2, M.
Kotelchuck4. 1Michigan State University,
East Lansing, MI; 2Boston University School of
Public Health, Boston, MA; 3Massachusetts
Department of Public Health, Boston, MA;
4
Harvard Medical School, Boston, MA.
P-503“IMMEDIATE” VERSUS “DELAYED”
CONSECUTIVE CYCLES IN IVF: DOES THE TIME
INTERVAL BETWEEN SUCCESSIVE IVF CYCLES
AFFECT OUTCOMES? D. E. Reichman1,
E. Greenwood2, L. Meyer1, O. Davis1, P.
Chung1, Z. Rosenwaks1. 1The Ronald O.
Perelman and Claudia Cohen Center
Medical College, New York, NY; 2Weill
P-504TWINS: SPONTANEOUS VERSUS ASSISTED
REPRODUCTIVE TECHNOLOGY, A STUDY
OF OUTCOMES AND MORBIDITIES. M. S.
Davis1, C. C. Ward1, L. Almonte1, D. Brown2,
F. Craparo1. 1Obstetrics and Gynecology,
Abington Memorial Hospital, Abington, PA;
2
Obstetrics and Gynecology, Washington
Hospital Center, Washington, DC.
P-505PUBLIC OPINON REGARDING POSTHUMOUS
REPRODUCTION AND ASSOCIATIONS
OF SUPPORT WITH DEMOGRAPHIC AND
PERSONAL CHARACTERISTICS. S. E. Barton1,
S. Shalev2, L. Lehmann3, K. F. Correia1,
D. K. Shah1, E. S. Ginsburg1. 1Division of
Reproductive Endocrinology; Department
of Obstetrics and Gynecology, Brigham
and Women’s Hospital, Boston, MA;
2
Department of Global Health and Social
Medicine, Harvard Medical School, Boston,
MA; 3Department of Medicine, Brigham and
Women’s Hospital, Boston, MA.
P-500CAN IVF CYCLES BE SALVAGED BY REPEAT
ADMINISTRATION OF INTRAMUSCULAR (IM)
hCG THE DAY AFTER FAILED INJECTION? D.
E. Reichman1, E. Greenwood2, L. Meyer1,
I. Kligman1, Z. Rosenwaks1. 1The Ronald
Medical College, New York, NY; 2Weill
128
P-506MATERNAL AND NEONATAL OUTCOMES
AFTER GnRH-AGONIST TRIGGER FOR
FINAL OOCYTE MATURATION IN PATIENTS
UNDERGOING IN VITRO FERTILIZATION (IVF).
T. H. Budinetz, D. W. Griffin, J. Pinto, C. A.
Benadvia, J. C. Nulsen, L. L. Engmann.
Connecticut Health Center, Farmington, CT.
P-507ANALYSIS OF CLINICAL OUTCOME OF
IVM-IVF-ET AND IVF-ET CYCLES. E. A. Park,
M. K. Kim, B. Y. Kim, J. S. Seo, J. H. Cho, W.
S. Lee. Fertility Center of CHA Gangnam
Medical Center, College of Medicine, CHA
University, Seoul, Korea.
P-509THE EFFECTS OF CHINESE MEDICINES FOR
TONIFYING THE KIDNEY ON DNMT1 PROTEIN
EXPRESSION IN ENDOMETRIUM OF INFERTILE
WOMEN DURING IMPLANTATION PERIOD. F.
Lian1, R. Wang2, F. Ma1, Z. Sun1, L. Wang1,
L. Shi1. 1Integrative Medicine Research
Centre of Reproduction and Heredity,
Affiliated Hospital of Shandong University
of Traditional Chinese Medicine, Jinan,
Shandong, China; 2Gynecology, Shandong
University of Traditional Chinese Medicine,
Jinan, Shandong, China.
P-510EFFECT OF THE NEW LEGISLATION AND
SINGLE-EMBRYO TRANSFER POLICY IN
TURKEY ON PREGNANCY, LIVE BIRTH RATES
AND PERINATAL OUTCOMES. N. Yilmaz, Y.
Ustun, H. Inal, U. Gorkem, Y. Bardakci, C.
Gulerman. ZTB Women’ Health Hospital,
Ankara, Altindag, Turkey.
P-511EFFECT OF INTRAVENOUS IMMUNOGLOBULIN
ON PREGNANCY OUTCOME FOLLOWING
IVF/ICSI IN INFERTILE PATIENTS WITH
ENDOMETRIOSIS. S.-K. Kwon1, C.-H. Kim1,
J.-W. Ahn2, K.-H. Lee1, H.-D. Chae1, B.-M.
Kang1. 1Obstetrics and Gynecology, Asan
Medical Center, Seoul, Korea; 2Department
of Obstetrics and Gynecology, Ulsan
University Hospital, Ulsan, Korea.
P-512CONCENTRATION OF VITAMIN AND
STEROIDS IN RELATION TO AGE IN
FOLLICULAR FLUID FROM IVF PATIENTS. Y.
Choi, Y. E. Jeon, S. Cho, Y. Choi, B. Lee.
Yonsei University, College of Medicine,
Seoul, Seodaemoon-gu, Korea.
P-514ASSISTED REPRODUCTION TECHNOLOGY
(ART) SERVES THE FERTILITY NEEDS OF
HEALTHY HIV SEROPOSITIVE WOMEN. S. K.
Nurudeen, L. C. Grossman, M. V. Sauer, N.
C. Douglas. Obstetrics and Gynecology,
Columbia University College of Physicians &
Surgeons, New York, NY.
P-515IVF OUTCOMES ARE PARADOXICALLY
POORER UNDER AGE 25. L. H. Wu1, K.
C. Humm2, L. E. Dodge1, D. Sakkas3, M.
R. Hacker1, A. S. Penzias2,3. 1Obstetrics
& Gynecology, Beth Israel Deaconess
Medical Center, Boston, MA; 2Obstetrics
& Gynecology; Division of Reproductive
Endocrinology & Infertility, Beth Israel
3
Boston IVF, Waltham, MA.
P-516COASTING VERSUS SINGLE DOSE GNnRH
ANTAGONIST FOR THE PREVENTION OF
OVARIAN HYPERSTIMULATION SYNDROME.
C. Gulerman, N. Yilmaz, A. Sargin, A.
Turkkani, E. Saikaya, O. Yenicesu. ZTB
Women’s Health Hospital, Ankara, Altindag,
Turkey.
P-517HIGHER GOOD BLASTOCYST RATE BY
USING AN INCUBATOR WITH A BUILT-IN A
TIME-LAPSE EMBRYO IMAGE MONITORING
SYSTEM. S. Watanabe1, M. Kamihata1, H.
Morita1, A. Kuwahata1, M. Ochi1, T. Horiuchi2.
1
2
Graduate School of Comprehensive
Scientific Research, Prefectural University of
Hiroshima, Shobara, Hiroshima, Japan.
P-520PATIENT PERCEPTIONS OF LIFESTYLE FACTORS
AND IN VITRO FERTILIZATION (IVF) SUCCESS.
L. K. Hawkins, B. V. Rossi, K. F. B. Correia, S.
T. Lipskind, M. D. Hornstein, S. A. Missmer.
Division of Reproductive Medicine,
School, Boston, MA.
P-521TWO TYPES OF DIFFERENT FORMULATION OF
GONADOTROPIN-RELEASING HORMONE
AGONIST OR HUMAN CHORIONIC
GONADOTROPIN RECOMBINANT (r-hCG)
FOR FINAL OOCYTE MATURATION IN DONOR
CYCLES. A. L. Torno, L. Ferle, V. E. Cañada,
E. A. Salama. Fertility, Procrearte, Ciudad
Autonoma Buenos Aires, Argentina.
P-522IMPROVEMENT OF IN VITRO MATURATION
OUTCOMES COMPARED WITH RESULTS OF A
CONVENTIONAL IN VITRO FERTILIZATION. M.
K. Kim1, H. H. Seok1, E. A. Park2, D. R. Lee2,
M. S. Kwan1. 1Obstetrics and Gynecology,
Fertility Center of CHA Gangnam Medical
Center, CHA University, Seoul, Republic of
Korea; 2Fertility Center of CHA Gangnam
Medical Center, CHA University, Seoul,
Republic of Korea.
P-523THE FRESH VS. ALL VITRIFIED-THAWED
EMBRYOS TRANSFER OF PCOS PATIENTS
HAVING OVARIAN HYPERSTIMULATION
SYNDROME SHOW SIMILAR CLINICAL
OUTCOME. E. K. Kim, E. A. Kim, S. Y. Park,
J. E. Shin, H. Kwon, D. H. Choi. Fertility
Center, CHA Bundang Medical Center,
CHA University, Seongnam-si, Gyeonggi-do,
Republic of Korea.
129
P-524
OUTCOMES OF 1503 CYCLES OF MODIFIED
NATURAL CYCLE IN VITRO FERTILIZATION : A
SINGLE INSTITUTION EXPERIENCE. T. Shaulov1,
M. P. Vélez1,2, K. Buzaglo1,2, S. J. Phillips2, J.
I. Kadoch1,2. 1Obsterics and Gynecology,
University of Montreal Hospital Centre,
Montreal, QC, Canada; 2Clinique OVO,
P-525LEADING FOLLICLE SIZE IN MODIFIED
NATURAL CYCLE IVF- PREDICTOR OF
SUCCESSFUL OUTCOME? K. Buzaglo1,
M. Velez1, T. Shaulov2, C. Sylvestre1, I.-J.
Kadoch1. 1Clinique OVO, Montreal, QC,
Canada; 2Obstetrics and Gynecology,
Université de Montréal, Montreal, QC,
Canada.
P-526STUDY OF THE OUTCOME OF IN VITRO
FERTILIZATION AND EMBRYO TRANSFER IN
FEMALE PATIENTS WITH LATENT SYPHILIS. L.
Li, S.-W. Li, Z.-Y. Huang, Y. Wang, Z. Xiao, W.
Fan. Reproductive Medical Centre, West
China Second University Hospital, Sichuan
University, Chengdu, Sichuan, China.
P-527CONSERVATIVE MEDICAL TREATMENT OF
(OHSS): RESULTS OF A LARGE SERIES IN
A SINGLE CENTRE AND COST ANALYSIS
STUDY. G. Casals1, F. Fábregues1, M.
Pavesi2, V. Arroyo2, J. Balasch1. 1Assisted
Reproduction Unit, Faculty of MedicineUniversity of Barcelona, Hospital Clínic Institut d’Investigacions Biomèdiques August
Pi i Sunyer (IDIBAPS), Barcelona, Spain;
2
Liver Unit, Faculty of Medicine-University
of Barcelona, Hospital Clínic - Institut
d’Investigacions Biomèdiques August Pi i
Sunyer (IDIBAPS), Barcelona, Spain.
P-528PREMATURE LUTEINIZATION DURING
(GnRH) ANTAGONIST CYCLES IMPAIRS IN
VITRO FERTILIZATION (IVF) OUTCOMES ONLY
IN THE POOR RESPONDERS. J. W. Kim, I. P.
Kwak, J. E. Han, H. J. Won, T. K. Yoon, W. S.
Lee. Obstetrics and Gynecology, Fertility
CHA University, Seoul, Korea.
P-529RESEARCH IN MAJOR INFERTILITY JOURNALS:
A QUALITY ASSESSMENT. D. Glujovsky1,
B. Riestra1, A. Coscia1, C. Boggino1, A.
Ciapponi2, C. Sueldo1. 1Reproductive
Medicine, CEGYR (Centro de Estudios en
Ginecología y Reproducción), Buenos Aires,
Argentina; 2Cochrane South-American
Branch, Instituto de Efectividad Clínica y
Sanitaria/Institute for Clinical Effectiveness
and Health Policy, Buenos Aires, Argentina.
Medical Academy, Ankara, Merkez,
Turkey; 2Obstetrics and Gynecology, Selcuk
University Selcuklu Medicine Faculty,
Konya, Merkez, Turkey; 3Obstetrics and
Gynecology, Akdeniz University Medical
Faculty, Antalya, Merkez, Turkey.
P-531PREDICTORS OF INFERTILE WOMEN
OBTAINING EVALUATION AND TREATMENT.
A. Y. Collier1, K. Correia1, P. F. B. Per Dr. La
Barbera2, J. E. Chavarro3, J. Rich-Edwards4,
S. A. Missmer2. 1Obstetrics and Gynecology,
UCLA Medical Center, Los Angeles, CA;
2
Nutrition, Harvard School of Public Health,
Boston, MA; 4Connors Center for Women’s
Health and Gender Biology, Brigham and
School, Boston, MA.
__________________________________________________________
ART - Laboratory/Basic
P-532EXPRESSION OF PROLIFERATIVE RECEPTORS
ON TROPHOBLASTIC CELLS IN WOMEN AFTER
ASSISTED REPRODUCTIVE TECHNOLOGIES.
G. Sukhikh, N. Aleksandrova, E. Dubova, O.
Baev, A. Shchegolev. Research Center for
OBGYN and perinatology, Moscow, Russian
Federation.
P-533THE SIMPLIFIED SART EMBRYO SCORING
SYSTEM IS HIGHLY CORRELATED TO
IMPLANTATION AND LIVE BIRTH IN SINGLE
BLASTOCYST TRANSFERS. M. J. Hill1,2, R. J.
Heitmann1,2, K. Richter1, J. R. Graham1, A.
H. DeCherney2, E. Widra1. 1Shady Grove
Rockville, MD; 2Program in Reproductive
P-534EMBRYO CHROMOSOMAL CONSTITUTION IS
DYNAMIC ALONG WITH DEVELOPMENT. G.
Grunert, R. Dunn, L. Schenk, S. Chauhan,
R. Mangal, W.-S. Wun. Fertility Specialists of
Houston, Houston, TX.
__________________________________________________________
P-530PREGNANCY OUTCOMES AFTER SINGLE
EMBRYO TRANSFER LEGAL REGULATION
IN A UNIVERSITY HOSPITAL. C. M. Ercan1,
O. Secilmis Kerimoglu2, M. Sakinci3, C.
Korkmaz1, N. K. Duru1, A. Ergün1. 1Obstetrics
and Gynecology, Gulhane Military
130
P-535INCREASED RECIPIENT PREGNANCY
RATES ARE ASSOCIATED WITH CGGn ON
DONORS’ FMR1 GENES. A. Weghofer1,2,
A. Kim1, D. H. Barad1,3, N. Gleicher1,2.
1
Center for Human Reproduction (CHR),
New York, NY; 2Obstetrics & Gynecology,
Medical University Vienna, Vienna, Austria;
3
New York, NY.
P-536HOW MANY MONTHS ARE REQUIRED FOR
RECOVERY AFTER CC+hMG/IUI FAILURE?
H.-G. Sun1, K. H. Lee1, I. H. Park1, S. G. Kim1,
J. H. Lee1, G.-H. Jeon2. 1Mamapapa & Baby
OB&GY, Ulsan, Republic of Korea; 2OB/GY,
Inje University, Haeundae Paik Hospital,
Busan, Republic of Korea.
P-538CAN ESTIMATIONS OF EARLY STAGE
EMBRYO WEIGHT PREDICT LATER EMBRYO
DEVELOPMENT RATES? S. D. Prien1, C.
Wessels2, L. Penrose1. 1Ob/Gyn, Texas Tech
University Health Sciences Center, Lubbock,
TX; 2Animal and Food Sciences, Texas Tech
University, Lubbock, TX.
P-539EFFECT OF DONOR OOCYTES OBTAINED
FROM INFERTILE PATIENTS ON DONOR AND
RECIPIENT OUTCOMES. G. T. Koulianos1,
T. F. Garth2, S. Degelos1, G. B. Inge1. 1The
Center for Reproductive Medicine, Mobile,
AL; 2University of South Alabama Medical
School, Mobile, AL.
P-540RELATIVE PREDICTIVE VALUE OF
DEMOGRAPHIC VARIABLES, BASELINE FSH,
ESTRADIOL, AND ANTRAL FOLLICLE COUNT
IN DETERMINING LIVE BIRTH RATES IN ART. R.
Najeemuddin, V. I. Shavell, J. Banerjee, J.
Bolnick, M. Singh, A. O. Awonuga. Division
Infertility, Detroit Medical Center/Wayne
State University, Detroit, MI.
P-541DETECTION AND QUANTIFICATION OOCYTESPECIFIC GENE TRANSCRIPTS IN SECOND
POLAR BODIES: POTENTIAL MARKERS OF
OOCYTE COMPETENCE. Z.-H. Jiao, T. K.
Woodruff. Obstetrics and Gynecology,
Feinberg School of Medicine, Northwestern
P-542SHOULD BODY MASS INDEX INFLUENCE THE
DOSE OF hCG FOR OVULATION INDUCTION
AFTER SUPEROVULATION IN IVF/ICSI CYCLES?
M. Thakur1, A. N. Imudia2, V. I. Shavell1, M.
Singh1, M. P. Diamond1, A. O. Awonuga1.
1
and Infertility, Wayne State University,
Detroit, MI; 2Massachusetts General Hospital
Fertility Center, Vincent Department of
Obstetrics and Gynecology, Massachusetts
P-543A VALIDATED, MULTI-CENTER MODEL FOR
PREDICTING PERSONALIZED PROBABILITIES
OF LIVE BIRTH WITH FIRST IVF CYCLE. B.
Choi1, A. S. Penzias2, E. Bosch3, A. Leader4,
A. Pellicer3, M. W. Yao1. 1Dept. Research
and Development, Univfy Inc., Los Altos,
CA; 2Boston IVF, Waltham, MA; 3Instituto
Valenciano de Infertilidad, Valencia, Spain;
4
Ottawa Fertility Centre, Ottawa, ON,
Canada.
P-544THE SEARCH FOR BIOMARKERS OF HUMAN
EMBRYO DEVELOPMENTAL POTENTIAL IN IVF:
A COMPREHENSIVE PROTEOMIC APPROACH.
S. Oehninger1, S. Bocca1, T. Burch2, J.
Semmes2, J. Nyalwidhe2. 1The Jones Institute
for Reproductive Medicine, EVMS, Norfolk,
VA; 2The Center for Biomedical Proteomics,
Eastern Virginia Medical School, Norfolk, VA.
P-545THE EFFECT OF MULTIPLE FETAL HEARTBEATS
IN EARLY PREGNANCY ON ASSISTED
REPRODUCTIVE TECHNOLOGY (ART)
SINGLETON PREGNANCY OUTCOMES. B.
Luke1, M. B. Brown2, D. A. Grainger3, N.
Klein4, M. I. Cedars5, J. E. Stern6. 1Michigan
State University, East Lansing, MI; 2University
of Michigan, Ann Arbor, MI; 3University of
Kansas, Wichita, KS; 4Seattle Reproductive
Medicine, Bellevue, WA; 5University of
CA; 6Dartmouth-Hitchcock Medical Center,
Lebanon, NH.
P-546THE ASSOCIATION BETWEEN CHANGES
IN CYCLE VOLUME AND ART CLINIC
PERFORMANCE. D. Gong, E. Seli. Obstetrics,
Haven, CT.
P-547DRAMATICALLY IMPAIRED OUTCOME FOR
ONE IVF TWIN PREGNANCY COMPARED
TO TWO IVF SINGLETON PREGNANCIES. A.
Sazonova1, K. Källen2, A. Thurin-Kjellberg1,
U.-B. Wennerholm1, C. Bergh1. 1Department
of Obstetrics and Gynecology, Institute
of Clinical Sciences, Sahlgrenska
Academy, Gothenburg University,
Reproductive Medicine, Gothenburg,
Sweden; 2Department of Reproduction
Epidemiology, Tornblad Institute, Institute of
Clinical Sciences, Lund, Sweden.
P-548BOTH AMH AND DAY 3 FSH LEVELS PREDICT
IVF STIMULATION OUTCOME REGARDLESS
OF PATIENT AGE; DAY 3 ESTRADIOL LEVELS
ARE NOT PREDICTIVE. K. Silverberg, T. Minter,
K. Silverberg, N. Burger, L. Hansard, T. C.
Vaughn. Texas Fertility Center, Austin, TX.
P-549IS THERE A RELATIONSHIP BETWEEN
PREMATURE GRAY HAIR AND OTHER
AUTOIMMUNE PHENOMENA WITH
DIMINISHED OVARIAN RESERVE? E. H.
Goldstein, M. B. Goldman, J. L. Fung, R. H.
Reindollar. Obstetrics and Gynecology,
Dartmouth-Hitchcock Medical Center,
Lebanon, NH.
P-550ANTIMÜLLERIAN HORMONE IN FOLLICULAR
FLUID OF NORMOGONADOTROPHIC
WOMEN UNDERTAKING IVF/ICSI CYCLES:
A CANDIDATE BIOMARKER OF OOCYTE
QUALITY AND EMBRYO IMPLANTATION
POTENTIAL. A. Nazzaro, A. Salerno.
Physiopathology of Human Reproduction,
AORN “G. Rummo” Hospital, Benevento,
Italy.
131
P-551ELEVATED ESTRADIOL LEVEL AT ANTAGONIST
START NEGATIVELY IMPACTS IVF SUCCESS
IN AN ANTAGONIST PROTOCOL. S. R.
Nayak1, M. Ochalski1, K. Wakim1, X. Dong2,
A. N. Wakim1. 1Obstetrics and Gynecology,
and Infertility, University of Pittsburgh
Medical Center, Magee Womens Hospital,
Pittsburgh, PA; 2Department of Biostatistics,
Univesity of Pittsburgh, Pittsburgh, PA.
P-552ROLE OF PERIFOLLICULAR DOPPLER BLOOD
FLOW IN PREDICTING CYCLE RESPONSE IN
NORMORESPONDERS UNDERGOING IVF/ICSI.
N. Malhotra, A. Bahadur, N. Singh, S. Mittal.
ART Center, Department of Obstetrics and
Gynecology, All India Institute of Medical
Sciences, New Delhi, Delhi, India.
P-553ELEVATED PROGESTERONE LEVEL THE DAY
PRIOR TO OOCYTE RETRIEVAL CORRELATES
WITH DIMINISHED CLINICAL PREGNANCY
RATES. D. A. Kelk, S. S. Richlin, A. C.
Fusina, E. L. Paganetti, S. L. Vadehra, M.
P. Leondires. Reproductive Medicine
P-554WHAT FACTORS ARE PREDICTIVE OF
IMMATURE OOCYTE PROPORTION IN ISCI
CYCLES? T. Brooker1, E. Lawrence1, Y.
Khalaf1,2. 1Assisted Conception unit, Guy’s
& St Thomas’ NHS Foundation Trust, London,
United Kingdom; 2Dept of Women’s Health,
King’s College London, London, United
Kingdom.
P-555PROGNOSTIC MODELS FOR HIGH AND
LOW OVARIAN RESPONSE IN CONTROLLED
OVARIAN STIMULATION (COS) USING A
(GnRH) ANTAGONIST PROTOCOL. F.
Broekmans1, P. Verweij2, M. Eijkemans1, B.
Mannaerts2, H. Witjes2. 1University Medical
Center Utrecht, Utrecht, Netherlands; 2MSD,
Oss, Noord-Brabant, Netherlands.
P-556THE ESCORT STUDY: EFFICACY, SAFETY
& CLINICAL OUTCOMES OF ASSISTED
REPRODUCTIVE TECHNIQUES. P. Kovacs1,
F. Rarosi2, L. Horvath3, I. Paczi3. 1Kaali
Institute IVF Center, Budapest, Hungary;
2
Department of Medical Physics and
Informatics, Szeged, Hungary; 3Unicorp
Research Organization, Budapest, Hungary.
P-557COMPARATIVE EVALUATION OF OOCYTE
QUALITY IN STIMULATED-INTRAUTERINE
INSEMINATION (IUI) TO IN VITRO
FERTILIZATION (IVF) CONVERSION CYCLES
VS CONVENTIONAL IVF CYCLES AND ITS
IMPACT ON PREGNANCY OUTCOME. S.
Singh, R. Chattopadhyay, S. Sharma, S.
Ghosh, S. K. Goswami, B. Chakravarty. ART,
Institute of Reproductive Medicine, Kolkata,
West Bengal, India.
__________________________________________________________
Outcome Predictors-Lab: ART
P-558THE RATE OF TESTICULAR SPERM CHROMATIN
DEFECT AND ITS FOLLOWING RESULT OF
IVF-ET CYCLE. Y.-S. Park1, S.-H. Lee1, J. W.
Cho1, J. T. Seo2, K. M. Yang3. 1Laboratory
of Reproductive Biology & Infertility, Cheil
General Hospital & Women’s Healthcare
Center, Kwandong University College
of Medicine, Seoul, Republic of Korea;
2
Department of Urology, Cheil General
Hospital & Women’s Healthcare Center,
Seoul, Republic of Korea; 3Department
of Ob&Gyn, Cheil General Hospital &
Women’s Healthcare Center, Kwandong
Republic of Korea.
P-559CORRELATION BETWEEN EMBRYO
MORPHOLOGY AND DEVELOPMENT AND
CHROMOSOMAL COMPLEMENT. K.-V. Phan,
E. Littman, D. Harris, C. Lopez, A. La. Red
Rock Fertility Center, Las Vegas, NV.
P-560POLYMORPHIC VARIANT KARYOTYPES
ARE NOT INNOCUOUS TO IVF OUTCOME.
M. Luna1, E. Cervantes1, G. Vela1, J. A.
Lee1, B. Sandler1,2, A. B. Copperman1,2.
1
York, New York, NY; 2Obstetrics, Gynecology
and Reproductive Science, Mount Sinai
School of Medicine, New York, NY.
P-561DEFINING NEW MORPHOKINETIC VARIABLES
FOR EMBRYO SELECTION BY TIME-LAPSE.
I. Rubio, J. Herrero, A. Tejera, C. Vidal,
S. Perez, M. M. Escrivá. IVI Valencia,
Universidad de Valencia, Valencia, Spain.
P-562DO MULTINUCLEATED EMBRYOS IN IVF
CYCLES AFFECT IVF OUTCOME? G. Sahin,
A. Akdogan, N. Çalimlioglu, A. Durmaz, E.
N. Tavmergen Goker, E. Tavmergen. IVF
Center, Ege University, Bornova/Izmir, Turkey.
P-563MONOZYGOTIC TWINNING (MZT) RATES
INCREASE WITH EMBRYO COHORT QUALITY
AND ARE NOT DIRECTLY RELATED TO
CLEAVAGE (CL) STAGE OR BLASTOCYST
(BL) STAGE TRANSFER. K. H. Hong1,2, M. D.
Werner1. 1Reproductive Endocrinology,
P-564THE CORRELATION BETWEEN THE ESTRADIOL/
OOCYTE RATIOS AND OUTCOMES OF
CONTROLLED OVARIAN STIMULATION FOR
IN VITRO FERTILIZATION. B. Choi, H. J. Lee,
S.-Y. Ku, S. H. Kim, Y. M. Choi, J. G. Kim, S.
Y. Moon. Department of Obstetrics and
Gynecology, Seoul National University
132
P-565HYPERGLYCOSYLATED HUMAN CHORIONIC
GONADOTROPIN AS AN EARLY PREDICTOR
OF PREGNANCY OUTCOMES AFTER IN VITRO
FERTILIZATION. M. V. Homer1, S. Chuan1,
R. Pandian2, D. Conway1, A. L. Yeo3, H. I.
Su1. 1Reproductive Medicine, University
of California, San Diego, San Diego, CA;
2
Endocrinology Reference Laboratory,
Quest Diagnostics Nichols Institute, San Juan
Capistrano, CA; 3Reproductive Partners,
UCSD Regional Fertility Center, La Jolla, CA.
P-566HYPERGLYCOSYLATED HUMAN CHORIONIC
GONADOTROPHIN LEVELS RELIABLY
DIAGNOSE CLINICAL IVF PREGNANCIES AT
6 DAYS FOLLOWING BLASTOCYST TRANSFER.
C. M. Strom1, R. Bonilla-Geurerro1, K. J.
Doody2, D. Tourgeman3, R. Alvero4, M. I.
Cedars5. 1Genetics, Quest Diagnostics
Nichols Institute, San Juan Capistrano, CA;
2
Center for Assisted Reproduction, Bedford,
TX; 3HRC Fertility, Westlake Village, CA;
4
University of Colorado at Denver, Aurora,
CO; 5University of California San Francisco,
San Francisco, CA.
P-567SERUM HUMAN CHORIONIC
GONADOTROPIN DOES NOT CORRELATE
WITH OOCYTE MATURITY. G. Levy1, M. J.
Hill1, T. Comeaux2, S. Beall1, J. H. Segars1,
J. Csokmay1,2. 1Program in Reproductive
Human Development, National Institute
of Health, Bethesda, MD; 2Department of
Ob/Gyn, Bayne-Jones Army Community
Hospital, Ft. Polk, LA; 3Department of
Walter Reed National Military Medical
Center, Bethesda, MD.
P-568THE EFFECT OF EXOGENOUS TESTOSTERONE
ON SMALL ANTRAL FOLLICLE COUNT
IN PATIENTS UNDERGOING ASSISTED
REPRODUCTION. M. V. Homer1, K. Maas1,
V. G. Garzo2, H. I. Su1, D. Conway1.
1
Reproductive Medicine, University of
California, San Diego, San Diego, CA;
2
Reproductive Partners, UCSD Regional
Fertility Center, La Jolla, CA.
__________________________________________________________
P-570COMPARING THE EFFECT OF GROWTH
HORMONE VERSUS CORTICOSTEROIDS
ON ICSI (INTRACYTOPLASMIC SPERM
INJECTION) OUTCOME IN POTENTIALLY LOWRESPONDER PATIENTS. S. H. Sakr. Obstetrics
and Gynecology, University of Alexandria,
Alexandria, Egypt.
__________________________________________________________
ART- In Vitro Fertilization
P-571RECOMBINANT LH SUPPLEMENTATION TO
RECOMBINANT FSH DURING INDUCED
OVARIAN STIMULATION IN THE GnRHANTAGONIST PROTOCOL IMPROVES
IMPLANTATION AND PREGNANCY RATES. A.
Nazzaro, A. Salerno. Physiopathology of
Human Reproduction, AORN “G. Rummo”
Hospital, Benevento, Italy.
P-572SEQUENTIAL LETROZOLE AND HMG: A
SUCCESSFUL NOVEL SUPER OVULATION
PROTOCOL SIGNIFICANTLY IMPROVES
PREGNANCY RATE IN PCOS PATIENTS
UNDERGOING ICSI. RANDOMIZED
CONTROLLED TRIAL. A. F. Galal. Ob&Gyn,
Alexandria University, Alexandria, Egypt.
P-573HIGH DOSE GONADOTROPINS IN IN
VITRO FERTILIZATION (IVF) TREATMENT – IS
IT JUSTIFIED TO PRESCRIBE MORE THAN
450 INTERNATIONAL UNITS (IU)? T. SokalArnon1, R. Ronn2, A. Wiser1, E. Shalom-Paz1.
1
MUHC Reproductive Center, Department
of Obstetrics and Gynecology, McGill
University, Montreal, QC, Canada;
2
Gynecology, Queen’s University, Kingston,
ON, Canada.
P-574A SHORT FOLLICULAR PHASE DOES NOT
COMPROMISE CLINICAL OUTCOME
FOLLOWING TREATMENT WITH
RECOMBINANT FSH AND GANIRELIX: A
LARGE COMBINED ANALYSIS OF INDIVIDUAL
SUBJECT DATA. B. Mannaerts1, H. Witjes1,
K. Gordon2. 1MSD, Oss, Noord-Brabant,
Netherlands; 2Merck, Kenilworth, NJ.
P-575TWO DOSES OF A SHORT-ACTING GnRH
AGONIST IS SUFFICIENT TO SUPPRESS LH FOR
THE DURATION OF ART STIMULATION. M. H.
Fakih, S. M. Farran. IVF Michigan, Rochester
Hills, MI.
P-576RELATIONSHIP BETWEEN OVARIAN RESPONSE
AND NUMBER OF EUPLOID EMBRYOS IN
OOCYTE DONOR CYCLES. E. Labarta, E.
Bosch, A. Mercader, P. Alama, E. Mateu,
A. Pellicer. Human Reproduction, Instituto
Valenciano de Infertilidad (IVI), Valencia,
Spain.
P-577CYCLE DYNAMICS OF OVULATION
INDUCTION (OI) WITH LETROZOLE (LET) IN
WOMEN WHO HAVE FAILED TO CONCEIVE
WITH CLOMIPHENE CITRATE (CC). H.
Ovarian Stimulation - Poor Responders: ART
P-569A COMPARISON OF IN-VITRO-MATURATION
OF OOCYTES (IVM) AND IN-VITROFERTILIZATION (IVF) WITH GONADOTROPINRELEASING HORMONE ANTAGONIST
PROTOCOL AMONG POOR RESPONDERS.
M. Das, W.-Y. Son, T. Sokal-Arnon, M.
Dahan, T. Tulandi, H. Hananel. Division
Infertility,Department of Obstetrics and
Gynecology, Royal Victoria Hospital,
133
Sharma1, I. Berin2, Z. Levine2, S. VanHorn3,
C. Salafia1. 1OB/GYN, Mount Sinai School
of Medicine, Queens Hospital Center,
Jamaica, NY; 2REI, The Fertility Institute of
New Jersey and New York, Westwood, NJ;
3
Placental Analytics LLC, Larchmont, NY.
P-578
Infertility, Johns Hopkins Medical Institutions,
Baltimore, MD.
P-584
COHORT ANEUPLOIDY RATES ARE NOT PREDICTIVE
OF SUSTAINED IMPLANTATION RATE
OF EUPLOID BLASTOCYSTS: GIVE THAT
BLASTOCYST A CHANCE! K. Hong1,2, T. A.
Molinaro1,2, E. Forman1, N. Treff1, R. Scott1.
1
Reproductive Endocrinology, Reproductive
Morristown, NJ; 2Obstetrics, Gynecology
& Reproductive Sciences, UMDNJ-Robert
Brunswick, NJ.
EFFECTS OF LASER ASSISTED HATCHING ON IVF/
ICSI CYCLES IN TWO AGE GROUPS. B.
Amorocho1, G. Calderón2, M. Mollá1, D.
Gumbao1, J. Marcos1, J. Landeras3. 1IVF
Laboratory, IVI Murcia, Murcia, Spain; 2IVF
Laboratory, IVI Barcelona, Barcelona, Spain;
3
Gynecologist, IVI Murcia, Murcia, Spain.
P-579AGE RELATED CORRECTION OF MOSAICISM
IN DAY 5 AND DAY 6 BLASTOCYSTS
REANALYZED FOR ANEUPLOIDY. E. Littman,
K.-V. Phan, D. Harris, C. Lopez, A. La. Red
Rock Fertility Center, Las Vegas, NV.
P-585FERTILIZATION METHOD PREDICTS EMBRYO
QUALITY. D. Berger1, B. McAvey1,2, M.
Goldsammler2, A. Zapantis1, E. Buyuk1,2,
S. Jindal1,2. 1Montefiore’s Institute for
Reproductive Medicine and Health,
Hartsdale, NY; 2Obstetrics and Gynecology
and Women’s Health, Albert Einstein
College of Medicine, Bronx, NY.
P-587EMBRYOLOGY TRAINING FOR REPRODUCTIVE
ENDOCRINOLOGY (RE) FELLOWS IN
THE CLINICAL HUMAN EMBRYOLOGY
LABORATORY: COMPREHENSIVE TRAINING
ON ACTUAL CLINICAL CASES WITH
EXCELLENT PATIENT OUTCOMES. R. T. Scott,
Jr.1,2, E. Forman1, M. D. Werner1, K. Hong1,
A. A. Ruiz1, K. M. Ferry1. 1Reproductive
2
Medical School, New Brunswick, NJ.
P-588THE IMPACT OF SUBOPTIMAL AIR QUALITY
IN EMBRYOLOGY LABORATORY ON IVF
OUTCOME. J. Kresowik, H. E. Duran, A.
Sparks, B. Van Voorhis. Obstetrics and
Gynecology, University of Iowa, Iowa City,
IA.
P-589DOES INTRACYTOPLASMIC SPERM INJECTION
(ICSI) IMPROVE THE FERTILIZATION RATE
AND DECREASE THE TOTAL FERTILIZATION
FAILURE RATE IN COUPLES WITH WELLDEFINED UNEXPLAINED INFERTILITY? L. N.
C. Johnson1, I. E. Sasson1, M. D. Sammel2,
A. Dokras1. 1Reproductive Endocrinology
and Infertility, Obstetrics and Gynecology,
University of Pennsylvania, Philadelphia, PA;
2
Epidemiology and Biostatistics, University of
P-590ART AND PREGNANCY OUTCOME IN
HYPOGONADOTROPHIC HYPOGONADISM
PATIENTS COMPARED TO MATCHED
CONTROLS. A. Caragia, A. Vlismas, L.
Pepas, M. Mohamed, A. Tozer, L. Sabatini.
Centre for Reproductive Medicine, Barts
Health, St Bartholomew’s Hospital, London,
West Smithfield, United Kingdom.
P-580IMPROVED PATIENT SATISFACTION, LESS
SEDATION AND EQUAL ANALGESIC
EFFICACY FOR REMIFENTANIL WHEN
COMPARED TO PETHIDINE DURING OOCYTE
RETRIEVAL IN IVF/ICSI-PROCEDURES. M. C. I.
Lier1, R. Schats1, P. G. A. Hompes1, C. Boer2,
V. Mijatovic1. 1Department of Reproductive
Medicine, VU University Medical Center,
Amsterdam, North Holland, Netherlands;
2
Department of Anesthesiology, VU
University Medical Center, Amsterdam,
North Holland, Netherlands.
P-581ELECTIVE SINGLE THAWED EUPLOID
EMBRYO TRANSFER (ESTEET) YIELDS SIMILAR
PREGANCY AND IMPLANTATION RATES TO
DONOR EGG. J. A. Grifo, B. Hodes-Wertz, H.L. Lee, E. Ampeloquio, M. Clarke-Williams, A.
Adler. Obstetrics and Gynecology, NYUFC,
NYU Langone Medical Center, New York,
NY.
P-582BALANCING IVF MEDICATION COSTS WITH
TOTAL NUMBER OF DAILY INJECTIONS: A
PATIENT PREFERENCE ANALYSIS OF GnRHAGONIST AND ANTAGONIST PROTOCOLS.
E. S. Sills1, G. S. Collins2, S. A. Salem1, C.
A. Jones3, A. C. Peck1, R. D. Salem1.
1
Reproductive Research Division, Pacific
Reproductive Center, Irvine, CA; 2Centre
for Statistics in Medicine, Wolfson College
Annexe, Oxford, Oxfordshire, United
Kingdom; 3Global Health Economics Unit,
University of Vermont College of Medicine,
Burlington, VT.
P-583FELLOWSHIP TRAINING IN EMBRYO TRANSFER:
THE JOHNS HOPKINS EXPERIENCE. P. R.
Brezina, M. M. Yates, E. E. Wallach, J. E.
Garcia, L. A. Kolp, H. A. Zacur. Department
of Gynecology and Obstetrics, Division
134
P-591BODY MASS INDEX (BMI) DOES NOT IMPACT
ENDOMETRIAL RECEPTIVITY IN FRESH IVF
CYCLES: EVALUATION OF IMPLANTATION
RATES (IR) AND ONGOING PREGNANCY
RATES (PR) FOLLOWING THE TRANSFER
OF EUPLOID BLASTOCYSTS. M. Werner,
E. Forman, K. Hong, N. Treff, R. Scott.
P-592IN VITRO CULTURE STRESS DUE TO AMBIENT
O2 INDUCES A SENESCENT-LIKE PHENOTYPE
WITH ABUNDANT DNA REPAIR ACTIVITY. L.
Rogmann, B. Winterhoff, J. Fredrickson,
T. Trejo, A. Meuter, M. Morbeck. OB Gyn,
Mayo Clinic, Rochester, MN.
P-593THE DNMT-3A AND DNMT-3B PROMOTER
POLYMORPHISMS AND RISK OF HUMAN
PREGNANCY LOSS. S.-L. Chen, H.-Y. Zheng,
X. Chen, D.-S. Ye, Y. Tang, X.-H. Yang. Center
for Reproductive Medicine, Gynecology
and Obstetrics Department, Nanfang
Hospital, Southern Medical University,
Guangzhou, Guangdong, China.
P-594METHYLATION ERRORS AT IMPRINTED
LOCI AFTER ASSISTED REPRODUCTIVE
TECHNOLOGIES (ART) CONCEPTION
ORIGINATE IN THE PARENTAL SPERM. T.
Utsunomiya1, T. Arima2. 1St. Luke Clinic,
Oita City, Oita, Japan; 2Tohoku University
Graduate School of Medicine, Sendai City,
Miyagi, Japan.
P-595SALPINGECTOMY IS COST EFFECTIVE
WHEN THE POST SURGICAL PREGNANCY
RATE IS TWICE THE PREGNANCY RATE
OF PATIENTS WITH HYDROSALPINGES: A
DECISION TREE MATHEMATICAL MODEL
WITH SENSITIVITY ANALYSIS. D. P.
Broomfield1, D. Kulak2, T. C. Plowden3, S.
Mumford4, A. Y. Armstrong5. 1Obstetrics &
Gynecology, Howard University Hospital,
Washington, DC; 2Obstetrics & Gynecology,
3
Obstetrics & Gynecology, Bayne-Jones
Army Community Hospital, Ft Polk, LA;
4
Epidemiology & Population Statistics,
National Institute of Health/NICHD,
Bethesda, MD; 5Clinical Services Program
National Institute of Health/NICHD,
Bethesda, MD.
P-596RATIO OF EUPLOID EMBRYOS FOLLOWING
COMPREHENSIVE CHROMOSOMAL
SCREENING (CCS) IN DAY 5 AND DAY 6
BLASTOCYTS. A. R. Anderson, T. Gibson,
S. B. Hudson, A. Browne, F. S. Arredondo.
Reproductive Medicine Associates of Texas,
San Antonio, TX.
P-597TRENDS AND FACTORS IN THE USE OF
INTRACYTOPLASMIC SPERM INJECTION (ICSI)
IN THE UNITED STATES. T.-c. [“A.” Chang, E.
S. Jacoby, G. M. Bareh, R. D. Robinson, R.
G. Brzyski, R. S. Schenken. Obstetrics and
Gynecology, University of Texas Health
Science Center, San Antonio, TX.
P-598DEVELOPMENT AND VALIDATION OF
AN AUTOMATED COMPUTER VISION
ALGORITHM FOR REAL-TIME EMBRYO
VIABILITY PREDICTION. K. Loewke1, F.
Moussavi1, M. Maddah1, K. Ivani2, B. Behr3,
V. Suraj1. 1Auxogyn, Inc., Menlo Park, CA;
2
Reproductive Science Center of the Bay
Area, San Ramon, CA; 3Stanford Fertility and
Reproductive Medicine Center, Palo Alto,
CA.
P-599PROMUCLEAR TRANSFER IN MICE YIELDS
MINIMAL MITOCHONDRIAL DNA CARRYOVER. M. Vandewoestyne1, J. Neupane2,
B. Heindryckx2, S. Lierman2, D. Deforce1, P.
De Sutter2. 1Laboratory of Pharmaceutical
Biotechnology, Faculty of Pharmaceutical
Sciences, Ghent University, Ghent, Flanders,
Belgium; 2Department for Reproductive
Medicine, Ghent University Hospital, Ghent,
Flanders, Belgium.
P-600GENDER RATIO VARIES ALONG WITH DAY3 BIOPSIED EMBRYOS (EGR), TRANSFERRED
EMBRYOS (TGR), AND DELIVERED INFANTS
(DGR). T. V. Pham, T. Dunn, G. Grunert, L.
Schenk, S. Chauhan, W.-S. Wun. Fertility
Specialists of Houston, Houston, TX.
135
ABSTRACTS TOPIC INDEX
ART In Vitro Fertilization
O13, O31, O48, O51, O52, O53, O59, O99, O100, O109, O153, O161, O163,
O164, O168, O171, O191, O198, O251, O253, O256, O257, O261, O268,
O325, O326, O333, O335, O339, O345, O353, O357, O365, O378, P105,
P472, P473, P474, P475, P479, P480, P482, P484, P488, P489, P491, P492,
P493, P496, P497, P499, P500, P501, P502, P503, P506, P507, P509, P514,
P515, P517, P520, P521, P523, P524, P525, P526, P527, P532, P533, P541,
P542, P543, P544, P545, P546, P547, P548, P549, P550, P551, P552, P553,
P554, P555, P556, P557, P559, P560, P561, P562, P563, P564, P565, P566,
P567, P568, P569, P571, P572, P573, P574, P575, P576, P578, P579, P580,
P581, P582, P583, P584, P585, P587, P588, P589, P590, P592, P595, P596,
P597
ART: Other
O47, O56, O93, O189, O258, O266, O267, O328, O352, P476, P477, P478,
P481, P483, P485, P487, P490, P494, P495, P-497, P498, P504, P505, P510,
P511, P512, P516, P522, P528, P529, P530, P531, P534, P535, P536, P538,
P539, P540, P558, P570, P577, P591, P593, P594, P598, P599, P600
Cancer
O38, O152, O286, O292, O374, P16, P17, P18, P19
Contraception/Family Planning
O15, O16, O18, O19, O20, O22, O110, O247, P273, P274, P275, P276, P277,
P278, P279, P280, P281, P282, P283, P284, P285
Cryopreservation
O24, O27, O96, O192, O216, O217, O218, O219, O220, O221, O222, O235,
O252, O299, O301, O302, O305, O317, O329, O362, P40, P41, P42, P43, P44,
P45, P46, P47, P48, P49, P50, P51, P52, P53, P54, P55, P56, P57, P58, P59, P60,
P61, P62, P63, P64
Embryo Biology
O46, O54, O58, O60, O98, O196, O200, O336, O363, O364, O369, P168,
P169, P170, P171, P172, P173, P174, P175, P176, P177, P178, P179, P180,
P181, P182, P183, P184
Embryo Culture
O94, O97, O270, O337, O338, O360, P185, P186, P187, P188, P189, P190,
P191, P192, P193, P194, P195, P196, P197, P198, P199
Embryo Transfer
O14, O49, O57, O167, O186, O188, O190, O202, O207, O304, O370, P227,
P228, P229, P230, P231, P232, P233, P234, P235, P236, P237, P238, P239,
P240, P241
Endometriosis
O33, O104, O121, O223, O224, O225, O226, O227, O228, O229, O309,
O312, O313, O314, P346, P347, P348, P349, P350, P351, P352, P353, P354,
P355, P356, P357, P358, P359, P360, P361, P362, P363, P364, P365
Endometrium
O80, O84, O204, O279, O280, O308, O310, O342, O368, P381, P382, P383,
P384, P385, P386, P387, P388
Environment and Toxicology
O101, O105, O106, O107, O108, P426
Female Reproductive Endocrinology
O7, O11, O17, O21, O83, O103, O112, O172, O205, O287, O288, O289,
O351, O371, P286, P287, P288, P289, P290, P291, P292, P293, P294, P295,
P296, P297, P298, P299, P300
Female Reproductive Surgery
O116, O117, O118, O120, O376, P389, P390, P391, P392, P393, P394, P395
Female Reproductive Tract
O37, O71, O119, O213, O377, P372, P373, P374
O5, O23, O25, O26, O28, O29, O30, O35, O113, O114, O115, O131, O150,
O230, O231, O232, O233, O234, O236, O249, O300, O303, O315, O-318,
O319, O320, O321, O322, O327, P20, P21, P23, P24, P-25, P26, P28, P29, P30,
P31, P32, P33, P34, P35, P36, P37, P38, P39
Fertilization
O10, O50, O269, O-355, O358, P159, P160, P161, P162, P163, P164, P165,
P166, P167
Genetic Counseling
O32, O195, O332, O372, P65, P66, P67, P68, P69, P70
Imaging
O123, O124, O125, O128, O129, O130, P375, P376, P377, P379
136
Implantation
O76, O89, O102, O331, O346, P242, P243, P244, P245, P246, P247, P249,
P250, P251, P252, P253, P254, P255, P256, P257, P258, P259, P260, P261, P262
Leiomyoma
O237, O238, O239, O240, O241, O242, O243, O323, P396, P397, P398, P399,
P400, P401, P402, P403, P404, P405, P406, P407, P408
Luteal Phase Support
O92, O187, P263, P264, P265, P266
Male Factor
O39, O40, O41, O42, O185, O272, O273, O276, O277, O278, O285, O296,
O316, O330, P435, P436, P437, P438, P439, P440, P441, P442, P443, P444,
P445, P446, P447, P448, P449, P450, P451, P452, P453, P454, P455, P456,
P457, P458, P459, P460, P461, P462, P463, P464, P465, P466
Male Reproductive Endocrinology
O90, P109, P110
Male Reproductive Urology
O3, O44, O133, O134, O135, O136, O293, O294, O295, O298, P111, P112,
P113, P114, P115, P116, P117, P118, P119, P120, P121, P122, P123, P124,
P125, P126, P127, P128, P129, P130
Menopause
O137, O143, O144, P1, P2, P3
Mental Health
O145, O146, O147, O148, O149, O151, O248, P412, P413, P414, P415, P416,
P417
Nursing
O166, O244, O245, O246, O250, P4, P5
Nutrition
O154, O155, O156, P410, P411
Obesity and Metabolism
O78, O139, O215, O306, P305, P306, P307, P308, P309, P310, P311, P312,
P313, P314, P315, P316, P317
Oocyte Biology
O55, O74, O77, O203, O341, O367, P139, P140, P141, P142, P143, P144,
P145, P146
Oocyte Maturation
O70, O75, P147, P148, P149, P150, P151, P152, P153, P154, P155, P156, P157,
P158
Ovarian Function
O2, O72, O85, O197, O212, P318, P319, P320, P321, P322, P323, P324, P325
Ovarian Reserve
O126, O127, O138, O142, O169, O283, O373, P6, P7, P8, P9, P10, P11, P12,
P13, P14, P15
Ovarian Stimulation
O8, O12, O122, O170, O173, O175, O176, O255, O259, O262, O263, O264,
O343, O347, O349, P200, P201, P202, P203, P204, P205, P206, P207, P208,
P209, P210, P211, P212, P213, P214, P215, P216, P217, P218, P219, P220,
P221, P222, P223, P224, P225, P226
Oxidative Stress
O361, P427, P428, P429, P430, P431, P432, P433, P434
Polycystic Ovary Syndrome
O6, O9, O79, O174, O201, O206, O209, O210, O211, O214, O282, O290,
O291, O340, O350, O354, O366, O375, P326, P327, P328, P329, P330, P331,
P332, P333, P334, P335, P336, P337, P338, P339, P340, P341, P342, P343,
P344, P345
Practice Management
O162, O324, P418, P419, P420, P421, P422, P423, P424, P425
Pregnancy Loss and Termination
O4, O45, O81, O88, O177, O199, P267, P268, P269, P270, P271
O1, O34, O95, O178, O179, O180, O181, O182, O183, O184, O194, O356,
O359, P71, P72, P73, P74, P75, P76, P78, P79, P80, P81, P82, P83, P84, P85,
P86, P87, P88, P89, P90, P91, P92, P93, P94, P95, P96, P97, P98, P99, P100,
P101, P102, P103, P104
Reproductive Hormones
O82, O141, O260, O281, P301, P302, P303, P304
O86, O87, O91, O311, P366, P367, P368, P369, P370, P371
137
Sexuality
O36, O111, O157, O158, O159, O160, P409
Sperm Biology
O43, O274, O284, O297, P131, P132, P133, P134, P135, P136, P137
Sperm Preparation
O265, O271, O275, P467, P468, P469, P470
Stem Cells
O61, O62, O63, O64, O65, O66, O67, O68, O69, O73, O307, O334, P471
Testis
O132, P106, P107, P108
138
ABSTRACTS AUTHOR INDEX
Abali, R., P-334
Aballa, T., O-298
Aballa, T. C., O-135
Abanto, E., O-176
Abboud, C., O-153, P-410
Abdo, G., O-173
Abeyta, M. J., O-301
Acacio, B., P-81
Acosta, M., O-244
Adler, A., O-183, P-78, P-82, P-581
Adler, N. E., O-138, O-142, P-412
Adur, M. K., O-311
Aelion Brauer, A., O-191, O-260, P-216, P-294
Afeiche, M., O-134, O-155
Afshar, Y., P-351
Agarwal, A., P-34, P-123, P-124, P-126, P-429
Agha Hosseini, M., P-286
Aghahosseini, M., O-13
Agirregoikoa, J. A., O-176, P-482
Agnani, G., P-224
Aguiar, A. S., P-183
Aguilar, J., P-198, P-266
Aguirre, M., O-222, O-256, O-342, P-54
Ahmady, A., O-75, O-299, O-338, P-156
Ahn, H. J., P-393
Ahn, J. W., P-326, P-480, P-511
Ahrendsen, C., O-131, P-39
Akber, S., P-236
Akdogan, A., P-562
Akiyama, I., P-297
Akula, K., O-231
Al Marby, A., P-446
Al Wattar, B. H., P-165
Alam, I., P-274
Alama, P., P-576
Albert, C., P-171
Albertsen, H., O-33, O-228, P-70, P-354, P-365, P-476
Alegretti, J. R., P-94
Aleksandrova, N., P-532
Alexander, C., P-473
Aleyasin, A., O-13
Alfarawati, S., P-179
Alhalabi, M., O-89, O-347
Al-Handy, A., P-402
Al-Hassan, S. H., P-309
Alhathal, N., P-130, P-436
Al-Hendy, A., O-239, O-242, P-399, P-403, P-406
Alkhayal, A., P-130
Alleyassin, A., P-286
Allsworth, J. E., O-101
Almodin, C. G., P-48, P-53
Almodin, P. M., P-53
Almog, B., P-24
Almonte, L., P-504
Alper, M. A., P-96
Alper, M. M., O-324, O-370
Alpsoy, S., P-334
Al-Sahan, N., P-309
Alsibiani, S., O-160
Alvarez, G., P-137
Alvarez, M. T., P-439
Alvarez Sedó, C., O-276, P-137, P-142, P-146, P-149, P-440
Alvero, R., O-211, O-354, P-566
Alwaeely, F. A., P-110
Amamah, S., P-147
Amaral, A., O-41
Amato, P., O-363
Ambartsumyan, G., O-46, P-159
Amir, H., O-63
Amit, A., O-63, O-322
Amo, A., P-40, P-252
Amorocho, B., P-479, P-492, P-584
Ampeloquio, E., O-183, P-78, P-85, P-581
An, N. K., P-11
Anan, M. A., P-267
Anarte, C., O-176, P-482
Anchan, R. M., O-364
Anckaert, E., P-338
Anderson, A. R., P-44, P-596
Anderson, M., O-223
Anderson, R. E., P-59, P-249
Anderson, S., P-170
Anderson, S. H., P-83, P-88
Ando, H., P-238
Anopa, J., P-301, P-346
Ansari, A. S., P-274
Antaki, R., O-187
Antonio, C., P-174
Aono, F., P-247
Aparicio, B., O-367
Appt, S. E., P-293
Apter, D., O-15, O-16, P-277
Arai, G., O-44
Araki, Y., P-18, P-18
Arav, A., O-65, P-46
Arce, J. C., O-169, P-147, P-242, P-382
Archer, D. F., P-282
Arima, T., P-594
Ariza, M., P-104
Armant, D. R., P-72
Armstrong, A., O-323
Armstrong, A. Y., O-236, P-397, P-481, P-595
Arnanz, A., O-358
Arny, M., P-157, P-250, P-260, P-484
Aronis, K. N., O-324
Arredondo, F. S., P-44, P-596
Arroyo, V., P-527
Arslan, E., O-115
Art, K. S., O-20
Artigues, A., O-302
Artonne, C., O-265, P-64
Arvas, A., P-110
Arya, S., P-301, P-303, P-312
Asada, Y., P-41, P-185, P-235, P-241
Asemota, O. A., P-308
Aslam, M., P-165
Aspichueta, F., O-358
Assou, S., O-68, O-350, P-147, P-182, P-327, P-386
Aston, K. I., O-43
Ata, B., P-219
Atamny, R., P-328
Attia, G. R., O-298
Austin, C., P-60
Avila, J., P-427
Awartani, K. A., P-309
Awonuga, A. O., P-246, P-540, P-542
Aydin, Y., P-166, P-431
Ayensu-Coker, L., O-157
Ayoubi, J. M., P-184
Azab, M., P-459
Azambuja, R., P-461
Azari, A., P-394
139
Azem, F., O-322
Aziz, N. M. D., P-329
Babayev, S., O-115
Bach, M., O-192
Bachman, E. A., O-129
Badalotti, M., P-461
Badicean, D., P-475
Baev, O., P-532
Bahadur, A., P-552
Bahceci, M., P-120
Bahia, A., O-277, P-445
Bailey, A. P., O-340
Bailey, S., O-29
Bajpayee, S., P-72
Baker, M., O-27
Baker, V. L., O-51, O-123, O-168
Bakircioglu, M. E., P-120
Bakos, H. W., P-112
Balasa, A., P-323
Balasch, J., P-527
Ballesteros, A., O-349, P-160
Ballesteros Boluda, A., P-261
Baner, J., O-95
Banerjee, J., P-540
Barad, D. H., P-290, P-299, P-535
Barbosa, C. P., O-351, P-353, P-362
Bardakci, Y., P-510
Bareh, G. M., P-597
Barkan, G., P-24
Barkat, J., P-226
Barnes, L. E., P-451
Barnes, R. B., O-202
Barnett, B., P-98
Barnhart, K., O-250, O-339
Barnhart, K. T., O-81, O-163, O-289, P-295, P-296
Baronio, M., P-142, P-146
Barragan, F., O-86, P-369
Barratt, C. L. R., O-40, O-284
Barrenetxea, G., O-176, P-482
Barret, B., P-433
Barrett, B., P-129
Barrett, C. B., O-370, P-96
Barri, P. N., P-163
Barriere, P., P-10, P-132, P-426
Barritt, J., O-67, O-355, O-359
Barros, B. C., P-233
Barry, J., O-79
Barton, S. E., O-11, O-25, P-505
Basile, N., P-104
Bastu, E., P-334, P-392
Bates, G. W., O-9, O-137, P-390
Battaglia, D., O-363
Baum, M., O-317
Baxter-Bendus, A., P-420
Bayoglu Tekin, Y., P-259, P-273
Bayram, A., P-120
Bazarnik, J., P-437, P-462
Beall, S., O-170, O-175, P-204, P-207, P-567
Bedaiwy, M. A., P-156
Bedient, C., O-121
Begari, M., O-48
Behr, B., O-123, P-86, P-598
Behr, B. R., O-301, P-83, P-92
Beim, P. Y., P-236
Belanoff, C. M., O-164
Belardo, A., P-280
Belén, A., P-144
Belkora, J., O-150, O-327, P-35
Bellavia, M., P-202
Belloc, S., O-31, O-274, O-297, P-469
Bellver, J., P-317
Belmonte, M., O-60
Beltsos, A., P-193, P-390
Benadiva, C., O-249, P-153
Benadiva, C. A., P-200
Benadvia, C. A., P-506
Bendarsky, O., P-321
Bendikson, K., O-27, O-156
Bendikson, K. A., O-219
Benjamín, I., P-439
Benjamin, L. E., O-233
Ben-Meir, A., P-139
Benner, A. T., O-179, P-101
Benoff, S. H., O-294
Bentov, Y., P-139
Ben-Yosef, D., O-63, O-322
Berberoglugil, M., O-185
Berchuck, S., O-245
Berdin, A., P-224
Berga, S. L., P-293
Berger, D., P-311, P-585
Bergh, C., P-547
Bergh, C. M., P-4
Berin, I., P-577
Berkeley, A., P-78
Berkeley, A. S., O-207, O-320
Bernabeu, R., P-6, P-133, P-205, P-442
Bernal, D. P., O-218, O-220, P-148
Bernuci, M. P., P-21
Bertolla, R. P., P-119, P-127, P-128, P-319, P-448
Bettahar, K., O-262
Betz, G., P-204
Beyer, C., P-225
Bhagavath, B., P-181
Bhattacharya, S. M., P-336, P-449
Bianco, B., O-351, P-353, P-362
Birkhäuser, M. H., P-202
Bishop, C., O-232
Bishop, C. V., O-212, O-213, P-375
Bisignano, A., O-195, P-279
Bissonnette, F., P-12
Bitterman, D. S., O-166
Blanchard, A., O-294
Blaney, B., O-294
Bleil, M. E., O-138, O-142, O-145, P-412
Blelloch, R., O-61
Blesa, D., P-383
Blockeel, C., P-242
Bloechle, M., O-119
Boada, M., P-163
Bocca, S., P-544
Bodri, D., P-288
Boehnlein, L. M., O-62
Boer, C., P-580
Boggino, C., P-529
Bollendorf, A., P-121
Bolnick, J., P-540
Bolnick, J. M., P-72
Bolyakov, A., O-275, P-437, P-462
Bonilla-Geurerro, R., P-566
Boorman, D., O-141
Boostanfar, R., O-100, O-109
140
Boots, C. E., P-203, P-313
Borah, B. J., P-400
Borba, J., P-199
Borgatta, L., P-278
Borges Jr., E., O-263, O-268, P-102, P-223, P-245
Bosch, E., P-210, P-217, P-543, P-576
Boscolo, F., O-63
Botchorishvili, R., P-389
Botes, A., P-86, P-92, P-100
Bouba, S., P-67
Boughton, A., O-266
Boumela, I., P-182
Bouquet de la Joliniere, J., P-184
Bowman, N., O-182
Boyd, B., O-179, P-101
Boyd, K. L., O-104
Boylan, C. F., O-99, O-304, P-93
Bozkurt, N., O-333, P-206
Bozza, L., P-280
Brackett, N. L., O-135, O-298
Bradford, A., O-78
Bradley, L., P-400
Bradshaw, H., O-112
Brady, P. C., O-11
Braga, D. P. A. F., O-263, O-268, P-102
Brahmbhatt, J., P-117, P-118, P-122
Brandes, A., P-358
Brandt, M., P-196
Brasile, D., P-244
Brassesco, M., P-466
Bravo, J., O-37
Bray, M. A., P-289, P-300
Brayboy, L. M., P-26
Breborowicz, A. K., P-337
Brennan, K. M., P-2, P-343
Brezina, P. R., O-179, O-364, P-101, P-583
Briton-Jones, C., O-46, P-107, P-159, P-168, P-485
Britten, J., P-401, P-407, P-408
Britten-Webb, J., O-237, O-243
Brocks, M. E., O-240
Broekmans, F., P-555
Brohammer, R., P-186
Bromer, J. G., O-49
Bronet, F., P-104
Brooker, T., P-554
Brookfield, K. F., O-128, P-422
Broomfield, D. P., P-595
Brown, D., P-504
Brown, M. B., O-51, O-257, P-545
Browne, A., P-44, P-596
Browne, P. E., O-331
Brudniewski, H. F., P-347
Brugnon, F., O-265, P-64
Bruner-Tran, K. L., O-104, O-223
Bryson, C. F., O-295
Brzyski, R. G., O-250, P-597
Buck Louis, G. M., P-352
Buckett, W., P-219
Budinetz, T., P-153
Budinetz, T. H., P-200, P-506
Buedefeldt-Pollard, J., P-305
Bugge, K., O-248
Bukulmez, O., O-280
Bulgarelli, D. L., P-21
Bulun, S. E., O-226, O-241, O-308
Burch, T., P-544
Burger, N., P-548
Bush, E., P-279
Busso, N. E., O-159
Butts, S., P-332
Buyuk, E., O-253, P-308, P-311, P-585
Buzaglo, K., P-524, P-525
Caballero Campo, P., O-41, O-345
Caballero-Peregrin, P., O-41
Cable, N. T., P-329
Cabral, E. C., P-245
Cabral, H., P-502
Cai, J., P-268
Caille, A., P-374
Cakmak, H., P-201
Calabro, A., P-158
Calderón, G., P-160, P-492, P-584
Calderón de Oya, G., P-261
Calderon, A., O-60
Calhoun, K., O-106
Calhoun, K. C., O-102
Çalimlioglu, N., P-562
Calingo, A., O-102
Calvo, I., P-482
Calzada, B., P-230
Camara, V. C. M., P-48, P-53
Camargo, L. S. A., P-190
Camargo, M., P-119, P-127, P-128, P-448
Cambiaghi, A. S., P-213, P-254
Cameron, J. L., O-212, O-213
Camlibel, T., O-185, P-110
Campbell, A., O-182
Campos, J., O-194, P-65
Campos, J. R., O-5
Campos, P., O-361
Cañada, V. E., P-521
Canis, M., P-64
Cao, Y., P-114
Caragia, A., P-590
Cardamone, S., O-35
Cardamone, S. C., P-23
Cardenas, C., P-280
Cardoso, M. C. A., P-183
Cardozo, E. R., O-240
Cardozo, K. H. M., P-127, P-128
Carlomagno, G., O-251
Carney, S. M., O-99, O-304, P-93
Caron, K., O-279
Carr, B. R., O-280
Carrell, D., P-310
Carrell, D. T., O-43
Carrick, K. S., O-280
Carrillo, A. J., O-357
Carson, S., P-26
Carson, S. A., P-181
Carter, S., P-287
Carvalho, L., O-122
Carvalho, V. M., P-127, P-128
Casals, G., P-527
Casciani, V., O-360
Casper, R., P-139
Casper, R. F., P-441
Casson, P. R., O-9, O-201
Cataldo, N. A., O-246
Catenacci, M., O-121, P-418
Catherino, W. H., O-237, O-243, P-401, P-407, P-408
Catt, K. J., P-304
141
Cavagna, F., P-28
Cavagna, M., P-28
Cebi, Z., O-185
Cedars, M., O-47, O-150, O-152, O-205, P-35, P-201
Cedars, M. I., O-138, O-142, O-345, P-545, P-566
Celebi, C., O-262
Celik, C., P-334, P-392
Cenksoy, C., P-208
Centola, G. M., O-294
Cervantes, E., P-7, P-257, P-560
Ceschin, A. P., P-48
Ceyhan, S. T., P-259
Cha, S. H., P-11
Cha, S. K., P-57
Cha, S. W., P-330
Chae, H. D., P-349
Chae, H.-D., P-511
Chakraborty, P., P-491
Chakravarty, A., P-491
Chakravarty, B., P-491, P-557
Chakrvarti, D., O-241
Chalfant, D., O-153, P-410
Chamié, L., P-361
Chan, J., P-31
Chan, J. L., O-111, O-148
Chan, L. m., O-148
Chan, S. w., O-327
Chang, C. C., O-218, O-220, O-278, P-148
Chang, F., O-170, O-175, P-204, P-207
Chang, R. J., P-333
Chang, S., P-396
Chang, T. c. “A.”, P-597
Chapron, C., P-67
Charles, C., P-346
Charron, M. J., P-308
Chason, R. J., P-304
Chatterjee, J., P-38
Chattopadhyay, R., P-491, P-557
Chau, P., P-337
Chaudhry, A., P-406
Chauhan, S., P-534, P-600
Chavarro, J. E., O-134, O-154, O-155, P-411, P-531
Chavez, S. L., O-123
Checa, M. A., P-466
Check, J. H., O-92, P-15, P-244
Chehin, M. B., P-233
Chemes, H., P-137
Chen, A. A., O-53, O-100
Chen, B., P-2
Chen, C. H., O-264, P-32
Chen, C. J., O-264
Chen, G., P-114
Chen, J., O-84, P-369
Chen, J. C., O-86
Chen, L., P-167
Chen, L. t., O-139
Chen, S. L., P-270, P-593
Chen, X., O-270, P-270, P-593
Chen, Z., O-266, P-352
Chenette, P. E., O-100
Cheng, G., P-368
Cheng, M. Z., O-57
Chettier, R., O-33, O-228, P-70, P-354, P-365, P-476
Cheung, L. P., P-292
Child, T., O-369
Chillik, C., O-276
Cho, J. H., P-507
Cho, J. W., P-558
Cho, M., P-444, P-452
Cho, S., P-357, P-363, P-364, P-512
Cho, Y. J., O-73
Choe, J. K., P-15, P-244
Choi, B., P-543
Choi, D. H., P-11, P-523
Choi, E. M., P-240
Choi, J., P-450
Choi, M., O-88
Choi, M. H., P-220, P-330, P-342
Choi, S. Y., P-326, P-480
Choi, W. Y., O-334, P-471
Choi, Y., P-512, P-512
Choi, Y. M., P-564
Choi, Y. S., P-357, P-363, P-364
Cholst, I. N., O-162, O-166
Chosich, J., O-78
Chow, V., O-39
Choy, D., P-292
Christensen, J., O-158
Christianson, M. S., O-26, P-164, P-373
Christofolini, D. M., O-351, P-353, P-362
Christofolini, J., P-358
Christos, P., P-17
Chrousos, G., O-225
Chua, Jr, S., P-311
Chuan, S., P-565
Chuan, S. S., P-333
Chung, C. J., P-473
Chung, J. T., O-269, O-318, P-150
Chung, K., O-27, O-219, O-289, P-295, P-296
Chung, M. K., O-171
Chung, P., P-503
Chuong, F. S., P-215
Chuva de Sousa Lopes, S., O-64
Ciapponi, A., P-529
Ciarmatori, S., P-280
Cibelli, J. B., O-341
Cil, A. P., O-252
Cipriani, L., O-235, P-55
Cirillo, P. M., O-205
Clarke, H., P-219
Clarke-Williams, M., P-581
Coates, A., O-356
Coddington, C. C., P-458
Coelingh Bennink, H. J. T., P-291
Coetzee, K., O-55
Cohen, B. B., P-502
Cohen, L., O-240
Cohen, R., O-92, P-244
Cohen, Y., O-233
Cohen-Bacrie, M., O-31, O-274, O-297, P-469
Cohen-Bacrie, P., O-31, O-274, O-297, P-469
Cohn, B. A., O-205
Colaci, D. S., O-154, P-411
Colasante, A., O-360
Coll, O., O-189, O-190
Collado, D., O-349
Collier, A. Y., P-531
Collins, G. S., P-582
Collins, L., O-302
Colls, P., P-73, P-82
Collura, B. L., O-247, P-420
Colturato, S. S., O-268
142
Comeaux, T., P-567
Comerford, K. P., O-127
Conaghan, J., O-53, P-61
Conrad, K. P., O-51
Conti, M., P-140
Conway, D., P-565, P-568
Cook, C. A., O-277
Cook, H., P-159, P-485
Cook-Andersen, H., P-333
Cooper, A. R., O-101
Cooper, B., O-328
Copperman, A. B., O-67, O-244, O-355, O-359, P-7, P-236,
P-257, P-560
Cordeiro, F. B., O-174
Cordts, E. B., O-351, P-362
Correia, K., O-11, P-531
Correia, K. F., O-340, P-505
Correia, K. F. B., O-186, P-315, P-520
Cortezzi, S. S., P-245
Coscia, A., P-529
Coskun, S., P-309
Costantini-Ferrando, M., P-17
Coticchio, G., P-499
Cotton, H. I. G., O-244
Cottrell, H., O-328
Coutifaris, C., O-339
Covington, L. S., O-151
Cox, J. M., O-8
Craparo, F., P-504
Cremers, S., P-283
Crespi, S., P-210, P-217
Cress, A. B., O-214
Crisci, A., P-39
Criscuolo, T. S., P-233
Crosby, J. A., O-341
Cross, M., O-27
Cruz, F., P-496
Cruz, M., P-169
Cruz-Almeida, Y., P-419
Cruz-Pachano, F., O-128
Csokmay, J., P-567
Cummings, S., P-490
Cuthbertson, D. J., P-329
Cwikel, J., O-147
Czamanski-Cohen, J., O-147
Da Broi, M. G., P-432, P-434
da Costa, L. do V. T., P-319
Da Silva, P. C., P-152
Da Silva-Grigoletto, M. E., O-285
Dacanay, D., P-483
Dada, R., P-435, P-454, P-457
Dafni, H., O-233
Dagerman, D. L., O-248
Dahan, M., P-150, P-569
Dahan, M. H., O-261, P-345
Dai, S., O-319
Dal Canto, M., P-499
Dalloul, M., P-301, P-303, P-312, P-346
Damiano, G., O-235, P-55
Daneshmand, S. T., O-222, O-256, O-342, P-54
Danzer, H., O-177, P-168
Dar, S., P-483
Darcha, C., P-350
Das, M., P-569
Das, S. K., O-76
Davis, J. B., O-103
Davis, M. S., P-504
Davis, O., P-216, P-503
Dayal, M., O-52
De Caldas, S. P., P-152
De Geyter, C., P-202
de Graaff, A., P-360
de Lamirande, E., P-441
De Leon, L., O-222
de Lima, C. B., P-448
De los Santos, J. M., P-317
De los Santos, M., P-171
de los Santos, M. J., O-361, P-447
De Martin, H., P-461
de Mouzon, J., O-31, O-274, O-297, P-469
De Neubourg, D., P-377
De Pablo, J. L., O-176, P-482
De Ponti, E., P-499
De Sutter, P., O-50, O-64, O-231, P-134, P-599
De Vos, M., P-45, P-151, P-218, P-338
De Vos, W., P-134
de Ziegler, D., P-67
De Ziegler, D., P-202
Deal, A. M., O-29
Dean, N., O-259
DeBosch, B., P-131
Dechaud, H., O-68, P-147, P-182, P-327, P-386, P-387
Déchelotte, P., P-64
DeCherney, A., O-175, O-197, O-281, P-207
DeCherney, A. H., O-8, O-331, O-346, P-304, P-533
Declercq, E., O-164
Deforce, D., P-599
Degelos, S., P-539
Degelos, S. D., P-188
Deka, D., P-454
Del Giudice, P. T., P-128
Del Priore, G., P-38
Delibasi, T., O-315
Demick, J., O-294
Demirtas, E., P-150
Demko, Z., O-93, O-180, P-105, P-269
Deng, Y., P-371
DeRosa, M., O-116
Desai, N., P-60, P-158, P-192
Deshmukh, R., P-310
Detti, L., O-368, P-36, P-384, P-394
DeUgarte, D., P-306
Devine, K., O-24, P-397
Devkota, B., O-83, O-178, O-300, O-352, P-321, P-490
Devor, E. J., P-255
Devroey, P., O-169, P-43, P-218
Deweese, M. H., O-151
D’Haeseleer, E., O-50
Dhariwal, L., P-303, P-312
D’Hooghe, T., P-360
D’Hooghe, T. M., P-377
Diamond, M., P-403
Diamond, M. P., O-368, P-72, P-384, P-542
DiAntonio, A., O-92
Diaz, L., P-31
Diaz, R. L., O-111, O-148
Diaz-Gimeno, P., P-383
Diaz-Spindola, P., P-256
Dib, L. A., P-432
Dickens, J., O-241
Dickler, M., O-77
Dietrich, J. E., O-37
143
Dilbaz, B., P-273
Diller, L. R., O-25
Dillon, K. E., O-286, O-289, O-292, O-374, P-30, P-295
DiLuigi, A. J., P-200
Dimitriadis, I., O-12, O-108
Ding, C., P-75
Ding, G. L., O-305
Ding, J., O-70, O-74
Dinnie, H., P-250, P-260
Diop, H., O-164
Dirksen, C. D., P-360
Dodge, L. E., P-314, P-515
Dogan, M., P-392
Doherty, L. F., O-204, P-63
Dokras, A., O-339, P-332, P-589
Domar, A. D., O-146
Domingo, A., P-482
Domingues, T., P-211
Domingues, T. S., P-152
Donadio, N. F., P-28
Dong, F., O-319
Dong, X., P-551
Dong, Y., O-302
Donjacour, A., O-335
Donohue, J. N., O-113
Dood, R. L., O-376
Doody, K. J., P-566
Dooley, B. A., P-47
dos Reis, M. B., P-107
dos Santos, A., P-358
Douglas, N. C., P-13, P-514
Dowling, C., P-250, P-260
Dreyer, K., P-379
Driggers, P. H., O-238, P-396
Drosman, S. R., P-284
Druckenmiller, S., O-24, P-417
Du, L., O-179, P-101
Du, W., P-114
Du Plessis, S. S., P-123, P-124, P-429
Duarte Filho, O. B., O-159
Dubourdeau, A.-L., P-224
Dubova, E., P-532
Dubuisson, J. B., P-184
Duffy, L., O-352
Duffy, S., O-182
Duggan, K., P-249
Dugghal, G., O-64
Duke, C. M. P., O-236
Duke, M., O-359
Duleba, A. J., O-214, O-223
Dune, T. J., O-240
Dunn, R., P-534
Dunn, T., P-600
Dunselman, G. A. J., P-360
Duran, E. H., O-255
Duran, H. E., P-588
Durban, M., O-189
Durmaz, A., P-562
Duru, N. K., P-530
Dyson, M., O-226, O-308
Dzieciatkowska, M., O-272, O-365
Dzik, A., P-28
Dzineku, F., O-126
Eaton, J. L., O-202, P-395
Ebbel, E., O-152
Eberlin, M. N., P-245
Eblen, A. C., P-99
Ebrahimi, N., O-13
Ectors, F., P-49
Edelman, A., P-275
Edwards, N. C., O-247, P-420
Egashira, A., O-337
Egli, D., O-67
Eguiguren, C. M., O-258
Eijkemans, M., P-555
Eisenberg, E., O-250
Ekart, J., O-55
Ekpo, G. E., O-240
Elbeg, S., P-208
Elbers, J., O-109
Eldar, I., P-24
Ellenbogen, A., P-155, P-322, P-328, P-367
Elliott, T. A., O-218, O-220, O-278, P-148
Elloumi, H., P-187
Eltoukhi, H., P-481
Emanuel, M. H., P-379
Enakpene, C. A., P-301
English, D., P-422
Engmann, L., O-249, P-153
Engmann, L. L., P-200, P-506
Epp, A., O-20
Eppsteiner, E. E., O-255
Ercan, C. M., P-530
Erdem, A., P-206
Erdem, M., P-206
Erdem, O., P-208
Erden, H., P-120
Ergün, A., P-530
Ergun, B., P-392
Erikson, D. W., O-86
Erkan, S., O-185, P-110
Ermanno, G., P-174
Esakky, P., P-131
Esbert, M., P-160
Escribá, M. J., P-144
Escriba, M. J., O-367
Escrich, L., O-367, P-144
Escrivá, M. M., P-561
Escriva, M. M., P-171, P-198
Escudero, T., P-81, P-87
Esfandiari, N., P-139, P-441
Esteves, S. C., P-195, P-231, P-438
Eum, J. H., P-57
Evans, J., O-71
Evans, J. P., P-164
Evans, S. F.. P-356
Evans-Hoeker, E.. O-279
Even, M.. O-23
Evenson, K.. O-102
Ezoe, K.. P-247
Ezzeldin, F.. P-232
Fabbri, F.. O-235, P-55
Fabregat, A. M.. P-442
Fábregues, F.. P-527
Fadini, R.. P-499
Fainaru, O.. P-155, P-322, P-328, P-367
Fakih, M. H.. P-575
Falcone, T.. O-120, O-121, O-122
Fan, W.. P-526
Fanchin, R.. O-23, O-371
Fang, C.. P-221, P-371
Farghaly, T. A., O-75, O-299, O-338, P-156
144
Farran, S. M., P-575
Farrington, P., O-33, O-228, P-66, P-354, P-365, P-476
Fatemi, H. M., P-43
Fathalla, M. M., P-267
Fazleabas, A. T., P-351
Fedick, A., O-178
Feetback, P., P-211, P-361
Feinberg, E., O-221
Feinberg, E. C., P-203
Feinberg, R. F., O-99, O-304, P-93
Feki, A., P-184
Feldbaum, V. M., P-394
Ferle, L., P-521
Fernández, E., O-341
Fernandez, D. O., P-416
Fernandez, I., P-266
Ferrando, M., O-358
Ferreira, R. C., P-102
Ferrero, S., O-216
Ferriani, R. A., O-375, P-347
Ferry, K., O-353, P-76
Ferry, K. M., O-57, O-161, O-194, O-378, P-189, P-587
Feskov, O., P-464
Feskova, I., P-464
Fields, T., P-108, P-135
Figueira, R. C. S., O-268, P-102
Figueroa, M., P-230
Filho, C. M. O., P-48
Filonenko, A., P-281
Fino, M. E., O-35, O-320, P-23
Fiorentino, F., P-174
FIRST Research Group, O-29
Fisch, B., P-459
Fischer, E., P-61
Fischer, J., O-195, P-279
Fischer, J. M., P-87
Fishel, S., O-182
Fisher, T. E., P-455
Fissore, R., P-157
Fitzpatrick, A. L., O-144
Fleetham, J., O-267
Fleming, A., P-80
Fletcher, N. M., O-368, P-384, P-403
Fleuren, G. J., P-37
Florensa, M., P-160
Flyckt, R., O-120
Flyckt, R. L., P-418
Foegh, M., P-282
Fogle, R. H., P-265
Fong, S., P-19
Ford, J. B., O-108
Forman, E., O-196, O-352, O-353, O-372, O-378, P-65, P-97,
P-321, P-578, P-587, P-591
Forman, E. J., O-57, O-161, O-203, O-300, P-76, P-189
Forsberg, K., O-47
Foster, L., P-409
Foster, W., P-324
Foster, W. G., P-372
Fourati, S., P-187
Fragouli, E., P-179
Fraietta, R., O-174, P-119
Franasiak, J. M., O-309
Frank, M., P-234
Frankfurter, D., O-52
Frattarelli, J. L., O-288
Fredrickson, J., P-592
Fredrickson, J. R., O-94, O-97
Freeman, E. W., O-141
Freitas, G. C., P-28
Freitas, L., P-94
Freour, T., P-10, P-132, P-426
Friedman, B. E., O-123
Fritz, M. A., O-309, P-58
Frydman, N., O-23, O-350
Frydman, R., O-350
Fujihara, L. S., P-48
Fujii, S., P-222
Fukuda, A., O-332, P-239
Fukuhara, R., P-222
Fukui, A., P-222
Fukunaga, N., P-41, P-185, P-235, P-241
Fung, J. L., P-472, P-549
Furuya, S., P-424
Fusina, A. C., P-553
Gadea, B., P-169
Gadea Navaro, B., P-180
Galache-Vega, P., P-256
Galal, A. F., P-572
Galán, A., O-58, P-447
Galera Fernandez, F., P-196
Galindo, N., P-172
Gallot, V., O-371
Gamzu, R., P-24
Ganaiem, M., O-316
Gandhi, A., O-122
Gannon, A. M., P-372
Gao, F., O-76
Gaona, M., P-92
Garaeva, S., P-475
García-Velasco, J. A., O-349, P-230, P-242
Garcia, A., O-269
Garcia, J. E., O-26, P-373, P-583
Garcia Fernandez, J. A., P-196
Garcia-Guixe, E., P-73
Garcia-Manso, J. M., O-285
Garcia-Velasco, J. A., P-487
Gardner, D. K., P-191
Gardner, K., O-182
Garijo Lopez, E., P-196
Garner, F. C., O-222, O-256, O-342, P-54
Garnsey, H. M., O-372
Garrido, N., O-181, P-172, P-210, P-217, P-487, P-496
Garth, T. F., P-539
Garza-Cavazos, A., P-305, P-388
Garzo, V. G., P-568
Gaskins, A. J., O-154, P-411
Gat, I., O-317
Gayet, V., P-67
Gebhardt, J., O-301
Gebrim, L. H., P-28
Geddes, K., P-423
Geisler, J. P., O-328
Gemelos, G., O-93, O-95
Gemmill, J. A. L., O-225
Gemzell Danielsson, K., P-278
Gemzell-Danielsson, K., O-15, O-16, P-277, P-284
George, N. J., O-62
Gerasimova, T., P-209
Gerhard, R. S., O-330, P-460
Geva, M., P-322
Ghaem-Maghami, S., P-38
Ghersevich, S., P-374
145
Ghosh, M., P-449
Ghosh, S., P-557
Gianaroli, L., P-184
Gibbons, W. E., P-14, P-323, P-325
Gibbs, M., O-153, P-410
Gibson, T., P-44, P-596
Gil, M. V., O-276
Gil, Y., P-163
Gilbert, B., O-136
Gilbert, R. S., P-197
Gilden, M., O-243, P-401, P-407, P-408
Giles, J., P-496
Gilman-Sachs, A., O-87
Gindoff, P. R., O-52
Gindri, G. M., P-183
Ginsberg, J. P., O-292, O-374
Ginsburg, E., O-186
Ginsburg, E. A., P-315
Ginsburg, E. S., O-25, P-505
Giorgi, V. S. I., P-432
Giovannetti, A. D., O-162
Giudice, L., P-351
Giudice, L. C., O-84, O-86, P-369
Glassner, M. J., P-83, P-88
Gleicher, N., P-299, P-535
Glore, D. R., O-104
Glujovsky, D., P-529
Gogorza, S., P-280
Gogusev, J., P-184
Gokturk, A., P-441
Goldberg, J., P-60, P-192, P-418
Goldenberg, E., O-136
Goldfarb, J., O-75, O-299, O-338, P-156
Goldman, C. S., P-353
Goldman, M. B., P-472, P-549
Goldsammler, M., P-585
Goldstein, E. H., P-472, P-549
Goldstein, J. S., P-80
Goldstein, M., O-133, P-115, P-462
Golombok, S., O-149
Gomes, C., P-94, P-361
Gonçalves, A. J., P-53
Gong, D., O-188, P-489, P-546
González, F., O-210
Gonzaga, M., P-444, P-452
Gonzales, E., P-262, P-337
Gonzalez, M., O-176
Gonzalez-Berchelmann, L., P-256
Gonzalez-Fernandez, R., P-427
Goodman, L. R., O-29
Goorah, B., P-345
Gordon, K., P-574
Gorkem, U., P-510
Gosiengfiao, Y., O-292, O-374
Goswami, S. K., P-491, P-557
Goto, A., P-2
Goto, M., O-373, P-428
Goto, T., O-217
Gozzo, F. C., P-119, P-319
Gracia, C., O-18
Gracia, C. R., O-286, O-292, O-374, O-376, P-30
Graff, K., P-199
Graff, R., O-116
Graham, J. R., O-331, O-346, P-197, P-533
Grainger, D. A., P-545
Grant, W., O-105
Grassa, H., P-230
Grau, N., O-367, P-144, P-317
Gray, D. W., O-284
Gray, K. E., O-144
Grazi, R. V., O-282, P-331
Greco, E., O-216, O-360
Green, D. J., P-329
Green, L. J., O-323
Greene, C., O-267
Greene, W. C., O-86
Greenwood, E., P-500, P-503
Gregorich, S. E., O-138, O-142
Gregory, K., P-473
Greiner, A., O-20
Griffin, D., P-153
Griffin, D. W., P-200, P-506
Grifo, J., O-125, O-177, O-183, O-356, P-78, P-85, P-87, P-145,
P-170
Grifo, J. A., O-207, P-82, P-581
Grigorescu, V., P-298
Grindler, N. M., O-101, P-390
Grobet, L., P-49
Groesch, K., P-305
Groll, J. M., O-288
Gross, J., O-146
Grossman, L. C., P-13, P-514
Grover, S. A., O-158, P-483
Grow, D., P-157
Grunebaum, A., P-495
Grunert, G., P-534, P-600
Grunfeld, L., O-244, P-236
Grynberg, M., O-23, O-371
Gualtieri, M., O-128, P-422
Guarnieri, T., P-499
Gudeloglu, A., P-117, P-118, P-122
Guerra, M. O., P-190
Guerrero, C. A., P-80
Guerrero, J., P-6, P-205
Gueye, N. A., P-177
Gulerman, C., P-510, P-516
Gumbao, D., P-479, P-492, P-584
Gumer, A. R., P-265
Gundell, C. R., P-307
Gungor-Ugurlucan, F., P-392
Guo, X. C., O-236
Guo, Y., O-199, P-173, P-474
Gupta, S., P-34
Gustofson, R. L., O-1, P-203
Guzel, E. C., P-334
Guzeloglu-Kayisli, O., O-234, O-333
Guzman, L., P-45, P-81, P-151
Gvakharia, M., O-53
Hacker, M. R., P-314, P-515
Hailpern, S., O-215
Haines, C., P-376
Haines, C. J., P-292
Halder, S., O-239, O-242, P-399, P-402
Halder, S. K., P-406
Hallak, M., P-322, P-367
Hama, S., P-40, P-252
Hamada, A. J., P-34, P-123, P-124, P-126, P-429
Hamamah, S., O-68, O-350, P-182, P-327, P-386, P-387
Hamilton, B., O-326, P-425
Hammadeh, M. E., O-90, P-446
Hammond, K. R., O-246
Hammoud, A. O., O-82, P-310
146
Han, A., O-87
Han, J. E., P-471, P-528
Hananel, H., P-569
Hanna, C., P-275
Hanna, C. B., O-19
Hannalie, A., P-98
Hannan, N. J., P-191
Hans, J. D., P-47
Hansard, L., P-548
Hansen, K., O-365
Hansen, K. C., O-272
Hanshew, K. K., P-88
Hantisteanu, S., P-155, P-322, P-367
Haouzi, D., O-68, O-350, P-182, P-327, P-386, P-387
Hara, R., O-21
Hara, S., P-318
Hara, T., P-237
Harada, T., O-313, O-314
Hardiman, P., O-79
Hariprashad, J., O-277, P-445
Harper, M. M., P-271, P-313
Harralson, A., O-52
Harris, D., P-91, P-559, P-579
Hartman, A., O-124, O-130
Hartman, M., O-124, O-130
Hartshorn, T., P-343
Haruki, A., P-239
Har-Vardi, I., O-147
Hasan, T., P-435
Hashimoto, S., P-40, P-252, P-253
Hassa, H., P-166, P-431
Hassan, F., P-281
Hassis, M., P-141
Hasson, Y., P-24
Hastings, J., P-351
Hatch, I., P-59
Hauck, B., O-15, O-16, P-277, P-278
Hauser, R., O-108, O-154, P-411
Hawkins, E., P-421
Hawkins, L. K., O-340, P-520
Hayashi, A., P-355
Haynes, K., O-376
Hazout, A., O-274, P-469
He, L., O-302
He, X., P-114
Hecht, B., O-338
Heindryck, B., P-134
Heindryckx, B., O-64, P-599
Heitmann, R. J., O-346, P-533
Helvaci, A., P-208
Henderson, S., O-269
Henne, M. B., O-8, O-118
Hennebold, J. D., O-72, O-110
Henry, N., P-281
Hergert, C., O-71
Hernandez, A. M., O-156
Hernandez, J., P-427
Herrero, J., O-58, P-171, P-561
Hertler, K., P-228
Hesters, L., O-23, O-350
Hickmon, C., O-253
Higaki, H., O-314
Hilders, C. G. J. M., P-37
Hill, B. J., P-19
Hill, D., O-46, P-159, P-168, P-170, P-485
Hill, G. A., P-99
Hill, M., O-93, O-95
Hill, M. J., O-281, O-331, O-346, P-533, P-567
Hillelsohn, J., O-136
Himeno, T., P-253
Hindkjær, J. J., O-336
Hino, T., P-175
Hiraoka, K., P-161
Hirohama, J., P-212
Hirosawa, T., P-162
Hirshfeld-Cytron, J., P-415
Hirshfeld-Cytron, J. E., O-117
Hirtz, C., P-387
Hiura, R., P-212
Hlinka, D., P-194
Ho, T. K., O-79
Hoang, L., P-502
Hodes-Wertz, B., O-24, O-125, O-183, P-85, P-417, P-581
Hodis, H. N., O-143
Hoekman, E. J., P-37
Hoest, T., O-366
Hoffman, D. I., P-419
Hokenstad, A. N., P-458
Holley, S. R., O-145, P-412
Holschneider, C., P-343
Holzer, H., O-10, O-269, O-318, P-150
Homburg, R., O-172
Homer, M. V., P-565, P-568
Hompes, P. G. A., P-379, P-580
Hong, J. Y., O-334
Hong, K., O-57, O-352, O-378, P-65, P-578, P-587, P-591
Hong, K. H., O-161, O-196, O-353, P-189, P-321, P-563
Honjou, K., P-227
Hope, A. G., O-284
Horcajadas, J., P-279
Horcajadas, J. A., O-195
Horiuchi, T., P-162, P-517
Horne, J. A., O-258
Hornstein, M. D., O-11, P-520
Horowitz, E., P-226
Horvath, L., P-556
Hossain, A., P-62
Hou, L., P-320
Hourvitz, A., O-317
Howard, B., O-14, O-197, P-263, P-285
Hsiao, W., O-330, P-460
Hsieh, T.-C., O-296
Hsu, M.-I., P-32
Hu, H., P-210, P-217
Hu, H. X., P-276
Hu, L., O-199
Hu, S., O-79
Hu, Y., P-167
Huang, H.-F., O-139, O-305, P-340
Huang, J. Y., P-391
Huang, R., P-221, P-371
Huang, T., O-303
Huang, X.-f., O-107, P-465
Huang, Z.-Y., P-526
Huddleston, H., O-47
Huddleston, H. G., O-206, P-368
Hudson, C., O-222, O-256, O-342, P-54
Hudson, S. B., P-44, P-596
Huerta Lorenzetti, M., P-149
Huleihel, M., O-316, P-459
Hull, L. M., P-356
Humaidan, P., P-218
147
Humberstone, F., P-409
Humm, K. C., P-515
Hummelshoj, L., O-229
Hung, F. c., P-42
Hunt, P., O-106
Huo, Y. W., P-136
Hur, J. Y., P-366
Hurliman, A. K., O-201
Hurst, B. S., O-127, O-343, O-377
Hurwitz, J. M., O-198, O-362, P-307
Hussain, M., P-274
Hussein, M., O-75
Huszar, J. M., O-69
Hutton, J. D., O-55
Hwan, S. F., P-197
Hwang, K., O-21
Hwang, Y. I., P-220
Hyman, J., O-10
Hyman, J. H., O-28, O-318
Iaconelli, C. A. R., P-223
Iaconelli Jr., A., O-263, O-268, P-102, P-223
Iager, A. E., O-341
Iba, Y., P-178
Ibecheole, V., P-202
Ibrahim, E., O-135, O-298
Ida, M., P-239
Igarashi, H., P-318
Ignaszewski, A., O-197
Ikebe, K., P-227
Iliani, S. V., P-477
Imajo, A., P-178
Imrie, S., O-149
Imudia, A. N., O-12, P-246, P-542
Inal, H., P-510
Inge, G. B., P-539
Ingerslev, J., O-336
Ingles, S., O-156
Intasqui, P., P-127, P-128, P-448
Irobunda, H. O., O-118
Irwin, J., P-369
Irwin, J. C., O-84, O-86
Isgro, J., P-13
Israel, S., O-299
Ito, K., P-252, P-253
Iuso, D., O-65
Ivani, K., O-53, P-598
Iwabe, T., O-313, O-314
Iwase, A., O-373, P-428
Iwata, K., P-178
Izawa, M., O-314
Izquierdo, A., O-349
Jabara, S., P-335
Jackson, S., P-473
Jacoby, E. S., P-597
Jadva, V., O-149
Jamal, W., O-126
Jamieson, D., P-298
Janesch, A., O-98, P-188
Jang, T. G., O-287
Janny, L., O-265, P-64
Jaroudi, S., P-179
Jasensky, J., O-266
Jayes, F. L., P-405
Jean, M., P-132
Jee, B. C., P-154, P-214
Jellerette-Nolan, T., P-157
Jelovsek, J. E., O-121
Jenkins, L. C., O-135
Jenkins, T. G., O-43
Jenkinson, C., O-229
Jensen, J., P-275
Jensen, J. T., O-19
Jeon, G. H., P-51, P-264, P-414, P-536
Jeon, Y. E., P-357, P-363, P-364, P-512
Jeong, H. J., O-171, P-50
Jeong, J. W., P-351
Jeong, K., O-77, O-321
Jesudasan, R., P-126
Jha, A., P-336
Jiang, D., O-270
Jiao, Z.-H., P-541
Jin, H., P-173
Jin, S. G., O-269
Jindal, S., P-311, P-585
Jindal, S. K., O-253, P-308
Jinno, M., P-212
Jo, J. D., P-243
Joda, L., P-163
John, N. S., P-289, P-300
Johnson, B. A., P-369
Johnson, D. S., P-93
Johnson, L. N. C., P-30, P-589
Johnson, S., P-409
Johnston-MacAnanny, E., O-357
Jones, A. E., P-99
Jones, C., P-368
Jones, C. A., P-582
Jones, H., P-329
Jones, J. M., O-62
Jordão Junior, A. A., P-434
Jorge, S., O-238
Jørgensen, N., O-134, O-155
Jorgez, C. J., O-3
José, R., P-144
Joseph, M., P-391
Jung, J. A., P-357, P-363
Jung, Y. H., P-243
Jungheim, E., P-390
Jungheim, E. S., O-326, O-329, P-306, P-425
Jurisicova, A., P-139
Kadoch, I. J., O-259
Kadoch, I.-J., O-126, O-187, P-525
Kadoch, J., P-12
Kadoch, J. I., P-524
Kafri, N., O-347
Kagawa, N., O-114
Kagawa, T., P-424
Kahn, J., O-218, O-220, O-278
Kaimal, A. J., P-246
Kakinuma, T., O-308
Källen, K., P-547
Kallio, S., O-17
Kamihata, M., P-162, P-517
Kanayama, N., P-370
Kang, B. M., P-349
Kang, B.-M., P-326, P-480, P-511
Kang, I. S., P-501
Kang, S. M., P-50
Kansal Kalra, S., O-129, O-339
Kao, C. N., O-205, O-206, O-345, P-9
Kaplan, B., P-87, P-170, P-420
Kar, S., O-290
148
Karabacak, O., O-333, P-206
Karacan, M., O-185, P-110
Karakaya, C., O-333
Karalok, H., O-312
Karmakar, D., P-494
Karsy, M., O-115, O-321
Kartchovsky, E., P-328
Kathiresan, A. S. Q., O-298, P-419
Kato, K., P-247
Kato, M., P-185
Kato, O., P-247
Kato, R., P-288
Katz, A., O-150, O-327, P-35, P-201
Katz, M., P-115
Katz, P. P., O-145
Katz-Jaffe, M., O-34, O-200, O-203, O-272, P-76
Katz-Jaffe, M. G., O-1, O-56, O-98, O-211, O-365
Kauffman, R. P., P-463
Kaunitz, A. M., P-282, P-285
Kawachiya, S., P-288
Kayisli, U., P-63
Kazer, R. R., P-415
Ke, R. W., P-228
Kearns, W. G., O-179, O-364, P-101
Keefe, D. L., O-291
Kelk, D. A., O-96, O-198, O-362, P-553
Keller, J., O-180, P-105, P-269
Kelly, E., P-199
Keltz, M., P-341
Keltz, M. D., P-337
Kennedy, S. H., O-229
Kenneth, B., O-87
Ketterson, K., O-195, P-279
Ketterson, K. A., O-356
Kettler, C., P-86, P-92
Keyhan, S., P-335
Khachikyan, I., O-225, O-236
Khafagy, A., O-26, P-373
Khalaf, M., O-89
Khalaf, Y., O-48, P-554
Khalifa, E.-A. M., O-75, P-156
Khan, S. R., P-274
Khan, Z., P-398
Khmaladze, A., O-266
Khoder, W., P-402, P-406
Khoury, C., P-105
Khrouf, M., P-187
Kidwai, N., O-105
Kikkawa, F., O-373, P-428
Kikkawa, Y., P-237
Kilburn, B. A., P-72
Kilic, S., O-315, P-259
Kim, A., O-7, P-3, P-290, P-535
Kim, B. Y., P-507
Kim, C. H., P-326, P-349, P-480
Kim, C. H., P-511
Kim, D., O-302
Kim, E. A., P-523
Kim, E. A., P-11
Kim, E. J., P-8
Kim, E. K., P-11, P-523
Kim, H. J., O-73
Kim, H. K., P-471
Kim, H. O., P-330, P-342
Kim, H. Y., P-364, P-501
Kim, J., P-58, P-69
Kim, J. C., P-50
Kim, J. G., P-564
Kim, J. H., P-214
Kim, J. W., P-501, P-528
Kim, J. Y., O-91, P-330, P-342
Kim, K. C., P-154
Kim, M. H., O-171, P-243
Kim, M. K., P-498, P-507, P-522
Kim, S., P-243
Kim, S. G., P-56, P-240, P-264, P-414, P-536
Kim, S. H., P-154, P-214, P-349, P-366, P-393, P-564
Kim, S. K., P-51
Kim, S. S., O-302
Kim, T., P-287, P-366
Kim, Y., O-334
Kim, Y. J., O-287
Kim, Y. Y., P-56, P-240, P-243, P-264, P-414
Kimura, H., P-222
Kinzer, D. R., O-370, P-96
Kiper, J., P-437, P-462
Kiriake, C., P-161
Kirkegaard, K., O-336
Kissin, D., P-298
Kissner, M., O-61
Kitamura, S., P-161
Kitasaka, H., P-41, P-185, P-235, P-241
Kiykac Altinbas, S., P-273
Klatsky, P., P-455
Klein, B. M., O-169, P-382
Klein, N., P-545
Kligman, I., P-500
Klock, S. C., P-415
Knopf, J. K., P-109
Knopman, J. M., O-54, O-320, P-176
Knowles, T. G., P-165
Kobayashi, M., P-430
Kobori, Y., O-44
Kocabas, A. M., O-341
Kodama, T., P-237
Koert, E., P-413
Kogan, S., O-115
Kogure, G. S., O-375
Koike, M., P-18
Kojima, E., P-41, P-241
Kokab, A. A., P-286
Kolahi, K. S., O-335
Kolibianakis, E.M., P-497
Kolp, L. A., O-26, P-373, P-583
Kondapalli, L. A., O-131, O-163, P-39
Kondo, M., P-428
Kong, G., P-292
Kono, N., O-143
Koo, H., O-88
Koong, M. K., P-220, P-342
Koong, M. K. K., P-330
Kopelman, S., P-149
Korkmaz, C., P-259, P-530
Kotelchuck, M., O-164, P-502
Koulianos, G., P-188
Koulianos, G. T., P-539
Kovacs, P., P-556
Kovalevsky, G., O-99, O-304
Kovanci, E., P-14, P-323, P-325
Kral, J. G., P-303, P-312
Kramer, E., O-247
Krause, M. S., P-388
149
Krebs, T., O-42, P-468
Kresowik, J., O-36, P-588
Kresowik, J. D. K., P-255
Krey, L. C., O-54, P-176
Krisher, R., P-143
Krisher, R. L., P-29, P-188
Kroener, L., O-46
Kruczek, A., P-495
Ku, L., P-98
Ku, S. Y., P-564
Kuehl, T. J., P-467
Kulak, D., O-253, P-595
Kullstam, S. M., O-377
Kumar, K., P-454
Kumar, R., P-435, P-457
Kumar, S., P-494
Kumasako, Y., P-18
Kummer, N., P-153
Kung, A., P-87, P-100
Kunitake, K., P-227
Kuokkanen, S., P-381
Kurachi, H., P-318
Kuramoto, T., O-337
Kuron, B., P-194
Kusakabe, H., P-175
Kutteh, W., P-228
Kuwahata, A., P-162, P-517
Kuwayama, M., O-114
Kuzcynski, W., P-382
Kvitko, D., P-461
Kwak, I. P., P-528
Kwak, K. H., O-334
Kwak-Kim, J., O-87, O-91, P-501
Kwak-Kim, J. Y., O-88
Kwan, M. S., P-522
Kwon, H., P-11, P-523
Kwon, S. K., P-326, P-480, P-511
Kyrou, D., P-43, P-497
La, A., P-91, P-559, P-579
La Marca, A., O-169
Labarta, E., O-58, P-576
Labhasetwar, V., O-132, P-106
LaBrie, S., P-260
Lachgar, H., O-167
Lafuente, R., P-466
Lainas, T. G., P-497
Laird, D., O-61
Lalioti, M., O-234
Lalioti, M. D., P-209
Lamb, D. J., O-3, O-296
Lammers, J., P-10, P-132, P-426
Landeras, J., P-479, P-492, P-584
Lane, M., P-112
Lang, M. B., O-377
Lanham, M., O-271
Lapensée, L., P-12
Lapensee, L., O-259
Larreategui, Z., O-358
Laskin, C., O-177
Lathi, R., O-177
Lathi, R. B., O-123, P-269
Lattes, S., P-10, P-132, P-426
Lau, M., P-453
Laughlin-Tommaso, S. K., P-398
Laurent, L., O-63
Lavolpe, M., P-146
Law, A., P-281
Lawrence, E., P-554
Lawson, A. K., P-415
Lawson, M., O-230
Lawson, M. S., O-5
Lay, S., P-305
Lazarin, G., P-68
Lazzaroni, E., P-290, P-299
Le, A., O-53
Le Parco, S., O-371
Leader, A., P-543
Leader, B., O-168, P-129
Leao, R. B. F., P-213, P-254
Lebiedzinski, M., P-177
Lechtenberg, L., O-286
Lederer, K., P-52, P-186
Lederman, M., P-337, P-341
Lee, A., O-287
Lee, B., P-512
Lee, B. S., P-357, P-364, P-501
Lee, D. M., O-232
Lee, D. R., O-73, P-57, P-471, P-498, P-522
Lee, H., P-189
Lee, H. C., P-157
Lee, H. J., P-564
Lee, H. S., O-171
Lee, H. J., P-299, P-488
Lee, H. L., P-78, P-85, P-176, P-581
Lee, J., O-355
Lee, J. A., O-67, O-244, O-359, P-236, P-560
Lee, J. H., P-51, P-56, P-240, P-536
Lee, J. R., P-214
Lee, J. S., P-220
Lee, K. E., P-50
Lee, K. H., P-51, P-56, P-240, P-264, P-414, P-536
Lee, K. Y., O-287
Lee, K. H., P-326, P-480, P-511
Lee, M., P-341
Lee, S. G., P-50
Lee, S. K., O-91
Lee, S. H., P-558
Lee, T. L., P-78
Lee, W. D., P-154
Lee, W. S., P-57, P-450, P-498, P-507, P-528
Lee, Y., P-363
Legidos, V., P-172
Lehert, P., O-262
Lehman, M., O-70
Lehmann, L., P-505
Lehmann, P., O-126, P-12
Lehmann, S., P-387
Leis, L., O-159
Lejeune, B., P-478
Leonard, P. H., P-458
Leondires, M. P., O-96, O-198, O-362, P-307, P-553
Leppert, P. C., P-405
Lerner-Biber, J., P-439
Lesh, J., O-78
Leslie, K. K., P-255
Lessard, M., O-36
Lessey, B., O-279
Lessey, B. A., O-309, O-311
Lessing, J., O-322, P-24
Lester, W. S., O-325
Letourneau, J., O-111, O-152
Letourneau, J. M., O-150, O-327, P-31, P-35
150
Leung, P. C., P-292
Leung, P. K., P-304
Levens, C. V., O-166
Levens, E. D., O-331
Levine, B. A., P-145
Levine, Z., P-577
Levitas, E., O-147
Levran, D., P-226
Levy, B., O-93, O-194
Levy, G., O-243, O-281, O-323, P-401, P-408, P-567
Levy, M., O-8
Levy, M. J., O-248, O-281, O-346, P-423
Lewis, A. M., O-325
Lewis, E. I., P-343
Li, F., O-77, O-231
Li, G., O-199, O-364, P-173, P-268
Li, J., O-270, P-348
Li, J. y., O-139
Li, L., P-526
Li, M., P-388
Li, P. S., O-133, P-115
Li, S. W., P-526
Li, Y., O-107, P-465
Lian, F., P-509
Liang, P., P-268
Liang, X., O-306, P-221, P-348, P-371
Liao, C., P-371
Libfraind, L. L., P-423
Librach, C. L., O-158, P-483
Licciardi, F., P-251
Lichtblau, I., O-31, O-274, O-297, P-469
Liebermann, J., O-221, P-52, P-186, P-193
Lieman, H., O-253
Lier, M. C. I., P-580
Lierman, S., P-134, P-599
Lim, J. H., P-50
Lim, J. J., O-73
Lima, C. B., O-174
Lin, S. N., P-495
Lin, W., O-335
Lin, X. H., P-340
Linden, M., O-34
Lindenthal, B., O-110
Lindheim, S. L., O-157
Lindqvist, P. G., P-493
Link, B., O-267
Link, C., P-420
Link, M. H., P-310
Lipshultz, L. I., O-3, O-296
Lipskind, S. T., P-520
Littman, E., P-91, P-559, P-579
Litwicka, K., O-216
Liu, D., O-36, O-255
Liu, H. C., O-85, P-8
Liu, J., P-90
Liu, Q., P-323, P-325
Liu, S., P-2
Liu, X., O-270, O-319, O-335, P-90
Liu, X. m., O-139
Liu, Y., O-199, O-270
Llacer, J., P-6, P-133, P-205, P-442
Lledo, B., P-6, P-133, P-442
Lo, J., O-198, O-362
Lo Turco, E. G., O-174, P-119, P-319, P-448
Lobascio, M., O-360
Lobo, R., P-13
Loeb, A., O-299
Loewke, K., O-100, P-598
Loh, S. F., P-453
Lohiya, N. K., P-274
Loi, L., O-65, P-46
Lonczak, A., O-372
Lopez, C., P-91, P-559, P-579
Lopez, G., P-466
Lopez, P., P-73
Lorch, S. A., O-163
Loret de Mola, J. R., P-388
Losonczi, E., P-194
Lourie, N., O-162
Louwe, L. A., P-37
Lu, C. w., O-184
Lu, N., P-474
Lucas, J. A., O-104
Luke, B., O-51, O-164, O-257, P-502, P-545
Luna, M., P-7, P-257, P-560
Lunenfeld, E., O-316, P-459
Lunsford, A. J., O-38
Lynch, K., P-250, P-260
Lynch, K. A., P-484
Lynen, R., P-278, P-284
Lynne, C. M., O-135, O-298
Lysakova-Devine, T., O-310
Ma, F., P-509
Ma, L., O-319
Ma, S., O-39
Ma, W., O-306
Ma, X., O-76, P-405
Maas, D. H. A., O-42, P-468
Maas, K., P-568
MacAdam, R., P-86
Mack, W. J., O-143
Macones, G. A., O-326
Maddah, M., P-598
Madjar, I., O-317
Maduro, M. R., P-234
Maezawa, T., P-253
Mafra, F. A., P-353, P-362
Maftoum, C., P-358
Mage, G., P-350
Mahadevan, S. K., P-325
Mahdavi, A., O-13
Mahller, Y., P-159
Mahony, M. C., O-247
Mahutte, N., O-167
Maille, N., O-201
Mainigi, M. A., P-30
Maisenbacher, M., O-180, P-269
Maitra, S., O-242, P-399, P-402
Makhijani, R. B., O-125
Makwana, P., P-477
Malcov, M., O-63
Malhotra, N., P-494, P-552
Malik, M., O-237, O-238, O-243, P-396, P-401, P-407, P-408
Malizia, B. A., P-314
Malmsten, J. E., O-162
Malpani, S., O-226, O-308
Malter, H. E., O-282, P-331
Mami, N., P-187
Manahan, K. J., O-328
Mancisidor, I., P-142
Mangal, R., P-534
Mannaerts, B., O-109, P-555, P-574
151
Mansell, S. A., O-40
Mansour, W., P-132
Maquire, M., O-8
Mar, M., P-172
Marconi, M., O-299
Marcos, J., P-479, P-584
Mariani, B. D., P-79, P-84
Marmar, J. L., P-121
Marqueta, J., O-60
Marr, S. G., O-119
Marsh, E. E., O-240, O-241
Marshall, M., O-52
Marshburn, P. B., O-127, O-343, O-377
Martínez, C., P-230
Martínez, E., P-104
Martínez Morales, M., P-180
Martin, D. C., P-394
Martin, J. R., P-63
Martin, K., P-262
Martinez, A. M., O-157
Martinez, B., P-266
Martinez, H., O-67
Martinez, S., O-112
Martins, M. C. E. C., P-183
Martins, W. de P., O-291, P-434
Martins, W. P., P-432
Martins da Silva, S. J., O-284
Maruniak, K., P-29
Maruoka, R., P-1
Maslow, B.-S. L., O-18
Massasa, E., O-66
Mateo, S., P-163
Mateu, E., P-576
Mathur, N., P-271
Matsumoto, H., P-239
Matsumoto, T., P-288
Matsuo, K., P-318
Matsuzaki, S., P-350, P-389
Matthews, J. M., O-221, P-52, P-193
Matthews, M. L., O-127, O-343, O-377
Mauny, F., P-224
Maxson, W. S., P-419
Mayer, J., O-267
Mazur, E. C., P-14
McAdoo, S., O-93
McAsey, M. E., P-305, P-388
McAvey, B., P-421, P-585
McAvey, B. A., P-381
McCaffrey, C., O-54, O-207, P-82, P-176
McCallie, B., O-211
McCallie, B. R., O-56, O-200
McCormick, K. L., O-38
McCormick, S., O-45
McGee, W. K., O-212, O-213
McGovern, P. G., P-444, P-452
McIntyre, M. G., O-296
McLaren, J. F., O-38
McLean, M. R., O-137
McMenamin, M., O-310
McNatty, K. P., O-55
McReynolds, S., O-272, O-365
Medina, R., P-439
Mehta, A., P-116, P-316, P-462
Meisler, H., P-53
Mejia, A., O-128
Melamed, A., O-219
Melnick, A. P., P-495
Melzer, K., O-35, P-23
Melzer, K. E., O-207, O-320, P-82
Menard, S., O-187
Mendiola, J., O-134, O-155
Meng, Y., O-305
Mennes, P., O-116
Mercader, A., P-95, P-576
Merhi, Z., O-103
Merhi, Z. O., P-311
Mersereau, J. E., O-29, O-292, O-374, P-58, P-69
Meseger, M., O-361
Meseguer, M., O-58, O-367, P-104, P-169, P-210, P-217, P-317
Meseguer Escrivá, M., P-180
Messeguer, M., P-144
METEX Study Group, O-4
Meuter, A., P-592
Mey Raz, N., O-322
Meyer, L., O-273, P-294, P-404, P-500, P-503
Meyer, W. R., O-245
Michaeli, M., P-155, P-322, P-328
Michaeli, T., P-299
Mickey, L. G., P-418
Micks, E., P-275
Mielnik, A., P-116
Mifsud, A., O-361, P-317
Mignini Renzini, M., P-499
Mijatovic, V., P-379, P-580
Mikkelsen, A. L., O-366
Milad, M. P., P-395
Milan, M., O-181
Milette, B., O-370
Miller, J., P-99
Milnes, R. C., P-165
Minasi, M. G., O-216, O-360
Mindes, E. J., O-151
Minium, J., O-210
Minjarez, D., O-1, O-211
Minter, T., P-548
Mio, Y., P-178
Miranda, R., P-211
Mishra, S., P-435
Missmer, S., O-224
Missmer, S. A., O-186, P-315, P-359, P-520, P-531
Mitalipov, S., O-363
Mitchell, L., O-21
Mitchell, S., O-34, O-56
Mittal, S., P-552
Mizunuma, H., P-222
Modi, M., O-66
Mohamed, M., P-590
Mohanty, K., P-435
Mok-Lin, E., O-191, O-260, P-216, P-294
Moley, K., P-131, P-258
Moley, K. H., O-80
Molina, J., P-160
Molina Sabater, J. M., P-261
Molinaro, T. A., O-163, P-490, P-578
Moliner, B., P-205
Mollá, M., P-479, P-492, P-584
Molskness, T. A., P-375
Monahan, D., O-293, P-135, P-456
Monceau, E., O-259
Monsivais, D., O-226, O-308
Montani, D. A., P-119
Montanino Oliva, M., O-251
152
Monzo, C., P-327, P-386
Moon, C., O-220
Moon, J. H., O-269
Moon, K., O-170, O-175, P-207
Moon, S. Y., P-564
Moore, M., P-307
Moore, M. E., O-96
Moragianni, V. A., O-146, O-324
Morales, R., P-133, P-442
Morbeck, D. E., O-94, O-97, P-458
Morbeck, M., P-592
Morelli, S., P-444
Morelli, S. S., P-452
Morente, C., P-374
Morgan, T., P-105
Mori, R., P-239
Morimoto, Y., O-332, P-40, P-252, P-253
Morin, S., O-183, P-85
Morin-Papunen, L., O-6
Morita, H., P-162, P-517
Moroi, H., P-238
Morrell, T. J., P-19
Morris, E. B., P-84
Morris, P. L., O-21
Morrison, L. S., O-99, O-304, P-93
Morse, C. B., O-18, O-339
Mosin, V., P-475
Moskovtsev, S. I., O-158, P-483
Mostafa, S., O-75, P-156
Motato, Y., O-367
Motta, E. L., P-94
Motta, E. L. A., P-152, P-211, P-233, P-361
Mouhayar, Y., O-128
Moussavi, F., P-598
Moy, F., O-30, P-20, P-25, P-33
Mrázek, M., P-242, P-382
Mu, F., O-224
Mucowski, S. J., O-143
Muela, L., P-172
Muela García, L., P-180
Mugica, A., O-60
Mugisha, J., P-455
Mukaida, T., O-217
Mukamal, K., O-224
Mukherjee, T., O-359
Mumford, S., O-24, P-397, P-595
Mumford, S. L., O-82
Munch, E. M., P-323
Muneto, T., P-237
Muneyyirci-Delale, O., P-301, P-303, P-312, P-346
Munne, S., O-177, P-73, P-82, P-168, P-170
Munoz, E., P-198, P-266
Munoz, M., O-349, P-169, P-172
Muñoz Cantero, M., P-180
Muñoz Ramirez, J., P-196
Munuce, M., P-374
Murakami, M., O-337
Murawski, M., O-275
Murdock, C. M., O-96, O-198, P-307
Murphy, M. J., O-72
Mutlu, F., P-431
Mutlu, L., O-66
Na, B. J., O-91
Nabel, A., P-149, P-416
Nacharaju, V., P-303, P-312
Nachtigall, R. D., O-145, P-412
Nada, Y., P-161
Nadarajah, S., P-453
Nagai, R., P-41, P-185, P-235, P-241
Nagaoka, Y., P-5
Nagarkatti, M., O-311
Nagata, Y., P-227
Nagayoshi, M., P-103
Nagy, Z. P., O-218, O-220, O-278, O-356, P-148
Nair, S., O-239, O-242, P-399, P-402
Najari, B. B., O-133, P-115
Najeemuddin, R., P-540
Najita, J., O-25
Nakahara, T., O-373, P-428
Nakamo, R. E., P-48
Nakamura, K., P-1
Nakamura, T., O-373, P-428
Nakaoka, Y., P-40, P-252, P-253
Nakayama, K., P-241
Nakayama, T., P-370
Nandi, N., P-336, P-449
Nangia, A. K., O-20, P-443
Napoly, V., O-297
Naqvi, H., O-307
Nardandrea, A., P-215
Nayak, S. R., P-551
Nazzaro, A., P-550, P-571
Neal-Perry, G., O-103, P-308
Neeman, M., O-233
Nehir, A., P-392
Nelson, A., O-15, O-16, P-277
Nelson, A. L., P-278, P-284
Neme, R. M., P-347
Neri, Q., O-295
Neri, Q. V., O-293, P-108, P-135, P-456
Neupane, J., P-599
Nguyen, K.-H. N., P-433
Ni, L., O-85, P-8
NICHD Reproductive Medicine Network, O-215
Nicholson, W. K., P-400
Niederberger, C., P-111
Nieman, L., O-323
Niemasik, E., O-111, P-31
Niemasik, E. E., O-150, O-152, O-327, P-35
Nikiforaki, D., P-134
Nisenblat, V., P-356
Nissar, M., P-477
Nnoaham, K. E., O-229
Noblia, F., P-149
Nodar, F., O-276, P-142, P-146, P-440
Noel, M., P-404
Nogales, M. del C., P-104
Norcross, A., P-121
Norian, J. M., P-19
Norkosky, L. A., O-62
Notarangelo, L., O-235, P-55
Nouchy, M., O-31
Novik, V., P-79, P-84
Nowak, R. A., O-311
Noyes, N., O-35, O-54, P-23, P-176, P-417
Noyes, N. N., O-24
Nugent, N., P-249
Nulsen, J., O-249, P-153
Nulsen, J. C., P-200, P-506
Nurudeen, S. K., P-13, P-514
Nutter, B., O-120, O-121, O-122
Nyalwidhe, J., P-544
153
Nyboe Andersen, A., O-169
Obeso-Montoya, I., P-256
Obradors, A., O-189
O’Brien, J., P-109
O’Brien, T., O-52
Ochalski, M., P-551
Ochi, M., P-162, P-517
Oddone, A., O-245
Odem, R. R., O-326, P-390, P-425
Odisho, A. Y., P-443
Oehninger, S., P-544
O’Farrelly, C., O-310
Oge, T., P-166
Ogut, S., P-431
Ogwo, C. C., P-36
Oh, C., O-54, P-176, P-251
O’Herlihy, C., O-310
Ohgaki, A., O-332
Ohmichi, M., P-1, P-16, P-355
Ohno, H., P-41, P-185
Ojeda, M., P-198
Oka, C., O-217
Okada, H., O-44
Okada, M., P-238
Oktay, K., O-30, O-77, O-115, O-231, O-252, O-321, P-20, P-25,
P-33
Oktem, M., P-206, P-208
Okuda, K., P-355
Okuka, M., O-291
Olcha, M., O-378
O’Leary, T., O-64
Oliveira, F. D., P-107
Omurtag, K., O-326, P-131
Omurtag, K. O., O-329
Omurtag, K. R., P-390
O’Neill, K. E., O-80, P-258
Oostra, A., O-50
Oosumi, K., P-40
Ori, A., O-369
Orozco, I., O-41
Orris, J. J., P-88
Ortega, I., O-214
Ortega-Hrepich, C., P-45, P-151, P-218, P-338
Ortiz, J. A., P-6, P-442
Orvieto, R., P-459
Orwig, K. E., O-113
Ory, S. J., P-419
Osborne, S. E., P-36
Osheroff, J. E., O-258
Osianlis, T., P-225
Osol, G., O-201
Osteen, K. G., O-104, O-223, P-406
Osterberg, E. C., P-111, P-113
Osuga, Y., P-297
Ota, K., O-87
Othman, A., O-89, O-347
O’Toole, P. D., P-289, P-300
Otsu, E., P-18
Otto, B. J., P-113
Otu, H. H., O-341
Ouchchane, L., O-265
Ouhilal, S., O-167
Oulhen, N., P-26
Owens, A. E., O-118
Ozatik, O., P-166, P-431
Ozgur, S., P-208
Ozkaya, E., O-30, O-231, P-20, P-25, P-33
Ozogul, C., O-315
Pabón, D., P-447
Paczi, I., P-556
Paczkowski, M., P-29, P-143
Padilla, W. O., P-111
Padilla-Banks, E., O-106
Paduch, D., P-462
Paduch, D. A., O-275, P-116, P-316, P-437
Paganetti, E. L., O-96, P-553
Page, A. M., P-228, P-394
Pal, L., O-105, O-209, O-215
Palermo, G., P-108, P-456
Palermo, G. D., O-293, O-295, P-135
Palhares Jr, M. B., P-432
Palhares Junior, M. B., P-434
Palmer, G., P-194
Palumbo, A., P-427
Pandian, R., P-565
Pani, J., P-435
Papadakis, M. H., O-343
Papaioannou, S., P-165
Papier, S., O-276, P-146, P-440
Papier, S. D., P-416
Parekattil, S., P-117, P-118, P-122
Park, C., O-88
Park, C. W., P-220, P-330, P-342
Park, E. A., P-498, P-507, P-522
Park, H. I., P-240
Park, H. T., P-366
Park, I. H., P-51, P-56, P-264, P-414, P-536
Park, J. C., O-287
Park, J. E., P-450
Park, J. K., O-245, P-471
Park, K. E., P-154
Park, S. Y., P-523
Park, Y.-S., P-558
Parker, J. B., O-241
Parks, J. C., O-56, O-200
Pasch, L., O-47, O-206
Pasch, L. A., O-138, O-145, P-412
Pasquale, P., P-234
Passoni, M. R., P-412
Pastuszak, A. W., O-3
Patel, A., O-22
Patrizio, P., O-65, P-46, P-63, P-68
Patton, P., O-363
Patuszack, A., O-296
Pau, K.-Y. F., P-293
Paull, D., O-67
Paulo, S., P-361
Paulson, R., O-27, O-143, P-335
Paulson, R. J., O-219
Pavesi, M., P-527
Pavone, M. E., O-226, O-308, P-415
Pawlowska, E., O-221
Payne, C. J., O-69
Paz, G., P-155, P-367
Peña, O., P-427
Peñalva, I., O-358
Peck, A. C., P-582
Pedroso, D. C. C., O-291
Peinado, V., P-95
Pellicer, A., O-181, P-383, P-487, P-496, P-543, P-576
Pellicer Martínez, A., P-261
Pelts, E. J., P-52, P-186, P-193
154
Peluffo, M. C., O-110
Peluso, C., O-351, P-353, P-362
Penrose, L., P-538
Penzias, A., O-168
Penzias, A. S., O-324, P-314, P-515, P-543
Pepas, L., P-590
Pepe, R., P-74
Pepin, L., O-249
Pereira, M. M., P-190
Peres, M. A., P-211
Perez, M., P-198, P-230, P-339, P-385
Pérez, S., O-361
Perez, O., P-98
Perez, S., P-561
Perez-Cano, I., P-169, P-180
Perisic, D., P-287
Perloe, M., O-14, P-81
Pesce, R., P-280
Peskin, B., O-338
Peters, V. M., P-190
Peterson, C. M., P-352
Petracco, A., P-461
Petrie, K. A., P-283
Petrozza, J. C., O-12, P-411
Petterkin, C., P-301
Pettersen, B., O-180
Pham, T. V., P-600
Phan, K. V., P-91, P-559, P-579
Phelps, J. Y., P-62
Phillips, S. J., P-524
Phung, K. G., P-368
Phy, J., P-463
Picchi, F. K., O-375
Piccinato, C. A., P-347
Piccolomini, M. M., P-233
Pierluigi, G., P-174
Pierson, R. A., P-242, P-382
Pilau, E. J., P-319, P-448
Piltonen, T., O-6, O-17
Piltonen, T. T., O-84
Pinarli, F., O-315
Pincus, S., O-116
Pinto, J., P-506
Pirrello, O., O-262
Pisarska, M., O-46, P-159, P-473
Pitangui, C. P., P-21
Pitigalaarachchige, S. L., O-39
Pitman, J. L., O-55
Pittenger, S. R., O-206, O-283, P-9
Pixley, R. M., O-127
Pliego, J. F., P-467
Plosker, S., P-215
Plowden, T. C., P-595
Plummer, K., P-502
Pocoski, J. L., P-281
Poirier, V., O-262
Poli, M., O-369, P-179
Polisseni, F., P-190
Polisseni, J., P-190
Pollack, L., O-326
Pollack, S. E., P-421
Pollard, J. W., P-381
Polotsky, A. J., O-78, O-354, P-293
Polyzos, N. P., P-218, P-338
Pons-Rejraji, H., O-265
Porcu, E., O-235, P-55
Portman, D. J., P-285
Portmann, M. P., O-99, O-304
Porucznik, C. A., O-82, P-310
Potter, D., P-105
Poulain, M., O-371
Pourret, E., O-68
Prates, R., P-87
Prewitt, M., O-286
Pribenszky, C., P-194
Prien, S. D., P-463, P-538
Priola, K., P-117, P-118, P-122
Pritchard, S., O-153, P-410
Privitera, L., P-317
Propst, A., O-24
Propst, A. M., O-288
Ptak, G., O-65
Puissant, F., P-49
Pujol, A., O-189
Purcell, M., O-248
Puurunen, J., O-6, O-17
Quaas, A. M., O-219
Quintana, F., O-358
Rabinowitz, M., O-93, O-95, O-180, P-105, P-269
Racowsky, C., O-186
Radaelli, M. R. M., P-53
Rader, D., P-332
Rahmanpour, H., P-286
Rainho, C. A., P-107
Ramalho-Santos, J., O-41
Ramanah, R., P-224
Ramasamy, R., O-295, P-111, P-113, P-115
Ramirez, L. B., O-112
Ramos, S. B., O-279, P-58
Rapelje, C., O-21
Rapisarda, J., P-52
Rarosi, F., P-556
Ratcliffe, S. J., O-163
Rauch, E. R., P-17
Ravhon, A., P-226
Raviv, G., O-317
Rawe, V., P-142
Rawe, V. Y., P-137
Rawlins, M., O-98
Ray, A., O-172
Raz, T., O-233
Reddy, J., P-20, P-25, P-33
Reddy, N., P-72
Reddy, V., O-301
Regiani, T., O-174, P-319
Reichart, A., P-194
Reichman, D. E., O-273, P-404, P-500, P-503
Reifsnyder, J., P-111
Reifsnyder, J. E., O-295, P-113
Reig, V., P-461
Reijo Pera, R. A., O-123
Reijo-Pera, R. A., O-283, P-9
Reinblatt, S., P-150
Reindollar, R. H., P-472, P-549
Reis, R. M., O-375
Reis, R. M. dos, O-291
Remohí, J., O-181, P-266, P-447, P-487
Reproductive Medicine Network Investigators, O-209
Requena, A., O-349
Rescildo, M., O-249
Resende, S., P-223
Ressler, I. B., O-157
155
Retzloff, M. G., O-288
Reyes, K., O-198, O-362
Rhee, J. H., O-287
Ribeiro, M. A., P-107
Riboldi, M., P-94, P-211, P-361
Ricciotti, N., P-285
Rich-Edwards, J., O-224, P-359, P-531
Richlin, S. S., O-96, O-362, P-307, P-553
Richter, K., O-49, O-168, O-170, O-175, O-281, O-331, O-346,
P-204, P-207, P-533
Richter, K. S., O-8, O-151, O-248, O-258, P-423
Riestra, B., P-529
Riestra Marteleur, B., P-416
Rimm, E., O-224
Rinaudo, P., O-41, O-335, O-345
Ripps, B., O-356
Riqueros, M., P-160
Riqueros Arévalo, M., P-261
Ritenour, C. W. M., O-330, P-460
Roan, N., P-369
Roberts, S., P-225
Robertson, S. A., P-356
Robins, J., P-26
Robins, J. C., P-181
Robinson, R. D., O-288, P-597
Roca, F. J., P-14
Rocca, W. A., P-398
Rocha, A. M., O-70
Roche, M., P-73
Rochetti, R. C., O-174
Rocio, C. P., P-174
Rodríguez, F., O-190
Rodrigo, L., P-95
Rodrigues, J. K., P-302
Rodrigues, R. S., O-263, P-223
Rodriguez, A., P-133, P-205
Rodriguez B., M. A., O-128
Roe, A., P-332
Roehl, K. A., O-101
Roeyers, H., O-50
Rogmann, L., P-592
Roldan, M., P-169
Romão, G. S., P-434
Romero, J. L., P-447
Rongieres, C., O-262
Ronn, R., P-573
Roqueiro, D., P-351
Rosa-e-Silva, J. C., P-347
Rosales-DeLeon, J., P-256
Rosario, M., O-131
Roseff, S. J., O-251
Rosen, K., O-15, O-16, P-277, P-278, P-284
Rosen, M., O-111
Rosen , M., O-150
Rosen, M., O-152, O-252, O-327, O-345, P-35
Rosen, M. P., O-138, O-142, P-201
Rosenberg, A. Z., O-236
Rosenbluth, E. M., O-59
Rosenwaks, Z., O-85, O-162, O-191, O-260, O-273, O-293, P-8,
P-71, P-89, P-108, P-135, P-216, P-294, P-391, P-404, P-456,
P-500, P-503
Ross, L. A., O-78, O-131
Rossi, B. V., O-338, P-520
Rote, N. S., O-210
Roth, L. W., O-211
Rothman, C., P-470
Rougier, N., P-440
Roux, I., O-28
Rouzi, A., O-160
Rova, K. V., P-493
Roy, R. R., P-336
Royer, P. A., O-72
Ruan, J., P-114
Rubal, L., O-156
Rubino, P., P-174
Rubio, C., O-181, P-95
Rubio, I., O-58, P-171, P-561
Ruiz, A. A., O-372, P-587
Ruiz, O., O-60
Ruiz-Alonso, M., P-383
Ruokonen, A., O-6, O-17
Russanova, V., O-197
Russell, J. B., O-153, P-410
Ryan, A., O-95
Ryan, A. R., O-354
Ryan, G., O-36
Ryan, G. L., O-325
Rybowski, S., O-16, P-277
Ryley, D., O-146
Sá, P. G., P-183
Sá Rosa-e-Silva, A. C., P-21
Sánchez, A., P-492
Sánchez León, A., P-479
Sabanegh, E. S., O-132, P-106
Sabanegh Jr, E., P-34, P-123, P-124, P-126, P-429
Sabatini, L., P-590
Sacara, V., P-475
Sachs, P., O-151
Sadeu, J. C., P-324
Saed, G. M., O-368, P-384, P-403
Safdarian, L., O-13, P-286
Saglam, O., O-312
Sahin, G., P-562
Saikaya, E., P-516
Saioa, T., P-68
Saker, A., O-347
Sakinci, M., P-530
Sakkas, D., O-324, O-370, P-63, P-96, P-433, P-515
Sakr, S. H., O-307, P-570
Salafia, C., P-577
Salama, E. A., P-521
Salamonsen, L. A., O-71
Salas Mann, J., O-49
Salem, R., P-90
Salem, R. D., P-582
Salem, S., P-90
Salem, S. A., P-582
Salem, W., O-111
Salerno, A., P-550, P-571
Sallam, A. N., P-232
Sallam, H. N., P-232
Sallam, N. H., P-232
Salman, S. A., P-267
Samama, M., P-229
Samawi, S., O-89, O-347
Sammel, M., O-81, O-289, O-376, P-295, P-296
Sammel, M. D., O-141, O-286, O-292, O-339, O-374, P-30,
P-589
Samplaski, M. K., O-132, P-106
San Gabriel, M., P-130, P-436, P-441
Sanchez, L. A., P-339, P-385
Sanchez, S. R., O-221, P-52, P-193
156
Sandalinas, M., P-73
Sandler, B., O-359, P-7, P-257, P-560
Sands, M. C., P-79
Sanfilippo, S., P-64
Santoro, N., O-78, O-250
Santos, X. M., O-37
Santos-Haliscak, R., P-256
Sarac, G. N., O-315
Sargin, A., P-516
Sarid, O., O-147
Sarvi, F., P-286
Saso, S., P-38
Sasson, I. E., P-589
Sato, K., P-237
Sauber-Schatz, E., P-298
Sauer, M. V., P-13, P-514
Sauerbrun-Cutler, M., P-341
Saumet, J., O-126, P-12
Savolainen, M. J., O-6
Saymé, N., O-42, P-468
Sazonova, A., P-547
Sbracia, M., O-2, O-227
Scarano, W. R., P-107
Scarpellin, F., O-227
Scarpellini, F., O-2
Scarselli, F., O-216, O-360
Schanne, A., O-18, O-286
Schats, R., P-580
Schattman, G., P-17, P-404
Schattman, G. L., O-275, P-89, P-391
Schelstraete, L., O-190
Schenk, L., P-534, P-600
Schenken, R. S., P-597
Schiewe, M. C., P-59, P-249, P-470
Schiff, M. A., O-144
Schisterman, E. F., O-82
Schleck, C. L., P-398
Schlegel, P., O-293, P-445
Schlegel, P. N., O-295, P-111, P-113, P-115
Schliep, K. C., O-82, P-310, P-352
Schmidt, E. M., P-245
Schneider, D. T., P-195, P-231
Schoeller, E., P-131
Schon, S., P-306
Schon, S. B., P-425
Schoolcraft, W., O-34, O-56, O-200, O-203, O-211, P-76, P-143
Schoolcraft, W. B., O-1, O-98, O-365, P-29, P-188
Schreiner, P., O-137
Schuetzle, M., O-32
Schulte, M., P-306
Schulte, M. B., P-258
Schulte, M. M. B., O-80, P-425
Schutt, A. K., P-14
Schwerda, D., O-192
Scosyrev, E., P-109
Scott, R., O-57, O-83, O-194, O-196, O-203, O-300, O-352,
O-353, O-372, O-378, P-65, P-74, P-76, P-177, P-189, P-321,
P-578, P-591
Scott III, R. T., P-97, P-177
Scott, Jr., R. T., O-1, O-45, O-161, O-178, P-587
Scrooc, M., O-156
Sebag-Peyrelevade, S., O-371
Secilmis Kerimoglu, O., P-530
Sedler, M., O-182
Segars, J., O-170, P-204, P-397
Segars, J. H., O-236, O-238, P-304, P-396, P-401, P-481, P-567
Segars, Jr., J., O-197
Seifalian, A., O-79
Seifer, D. B., O-282, P-331
Seita, Y., O-184
Seli, E., O-188, O-234, O-312, O-333, P-209, P-489, P-546
Semião-Francisco, L., P-229
Semmes, J., P-544
Senapati, S., O-129, O-376, P-295, P-296
Seo, B. K., P-456
Seo, J. S., P-507
Seo, J. T., P-558
Seo, S. K., P-357, P-363, P-364
Seok, H. H., P-522
Serafini, P., P-94, P-152, P-233
Serdarogullari, M., P-120
Serna, J., O-276
Serra, A., O-60
Servaes, K., P-377
Sethi, R., P-433
Setti, A. S., O-263, O-268, P-102, P-223
Seungdamrong, A., P-444, P-452
Sfontouris, I., P-497
Shaaban, O. M., P-267
Shah, A., O-172
Shah, D. K., O-186, P-315, P-505
Shah, M., O-152
Shah, P., O-296
Shalev, S., P-505
Shalom-Paz, E., O-10, O-28, O-318, P-573
Shamsi, M. B., P-457
Shanis, D., O-225
Shao, X.-G., P-136
Shapiro, B., O-109
Shapiro, B. S., O-222, O-256, O-342, P-54, P-81
Shapiro, D., O-218
Shapiro, D. B., P-148
Sharan, C., O-239, O-242, P-399, P-402
Sharara, F. I., O-173
Sharif, J., O-89, O-347
Sharma, H., P-577
Sharma, R., P-34, P-123, P-124, P-126, P-429
Sharma, S., P-557
Sharma Palchaudhuri, S., P-491
Shastri, S. M., O-83
Shaulov, T., P-524, P-525
Shaunik, A., O-81, P-296
Shavell, V. I., P-540, P-542
Shavit, T., P-155, P-328
Shchegolev, A., P-532
Shehab, D., O-145
Shelly, K. E., P-93
Shelton, D. N., O-59
Shen, M. S., O-264
Shen, S., O-53, O-100
Shen, X., P-75
Sheng, J. Z., O-305
Shepard, M. K., O-210
Sherri, W., P-86
Shi, H. J., O-107, P-465
Shi, L., P-509
Shi, S., O-139, O-319
Shim, S. H., P-450
Shin, D. H., O-334
Shin, J. E., P-523
Shin, J. H., P-366
Shinkai, K., O-206
157
Shinkunas, L. A., O-325
Shmorgun, Z., O-158
Shohat-Tal, A., O-282, P-299, P-331
Shoupe, D., O-143
Shrestha, S. L., P-79
Sia, C. L., O-210
Siddique, S. A., P-305
Siero, V., P-385
Sigurjonsson, S., O-180, P-269
Silber, D. Z., O-114, O-116
Silber, S. J., O-114, O-116
Sills, E. S., P-582
Sills, S., P-90
Silva, C., O-291, O-375, P-215
Silva-de-Sá, M. F., P-21
Silván Bueno, A., P-196
Silverberg, K., P-548, P-548
Silverberg, K. M., P-263
Simbulan, R., O-335
Simoens, S., P-360
Simon, C., O-112, O-181, P-95, P-383
Simpson, J. L., P-323, P-325
Sims, C. A., P-470
Sina, S., O-13
Sinaii, N., O-225, P-346
Singer, C. F., P-3
Singer, T., P-89, P-391
Singh, M., P-540, P-542
Singh, N., P-552
Singh, S., P-557
Singh, S. R., O-357
Sioulas, V. D., O-289
Sipe, C., O-221, P-186
Sirota, I., P-262, P-344
Siscovick, D., O-137
Sisti, J. S., P-314
Sites, C., P-484
Skaznik-Wikiel, M. E., O-113
Skillern, A., O-47
Slawny, N. A., O-74
Slayden, O., O-309, P-275
Slayden, O. D., O-71, O-213, P-375
Slayden, S. M., O-278
Smit, V. T. H. B. M., P-37
Smith, G. D., O-70, O-74, O-266
Smith, J. F., P-443
Smith, J. R., P-38
Smith, K. N., P-415
Smith, K. W., O-108
Smith, M., P-332, P-417
Smith, M. B., O-54
Smith, R., O-45
Smitz, J., P-45, P-151, P-338
Smotrich, D., P-86, P-100, P-170
Smotrich, D. B., P-83, P-92
Snegovskikh, V., O-66
Snow-Lisy, D. C., O-132, P-106
Soares, J. B., O-159
Soh, S., O-44
Sojecki, A., O-158
Sokal-Arnon, T., O-10, O-28, O-318, P-569, P-573
Sokalska, A., O-214, O-223
Soligo, A. G., O-263
Sollmann, K., P-468
Solomayer, E., P-446
Son, W. Y., O-261
Son, W. Y., O-28, P-150, P-569
Song, S. H., O-334, P-471
Song, S. H., O-73, P-450
Sorby, K., P-225
Sorici, N., P-475
Soto, E., O-120, P-418
Souter, I., O-12, O-108
Spaine, D. M., P-127
Spandorfer, S., O-191, O-273
Spandorfer, S. D., O-260, P-294
Sparks, A., O-255, P-588
Sparks, A. E., O-59
Sparman, M., O-363
Spitzer, T. L. B., O-84
Splingart, C., P-10, P-426
Sprung, V. S., P-329
Srivastava, M. D., O-92
Sroga, J. M., O-76, O-157
St. Marie, P., P-250, P-260, P-484
Stahl, P., P-316
Stampfli, M. R., P-372
Stanford, J. B., O-82, P-352
Stanford, J. L., P-125
Stankewicz, T. L., P-88
Stanley, J., O-110
Stanley, S. D., O-214
Stanley, W. S., P-84
Starr, J. R., O-144
Stecher, A., O-192
Steenblock, K., O-32
Stein, D., P-262, P-337, P-341
Stein, D. E., P-344
Steiner, A. Z., O-102
Steinkampf, M. P., O-246
Stelling, J. R., P-289, P-300
Stephens, S. M., P-293
Stephenson, M. D., P-271, P-313
Stern, H. J., P-79, P-84
Stern, J. E., O-164, O-257, P-545
Sternfeld, B., O-137, O-142, O-283, P-9
Stevens, J., O-45, O-98, O-365, P-74, P-188
Stevens, J. M., O-203
Stevenson, E. L., P-4
Stewart, E. A., P-398, P-400
Stillman, R. J., O-49
Stoop, D., P-43
Stouffer, R., O-230
Stouffer, R. L., O-110, O-212, O-213, P-302, P-375
Stratton, P., O-225, P-346
Streiby, A., O-56
Streuli, I., P-67
Streuli, I. M., P-202
Strieby, A., O-200
Strom, B. L., O-376
Strom, C. M., P-566
Stuart, J. M., O-112
Stuart, S. P., O-325
Stubbs, R., O-275, P-17
Stubbs, R. E., P-391
Stubezski, R., O-77
Styer, A. K., P-246
Su, H. I., O-29, P-333, P-565, P-568
Su, J., O-300, P-74, P-97, P-177
Su, Y., O-199, P-173
Suarez, M., O-301
Suciu, N., P-212
158
Sueldo, C., P-149, P-440, P-529
Sueldo, C. E., P-199, P-416
Sueldo, C. M., P-199
Sugita, A., O-373
Suh, C. S., P-154, P-214, P-393
Sukhikh, G., P-532
Sukhwani, M., O-113
Sullivan, M., O-267
Summers-Chase, D., P-244
Sun, H., P-167
Sun, H. G., P-51, P-264
Sun, H. G., P-56, P-414, P-536
Sun, Y., O-199, O-319, O-364, P-173, P-474
Sun, Z., P-509
Sunderam, M., P-298
Sunkara, S. K., O-48
Suraj, V., P-598
Surrey, E., O-1
Surrey, M., O-46, P-168
Suryanarayana, A., P-158
Suthar, G., O-281
Sutphen, R., O-32
Suzuki, N., P-238
Swain, J. E., O-266, O-271
Swan, S., O-155
Swan, S. H., O-134
Sylvestre, C., P-525
Synn, M., P-199
Taboas, E., P-198, P-266
Tachibana, M., O-363
Taha, A., O-89
Tajima, T., O-217
Tajkarimi, K., O-135
Takacs, P., O-289, P-295, P-296
Takahashi, K., O-217
Takahashi, T., P-318
Takai, E., O-313
Takai, M., P-1
Takayanagi, T., P-238
Takehara, Y., P-247
Takeuchi, M., P-212, P-235
Takeuchi, T., P-430
Tal, R., O-282, P-331
Talmor, A., P-225
Tamaki, T., P-161
Tan, C., P-453
Tan, H. H., P-453
Tan, O., O-280
Tan, S. L., O-261, P-219
Tan, T. Y., P-453
Tan, Y., O-305
Tanabe, A., P-1, P-16, P-355
Tanaka, A., P-103
Tanaka, I., P-103
Tanaka, J., P-237
Tanaka, Y., P-16
Tang, Y., O-85, P-8, P-270, P-593
Taniguchi, F., O-313, O-314
Tannus, S., P-226
Tao, X., O-161, O-178, O-194, O-196, P-74, P-97
Tapanainen, J. S., O-6, O-17
Taplamacioglu, F., P-166
Tarlatzis, B.C., P-497
Tasdemir, N., O-315
Tash, J., O-20
Tateno, H., P-175
Tavmergen, E., P-562
Tavmergen Goker, E. N., P-562
Tawara, F., P-370
Taylor, D., O-178, O-300, P-97, P-490
Taylor, D. M., O-83, O-196
Taylor, H., O-66, O-307
Taylor, H. S., O-204
Taylor, T., O-177
Taylor, T. H., P-88
Tea, M. K. M., P-3
Tejera, A., O-58, P-171, P-561
Tekeli, A., P-273
Teles, J., P-358
Ten, J., P-6, P-133, P-205
Terai, Y., P-16
Terakawa, N., O-313, O-314
Teranishi, Y., P-238
Teruel López, J., P-261
Thakur, M., P-542
Tholozan, A.-S., P-224
Thomas, C., O-232
Thomas, M. A., O-157
Thompson, S. M., P-444, P-452
Thoppil, J. J., O-288
Thouas, G. A., P-191
Thum, Y., P-38
Thurin-Kjellberg, A., P-547
Tian, S., P-340
Tiers, L., P-387
Timmerman, K. W., P-39
Ting, A., O-232
Ting, A. Y., O-5
Tirado, E., P-129, P-433
Titus, S., O-77
Tobias, T. M., O-247
Tobler, K. J., O-179, P-101
Tognotti, E., O-159
Toledo, A. A., P-148
Tolga-Suntay, B., O-103
Toll, C. B., O-151
Tomari, H., P-227
Toner, J. P., P-265
Toren, A., O-317
Tormasi, S., P-83, P-100
Torno, A. L., P-521
Torrealday, S., O-234
Torres, A., P-152
Torres, N., P-347
Torun, A., O-312
Toth, T. L., O-154, P-246
Tourgeman, D., P-566
Tournaye, H., P-43, P-45, P-151, P-218, P-338
Tozer, A., P-590
Tran, K. D., P-79, P-84
Tran, N. D., O-61
Treff, N., O-34, O-83, O-98, O-203, O-300, O-372, O-378, P-65,
P-74, P-76, P-97, P-177, P-189, P-321, P-578, P-591
Treff, N. R., O-161, O-178, O-194, O-196
Trejo, T., P-592
Tremellen, K. P., P-112
Treves, R., O-23
Trevisan, C. M., O-351
Trevisan, M. G., P-245
Trinh, T., P-192
Triplett, L., P-271
Trivedi, A., O-32
159
Truong, M., P-191
Trussell, J., P-281
Tsai, J. H., O-80, P-258
Tschirhart, M. J., O-184
Tso, L. O., O-159
Tsunetoh, S., P-16
Tsutsumi, R., O-303
Tucker, M. J., P-197
Tulandi, T., O-10, O-28, P-569
Turkkani, A., P-516
Turner, B. C., P-164
Turner, K., O-369
Tuuli, M. G., P-306
Tzebg, C. R., P-32
Tzeng, C. R., O-264
Uchimura, K., P-227
Ueda, M., P-178
Ueno, J., P-229
Ugozzoli Llugdar, M. F., P-416
Uhler, M., P-193
Uhlmann, R. A., O-368, P-36, P-384
Ulug, M., O-185, P-110
Ulug, U., P-120
Ulusoy Karatopuk, D., P-431
Underhill, L. A., P-181
Unfer, V., O-251
Urato, A., O-146
Urbina, M. T., P-439
Uriondo, H., P-440
Usadi, R. S., O-127, O-343, O-377
Ustun, Y., P-510
Usurelu, N., P-475
Utsunomiya, T., P-18, P-594
Uyar, A., O-333
Vaamonde, D., O-285
Vaamonde-Lemos, R., O-285
Vadehra, S. L., P-553
Vagman, I., O-322
Valentina, S., P-339
Vallejo, B., O-361
Valthaty, R., P-419
Van den Abbeel, E., P-147
Van den Veyver, I. B., O-37
Van der Jeught, M., O-64
Van Landuyt, L., P-45
Van Lierde, K., O-50
van Mello, N. M., O-4
Van Schoubroeck, D., P-377
Van Voorhis, B., O-255, P-588
Van Voorhis, B. J., O-59, P-255
Vanden Meerschaut, F., O-50, P-134
Vanderzwalmen, P., O-192, P-49, P-478
VandeVoort, C., O-106
Vandewoestyne, M., P-599
VanHorn, S., P-577
Varricchio, M. T., O-216
Vassena, R., O-189, O-190
Vasundhara, K. P., P-477
Vaughn, T. C., P-548
Vega, M., P-262
Veiga, A., P-163
Vela, G., P-7, P-257, P-560
Velez, F. F., O-247, P-420
Velez, M., P-525
Velez, M. Del P., O-126, P-12
Vélez, M. P., O-187, O-259, P-524
Venier, W., P-81
Venetis, C.A., P-497
Vera, M., P-95
Verheyen, G., P-151
Verma, U., P-422
Vermilyea, M. D., P-197
Vernaeve, V., O-189, O-190
Verweij, P., P-555
Verza Jr, S., P-195, P-438
Victor, A. R., P-71, P-89
Vidal, C., P-496, P-561
Vidal, R., O-190
Vieira, C. S., O-375
Vilella, F., O-112, P-383
Villanueva, J., O-223
Villanueva, J. A., O-214
Viloria, T., P-447
Vincens, C., P-386
Vincent, C., O-68
Viot, G., P-67
Vireque, A. A., P-21
Visnova, H., P-242
Vitonis, A., P-359
Vitthala, S., P-477
Vlismas, A., P-590
Vollenhoven, B., P-225
W. E. R. F. EndoCost Consortium, P-360
Wagner, K., P-3
Wagner, Y., P-186
Wagner-Coughlin, C., O-356
Waisman, J., O-27
Wakim, A. N., P-551
Wakim, K., P-551
Walker, D. L., O-94, O-97
Wallach, E. E., P-583
Walsh, K., O-233
Walsh, T. J., P-125
Wang, C. W., O-264, P-32
Wang, E. T., O-205
Wang, L., P-136, P-509
Wang, R., P-509
Wang, S., O-354, P-92, P-100
Wang, W., O-85, P-8
Wang, X., O-37
Wang, Y., P-526
Wantman, E., O-257
Ward, C. C., P-504
Ward, K., O-33, O-228, P-70, P-354, P-365, P-476
Watanabe, A., P-1, P-16, P-212
Watanabe, S., P-517
Weaver, A. L., P-398, P-458
Weghofer, A., O-7, P-3, P-488, P-535
Wei, Q., P-396
Weiss, D., O-277
Weiss, H., O-14, P-285
Weissman, A., P-226
Weitzman, G. A., P-99
Welch, C., P-83, P-100
Welch, L., P-463
Welkenhuysen, M., P-377
Wellons, M., O-137
Wellons, M. F., O-9
Wells, D., O-369, P-179, P-279
Wells, L., O-36
Wells, L. M., O-59
Wen, M., O-102
160
Wennerholm, U. B., P-547
Werneck, C. L. V., P-183
Werner, M., O-83, P-591
Werner, M. D., O-352, P-65, P-563, P-587
Wesley, R., O-323
Wessel, G., P-26
Wessels, C., P-538
Westhoff, C. L., P-283
Whelan, K., O-38
Whetstone, A., P-15
Whitehouse, M., O-244, O-355, P-7, P-236
Whitehouse, M. C., P-257
Whitney, J., P-59, P-249
Whitworth, C. M., P-99
Wiczyk, H., P-484
Widra, E., O-170, O-175, P-207, P-533
Widra, E. A., O-49, O-258
Wieser, F., P-359
Wilkinson, A., P-164
Willard, B., P-123
Williams, A., O-153, P-410
Williams, C. J., O-106
Williams, J., O-209, O-215
Williams, K., P-141
Williams, L. J., P-36
Williams, P. L., O-108
Williams, R. W., P-36
Willman, S. P., O-100
Wilson, C., P-15
Wilson, S. M., O-40
Wincek, T. J., P-467
Windsperger, A. P., O-20
Wingfield, M., O-310
Winter, J. A., O-117
Winterhoff, B., P-592
Wirleitner, B., O-192, P-478
Wiser, A., O-10, O-318, P-573
Wissing, M. L., O-366
Witjes, H., O-109, P-555, P-574
Witmyer, J., P-26
Witt, M. A., O-278
Wojcik, C., P-142
Wolff, E. F., P-423
Wolff, H. S., O-97
Won, H. J., P-498, P-528
Wong, A. W. Y., P-292
Wong, B., O-267
Wong, K. H., P-19
Wong, W. Y., P-376
Woo, I., O-26, P-373
Woodruff, T. K., P-39, P-541
Word, A. R., O-280
Wright, D., P-411
Wright, D. L., O-154, P-246
Wright, J. L., P-125
Wright, K. E., P-289, P-300
Wu, H. M., O-264
Wu, J., O-241
Wu, J. L., P-467
Wu, L. H., P-515
Wu, T., P-268
Wun, W.-S., P-534, P-600
Wyckoff, K. A., P-484
Xiao, Z., P-526
Xie, F., P-140
Xie, Y., P-352
Xin, Z., P-173
Xiong, L., P-140
Xiong, Y., O-305
Xu, F., O-232
Xu, G. F., P-340
Xu, J., O-230, P-302
Xu, K., P-71, P-89
Xu, Y., P-75
Yabuuchi, A., P-247
Yadav, S., P-124, P-126
Yadav, S. P., P-429
Yalcinkaya, T., O-357
Yalcinkaya, T. M., P-293, P-320
Yamamoto, A., O-332
Yamashita, Y., P-355
Yang, K. M., O-88, P-220, P-342, P-558
Yang, N. J., P-57
Yang, X., O-306, P-221, P-371
Yang, X. H., P-270, P-593
Yang, Z., P-90
Yano, T., P-297
Yanushpolsky, E. H., O-340
Yao, M. W., P-543
Yao, S., O-19, P-275
Yap, J., O-71
Yates, M. M., O-26, P-373, P-583
Ye, D. S., P-270, P-593
Yeh, J., P-334
Yeko, T., O-109
Yenicesu, O., P-516
Yeo, A. L., P-565
Yeoman, R., O-230
Yeoman, R. R., O-5, P-302
Yi, H., O-88
Yi, K. W., P-366
Yildiz, F., P-206
Yilmaz, N., P-510, P-516
Yin, B., P-268
Yoo, Y. J., P-243
Yoon, S. Y., P-57
Yoon, T. K., O-73, P-450, P-498, P-528
Yoshida, A., P-430
Yoshimura, T., P-235
Yoshino, O., P-297
Young, D., O-34
Young, S. L., O-279, O-309, O-311
Younger, J., P-421
Younis, J., P-459
Yu, A., O-253
Yu, B., O-197
Yu, J., P-276
Yuan, L., O-279, O-309
Yuguchi, H., P-355
Yumoto, K., P-178
Zacà, C., O-235, P-55
Zacur, H. A., P-583
Zahran, K. M., P-267
Zakarin, L., O-273
Zamah, A. M., P-140, P-141, P-201
Zaninovic, N., O-162, O-275, O-277, P-445
Zanirato, M., O-345
Zapantis, A., P-311, P-585
Zeadna, A., O-147
Zech, N. H., O-192, P-49, P-478
Zee, J., O-81
Zeidan, K., P-130
161
Zelinski, M., O-230
Zelinski, M. B., O-5, O-110, O-212, O-232, P-302
Zeng, Y., P-75, P-268
Zhang, C., P-71, P-89
Zhang, H. Q., O-107, P-465
Zhang, J., P-136
Zhang, J. J., P-145
Zhang, M., P-19
Zhang, N., P-167
Zhang, X., O-202
Zhang, Y., P-298
Zhao, Q., O-301
Zhao, T., O-57
Zhao, W., P-340
Zhao, Y., O-364
Zheng, H. Y., P-270, P-593
Zheng, X., P-168
Zhioua, A., P-187
Zhioua, F., P-187
Zhong, Y., P-75
Zhou, C., P-75
Zhou, J., O-311
Zhu, L., P-381
Zhuang, G., O-270
Zhylkova, I., P-464
Ziebell, K., P-335
Zieman, M., O-22
Zimmerman, Y. X., P-291
Zimmermann, B., O-95
Zini, A., P-130, P-436, P-441
Zondervan, K. T., O-229
Zozula, S., P-59, P-249
Zozulina, O., P-464
Zumoffen, C., P-374
Zuo, X., P-114
Zurth, C., O-15
162
PROGRAM PARTICIPANTS - NON-ORAL/POSTER PRESENTERS
Participants are indexed by page number.
Aboulghar, Mohamed A. p24, p46
Abuzeid, Mustafa p24
Acosta, M. p22
Adamson, G. David, p25, p34, p37,
p38, p42
Adaniya, Glen p12
Advincula, Arnold P. p48
Afeiche, M. p16
Agarwal, Ashok p12
Ahmady, A. p18
Akula, K. p18
Albert, Judith L. p48
Albertini, David F. p12, p34, p44
Al-Hendy, Ayman p12, p39
Allen, Rebecca H. p12, p33
Alper, Michael p24
Alvero, Ruben p12, p79
Amato, Paula p12
Anderson, Richard p44
Anderson, Tony p12
Angle, Marlane p12
Applegarth, Linda p25
Archer, David p24
Armstrong, Alicia Y. p12, p20, p24, p47
Arny, M. p22
Arslan, E. p17
Aubuchon, Mira p47
Awonuga, Awoniyi p12
Azem, Foad p24
Azziz, Ricardo p24, p25
Babayev, S. p17
Bacon, Janice L. p33, p53
Baillargeon, Jean-Patrice p12
Baird, Donna p12
Baker, Valerie L. p12, p49
Ball, G. David p12, p24, p25, p36, p73
Bailey, A. P. p23
Banker, Manish p34, p65
Barad, David p24
Bardin, C. Wayne p33, p40
Barnhart, Kurt T. p12, p24, p36
Barratt, Christopher L. p48
Barrett, C. Brent p12, p33
Barrett-Connor, Elizabeth p35, p43
Barritt, Jason p12, p24
Barton, S. E. p17, p19
Bates, G. Wright p12
Battaglia, David p12
Bedaiway, M. A. p23, p24
Bedient, C. p20
Begfun, Mosammat Rashida p12
Behr, Barry p24
Benadiva, Claudio p12, p22, p24
Benjamin, L. E. p22
Benoff, Susan p12, p24
Berger, Joshua J. p16
Berges, Trevor Tejada p33, p40
Bergh, Catherine M. p22, p32, p47
Bergh, Paul A. p32
Bernat, Katherine M. p38
Bernuci, M. P. p19
Bishop, Cecily p12
Bisignano, A. p21
Black, Lauri D. p12, p46
Bleil, M. E. p21
Blumenfeld, Zeer p12
Bocca, Silvina p12, p47
Boldt, Jeffrey P. p12, p77
Boone, William p24
Bornini, Andrea p12
Boswell, Hillary B. p12, p49
Boughton, Lee H. p12
Brackett, NancyL. p10, p12, p24, p46,
p62
Brannigan, Robert p24
Braverman, Andrea p24, p25
Breton, Sylvie p33
Briton-Jones, Christine p12
Bronson, Richard p12, p49
Bruner-Tran, Kaylon L. p12, p33, p39
Bukulmez, Orhan p12
Bulgarelli, D. L. p19
Bulun, Serdar E. p12, p15, p24
Buster, John p24, p25
Bustillo, Maria p12, p25
Butler, William J. p48
Butts, Samantha F. p12, p49
Buyuk, Erkan p12, p49
Campos, J. R. p17
Carrell, DouglasT. p24, p49
Carson, Sandra A. p24, p25, p35, p38,
p39, p43
Carvalho, L. p20
Casper, Robert F. p12, p24, p37
Castelbaum, Arthur p12
Castrillon, Diego p44
Cataldo, N. A. p22
Catenacci, M. p20, p22
Catherino, William H. p12, p24
Cedars, Marcelle I. p10, p24, p25, p36,
p44
Centola, Grace M. p12, p33, p38, p47,
p62
Chan, Peter p39, p42
Chang, Ching-chien p12
Chang, Jeremy p49, p56
Chang, R. Jeffrey p12, p25, p44
Chang, Tien-Cheng A. p12, p46
Chapman, Carli W. p58
Chavarro, Jeorge p12
Check, Jerome p24
Chen, Christopher p12
Chen, Zi-Jiang p39
Chian, Ri-Cheng p47
Cho, Y. J. p19
Christman, Gregory M. p12
Chung, J. T. p19
Chung, Karine p12, p36, p52
Clark, Amander p37
Coates, Alison p46
Cochran, Bonnie C. p47
Coddington, Charles p12, p24
Coetzee, K. p18
Cohen, Y. p22
Conaghan, Joep12, p48
Confino, Edmond p36
Conn, P. Michael p32, p33
Cooper, Amber R. p48, p75
Copperman, Alan B. p12, p22, p24, p35
Copperman, Kira B. p12, p38
163
Coskun, Serdar p12
Cotton, H. I. G. p22
Coulam, Carolyn p12
Coutifaris, Christos p10
Covington, Sharon p12, p25, p63
Cox, J. M. p19
Crockin, Susan L. p33, p35
Crowley, William F. p37, p38
Cwikel, J. p18
Czamanski-Cohen, J. p18
D'Hooghe, Thomas p24, p46
da Rocha, Andre Monteiro p12
Dafni, H. p22
dal Canto, Mariabeatrice p12
Damario, Mark p12
Damewood, Marian p25
Davis, Ann p10
Davis, Gina M. p12
Davis, Lynn p12
Davis, Owen p12, p25, p65
de jesus Parra, Guido p81
De Jonge, Chris p12
De Paolo, Louis V. p79
De Sutter, P. p18
DeCherney, Alan H. p12, p19, p24, p25
Desai, Nidhi p12, p47
Deutch, Todd p12
Devroey, Paul p37
Deweese, Marsha H. p38
Diamond, Michael P. p10, p24, p48
Diller, L. R. p17, p19
Dimitriadis, I. p18
Dlugi, Alexander p12
Dmowski, W. Paul p24
Dodson, William C. p49
Dokras, Anuja p24, p46
Domar, Alice D. p12, p47, p63
Donnez, Jacques G. p38
Drobnis, Erma Z. p34, p38, p46, p76
Dudley, Paul S. p36
Dudkiewicz, Alan p12
Duke, C. M. P. p20
Duleba, Antoni p12, p24, p36, p39, p69
Dumesic, Daniel p24
Duran, Eyup Haken p12
Dzieciatkowska, M. p18
Edelman, Alison p12
Egli, Dieter p37
Eguiguren, C. M. p19, p20
Ehrensaft, Dianep32
Eichenlaub-Ritter, Ursula p37
Eisenberg, Esther p25
Eisenberg, Michael p12
Ekart, J. p18
Elkind-Hirsch, Karen p12
Ellenbogen, Adrien p24
Ellington, Joanna p12
Emmi, Adelina M. p48
Engmann, L. p22
Erb, Teresa p12
Esfandiari, Navid p24
Estes, Christopher M. p33, p40
Esteves, Sandro p24
Ezzell, Windy p49
Fainaru, Ofer p12
Falcone, Tommaso p12, p20, p23, p24,
p32, p33, p34, p41
Falk, Richard p25
Fanchin, Renato p24
Farghaly, T. A. p18
Feingold, Madeline L. p32, p46
Feng, Huai L. p12
Feng, Bo p12
Fernandez, Emilio p12
Ferris, Jacqueline B. p47
Ferry, K. M. p18
Fields, Rita p12
Fino, Mary Elizabeth p16
Fischer, Jill p12, p21, p25, p53
Flyckt, R. p20, p22
Forman, E. J. p18
Fossum, Gregory T. p12, p32, p33, p35,
p36
Foyouzi, Nastaran p12
Fragouli, Elpida p12
Francis, Mary M. p12, p48
Frankferter, David p24
Frattarelli, John p12
Fritz, Marc A. p10, p25
Frydman, Rene p24
Fujimoto, Victor Y. p12, p24, p33, p47,
p59
Fuldeore, Mahesh p12
Gada, Dhiraj B. p34
Galst, Joann P. p24, p46
Gandhi, A. p20
Gangrad, Bhushan K. p12
Gaona-Arreloa, Ranferi p39
Garcia-Velasco, Juan p12, p24
Gardner, David p24
Gargiulo, Antonio R. p12, p23, p32, p41,
p49
Garner, Forest p12
Genc, Mehmet R. p12, p58
Genro, Vanessa Krebs p12
Gerrity, Marybeth p12, p48
Ghahremani, Manda p12
Gianaroli, Luca p55
Gibbons, William E. p10, p24, p25, p35
Gilbert, Bruce p12
Giles, Dobie p32, p34, p35, p36, p41
Gindoff, Paul p25
Ginsburg, Elizabeth S. p12, p17, p19,
p24, p38, p65
Giritharan, Gnanaratnam p12
Gitlin, Susan A. p12, p48, p75
Giudice, Linda C. p10, p24, p33
Glass, Karen B. p12, p71
Gleicher, Norbert p24
Go, Kathryn J. p12, p46, p55
Goldberg, Jeffrey M. p22, p34, p42
Goldenberg, E. p16
Goldfarb, James M. p12, p18, p24, p37
Goldstein, Lawrence S. B. p37
Goldstein, Marcp24, p34, p42, p47
Golombok, Susan E. p32
Gonzalez, Frankp12, p49
Gordon, Elaine R. p38
Gordon-Pinnell, Susan p35
Gosden, Roger p44
Gracia, Clarisa p12, p15, p24, p44, p46,
p52
Greenfeld, Dorothy p25
Griffin, Adam M. p12
Grifo, James p24, p25
Grow, Daniel R. p12
Gruber, Rita p32
Grunfeld, L. p22
Gunawardena, Shalini S. p72
Guo, X. C. p20
Gupta, Sajal p12
Gurtcheff, Shawn p12
Gutmann, Jacqueline p24
Guzick, David S. p38
Gvakharia, Marina p12
Halder, Sunil K. p48
Halvorson, Lisa p12
Hammond, Karen p12, p22, p24, p25
Handyside, Alan H. p34
Haney, Arthur p25
Hansen, K. C. p18
Harton, Gary L. p12
Har-Vardi, I. p18
Heard, Michael J. p12, p33
Henne, Melinda. B. p19, p32, p33, p35,
p36, p41
Hennebold, Jon p12
Henry, D. p23
Hershberger, Patricia p12
Hertweck, Paige p53
Hewitson, Laura p12
Hickman, Timothy N. p13, p73
Hill, David p24
Hill, George A. p25
Hill, Michah p13
Hinckley, Ramie p13
Hirshfeld-Cytron, Jennifer p13, p18
Hoeger, Kathleen p24
Hoffman, David p25
Holley, S. R. p21
Holzer, Hananel p13, p19
Hong, K. H. p18
Honig, Stanton p13
Horcajadas, J. A. p21
Horne, J. A. p19, p20
Horowitz, Judith E. p47
Hossain, Amjud p13
Houmard, Brenda p13
Howard, Fred M. p33, p42
Howards, Stuart S. p10, p25
Hsueh, Aaron p44
Huddleston, Heather p16
Hudgens, Jay L.
Hughes, Holly A. p49
Hughes, Mark p13, p24
Hurd, William p13, p25
Hurst, Bradley p13, p24
Huszar, J. M. p21
Hutton, J. D. p18
Hwang, Kathleen p16
Hyman, J. H. p19
Imudia, A. N. p18
Isaacson, Keith B. p24, p48
Israel, S. p18
Iva, Y. p23
164
Ivani, Kristen A. p13, p49
Iwata, K. p23
Jackson, Maria M. p46
Jaffe, Deb p12
Jain, Tarun p13
Janik, Grace M. p12, p13, p33, p34,
p41, p42
Jarvi, Keith p13
Jellerette-Nolan, Teru p13
Jelovsek, J. E. p20
Jenkins, L. C. p16
Jensen, Jeffrey T. p33, p40
Jindal, Sangita K. p10, p13, p34, p67
Johnson, Beth p13
Johnson, Julia V. p35, p43, p46
Johnson, Mark D. p46
Johnstone, Erica p13
Jordan, Amy p13, p53
Jorgez, C. J. p21
Jungheim, Emily S. p13, p46
Kagawa, N. p21
Kahne, Arik p12
Kaneshiro, Bliss p51
Kansal Kalra, Suleena p13, p47, p82
Kapfhamer, Joshua
Karabinus, David p13
Karsy, M. p17
Katz, P. P. p21
Katz-Jaffe, Mandy p18, p34
Kearns, William G. p24, p36
Keefe, David p24
Kempers, Roger p25
Kelk, Dawn A. p13
Ketterson, K. p21
Keye, William p25
Khachikyan, I. p20
Khera, Mohit p37
Kiessling, Ann p34
Kim, Edward D. p33, p34, p42
Kim, Helen p13, p19
Kim, S. Samuel p13, p34
Kingsburg, Sheryl p13, p24
Klein, Nancy p13, p80
Kogan, S. p17
Koh, Charles H. p33, p41, p61
Kolettis, Peter p13
Kovalevsky, George p24
Kovanci, Ertug p13
Kramer, Wendy p13
Krey, Lewis p24
Krieg, Sacha p13
Ku, Seung-Yup p13
Kuliev, Anver p13
Kuohung, Wendy p12
Kutteh, William p24
Kuwayama, M. p21
Kwak-Kim, Joanne Y. p13, p58
La Barbera, Andrew R. p10, p12
Lamb, Dolores J. p10, p12, p21, p25,
p32, p36
LaMothe, Sharon Lee p38
Lathi, Ruth p36
Latronico, Ana Claudia p36
Laughlin-Tommaso, Shannon K. p13
Lawson, M. S. p17
Layman, Lawrence C. p12, p39
Leader, Arthur p13
Ledy-Gurren, Nancy
Lee, D. R. p19
Lee, J. A. p22
Lee, Shelley S. p35
Legro, Richard S. p13, p24, p32, p36,
p40
Leppert, Phyllis C. p13, p39
Lessey, Bruce A. p13, p24, p70
Letterie, GerardS. p13, p47
Levens, Eric p13
Levitas, E. p18
Levy, Brynn p34
Levy, Carol A. p38
Levy, Gary p16
Levy, M. p19
Levy, Sherilyn p13
Li, F. p18
Li, Philip S. p12
Licciardi, Frederick p13, p24
Lieberman, Juergen p13
Lim, J. J. p19
Lin, Paul p13
Lindheim, Steven R. p12, p13
Lipshultz, Larry I. p21, p25, p49
Liu, H. C. p21
Liu, James p25
Lobo, Roger A. p10, p24, p25, p36, p39,
p43
Loeb, A. p18
Lucidi, Richard p13
Luzzo, Kerri p13
Lynch, Courtney p13
Lynch, K. A. p22
Magli, Cristina
Magarelli, Paul p13
Maguire, M. p19
Mainagi, Monica A. p57
Malhotra, Narendra p34
Malter, Henry p13
Mansour, Ragga T. p51
Marconi, Guillermo L. p25, p71
Marconi, M. p18
Marmar, Joel p24
Maroulis, George p13, p25
Marsh, Erica E. p39, p47, p71
Mashburn, Pablo p24
Matsuzaki, Sachiko p13, p24
Matt, Dennis W. p13, p48, p56
Matthews, Michelle L. p13, p48
Mayer, Jacob F. p13, p33, p77
McCarthy, Jennifer p13
McClaren, Janet p13
McClamrock, Howard p25
McClure, R. Dale p25
McReynolds, S. p18
McNamee, Philip p25
McNatty, K. P. p18
Mecerod, Deborah p32
Meintjes, Marius p12
Mendell, Patricia A. p38
Merhi, Zaher p13
Mersereau, Jennifer p13
Mettler, Liselotte p61
Mickey, L. G. p22
Milad, Magdy p24
Miller, Charles E. p32, p33, p35, p36,
p41, p49
Mio, Y. p23
Missmer, S. p17
Mitalipov, Shoukhrat p13
Moghissi, Kamran p25
Moley, Kelle p16
Molinaro, Thomas p13
Monk, Catherine p35
Moran, Carlos p39
Morimoto, Yoshiharu p24, p67
Morshedi, Mahmood p13
Muasher, Suheil J. p24, p25, p37
Mu, F. p17
Mukamal, K. p17
Mullin, Christine M. p16
Munne, Santiago p13, p24, p48
Murabito, Joanne p44
Nachtigall, R. D. p21
Nagy, Z. Peter p13, p24, p37, p46, p82
Nakajima, Steve p13
Nangia, Ajay K. p13, p37, p38
Najita, j. p17, p19
Nardo, Luciano G. p48
Nasr, Ahmed p13
Nayarit, B. B. p16
Neal-Perry, Genevieve S. p13, p35, p43
Neeman, M. p22
Neri, Queenie p24
Nezhat, Camran R. p32, p34, p35, p36,
p41
Nezhat, Ceana H. p32, p33, p35, p36,
p41, p48
Ng, Ernest H. p48
Ni, Daoshing p46
Ni, L. p21
Nichols, John, Jr. p13
Nothnic, Warren p13
Noyes, Nicole p13, p36, p38
Ntrivalas, Evangelos p13
Nulsen, John C. p13, p22, p73
Nutter, B. p20
O'Brien, Jeanne p13
Oates, Robert D. p10, p12, p37
Oehninger, Sergio C. p13, p24, p37,
p38, p74
Ohl, Dana A. p12
Oktay, Kutluk p13, p17, p18, p24, p44
Olive, David L. p12
Oliveira, Joao Batista Alcantara p12
Olivennes, Francois p24
Omurtag, Kenan R. p47, p50
Orwig, Kyle E. p48
Ory, Steven p25
Osheroff, J. E. p19, p20
Osteen, Kevin G. p24, p33, p64
Ozkaya, E. p18
Paduch, Darius A. p47, p54
Pal, Lubna p13, p24, p35, p36, p43, p50
Palatnik, Anna
Palermo, Gianpiero D. p13, p33, p34,
p37
Palter, Steven F. p12, p32, p34, p41, p42
165
Pastuszak, A. W. p21
Park, John p13
Parihar, Mandakini p34
Pascale, Claudia p12
Pasch, L. A. p21
Pasquale, Patrizio p13
Patel, Sejal P. p32, p34, p35, p36, p41
Patrizio, Pasquale p47, p66, p78
Pauli, Samuel A. p13
Paulson, Richard J. p24, p25, p38, p39
Pavone, Mary Ellen p13
Payne, C. J. p21
Pellicer, Antoniop13, p24, p49
Peluffo, Marina p13
Pennings, Guidop37
Penzias, Alan p13
Pepin, L. p22
Perez-Pena, Efrain p39
Petok, William D. p24, p37, p49
Petrozza, J. C. p18
Pfaus, James G. p35
Pfeifer, Samantha M. p49, p54
Phelps, John Y. p34
Picker, James p13
Picton, Helen M. p37
Pinborg, Anjay p13
Pisarska, Margareta D. p13, p16, p60
Pitangui, C. P. p19
Pitman, J. L. p18
Polan, Mary Lake p25
Polotsky, Alex J. p13, p51, p64
Portmann, Marc P. p12, p24
Prien, Samuel p24
Propst, Anthony p13
Purcell, Scott p13
Puscheck, Elizabeth E. p13, p24, p46
Qiao, Jie p39
Rackow, Beth W. p38
Racowsky, Catherine p10, p13, p24,
p25, p73
Rajkovic, Aleks p44
Rao, Mahendra S. p33
Rasnic, Raegen N. p49
Ratts, Valerie p13
Raz, T. p22
Rebar, Robert W. p10, p12
Reh, Andrea p16
Reindollar, Richard p10, p24, p39
Remohi, Jose p24
Rescildo, M. p22
Reshef, Eli p15
Reynolds, Kasey p16
Rhoton, Alice p13
Rich-Edwards, J. p17
Richard-Davis, Gloria p13, p38, p79
Richards, Jon p13
Richter, K. S. p19, p20
Rimm, E. p17
Rinauldo, Paolo p13
Rizk, Botros B. p24, p25, p37
Robins, Jared C. p13, p68
Robinson, Randal p13
Rodriguez, Jeanette p13
Rosen, Greg p13
Rosen, Mitchell P. p13, p71
Rosenberg, A. Z. p20
Rosenbluth, E. M. p20
Rosenquist, Sara E. p49
Rosenwaks, Zev p21, p24, p34
Ross, L. A. p16
Ryan, Ginny L. p48
Sa Rosa-e-Silva, A. C. p19
Saed, Ghassan p24
Sakkas, Denny p13, p24, p74
Salcedo, Jennifer p40, p46
Sammel, Mary p24
Sandlow, Jay p24
Sanfillippo, Joseph p25
Santoro, Nanette F. p13, p24, p25, p36,
p43
Sarid, O. p18
Sauer, Mark p24
Sbracia, M. p20
Scarpellini, F. p20
Schattman, Glenn L. p10, p13, p24, p81
Schatten, Gerald p13, p55
Schenken, Robert p24, p25
Schlaff, William p25
Schlegel, Peter N. p24, p25, p39, p42,
p47
Schnorr, John A. p47
Schoolcraft, William p24
Schust, Danny p13, p24
Scoccia, Humberto p13
Scott, Jr., Richard T. p18, p24
Segars, James p13, p20, p24
Seifer, David B. p13
Senturk, Levent M. p13
Serafini, Paulo p13, p25
Serna, Tania Basu p40, p46
Session, Donna p13
Seungdamrong, Aimee p62
Shalom-Paz, E. p19
Shapiro, Daniel B. p13
Sharara, Fady p25
Sharma, Rakesh p25
Sharpe-Timms, Kathy L. p13, p46
Shehab, D. p21
Shelton, D. N. p20
Shen, Shehua p25
Shepperson-Mills, Dian p47
Sher, Geoffrey p25
Shu, Yimin p25
Shuman, Lisa p49
Shwayder, James M.
Sigman, Mark p10, p25, p32
Silber, D. Z. p21
Silber, S. J. p21
Silva-de-Sa, M. F. p19
Silverberg, Kaylen M. p13
Simon, Carlos p13, p25, p66
Simon, Judy p13
Sites, Cynthia p22, p25
Skaznik-Wikiel, Malgorzata p13, p16
Smith, Gary D. p13, p25
Smith, Samuel p25
Smith, Steven J. p36
Smotrich, David B. p35
Snow-Lisy, D. C. p16
Soares, Claudio N. p35, p43
Song, S. H. p19
Sokal-Arnon, T. p19
Sokol, Rebecca Z. p13, p25, p34, p37
Soto, E. p20, p22
Soubra, Samer p13
Soules, Michael p25
Souter, I. p18
Spandorfer, Steven D. p13, p25
Sparks, Amy E. p13, p20, p25, p38, p82
Speck-Zulak, Andrea J. p32
Srinivasan, Vyjayanthi p13
Srouji, Serene p13, p23, p32, p33, p35,
p36, p41
St. Marie, P. p22
Stachecki, James J. p48
Stadtmauer, Laurel p13, p25, p38, p61
Stanick-Kostic, Aleksander p13
Stegmann, Barbara J. p13, p46, p78
Stein, Andrea p13
Steinbock, Bonnie p37
Steiner, Ann p13, p44, p68
Steinkamp, Michael p13
Steinkampf, M. P. p22
Stephenson, Mary D. p36
Stern, Judy E. p13, p16, p46, p82
Stevenson, E. L. p22
Stewart, Elizabeth A. p36
Stouffer, Richard p44
Stovall, Dale p25
Stratton, Pamela p13, p38, p70
Strickland, Robert R. p35
Strickler, Ronald p25
Stubbs, Rodrique E. p13
Su, H. Irene p13, p46, p75
Sueldo, Carlos p13, p25, p37
Surrey, Eric S. p13, p25, p54
Sweet, Craig R. p47
Takefman, Janet p13
Takeuchi, Takumi p13, p25
Tan, Seang Lin p46
Tang, Y. p21
Tapanainen, Juha S. p57
Tao, Tao p13
Tao, X. p18
Tarlatzis, Basil p25
Tatpati, Laura p13
Taylor, Hugh S. p13, p36, p43
Taylor, Maida p13
Taylor, Tyl p13
Telfer, Evelyn E. p34
Thomas, Michael p13, p25, p64
Thyer, Angela p13
Tilly, Jonathan p44
Timms, Kathy L. p77
Ting, A. Y. p17
Tobias, Tamara M. p49
Toner, James p13
Toth, Thomas L. p12
Tran, Nam p13, p16
Travia, Jr., Joseph J. p35, p48
Treff, Nathan R. p13, p18, p34, p49, p60
Trounson, Alan O. p34, p39
Trussell, J. C. p13
Tulandi, Togas p12
Turek, Paul J. p12, p25, p33, p39, p47
166
Tur-Kaspa, Ilan p25, p36, p38, p61
Turner, Thomas G. p12, p13, p75
Tycko, Benjaminp35
Uhler, Meike L. p13
Urman, Bulent p25
Usadi, Rebecca S. p49
van Mellow, N. M. p21
Van Voorhis, Bradley J. p10, p13, p20,
p25, p37
Vance, Amy C. p13, p47
Veiga, Anna M. p37, p55
Venier, Bill p13
Vercellini, Paolo p38, p46
Verkauf, Barry p25
Vernon, Michael W. p38, p82
Vireque, A. A. p19
Vorzimer, Andrew W. p38
Wallace, Kedra p13, p16
Walsh, K. p22
Wang, W. p21
Weiss, Douglas M. p38
Wellons, Melissa F. p13, p35, p43, p49,
p62
Wells, Dagan p13, p35
Wells, L. M. p20
Werlin, Lawrence p25
West, Elizabeth B. p25
Westphal, Lynn p25, p32
Whitehouse, M. p22
Wiczyk, H. p22
Widra, Eric p13, p19, p20, p25, p67
Wilkins-Haug, Louise p38
Williams, Daniel H. p46
Williams, R. Stan p25
Wilshire, Gilbert B. p13, p39
Willson, Cynthia p13, p72
Wilson, Erik B. p33
Wininger, David p69
Winter, J. A. p18
Wiser, A. p19
Witz, Craig p25
Wolin-Riklin, Carol p33
Woodard, Terri L. p48
Worrilow, Kathryn C. p13, p25, p46, p58
Wright, Diane p13
Wyckoff, K. A. p22
Yee, Bill p13, p25, p69
Yeoman, R. R. p17
Ying, Ying p13
Yoon, T. K. p19
Young, Steven L. p13, p48, p77
Younis, Abdelmoneim p13
Yumoto, K. p23
Zamah, Alberuni p16
Zamah, Musa p13
Zaninovic, Nikica p13, p79
Zarutskie, Paul p13
Zeadna, A. p18
Zegers-Hochschild, Fernando p65
Zelinski, M. B. p17
Zhao, Yulian p13
Zhou, Canquan p39
Zini, Armand p34, p38, p42
We would like to thank all of our
Premier Supporters of the
2012 ASRM Annual Meeting:
Ruby Level
Ferring Pharmaceuticals, Inc.
Merck
Pfizer, Inc.
Teva Women’s Health
Platinum Level
EMD Serono, Inc.
Gold Level
Origio
Watson Pharmaceuticals, Inc.
Silver Level
Unisense FertiliTech
Walgreens Specialty Pharmacy
Bronze Level
Genesis Genetics Institute
Sage In Vitro Fertilization
2012 ASRM Corporate Member Council
Abbott Laboratories
Auxogyn, Inc.
Bayer Healthcare Pharmaceuticals
Cook Medical
Elsevier, Inc.
EMD Serono, Inc.
Ferring Pharmaceuticals, Inc.
Freedom Pharmacy
Good Start Genetics
Novo Nordisk
Pfizer, Inc.
Teva Women’s Health
Unisense Fertilitech, A/S
Upsher-Smith Laboratories
Walgreens
Watson Pharma, Inc.
167
25th Annual
ASRM RESIDENT REPORTER PROGRAM
The ASRM Resident Reporter Program
allows OB/GYN residents to attend the
ASRM Annual Meeting
and participate in postgraduate courses,
special programs, speaker sessions, symposia
and other scientific sessions of interest.
Supported by:
Merck • Pfizer, Inc. • Teva Women’s Health
ASRM Membership Pays for Itself!
With the savings and benefits ASRM members receive, it’s only a matter of time
before your membership pays for itself. Member discounts on meetings, subscriptions,
and continuing education credits can add up to more than $1,000 a year.
Free print and online subscriptions to Fertility and Sterility
Member discount on ASRM eLearn™
Member discount on ASRM Annual Meeting Scientific Program
Member discount on ASRM Annual Meeting Postgraduate Courses
Member discount rate for posting positions on the ASRM Career Center
Total Value
Up to $607
Up to $200
Up to $275
Up to $80 per course
Up to $113 per posting
More than $1,000 annually
Membership also offers savings on patient forms and booklets, ASRM-branded keepsakes, and
much more. Given all this value, ASRM membership is an easy financial decision to make.
Join online at www.asrm.org.
168
Make plans to join IFFS and ASRM
October 12 - 17, 2013 in Boston, MA!
169
START PLANNING
170
Benchtop Incubator Labo C-Top
Quality - Made in Germany
• Two independent and separate incubation chambers
• Optimized temperature distribution by double heated
chamber from top and bottom
• Optimized gassing with premixed gas
• Reliable humidity system
• Convenient glass control panel
• Very fast heating up and recovery times
• Space saving
www.labotect.com
[email protected]
+49 551 / 50 50 125
Natera Introduces Next Generation
Non-Invasive Prenatal Testing
Natera can detect more chromosomal abnormalities than
other non-invasive tests
•
NIPTfromNateraprovidestwicethediseasedetectionandistheonlytestto
detectXandYchromosomeabnormalities
•
Natera’sParentalSupportistheonlytechnologywithconsistentlyhighdetection
accuracyacrossallfivechromosomes[>99%]:13,18,21,X,andY.
Natera also offers the following:
•Noninvasive Prenatal Paternity Testing
•Products of Conception (POC) Molecular Karyotype
Contact Mollie Larson at [email protected] to learn
more or to have kits sent directly to your office.
Visit us at the ASRM Annual Meeting, bOOTh 143
www.natera.com
1-877-476-4743
171
•Preimplantation Genetic Diagnosis (PGD)
•Natera One™ Multi-Disease Carrier Screening
Clinical excellence dedicated to
women’s health and the field of
reproductive medicine
With over four decades of innovation, Quest Diagnostics
test menu of over 3,500 tests is one of the most
comprehensive in the industry today, including:
•
•
•
•
•
Prenatal genetics
Coagulation
Reproductive Endocrinology
Infectious Disease
FDA-Registered For Donor Testing (HCT/P)
Quest Diagnostics is driven to discover and deliver
diagnostic insight and innovations that help improve the
health of women and their loved ones.
1-866-MYQUEST (1-866-697-8378)
www.QuestDiagnostics.com/WomensHealth
Visit our booth #114
QuestDiagnostics.com
Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered
trademarks are the property of Quest Diagnostics. All third party marks – ® and ™ – are the property of their
respective owners. © 2012 Quest Diagnostics Incorporated. All rights reserved. XXXXXX 04/2012
172
#1
t h
si ot
Vi Bo
at
us
31
3
Vivere partners with reproductive endocrinologists
to create Fertility Centers of Excellence
by providing capital for an Ambulatory
Surgery Center (ASC), ART laboratory, and
other ancillary services. We help our partners:
Maintain the hiGhest
QUaLitY OUtCOMes
Create sUstainaBLe
Center GrOWth
MiniMize
adMinistrative BUrden
www.viverehealth.com | 615-550-4900
Booth# 1144
Vivere_HalfPgASRM_4c12.indd 1
Come to our booth and experience
the smooth responce of our new
IM-11-2A Pneumatic Microinjector
Simply set the pipette and it is ready to use!
Superior performance. Comparable to an oil injector.
Perfectly controlled air pressure. Large and small movement controls.
User friendly. No more time-consuming preparation such as adjusting
oil level or checking for air bubbles.
Easy maintenance. Tool free tubing replacement.
Just push in and out.
CAUTION: Federal law restricts this device to sale by or on the
order of a physician or practitioner licensed by the law of the
State in which he practices to use or order the use of the device.
Don’t forget to ask us about our special promotional discount!
For full description of our product line, please visit our web site.
http://usa.narishige-group.com
173
8/24/12 3:47 PM
What differentiates SAGE
from other IVF Media?
™
Quinn’s Advantage !
®
Have Confidence When Using SAGE Media™
– Quality and Consistency at its Best!
“My Quinn’s line is designed to provide consistent results during every stage of fertilization and embryo development.
Particularly, the Quinn’s Advantage Sequential Culture Media line, which was the first clinically proven sequential media
system designed to optimize the in vitro environment for improved fertilization rates.”
Patrick Quinn, PhD, HCLD
Vice President of Research and Development
SAGE In Vitro Fertilization
Stop by our Booth #419 today to learn more about Quinn’s Advantage and
our new atomic fingerprinting technologies for optimal product purity and
lot-to-lot consistency!
To find out how SAGE In Vitro Fertilization can benefit your practice and your patients,
call 800.243.2974 or visit www.coopersurgical.com
®
In Vitro Fertilization
A CooperSurgical Company
82196 Rev. 08/12
REQUESTS THE PLEASURE OF YOUR COMPANY AT A SCIENTIFIC SESSION, DINNER & RECEPTION
BIOENERGETICS & EGG QUALITY:
EMERGING CONCEPTS
MODERATED BY
ALAN H. DECHERNEY, MD
TUESDAY, OCTOBER 23, 2012 • 7:30 PM – 10:00 PM
University Club ATOP Symphony Towers
34TH FLOOR PENTHOUSE • 750 B ST. • SAN DIEGO, CALIFORNIA
AGENDA
7:15 PM
7:45 PM
DINNER SEATING
WELCOME & INTRODUCTION
SCOTT CHAPPEL, PHD
CHIEF SCIENTIFIC OFFICER, OVASCIENCE
8:00 PM
SM
BIOENERGETICS: REVISITING CYTOPLASMIC TRANSFER
JACQUES COHEN, PHD, HCLD
FOUNDER AND DIRECTOR, TYHO-GALILEO RESEARCH LABORATORIES
SCIENTIFIC DIRECTOR, REPROGENETICS, LLC
PRESIDENT, ART INSTITUTE OF WASHINGTON
WALTER REED NATIONAL MILITARY MEDICAL CENTER
8:20 PM
MITOCHONDRIA & THE ROLE OF EGG QUALITY
KELLE H. MOLEY, MD
JAMES P. CRANE PROFESSOR OF OBSTETRICS & GYNECOLOGY
DIRECTOR, DIVISION OF BASIC SCIENCE RESEARCH
DEPARTMENT OF OBSTETRICS AND GYNECOLOGY
WASHINGTON UNIVERSITY IN ST. LOUIS
8:40 PM
EGG PCS & NEW TREATMENT OPTIONS
JONATHAN L. TILLY, PHD
DIRECTOR, VINCENT CENTER FOR REPRODUCTIVE BIOLOGY
CHIEF, RESEARCH FOR MGH VINCENT DEPT. OF OBSTETRICS & GYNECOLOGY
PROFESSOR, DEPT. OF OBSTETRICS, GYNECOLOGY & REPRODUCTIVE BIOLOGY
HARVARD MEDICAL SCHOOL
FACULTY, HARVARD STEM CELL INSTITUTE
9:00 PM
DISCUSSION OF EMERGING CONCEPTS
MODERATED BY ALAN H. DECHERNEY, MD
HEAD OF THE REPRODUCTIVE BIOLOGY AND MEDICINE BRANCH
EUNICE KENNEDY SHRIVER INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
NATIONAL INSTITUTES OF HEALTH
9:20 PM
10:00 PM
DESSERT & CORDIALS RECEPTION
BUSES DEPART UNIVERSITY CLUB
RETURNING TO MARRIOTT MARQUIS WATERFALL
KINDLY REGISTER ONLINE TO ATTEND WWW.123ENROLL.COM/OVASCIENCE
VISIT US AT
WWW.OVASCIENCE.COM
BUSES DEPART MARRIOTT MARQUIS WATERFALL AT 7:00 PM
175
333 WEST HARBOR DRIVE
BUSINESS ATTIRE SUGGESTED
Argentina
Brasil
Jordan
Taiwan
United Kingdom
United States
The Leaders in PGD
Preimplantation Genetics Diagnosis
More than Two Decades of Experience in Single Gene Testing
Genesis • 24™
24 Chromosomes Tested in 24 Hours with Microarray CGH Chips
Visit us in Booth 413
Building Healthy Families
www.genesisgenetics.org
176
177
15 Reasons
to Join ASRM Today
T
housands of doctors, nurses, and other professionals in the field of
reproductive medicine are enjoying the benefits of ASRM membership.
If you want to advance your career with the latest news, continuing
education, discounts, and networking opportunities, here are some of the
reasons you should join:
News and Education
•
•
•
Access to cutting-edge research in the
Society’s peer-reviewed journals, Fertility
and Sterility and the Journal of Assisted
Reproduction and Genetics
Electronic bulletins from our Washington
D.C. office that help you stay up to date on
the latest reproductive health policy news
Access to printable Practice Guidelines and
Ethics Statements
Professional Development
and Recognition
•
•
•
•
Opportunities for continuing medical
education in-person and online
Input into shaping policies and protocols
through Affiliated Societies, Special Interest
Groups, and Professional Groups
Networking opportunities including online
listservs and small group meetings
Eligibility to receive ASRM research grants
and awards
Specials and Discounts
•
•
•
Savings of at least $200 at the ASRM
Annual Meeting
Discounts on CME, CE, and PEER credits
through ASRM eLearn™
Promotional rates on products and services
for ASRM members only
Online Resources
for Members Only
•
•
•
•
•
A one-stop ASRM member profile to
help you track meetings, activities, learning,
and financial transactions
Full access to the ASRM Membership
Directory
Access to ASRM’s Career Center to help you
find qualified job candidates while enjoying
member discounts on job postings—or to
help you find that perfect job!
Full text access to ASRM journals and
newsletters online
Answers to CPT coding questions at the
Coding Corner
Join ASRM today!
•
•
•
•
Visit us online at www.asrm.org.
Phone us at + 1-205-978-5000.
Email us at [email protected].
Or visit us at the ASRM booth during our Annual Meeting or
at other selected meetings throughout the year.
ORIGIO Breakfast Symposium
Wednesday October 27, 7:15-8:45 AM,
San Diego Convention Center, Ballroom 20D
Join us for a morning
symposium on
Wednesday!
No charge, No
registration required,
Continental breakfast
included!
This is a non-CME activity
Cytokines in human reproduction:
Using GM-CSF in IVF media
- preclinical and clinical data
Speakers:
Prof. Sarah A. Robertson, University of Adelaide, Australia
Dr. Søren Ziebe, Copenhagen Fertility Clinic, Denmark
EmbryoGen
®
The first IVF medium
with rhGM-CSF cytokine
•
•
•
A new and different IVF medium
Supports the natural
mother-embryo communication
Improves the prospects for some
of the most challenged patients
510K pending
For more information visit the ORIGIO Booth #701 or call 1-800-648-1151
Booths
627 & 633
Re.Imagine
ways to meet your
patients’ needs
What is your inspiration?
Come by booths 627 and 633 to see changes inspired by you
and your patients.
EMD Serono, Inc. is
a subsidiary of Merck KGaA,
Darmstadt, Germany
©2012 EMD Serono, Inc. 120711-112220
180

Final Program

Transcription

Similar documents